type,name,median_tau_score,description,ts_pc,belongs_to,id,pc,target
CP,cetraxate,96.74,"gastrin inhibitor, mucus protecting agent","1.48, 0.39",,BRD-K48932581,"62.50, 50.00",GAST
CP,equol,94.89,estrogen receptor agonist,"0.52, 0.39",,BRD-A74907996,"44.44, 33.33","ESR2, ESR1"
CP,methapyrilene,94.87,histamine receptor antagonist,"1.35, 0.44",HRH1 antagonist,BRD-K47323024,"44.44, 22.22",
CP,ISOX,94.23,HDAC inhibitor,"1.81, 0.60",HDAC inhibitor,BRD-K69840642,"50.00, 30.00",HDAC6
CP,phensuximide,92.55,anticonvulsant,"0.60, 0.25",,BRD-A18043272,"44.44, 33.33",
CP,BMS-754807,92.43,insulin growth factor receptor inhibitor,"2.85, 0.90",IGF-1 inhibitor,BRD-K13049116,"30.00, 10.00","IGF1R, AKT1"
CP,SU-6656,92.29,src inhibitor,"1.23, 0.32",,BRD-K97354755,"20.00, 20.00","LYN, AURKB, AURKC, BRSK2, CALM1, CAMK2D, LCK, RET, SRC, YES1"
CP,KU-0063794,92,mTOR inhibitor,"2.21, 0.76",MTOR inhibitor,BRD-K67566344,"50.00, 30.00",MTOR
CP,CV-1808,91.02,adenosine receptor agonist,"1.07, 0.36",Adenosine receptor agonist,BRD-A64933752,"44.44, 44.44","ADORA2A, ADORA2B"
CP,L-741742,90.85,dopamine receptor antagonist,"1.61, 0.43",,BRD-K13211965,"33.33, 22.22","DRD4, DRD3, SCN1A, SCN3A"
CP,vinorelbine,-91.76,"tubulin inhibitor, apoptosis stimulant, microtubule inhibitor, mitosis inhibitor, mitotic inhibitor, tubulin polymerisation inhibitor, vinca alkaloid","1.24, 0.56",Tubulin inhibitor,BRD-M30523314,"10.00, 10.00",TUBB
CP,prunetin,-92.86,breast cancer resistance protein inhibitor,"1.04, 0.31",,BRD-K57546357,"0.00, 0.00","ABCG2, ALDH2"
CP,"7,4'-dihydroxyflavone",-93.74,opioid receptor antagonist,"2.32, 0.66",,BRD-K50384076,"16.67, 16.67",CYP19A1
CP,ponalrestat,-93.86,"aldose reductase inhibitor, reductase inhibitor","1.34, 0.30",,BRD-K68332390,"0.00, 0.00",AKR1B1
CP,RO-3306,-95.88,CDK inhibitor,"1.35, 0.31",CDK inhibitor,BRD-K78373679,"0.00, 0.00",CDK1
CP,SN-38,-96.05,topoisomerase inhibitor,"3.27, 1.09",Topoisomerase inhibitor,BRD-A36630025,"0.00, 0.00",TOP1
CP,importazole,-97.38,importin-???????? transport receptor inhibitor,"1.51, 0.24",,BRD-A02481876,"0.00, 0.00",KPNB1
CP,nornicotine,-97.4,acetylcholine receptor agonist,"0.83, 0.20",,BRD-A24543851,"0.00, 0.00",
CP,mitomycin-c,-98.49,"DNA alkylating drug, DNA inhibitor, DNA synthesis inhibitor","1.81, 0.56",DNA synthesis inhibitor,BRD-A48237631,"0.00, 0.00",
CP,megestrol,-98.86,"progesterone receptor agonist, DNA inhibitor, HegG2 inhibitor","1.46, 0.42",Progesterone receptor agonist,BRD-A35989968,"0.00, 0.00",PGR
CP,piperacillin,90.8,cell wall synthesis inhibitor,"1.52, 0.67",,BRD-K86873305,"11.11, 11.11",
CP,n-formylmethionylalanine,90.3,macrophage activator,"1.38, 0.47",,BRD-A61470182,"11.11, 11.11",
CP,WYE-354,90.08,mTOR inhibitor,"1.44, 0.57",MTOR inhibitor,BRD-K77008974,"20.00, 20.00",MTOR
CP,CS-110266,89.87,dopamine receptor agonist,"3.87, 1.32",,BRD-K15519488,"20.00, 0.00",SLC6A3
CP,rutin,89.63,"aldose reductase inhibitor, antioxidant, capillary stabilizing agent, nitric oxide scavenger, prolyl 4-hydroxylase inhibitor","0.81, 0.10",,BRD-K20482099,"30.00, 10.00","AKR1C3, AKR1B1, F10"
CP,alisertib,89.62,"Aurora kinase inhibitor, mitotic inhibitor, protein kinase inhibitor","0.98, 0.51",Aurora kinase inhibitor,BRD-K75295174,"22.22, 22.22",AURKA
CP,ipsapirone,88.5,serotonin receptor agonist,"1.03, 0.32",,BRD-K90574421,"44.44, 33.33",HTR1A
CP,zacopride,88.05,"serotonin receptor antagonist, serotonin receptor agonist","0.26, 0.05",,BRD-A65615053,"22.22, 22.22","HTR3A, HTR4, HTR3B, HTR5A"
CP,varenicline,87.69,acetylcholine receptor partial agonist,"1.34, 0.34",,BRD-K18855837,"22.22, 22.22","CHRNA4, CHRNA3, CHRNA6, CHRNA7, CHRNB2"
CP,AT-9283,86,"Aurora kinase inhibitor, JAK inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, mitotic inhibitor, protein kinase inhibitor","0.88, 0.31",Aurora kinase inhibitor,BRD-K24576554,"33.33, 22.22","AURKA, AURKB, ABL1, BCR, FLT3, JAK2, JAK3, RPS6KA6, STK17A"
CP,HNHA,-89.57,HDAC inhibitor,"0.94, 0.40",,BRD-K76698671,"0.00, 0.00",HDAC1
CP,BRD-K06217810,-89.69,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor","1.18, 0.31",,BRD-K06217810,"0.00, 0.00","CLK1, CLK4, DYRK1A, DYRK1B"
CP,altanserin,-89.8,"serotonin receptor antagonist, collagen stimulant","0.55, 0.14",,BRD-K00610438,"10.00, 10.00","HTR2A, HTR2C"
CP,epoxycholesterol,-89.81,LXR agonist,"1.11, 0.42",,BRD-K61480498,"0.00, 0.00","NR1H2, NR1H3"
CP,metrizamide,-89.88,iodine contrast agent,"0.84, 0.24",,BRD-A45543382,"0.00, 0.00",
CP,damnacanthal,-90.56,src inhibitor,"1.81, 0.50",,BRD-K93325701,"0.00, 0.00",
CP,W-9,-90.88,calmodulin antagonist,"0.93, 0.22",Calmodulin antagonist,BRD-K68341547,"0.00, 0.00",CALM2
CP,naftopidil,-91.04,"adrenergic receptor antagonist, calcium channel antagonist","0.68, 0.25",,BRD-A01787639,"0.00, 0.00","ADRA1A, ADRA1D"
CP,BRD-K86682249,-91.3,tyrosine phosphatase inhibitor,"0.90, 0.23",,BRD-K86682249,"0.00, 0.00","PTPN1, PTPN11"
CP,neratinib,-91.44,"EGFR inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor","1.48, 0.31",EGFR inhibitor,BRD-K85606544,"0.00, 0.00","EGFR, ERBB2, ERBB4, KDR"
CP,tocainide,85.32,"sodium channel blocker, voltage-gated sodium channel blocker","0.43, 0.11",,BRD-A92670106,"11.11, 11.11",SCN5A
CP,salvinorin-a,85.06,opioid receptor agonist,"0.56, 0.23",,BRD-K19284129,"10.00, 10.00","OPRK1, OPRD1, OPRM1"
CP,montelukast,84.07,leukotriene receptor antagonist,"1.17, 0.31",,BRD-A31312900,"22.22, 11.11","CYSLTR1, ALOX5, CYP2C8"
CP,NNC-63-0532,83.92,opioid receptor agonist,"0.88, 0.19",,BRD-K36009368,"40.00, 10.00",OPRL1
CP,haloperidol,83.8,dopamine receptor antagonist,"1.23, 0.23",,BRD-K67783091,"30.00, 20.00","DRD2, DRD1, DRD3, HTR2A, CYP3A7, DRD4, DRD5, GRIN2B, HRH1, HTR1A, HTR1D, HTR2B, HTR7, KCNH1"
CP,ON-01910,83.58,"PLK inhibitor, cell cycle inhibitor, MCL1 inhibitor, protein kinase inhibitor","1.68, 0.69",,BRD-K35687265,"10.00, 10.00","CDK1, FLT1, FYN, MCL1, PDGFRA, PLK1, PLK2, SRC"
CP,avrainvillamide-analog-1,83.52,nucleophosmin inhibitor,"0.49, 0.40",Nucleophosmin inhibitor,BRD-K61691971,"33.33, 33.33",NPM1
CP,tozasertib,83.49,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor","0.77, 0.23",Aurora kinase inhibitor,BRD-K59369769,"20.00, 10.00","AURKA, AURKB, ABL1, AURKC, BCR, FLT3, JAK2, DDR2, LCK"
CP,piribedil,83.3,"dopamine receptor agonist, adrenergic receptor antagonist","0.93, 0.11",,BRD-K47936004,"11.11, 11.11","DRD2, DRD3, ADRA1A, ADRA2A, ADRA2C, DRD4, HTR1A, HTR2B"
CP,paxilline,83.02,"ABC transporter expression enhancer, high conductance calcium activated potassium blocker, LXR agonist","0.91, 0.25",Potassium channel blocker,BRD-K38251852,"0.00, 0.00","ABCA1, KCNMA1, NR1H3"
CP,orlistat,-87.94,"cholesterol inhibitor, diacylglycerol lipase inhibitor, fatty acid synthase inhibitor, gastric triacylglycerol lipase inhibitor, Hypolipemic pancreatic, gastric and carboxylester lipase inhibitor, lipase inhibitor, pancreatic lipase inhibitor","1.16, 0.32",,BRD-K63343048,"0.00, 0.00","PNLIP, DAGLA, FASN, LIPF, CNR1, DAGLB"
CP,YM-298198,-88.07,glutamate receptor antagonist,"0.99, 0.30",,BRD-K59650319,"0.00, 0.00",GRM1
CP,benzanthrone,-88.29,aromatic hydrocarbon derivate with fluorescent and luminescent properties,"1.09, 0.34",,BRD-K76872913,"0.00, 0.00",
CP,tretinoin,-88.29,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand","0.60, 0.19",,BRD-K71879491,"0.00, 0.00","RARG, RORB, ALDH1A1, ALDH1A2, GPRC5A, NR0B1, NR2C2, PPARD, RARA, RARB, RARRES1, RORC, RXRB, RXRG"
CP,BRD-K59222562,-88.56,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor","1.36, 0.33",,BRD-K59222562,"0.00, 0.00","CLK1, CLK4, DYRK1A, DYRK1B"
CP,saracatinib,-88.58,"src inhibitor, Abl kinase inhibitor","1.24, 0.47",SRC inhibitor,BRD-K19540840,"0.00, 0.00","SRC, ABL1, LCK, YES1"
CP,TCS-359,-88.74,FLT3 inhibitor,"1.22, 0.43",,BRD-K81376179,"0.00, 0.00",FLT3
CP,felbamate,-88.97,"carbonic anhydrase inhibitor, GABA receptor modulator, glutamate receptor blocker","0.57, 0.11",,BRD-K99107520,"0.00, 0.00","GRIN2A, GRIN2B, GRIN3A"
CP,oleanolic-acid,-89.08,antitumor agent,"2.12, 0.63",,BRD-A41112154,"0.00, 0.00",
CP,BRD-K39187410,-89.52,antiamyloidogenic agent,"0.81, 0.28",,BRD-K39187410,"0.00, 0.00",
CP,PP-30,82.88,RAF inhibitor,"1.25, 0.48",,BRD-K30677119,"10.00, 10.00",RAF1
CP,doxercalciferol,82.83,vitamin D receptor agonist,"1.52, 0.33",Vitamin D receptor agonist,BRD-K14550461,"11.11, 0.00",VDR
CP,entinostat,82.67,"HDAC inhibitor, cell cycle inhibitor","1.00, 0.38",HDAC inhibitor,BRD-K77908580,"10.00, 0.00","HDAC1, HDAC2, HDAC3, HDAC9"
CP,AM-404,82.47,"FAAH transport inhibitor, anandamide transport inhibitor, nucelar factor of activated T-cells inhibitor, TRPV agonist","0.82, 0.23",,BRD-K55462201,"0.00, 0.00","TRPV1, CNR1, CNR2, FAAH"
CP,apafant,82.38,platelet activating factor receptor antagonist,"1.13, 0.28",,BRD-K28115081,"0.00, 0.00",PTAFR
CP,latrunculin-b,82.28,"actin destabilizer, unidentified pharmacological activity","1.32, 0.42",,BRD-A19248578,"0.00, 0.00","ACTA1, MKL1, SPIRE2"
CP,geldanamycin,82.23,HSP inhibitor,"0.99, 0.30",HSP inhibitor,BRD-A19500257,"0.00, 0.00","HSP90AA1, HSP90AB1"
CP,nifurtimox,82,DNA inhibitor,"0.97, 0.34",,BRD-A00100033,"0.00, 0.00",
CP,R-59022,81.48,"diacylglycerol kinase inhibitor, protein kinase inhibitor","1.57, 0.51",,BRD-K54665485,"0.00, 0.00",DGKA
CP,dictamnine,81.36,furoquinoline alkaloid that causes smooth muscle contraction,"1.32, 0.44",,BRD-K29178788,"20.00, 20.00",
CP,piceatannol,-85.73,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor","0.63, 0.10",,BRD-K91509126,"0.00, 0.00","ATP5A1, ATP5B, ATP5C1, IRF3, PTGS2, SIRT1, SYK, TYR"
CP,testosterone,-86.24,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist","1.01, 0.38",,BRD-A79479878,"11.11, 11.11","AR, CYP19A1, CYP2C19, CYP2C8, CYP3A5"
CP,heraclenol,-86.29,furocoumarin compound with antiproliferative activity at G2/M phase,"1.02, 0.30",,BRD-A77050075,"0.00, 0.00",
CP,acepromazine,-86.68,dopamine receptor antagonist,"1.01, 0.24",Dopamine receptor antagonist,BRD-K37814297,"14.29, 0.00","ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A"
CP,hydrocortisone,-86.84,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist","1.44, 0.70",Glucocorticoid receptor agonist,BRD-A46186775,"11.11, 0.00","ANXA1, NOS2, NR3C1, NR3C2"
CP,budesonide,-87.18,"glucocorticoid receptor agonist, glucocordicoid receptor antagonist, immunosuppressant","1.40, 0.83",Glucocorticoid receptor agonist,BRD-A82238138,"0.00, 0.00","NR3C1, CYP3A5, CYP3A7"
CP,BRD-K06817181,-87.32,JAK inhibitor,"1.34, 0.46",,BRD-K06817181,"0.00, 0.00",JAK2
CP,bisindolylmaleimide,-87.46,"CDK inhibitor, PKC inhibitor, leucine rich repeat kinase inhibitor","1.35, 0.41",,BRD-K31342827,"0.00, 0.00","CCND1, CDK4, LRRK2, PDPK1, PIM1, PRKCA, PRKCB, PRKCI, PRKCZ"
CP,hydrocortisone,-87.68,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist","1.55, 0.57",Glucocorticoid receptor agonist,BRD-A07000685,"0.00, 0.00","ANXA1, NOS2, NR3C1, NR3C2"
CP,LY-2140023,-87.77,glutamate receptor agonist,"0.95, 0.25",,BRD-K49519144,"0.00, 0.00","GRM3, GRM2"
CP,apicidin,80.7,HDAC inhibitor,"1.56, 0.50",HDAC inhibitor,BRD-K64606589,"20.00, 10.00","HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
CP,diprotin-a,80.62,dipeptidyl peptidase inhibitor,"1.52, 0.38",,BRD-K69032158,"20.00, 20.00",DPP4
CP,pentobarbital,80.44,GABA receptor modulator,"1.23, 0.52",,BRD-A44448661,"0.00, 0.00","GABRA1, CHRNA4, CHRNA7, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B"
CP,dipivefrine,80.09,adrenergic receptor agonist,"0.67, 0.17",,BRD-A47494775,"11.11, 11.11","ADRA1A, ACHE, ADRA2A, ADRB2, BCHE"
CP,vindesine,79.15,"tubulin inhibitor, microtubule inhibitor, vinca alkaloid","1.41, 0.49",Tubulin inhibitor,BRD-K59753975,"25.00, 0.00","TUBB, TUBB1"
CP,MPEP,78.71,glutamate receptor antagonist,"1.56, 0.49",,BRD-K60690191,"16.67, 0.00","GRM5, GRM1, GRM4"
CP,indoprofen,78.48,"cyclooxygenase inhibitor, platelet aggregation inhibitor, prostanoid receptor inhibitor","0.86, 0.19",Cyclooxygenase inhibitor,BRD-A44090213,"11.11, 11.11","PTGS1, PTGS2, CXCR1, CXCR2"
CP,barasertib,78.47,"Aurora kinase inhibitor, mitotic inhibitor, protein kinase inhibitor","0.64, 0.41",Aurora kinase inhibitor,BRD-K63923597,"10.00, 10.00","AURKB, AURKC"
CP,wortmannin,78.27,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor","1.68, 0.48",,BRD-K87343924,"11.11, 0.00","PIK3CA, PIK3CG, PLK1, ATM, ATR, MTOR, PI4KA, PI4KB, PIK3CD, PIK3R1, PLK3, PRKDC"
CP,kawain,77.97,"calcium channel modulator, mTOR inhibitor, Sodium Channel  Blockers","1.07, 0.28",,BRD-K09497549,"22.22, 11.11",MTOR
CP,hydrocortisone,-84.53,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist","1.27, 0.64",Glucocorticoid receptor agonist,BRD-A25143711,"10.00, 10.00","ANXA1, NOS2, NR3C1, NR3C2"
CP,orciprenaline,-84.75,adrenergic receptor agonist,"1.14, 0.48",Beta-adrenergic receptor agonist,BRD-A07780951,"11.11, 0.00",ADRB2
CP,BRD-K06956503,-84.91,glucosylceramidase inhibitor,"1.31, 0.48",,BRD-K06956503,"0.00, 0.00",GBA
CP,fenretinide,-84.99,"apoptosis stimulant, retinoid receptor agonist, RAR agonist","0.78, 0.20",,BRD-K89085489,"10.00, 0.00","CYP2C8, CYP3A5, RARA, RARG"
CP,avrainvillamide-analog-3,-85.16,nucleophosmin inhibitor,"0.43, 0.32",Nucleophosmin inhibitor,BRD-K39569857,"11.11, 11.11",NPM1
CP,DMBI,-85.17,"platelet-derived growth factor receptor (PDGFR) inhibitor, tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor","0.66, 0.17",,BRD-K96084870,"20.00, 0.00",PDGFRB
CP,L-BSO,-85.18,¦Ã-glutamylcysteine synthetase inhibitor,"0.60, 0.16",,BRD-A47706533,"0.00, 0.00",GCLM
CP,ritonavir,-85.24,"HIV protease inhibitor, cytochrome P450 inhibitor","0.77, 0.18",HIV protease inhibitor,BRD-K51485625,"0.00, 0.00","CYP3A4, CYP1A2, CYP2B6, CYP2C19, CYP3A5, CYP3A7"
CP,loratadine,-85.44,histamine receptor antagonist,"1.14, 0.22",HRH1 antagonist,BRD-K82795137,"0.00, 0.00","HRH1, CYP2C19, CYP3A5"
CP,liothyronine,-85.68,thyroid hormone function stimulant,"0.84, 0.28",,BRD-K89152108,"0.00, 0.00","THRA, THRB"
CP,BRD-A80383043,77.95,"glutamate receptor agonist, glutamate receptor antagonist","2.20, 0.90",,BRD-A80383043,"16.67, 0.00","GRM1, GRM2"
CP,ellipticine,77.85,"topoisomerase inhibitor, DNA intercalating drug","1.99, 0.44",Topoisomerase inhibitor,BRD-K85985071,"10.00, 10.00","TOP2A, TOP2B"
CP,rifampicin,77.56,"DNA directed RNA polymerase inhibitor, enzyme inducer","0.55, 0.14",,BRD-K01507359,"10.00, 10.00","NR1I2, ABCB1, CYP2B6, CYP2C19, CYP2C8, CYP3A4, CYP3A5, SLCO1A2, SLCO1B1, SLCO1B3"
CP,dihydrodeoxygedunin,77.45,growth factor receptor activator,"1.14, 0.33",,BRD-A02713983,"11.11, 11.11",NTRK2
CP,panobinostat,77.26,"HDAC inhibitor, apoptosis stimulant, cell cycle inhibitor","1.89, 0.52",HDAC inhibitor,BRD-K02130563,"0.00, 0.00","HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, HDAC7, HDAC8, HDAC9"
CP,BX-912,77.23,"AKT inhibitor, phosphoinositide dependent kinase inhibitor, pyruvate dehydrogenase kinase inhibitor","0.92, 0.26",,BRD-K49669041,"0.00, 0.00","PDPK1, AKT2, CDK2, CHEK1, GSK3B, KDR, PDK1"
CP,GSK-1059615,77.15,"PI3K inhibitor, mTOR inhibitor","1.64, 0.68","MTOR inhibitor, PI3K inhibitor",BRD-K06750613,"0.00, 0.00","PIK3CA, PIK3CG"
CP,NVP-BEZ235,76.86,"mTOR inhibitor, PI3K inhibitor, protein kinase inhibitor","2.02, 0.53","MTOR inhibitor, PI3K inhibitor",BRD-K12184916,"20.00, 10.00","MTOR, PIK3CA, PIK3CG, PIK3CD, ATR, PIK3CB"
CP,RO-08-2750,76.65,"nerve growth factor receptor ligand, NGF binding inhibitor","1.11, 0.30",,BRD-K00486786,"10.00, 10.00","NGFR, NGF"
CP,caffeic-acid,76.49,"lipoxygenase inhibitor, HIV integrase inhibitor, NFkB pathway inhibitor, nitric oxide production inhibitor, PPAR receptor modulator, tumor necrosis factor production inhibitor","1.11, 0.36",,BRD-K09900591,"11.11, 0.00","ALOX5, MIF, RELA, TNF"
CP,1-phenylbiguanide,-82.15,serotonin receptor agonist,"1.35, 0.42",,BRD-K31491153,"0.00, 0.00","HTR3A, HTR3B"
CP,teniposide,-82.65,"topoisomerase inhibitor, DNA inhibitor, DNA repair enzyme inhibitor, mitotic inhibitor","2.61, 0.64",Topoisomerase inhibitor,BRD-A35588707,"0.00, 0.00","TOP2A, CYP3A5"
CP,CS-1657,-82.84,PARP inhibitor,"0.98, 0.32",,BRD-K50214219,"0.00, 0.00",PARP1
CP,biotin,-83.42,vitamin cofactor for many metabolic reactions,"1.50, 0.53",,BRD-K89210380,"0.00, 0.00","ACACA, ACACB, HLCS, MCCC1, MCCC2, PC, PCCA, PCCB, SLC5A6"
CP,purvalanol-b,-83.66,tyrosine kinase inhibitor,"1.24, 0.31",,BRD-K41564320,"11.11, 11.11","CDK2, CDK4, MAPK1, MAPK3, CDK5, SRPK2"
CP,SR-59230A,-83.69,adrenergic receptor antagonist,"0.66, 0.16",,BRD-K35430135,"10.00, 10.00","ADRB3, ADRB1, ADRB2"
CP,albendazole,-83.74,"tubulin inhibitor, acetylcholinesterase inhibitor, microtubule inhibitor","0.83, 0.44",Tubulin inhibitor,BRD-K79131256,"0.00, 0.00","CYP1A2, CYP2J2, TUBA1A, TUBB, TUBB4B"
CP,serdemetan,-84.13,"MDM inhibitor, angiogenesis stimulant, apoptosis stimulant, oncogene inhibitor","1.31, 0.38",,BRD-K60219430,"0.00, 0.00",MDM2
CP,irinotecan,-84.14,topoisomerase inhibitor,"1.91, 0.52",Topoisomerase inhibitor,BRD-K08547377,"0.00, 0.00","TOP1, CYP3A5, TOP1MT"
CP,baeomycesic-acid,-84.16,lipoxygenase inhibitor,"2.02, 0.40",,BRD-K40742111,"20.00, 20.00",
CP,cycloheximide,76.27,"glycogen synthase kinase inhibitor, protein synthesis inhibitor","2.40, 0.60",Protein synthesis inhibitor,BRD-A62184259,"10.00, 10.00","GSK3B, RPL3"
CP,cycloheximide,76.24,"glycogen synthase kinase inhibitor, protein synthesis inhibitor","2.15, 0.60",,BRD-K36055864,"0.00, 0.00","GSK3B, RPL3"
CP,H-9,76.23,"cAMP dependent protein kinase inhibitor, PKA inhibitor","0.55, 0.11",PKA inhibitor,BRD-K70577657,"30.00, 20.00",PRKACA
CP,ceramide,76.2,"nitric oxide production inhibitor, phosphoenolpyruvate carboxylase activator, serine/threonine protein phosphatase activator","1.00, 0.25",,BRD-K41707108,"11.11, 0.00",
CP,ketoprofen,76.16,cyclooxygenase inhibitor,"1.07, 0.39",,BRD-A97739905,"10.00, 10.00","PTGS2, PTGS1, CXCR1, SLC5A8"
CP,ENMD-2076,76.05,"Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, ephrin receptor inhibitor, FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor","1.09, 0.32",Aurora kinase inhibitor,BRD-K68488863,"11.11, 11.11","AURKA, FLT3, KDR, PDGFRA, SRC, CSF1R, EPHA1, FGFR1, FGFR2, FGFR3, FLT4, KIT, PTK2"
CP,nateglinide,76.03,"insulin secretagogue, ATP-sensitive potassium channel antagonist, meglitinide, sulphonylurea receptor activator","1.57, 0.31",,BRD-K44353683,"25.00, 12.50","ABCC8, KCNJ11, CYP3A4, INS, KCNJ10, PPARG"
CP,flunarizine,76.01,"calcium channel blocker, T-type calcium channel blocker","0.95, 0.27",,BRD-K12184470,"10.00, 10.00","CACNA1G, CACNA1H, CACNA1I, CALM1, CYP2J2, HRH1"
CP,o-3M3FBS,75.52,phospholipase activator,"0.64, 0.14",,BRD-K46384212,"10.00, 10.00",
CP,dacinostat,75.52,HDAC inhibitor,"1.48, 0.63",HDAC inhibitor,BRD-K56957086,"0.00, 0.00","HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
CP,warfarin,-79.68,"cytochrome P450 inhibitor, vitamin inhibitor, vitamin K epoxide reductase inhibitor","1.11, 0.39",,BRD-K25991148,"0.00, 0.00","VKORC1, CYP2C19, CYP2C8, CYP4F2"
CP,CDK1-5-inhibitor,-79.76,CDK inhibitor,"0.94, 0.28","CDK inhibitor, Glycogen synthase kinase inhibitor",BRD-K87932577,"0.00, 0.00","CDK1, CDK5, GSK3B"
CP,BRD-K65285700,-80.4,cannabinoid receptor agonist,"0.86, 0.26",Cannabinoid receptor agonist,BRD-K65285700,"0.00, 0.00",CNR2
CP,erbstatin-analog,-80.46,"EGFR inhibitor, tyrosine kinase inhibitor","1.30, 0.33",,BRD-K35573744,"0.00, 0.00",EGFR
CP,BRD-A16820783,-80.95,phosphodiesterase inhibitor,"1.20, 0.42",,BRD-A16820783,"0.00, 0.00",
CP,dexamethasone,-81.08,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant","1.30, 0.85",Glucocorticoid receptor agonist,BRD-A35108200,"0.00, 0.00","ANXA1, CYP3A4, CYP3A5, NOS2, NR0B1, NR3C1, NR3C2"
CP,tacrolimus,-81.43,"calcineurin inhibitor, FK506-binding protein inhibitor, immunosuppressant, insulin expression inhibitor, interleukin receptor antagonist, macrolide calcineurin inhibitor, rotamase inhibitor, T cell inhibitor","1.06, 0.14",,BRD-K65261396,"0.00, 0.00","FKBP1A, CYP3A5, CYP3A7"
CP,glycodeoxycholic-acid,-81.54,apoptosis activator,"0.91, 0.24",,BRD-A73859745,"22.22, 11.11",
CP,flucytosine,-81.74,"pyrimidine analog, inhibits fungal DNA synthesis","0.98, 0.39",,BRD-K82143716,"0.00, 0.00",DNMT1
CP,estradiol,-81.81,estrogen receptor agonist,"0.77, 0.14",,BRD-A23226398,"0.00, 0.00","ESR1, ESR2, NR1I2, CYP2B6, CYP2C19, CYP2C8, CYP2E1, CYP3A5, CYP3A7, GPER1, KCNMA1"
CP,HA-1004,75.46,calcium channel blocker,"0.84, 0.19",,BRD-K05434375,"20.00, 0.00",
CP,GTP-14564,75.45,"FLT3 inhibitor, tyrosine kinase receptor inhibitor","0.93, 0.17",,BRD-K16664969,"10.00, 0.00","FLT3, CSF1R, KIT, PDGFRB"
CP,scoulerine,74.94,"adrenergic receptor antagonist, GABA receptor antagonist, serotonin receptor antagonist","0.44, 0.09",,BRD-K62609077,"0.00, 0.00","ADRA1D, ADRA2A, GABRA1"
CP,RO-90-7501,74.9,"amyloid precursor protein inhibitor, beta amyloid aggregation inhibitor","1.18, 0.27",,BRD-K58299615,"22.22, 11.11",APP
CP,gamma-homolinolenic-acid,74.85,"cholesterol inhibitor, platelet aggregation inhibitor, prostaglandin G/H synthase 1, prostanoid receptor stimulant","1.63, 0.60",,BRD-K20152659,"11.11, 0.00","PTGS1, PTGS2"
CP,MRS-1334,74.83,adenosine receptor antagonist,"0.56, 0.14",,BRD-A06784547,"10.00, 10.00",
CP,olaparib,74.57,"PARP inhibitor, DNA repair enzyme inhibitor","0.59, 0.13",PARP inhibitor,BRD-K02113016,"30.00, 20.00","PARP1, PARP2, PARP3"
CP,vincristine,74.56,"tubulin inhibitor, microtubule inhibitor, microtubule polymerization inhibitor, tubulin polymerisation inhibitor, vinca alkaloid","1.67, 0.57",,BRD-A76528577,"30.00, 20.00","TUBB, TUBA4A"
CP,tubaic-acid,74.54,"mitochondrial complex I inhibitor, NADH-ubiquinone oxidoreductase (Complex I) inhibitor","1.72, 0.74",,BRD-K96362535,"0.00, 0.00",MT-ND1
CP,oxaprozin,74.43,cyclooxygenase inhibitor,"0.91, 0.16",,BRD-K25394294,"10.00, 0.00","PTGS1, PTGS2"
CP,L-2167,-78.15,PPAR receptor agonist,"1.02, 0.34",,BRD-K98372770,"0.00, 0.00",PPARD
CP,LY-2183240,-78.24,"FAAH inhibitor, FAAH reuptake inhibitor","1.76, 0.63",,BRD-K37865504,"0.00, 0.00",FAAH
CP,teicoplanin,-78.31,bacterial cell wall synthesis inhibitor,"1.33, 0.49",,BRD-U97083655,"10.00, 10.00",
CP,PD-184352,-78.51,"MEK inhibitor, MAP kinase inhibitor","1.43, 0.49",MEK inhibitor,BRD-K05104363,"0.00, 0.00","MAP2K1, MAP2K2, MAP3K1, MAP3K2"
CP,GR-144053,-78.83,integrin antagonist,"1.01, 0.33",,BRD-K12120659,"0.00, 0.00","ITGB3, ITGA2B"
CP,phenytoin,-78.93,sodium channel blocker,"1.84, 0.61",,BRD-K55930204,"0.00, 0.00","ABCB1, CYP2B6, CYP2C19, CYP3A4, SCN1A, SCN2A, SCN5A"
CP,nelfinavir,-79.04,"HIV protease inhibitor, proteasome inhibitor","1.32, 0.41",HIV protease inhibitor,BRD-K60460488,"10.00, 0.00","CYP2C19, CYP3A5, CYP3A7"
CP,xylazine,-79.13,adrenergic receptor agonist,"1.05, 0.38",,BRD-K21565985,"0.00, 0.00","ADRA2A, ADRA2B, ADRA2C"
CP,physostigmine,-79.39,"acetylcholinesterase inhibitor, cholinesterase inhibitor","0.83, 0.26",,BRD-A37052580,"0.00, 0.00","ACHE, BCHE"
CP,BRD-K34437622,-79.45,thymidylate synthase inhibitor,"1.73, 0.50",,BRD-K34437622,"0.00, 0.00",TYMS
CP,spiroxatrine,74.29,serotonin receptor antagonist,"1.03, 0.24",,BRD-A72483914,"33.33, 11.11","HTR1A, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR2B"
CP,vincamine,74.11,adrenergic receptor antagonist,"0.98, 0.38",,BRD-K40902647,"10.00, 10.00","CHRM1, CHRM2, CHRM3, CHRM4"
CP,cytochalasin-b,73.99,"microtubule inhibitor, phagocytosis inhibitor","2.51, 0.58",,BRD-K26664453,"10.00, 10.00",ACTB
CP,epothilone,73.75,"inhibition of microtubulefunction, microtubule stabilizing agent, microtubule stimulant, tubulin inhibitor","1.24, 0.32",Tubulin inhibitor,BRD-K48935217,"0.00, 0.00","TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B"
CP,vemurafenib,73.71,"RAF inhibitor, protein kinase inhibitor","1.58, 0.60",RAF inhibitor,BRD-K56343971,"10.00, 10.00","BRAF, CYP2C19, CYP3A4, CYP3A5, RAF1"
CP,nicotinamide,73.68,"oxidoreductase stimulant, protein synthesis stimulant","2.00, 0.57",,BRD-K28912512,"0.00, 0.00","PARP1, AOX1, BST1, CYP2E1, LDHA, SIRT5"
CP,nor-binaltorphimine,73.66,opioid receptor antagonist,"0.80, 0.19",,BRD-A11135865,"0.00, 0.00",
CP,cosmosiin,73.35,cytochrome P450 inhibitor,"1.77, 0.51",,BRD-K13642330,"0.00, 0.00",
CP,methocarbamol,73.24,muscle relaxant,"1.09, 0.24",,BRD-A31521121,"0.00, 0.00",CA1
CP,levcromakalim,73.06,"potassium channel activator, potassium channel agonist","0.81, 0.26",Potassium channel activator,BRD-K24526313,"10.00, 0.00","KCNJ8, ABCC9, KCNJ5"
CP,isoliquiritigenin,-77.32,"guanylate cyclase activator, aldose reductase inhibitor, glutamate receptor antagonist, histamine receptor antagonist, SIRT activator","1.63, 0.59",,BRD-K33583600,"0.00, 0.00","AKR1B1, HRH2, SIRT1"
CP,nicotine,-77.33,acetylcholine receptor agonist,"0.69, 0.14",,BRD-K05395900,"0.00, 0.00","CHRNA10, CHRNA9, AOX1, CHAT, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNB2, CHRNB3, CHRNB4, CYP19A1, CYP2B6, TBXAS1, TRPA1"
CP,razoxane,-77.34,"topoisomerase inhibitor, chelating agent","0.93, 0.33",,BRD-K07265709,"0.00, 0.00","TOP2A, TOP2B"
CP,vidarabine,-77.37,"adenylyl cyclase inhibitor, DNA directed DNA polymerase inhibitor, viral DNA synthesis inhibitor","0.84, 0.34",Ribonucleotide reductase inhibitor,BRD-K72093121,"0.00, 0.00",ADCY5
CP,catechin,-77.46,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker","1.22, 0.33",,BRD-A61899133,"0.00, 0.00","BACE1, CA1, CA12, CA14, CA2, CA4, CA6, CA9, FASN, PTGS1, SCN5A"
CP,terfenadine,-77.59,histamine receptor antagonist,"1.94, 0.60",,BRD-A06352418,"0.00, 0.00","HRH1, KCNH2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, KCNH1"
CP,BRD-K97274161,-77.66,"beta-catenin inhibitor, opioid receptor antagonist","1.31, 0.45",,BRD-K97274161,"0.00, 0.00",OPRK1
CP,etomoxir,-77.8,"carnitine palmitoyltransferase inhibitor, carnitine O-palmitoyltransferase inhibitor, fatty acid oxidation inhibitor","0.90, 0.38",,BRD-K77625572,"0.00, 0.00","CPT1A, CPT1B"
CP,skatole,-78,thrombin inhibitor,"0.92, 0.19",,BRD-K73824630,"0.00, 0.00",F2
CP,SDM25N,-78.11,opioid receptor antagonist,"0.41, 0.07",,BRD-A75769826,"0.00, 0.00",OPRD1
CP,vinblastine,72.97,"microtubule formation inhibitor, tubulin inhibitor, tubulin polymerisation inhibitor","1.43, 0.39",Tubulin inhibitor,BRD-A55594068,"0.00, 0.00","TUBB, JUN, TUBA1A, TUBD1, TUBE1, TUBG1"
CP,BRD-K14236372,72.79,lysophospholipid receptor agonist,"1.22, 0.28",,BRD-K14236372,"0.00, 0.00",S1PR4
CP,olopatadine,72.78,"histamine receptor antagonist, histamine blocker, mediator release inhibitor","1.86, 0.53",,BRD-K67637637,"0.00, 0.00","HRH1, S100A1, S100A12, S100A13, S100A2, S100B"
CP,imatinib,72.46,"PDGFR tyrosine kinase receptor inhibitor, Bcr-Abl kinase inhibitor, KIT inhibitor, Abl kinase inhibitor, apoptosis stimulant, breast cancer resistance protein inhibitor, colony stimulating factor receptor inhibitor","1.03, 0.19",,BRD-K92723993,"10.00, 10.00","ABL1, KIT, PDGFRA, BCR, CSF1R, PDGFRB, ABCG2, CYP2C19, CYP2C8, CYP3A5, DDR1, NTRK1, RET"
CP,PI-828,72.46,PI3K inhibitor,"1.73, 0.70",PI3K inhibitor,BRD-K97365803,"30.00, 10.00",
CP,etodolac,72.38,"cyclooxygenase inhibitor, TRPV agonist","2.77, 0.81",,BRD-A16998493,"0.00, 0.00","PTGS2, PTGS1, RXRA, TRPV1"
CP,WAY-213613,72.12,glutamate transporter inhibitor,"0.76, 0.27",,BRD-A20968261,"20.00, 0.00",SLC1A2
CP,Merck60,71.91,HDAC inhibitor,"0.11, 0.02",,BRD-K04466929,"40.00, 20.00","HDAC1, HDAC2"
CP,AZD-6482,71.88,PI3K inhibitor,"1.38, 0.60",PI3K inhibitor,BRD-K58772419,"0.00, 0.00","PIK3CD, PIK3CG, PIK3CA, PIK3CB"
CP,CDK2-5-inhibitor,71.76,inhibitor of CDK2/cyclin E and CDK5/p25,"1.09, 0.31",,BRD-K71860425,"20.00, 10.00","CDK2, CDK5"
CP,naftifine,-75.33,"squalene epoxidase inhibitor, steroid sulfatase inhibitor","0.83, 0.30",,BRD-K74141488,"0.00, 0.00",SQLE
CP,memantine,-75.39,"glutamate receptor antagonist, glutamate release inhibitor","1.36, 0.72",,BRD-A79803969,"0.00, 0.00","GRIN1, CHRFAM7A, CYP2E1, DRD2, GRIN2A, GRIN2B, GRIN3A, HTR3A"
CP,lacidipine,-75.55,"calcium channel blocker, L-type calcium channel blocker","0.85, 0.20",Calcium channel blocker,BRD-A52282606,"12.50, 12.50",CACNA1C
CP,parthenolide,-75.6,"NFkB pathway inhibitor, adiponectin receptor agonist","2.27, 0.65",NFkB pathway inhibitor,BRD-K98548675,"0.00, 0.00","ADIPOR2, IKBKB, RELA"
CP,tosyl-phenylalanyl-chloromethyl-ketone,-76.19,"chymotrypsin inhibitor, serine protease inhibitor","1.01, 0.35",,BRD-K50311478,"10.00, 10.00",
CP,GW-5074,-76.25,"RAF inhibitor, leucine rich repeat kinase inhibitor","0.77, 0.22",RAF inhibitor,BRD-K39520573,"0.00, 0.00","LRRK1, LRRK2, NTRK1, RAF1"
CP,molindone,-76.8,dopamine receptor antagonist,"1.01, 0.30",,BRD-A65280694,"0.00, 0.00","DRD2, HTR2A, CHRM1, DRD5, HRH1, HTR1A"
CP,15-delta-prostaglandin-j2,-77.03,"PPAR receptor agonist, FXR antagonist","1.39, 0.63",PPAR receptor agonist,BRD-K05396879,"0.00, 0.00","PPARG, NR1H4"
CP,bromocriptine,-77.16,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor","1.01, 0.19",,BRD-A69960130,"0.00, 0.00","DRD2, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, ADRA1A, ADRA1B, ADRA1D, HTR6, HTR7, PRL"
CP,tamoxifen,-77.31,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor","0.38, 0.17",,BRD-K93754473,"0.00, 0.00","ESR1, ESR2, CYP3A5, EBP, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ"
CP,sarmentogenin,71.74,ATPase inhibitor,"2.40, 0.72",ATPase inhibitor,BRD-A89434049,"0.00, 0.00",ATP1A1
CP,methylergometrine,71.63,"dopamine receptor antagonist, partial serotonin receptor agonist","0.91, 0.26",,BRD-K34685430,"11.11, 0.00","DRD1, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C"
CP,BRD-K64314806,71.44,lipoxygenase inhibitor,"1.25, 0.23",,BRD-K64314806,"20.00, 10.00",
CP,z-leu3-VS,71.17,"PGPH inhibitor, proteasome inhibitor","3.00, 0.82",Proteasome inhibitor,BRD-K15935639,"20.00, 0.00",
CP,guanabenz,71.13,adrenergic receptor agonist,"0.78, 0.25",,BRD-K56800335,"0.00, 0.00","ADRA2A, ADRA2B, ADRA2C"
CP,ethinyl-estradiol,71.12,"DNA directed DNA polymerase stimunlant, estrogen receptor agonist, estrogenic component in oral contraceptives","1.19, 0.38",Estrogen receptor agonist,BRD-A02367930,"22.22, 0.00","CYP2C8, ESR1, ESR2, NR1I2"
CP,guanabenz,71.1,adrenergic receptor agonist,"0.53, 0.08",,BRD-K62736196,"0.00, 0.00","ADRA2A, ADRA2B, ADRA2C"
CP,prostaglandin-e1,71.05,"prostanoid receptor agonist, prostanoid receptor antagonist","1.02, 0.34",,BRD-K52459643,"0.00, 0.00","PTGER1, PTGER2, CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGER4, PTGIR"
CP,BRD-K98948170,71.03,kelch-like ECH-associated protein ligand,"0.55, 0.43",,BRD-K98948170,"33.33, 33.33",KEAP1
CP,CITCO,70.77,constitutive androstane receptor (CAR) agonist,"1.18, 0.35",,BRD-K53263234,"11.11, 0.00",NR1I3
CP,enalaprilat,-74.65,angiotensin converting enzyme inhibitor,"1.80, 0.55",,BRD-K99447003,"0.00, 0.00",ACE
CP,tripelennamine,-74.69,histamine receptor antagonist,"0.50, 0.18",,BRD-K57033106,"0.00, 0.00",HRH1
CP,BRD-K77690805,-74.69,pyruvate kinase isozyme activator,"0.74, 0.14",,BRD-K77690805,"10.00, 0.00",PKM
CP,dovitinib,-74.73,"EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, FGFR antagonist, KIT inhibitor, VEGFR antagonist","0.99, 0.19","EGFR inhibitor, FGFR inhibitor, VEGFR inhibitor",BRD-K85402309,"0.00, 0.00","EGFR, FGFR3, PDGFRB, CSF1R, FGFR1, FGFR2, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA"
CP,bucladesine,-74.74,"adenosine receptor agonist, cAMP stimulant, vasodilator","1.11, 0.24",,BRD-A15070535,"22.22, 22.22",PRKACA
CP,testosterone,-74.75,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist","0.67, 0.25",,BRD-K90553655,"0.00, 0.00","AR, CYP19A1, CYP2C19, CYP2C8, CYP3A5"
CP,IB-MECA,-74.76,"adenosine receptor agonist, granulocyte colony stimulating factor agonist","0.89, 0.24",Adenosine receptor agonist,BRD-A48809242,"11.11, 0.00","ADORA3, ADORA1, ADORA2A, ADORA2B"
CP,QX-222,-74.87,sodium channel blocker,"1.09, 0.33",,BRD-K40782193,"0.00, 0.00",
CP,spectinomycin,-74.91,30S ribosomal subunit inhibitor,"0.88, 0.34",Bacterial 30S ribosomal subunit inhibitor,BRD-K11905747,"0.00, 0.00",
CP,BRD-K88742110,-75.22,"HDAC inhibitor, interleukin synthesis inhibitor","0.26, 0.17",,BRD-K88742110,"0.00, 0.00","HDAC8, IL1B"
CP,dapsone,70.7,"dihydrofolate reductase inhibitor, dihydropteroate synthase inhibitor, FOLP inhibitor","1.40, 0.41",Dihydrofolate reductase inhibitor,BRD-K62363391,"0.00, 0.00",DHFR
CP,labetalol,70.64,adrenergic receptor antagonist,"1.38, 0.41",,BRD-K04389336,"0.00, 0.00","ADRB1, ADRB2, ADRA1A, ADRA1D, ADRA1B"
CP,dihydro-7-desacetyldeoxygedunin,70.63,HSP90 inhibitor,"1.03, 0.27",,BRD-A47144777,"11.11, 0.00",HSP90AA1
CP,retinol,70.63,RAR receptor binder,"1.06, 0.43",,BRD-K13927029,"20.00, 10.00","ALDH1A1, ALDH1A2, ALDH1A3, DHRS3, DHRS4, LRAT, NR2C2, RBP1, RBP3, RDH11, RDH12, RDH13, RDH14, RDH5, RDH8, RETSAT, RHO, RLBP1, RXRA, RXRB, RXRG"
CP,sulforaphane,70.49,"anticancer agent, aryl hydrocarbon receptor antagonist, nuclear factor erythroid derived, like (NRF2) activator","0.83, 0.22",,BRD-A58955223,"20.00, 10.00",NFE2L2
CP,ZM-306416,70.43,"Src and Abl inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor","0.83, 0.25","SRC inhibitor, VEGFR inhibitor",BRD-K41337261,"0.00, 0.00","FLT1, KDR, EGFR, FLT4"
CP,SB-239063,70.39,"p38 MAPK inhibitor, interleukin inhibitor, tumor necrosis factor production inhibitor","1.15, 0.27",,BRD-K98143437,"20.00, 0.00","MAPK11, MAPK14, PTGS2, TNF"
CP,CAM-9-026,70.33,ADAM10 inhibitor,"1.27, 0.26",,BRD-K91442916,"11.11, 11.11",
CP,ryanodine,70.33,calcium channel inhibitor,"1.49, 0.45",,BRD-K69556541,"0.00, 0.00","RYR1, RYR2, RYR3"
CP,megestrol,70.26,"progesterone receptor agonist, DNA inhibitor, HegG2 inhibitor","1.00, 0.32",,BRD-K19507340,"0.00, 0.00",PGR
CP,clomifene,-73.59,"estrogen receptor antagonist, estrogen receptor modulator, selective estrogen receptor modulator (SERM), testosterone receptor agonist","0.81, 0.19",Estrogen receptor antagonist,BRD-K29950728,"0.00, 0.00","ESR1, AR"
CP,losartan,-73.74,angiotensin receptor antagonist,"0.31, 0.02",,BRD-K76205745,"0.00, 0.00",AGTR1
CP,geranylgeraniol,-73.89,farnesyltransferase inhibitor,"1.39, 0.45",,BRD-K95402279,"0.00, 0.00",
CP,eicosatetraynoic-acid,-74.06,"cyclooxygenase inhibitor, lipoxygenase inhibitor","0.90, 0.25",,BRD-K06080977,"10.00, 10.00","ALOX12, PPARA, PPARG, PTGS1"
CP,caffeic-acid,-74.13,"lipoxygenase inhibitor, HIV integrase inhibitor, NFkB pathway inhibitor, nitric oxide production inhibitor, PPAR receptor modulator, tumor necrosis factor production inhibitor","1.24, 0.43",,BRD-K84709232,"0.00, 0.00","ALOX5, MIF, RELA, TNF"
CP,etilefrine,-74.16,adrenergic receptor agonist,"0.82, 0.22",,BRD-A09925278,"0.00, 0.00","ADRA1A, ADRB1"
CP,linezolid,-74.21,"50S ribosomal subunit inhibitor, protein synthesis inhibitor, monoamine oxidase inhibitor","1.05, 0.20",,BRD-K66876909,"0.00, 0.00",MAOA
CP,cediranib,-74.23,"VEGFR inhibitor, KIT inhibitor, angiogenesis inhibitor, VEGFR antagonist","1.56, 0.56","PDGFR/KIT inhibitor, VEGFR inhibitor",BRD-K86930074,"0.00, 0.00","KDR, FLT1, FLT4, KIT, PDGFRB, CSF1R, FLT3, PDGFRA"
CP,BRD-K56658166,-74.31,"N-type calcium channel blocker, Sodium Channel  Blockers","0.53, 0.09",,BRD-K56658166,"0.00, 0.00",CACNA1B
CP,androstenedione,-74.5,cytochrome P450 inhibitor,"1.32, 0.38",,BRD-K32610195,"10.00, 0.00","AKR1C3, HSD17B1, HSD3B1"
CP,bucladesine,70.22,"adenosine receptor agonist, cAMP stimulant, vasodilator","1.49, 0.35",,BRD-A15931911,"20.00, 20.00",PRKACA
CP,cefotiam,70.2,cell wall synthesis inhibitor,"1.11, 0.27",,BRD-K02275692,"0.00, 0.00",
CP,ribavirin,70.18,"antiviral guanosine ribonucleoside analog, IMPDH inhibitor, inosine monophosphate dehydrogenase inhibitor","1.03, 0.22",,BRD-A96255180,"10.00, 10.00","IMPDH1, ADK, ENPP1, IMPDH2, NT5C2"
CP,diphenyleneiodonium,70.02,"nitric oxide synthase inhibitor, aldehyde dehydrogenase inhibitor, cytochrome P450 inhibitor, NADPH oxidase inhibitor, xanthine oxidase inhibitor","0.86, 0.14",,BRD-K65814004,"10.00, 10.00","ALDH1A2, ALDH2, ALDH5A1, ALDH7A1, NOX3, XDH"
CP,nitrofural,69.96,POXB inhibitor,"1.19, 0.31",,BRD-K79092138,"0.00, 0.00",
CP,AZD-8055,69.92,mTOR inhibitor,"2.34, 0.75",MTOR inhibitor,BRD-K69932463,"0.00, 0.00",MTOR
CP,MLN-2238,69.92,proteasome inhibitor,"2.44, 0.85",Proteasome inhibitor,BRD-K78659596,"0.00, 0.00",PSMB1
CP,baccatin-III,69.83,paclitaxel precursor,"1.48, 0.32",,BRD-A84189516,"0.00, 0.00",
CP,dubinidine,69.79,anticonvulsant that reduces motor activity,"2.11, 0.59",,BRD-A99571536,"22.22, 11.11",
CP,peucedanin,69.66,"apoptosis inducer, antileukemic","1.21, 0.50",,BRD-K72034655,"0.00, 0.00",
CP,AS-703026,-72.64,MEK inhibitor,"1.41, 0.55",MEK inhibitor,BRD-K89014967,"0.00, 0.00","MAP2K1, MAP2K2"
CP,piceid,-72.8,"glucosidase inhibitor, ICAM1 expression inhibitor, VCAM expression inhibitor, xanthine oxidase inhibitor","0.99, 0.28",,BRD-K43236057,"0.00, 0.00","GAA, XDH"
CP,benazepril,-72.81,angiotensin converting enzyme inhibitor,"1.23, 0.41",,BRD-K49807096,"0.00, 0.00",ACE
CP,dibenzoylmethane,-72.82,tumorigenesis inhibitor,"0.65, 0.11",,BRD-K01555864,"0.00, 0.00",
CP,quinine,-72.83,"cytochrome P450 inhibitor, hemozoin biocrystallization inhibitor, P glycoprotein inhibitor","2.16, 0.49",,BRD-U94846492,"0.00, 0.00","KCNN4, ABCB1, CYP2D6, GP9, KCNB2, SLC29A4"
CP,quercetagetin,-72.95,Pim kinase inhibitor,"0.70, 0.18",,BRD-K95885906,"10.00, 0.00",PIM1
CP,carmofur,-73.04,"thymidylate synthase inhibitor, pyrimidine antagonist","1.19, 0.41",Thymidylate synthase inhibitor,BRD-K11630072,"0.00, 0.00",TYMS
CP,benzohydroxamic-acid,-73.2,"metal chelator, anti bacterial","0.43, 0.34",,BRD-K59773493,"0.00, 0.00",
CP,cilnidipine,-73.45,"calcium channel blocker, L-type calcium channel blocker, N-type calcium channel blocker","0.75, 0.28",,BRD-A07875874,"0.00, 0.00","CACNA1B, CACNA1C"
CP,mirin,-73.49,inhibitor of MRE11A exonuclease activity,"1.16, 0.47",,BRD-K55420858,"10.00, 0.00",MRE11A
CP,triamcinolone,69.61,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent","1.36, 0.57",,BRD-A30717181,"0.00, 0.00","NR3C1, CYP3A5, CYP3A7, SERPINA6"
CP,levocabastine,69.61,histamine receptor antagonist,"0.60, 0.17",,BRD-K33453211,"10.00, 0.00","HRH1, NTSR2"
CP,oxprenolol,69.38,adrenergic receptor antagonist,"0.88, 0.22",,BRD-A43671941,"11.11, 11.11","ADRB1, ADRB2"
CP,SA-792574,69.37,"microtubule inhibitor, tubulin inhibitor","0.97, 0.43",Tubulin inhibitor,BRD-K26997899,"10.00, 0.00",TUBB
CP,aminogenistein,69.24,"PKC inhibitor, src inhibitor","1.01, 0.20",,BRD-K04976539,"20.00, 10.00",LCK
CP,crizotinib,69.2,"ALK tyrosine kinase receptor inhibitor, c-Met inhibitor, hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor","0.97, 0.19",,BRD-K78431006,"0.00, 0.00","ALK, MET, CYP2B6, CYP3A5, MST1R, ROS1"
CP,deguelin,69.15,"NADH-ubiquinone oxidoreductase (Complex I) inhibitor, AKT inhibitor, cyclooxygenase inhibitor, NFkB pathway inhibitor, phorbol ester-induced ornithine decarboxylase (ODC) activity suppressor, PI3K inhibitor","1.01, 0.14",,BRD-K61401890,"0.00, 0.00","AKT1, PTGS2"
CP,phenothiazine,69.14,dopamine receptor antagonist,"0.60, 0.10",,BRD-K59597909,"20.00, 10.00",
CP,tyrphostin-AG-1288,69.07,"catechol O methyltransferase inhibitor, tumor necrosis factor inhibitor","1.44, 0.39",,BRD-K08115555,"10.00, 0.00",COMT
CP,etacrynic-acid,68.98,"not applicable, sodium/potassium/chloride transporter inhibitor","0.82, 0.19",,BRD-K63630713,"0.00, 0.00","SLC12A1, ATP1A1, SLC12A2"
CP,naloxone,-71.89,opioid receptor antagonist,"0.89, 0.30",,BRD-A70461345,"0.00, 0.00","OPRM1, OPRK1, OPRD1, CREB1, ESR1, TLR4"
CP,caffeine,-71.92,"adenosine receptor antagonist, ATM kinase inhibitor, ATR kinase inhibitor","0.43, 0.13",,BRD-K02404261,"10.00, 0.00","ADORA1, ADORA2A, ADORA2B, ATM, ITPR1, RYR1, ADORA3, ATR, ITPR2, ITPR3, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, PIK3CA, PIK3CB, PIK3CD, PRKDC, RYR2, RYR3"
CP,SANT-1,-72.13,smoothened receptor antagonist,"0.78, 0.17",,BRD-K83637872,"0.00, 0.00","DHH, IHH, PTCH1, SMO"
CP,aminoglutethimide,-72.14,"antiglucocorticoid, aromatase inhibitor, corticosteroid antagonist, steroid sulfatase inhibitor","0.45, 0.10",,BRD-A25234499,"0.00, 0.00","CYP19A1, CYP11A1, NR3C1"
CP,VU-0365114-2,-72.27,"acetylcholine receptor allosteric modulator, M5 modulator","1.65, 0.58",,BRD-K37456065,"0.00, 0.00",CHRM5
CP,BRD-K61463582,-72.47,aryl hydrocarbon receptor agonist,"1.20, 0.42",,BRD-K61463582,"0.00, 0.00","AHR, CYP1A2"
CP,triprolidine,-72.47,histamine receptor antagonist,"1.49, 0.60",,BRD-K11742128,"11.11, 0.00",HRH1
CP,5-nonyloxytryptamine,-72.55,serotonin receptor agonist,"1.58, 0.38",,BRD-K08219523,"0.00, 0.00","HTR1B, HTR1D"
CP,BRD-A93048969,-72.59,acetylcholine receptor antagonist,"1.01, 0.28",,BRD-A93048969,"0.00, 0.00","CHRM2, CHRM1, CHRM3, CHRM4, CHRM5, SI"
CP,fexaramine,-72.63,FXR agonist,"1.27, 0.36",,BRD-K34170797,"0.00, 0.00",NR1H4
CP,genistein,68.82,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor","1.30, 0.41",,BRD-A36151937,"10.00, 10.00","CFTR, ESR2, EGFR, ESR1, ESRRA, ESRRB, ESRRG, NCOA1, NCOA2, PPARG, PTK2B, TOP2A, TRPC5"
CP,glycopyrrolate,68.77,acetylcholine receptor antagonist,"0.88, 0.26",,BRD-A81233518,"30.00, 0.00","CHRM1, CHRM3, CHRM2, CHRM4, CHRM5"
CP,PNU-282987,68.75,acetylcholine receptor antagonist,"0.78, 0.19",,BRD-K28863208,"20.00, 0.00",CHRNA7
CP,estropipate,68.74,estrogen receptor agonist,"0.74, 0.14",,BRD-K51095933,"22.22, 22.22","ESR1, ESR2"
CP,GW-843682X,68.71,PLK inhibitor,"0.77, 0.28",,BRD-K90382497,"0.00, 0.00","PLK1, PLK3"
CP,SB-206553,68.71,"serotonin receptor antagonist, serotonin receptor partial agonist","1.20, 0.42",,BRD-K36395411,"0.00, 0.00","HTR2B, HTR2C, HTR1A, HTR2A"
CP,APHA-compound-8,68.59,HDAC inhibitor,"1.50, 0.48",HDAC inhibitor,BRD-K74733595,"20.00, 20.00",HDAC8
CP,AM-580,68.56,"RAR agonist, retinoid receptor agonist","0.38, 0.13",Retinoid receptor agonist,BRD-K06854232,"20.00, 10.00",RARA
CP,LY-341495,68.54,glutamate receptor antagonist,"1.00, 0.32",,BRD-K69763916,"30.00, 10.00","GRM2, GRM3"
CP,cephaeline,68.54,protein synthesis inhibitor,"3.33, 0.78",Protein synthesis inhibitor,BRD-K80348542,"0.00, 0.00",RPS2
CP,methotrexate,-71.26,"dihydrofolate reductase inhibitor, disease modifying antirheumatic drug, folate receptor antagonist, immunosuppressant, thymidylate synthase inhibitor","0.97, 0.23",Dihydrofolate reductase inhibitor,BRD-K59456551,"0.00, 0.00","DHFR, AOX1, FOLR1, TYMS"
CP,methyl-angolensate,-71.3,apoptosis inhibitor,"1.50, 0.33",,BRD-A32349859,"0.00, 0.00",HTR2B
CP,mocimycin,-71.32,protein synthesis inhibitor,"0.90, 0.30",,BRD-A73605923,"0.00, 0.00",
CP,toremifene,-71.36,"selective estrogen receptor modulator (SERM), estrogen receptor antagonist","0.51, 0.34",Estrogen receptor antagonist,BRD-K67174588,"11.11, 11.11","ESR1, CYP3A5"
CP,sildenafil,-71.51,phosphodiesterase inhibitor,"0.40, 0.06",,BRD-K50128260,"0.00, 0.00","PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3"
CP,paroxetine,-71.65,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor","0.93, 0.22",,BRD-K19277754,"0.00, 0.00","SLC6A4, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2"
CP,raloxifene,-71.69,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), ALK expression enhancer, cholesterol inhibitor, endoglin expression enhancer, estrogen receptor agonist","0.43, 0.34",Estrogen receptor antagonist,BRD-K63828191,"10.00, 10.00","ESR1, ESR2, ACVRL1, ENG"
CP,oxymetholone,-71.7,"androgen receptor agonist, synthetic hormone with anabolic and androgenic properties","0.65, 0.24",Androgen receptor modulator,BRD-A23637604,"0.00, 0.00",AR
CP,candesartan,-71.78,angiotensin receptor antagonist,"0.53, 0.10",Angiotensin receptor antagonist,BRD-A65671304,"0.00, 0.00","AGTR1, AGTR2"
CP,oligomycin-a,-71.89,"ATP synthase inhibitor, ATPase inhibitor","1.85, 0.44","ATP synthase inhibitor, ATPase inhibitor",BRD-K74133369,"0.00, 0.00",ATP5A1
CP,WZ-3146,68.39,"EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor","1.74, 0.50",,BRD-K73293050,"0.00, 0.00",EGFR
CP,methyllycaconitine,68.32,acetylcholine receptor antagonist,"1.06, 0.31",,BRD-A32164164,"10.00, 0.00",CHRNA7
CP,AMG-9810,68.31,TRPV antagonist,"0.85, 0.15",,BRD-K43068349,"10.00, 0.00",TRPV1
CP,trichostatin-a,68.28,"HDAC inhibitor, CDK expression enhancer, ID1 expression inhibitor","2.10, 0.64",,BRD-A19037878,"10.00, 0.00","HDAC7, HDAC8, HDAC1, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC9"
CP,VU-0418946-1,68.18,hypoxia inducible factor activator,"1.80, 0.63",HIF activator,BRD-K44432556,"20.00, 10.00",HIF1A
CP,TG-101348,68.18,"JAK inhibitor, FLT3 inhibitor, RET tyrosine kinase inhibitor","1.65, 0.56","Bromodomain Inhibitor, FLT3 inhibitor, JAK inhibitor",BRD-K12502280,"0.00, 0.00","JAK2, FLT3, BRD4, JAK1, JAK3, RET, TYK2"
CP,hydrocortisone,68.08,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist","1.58, 0.39",Glucocorticoid receptor agonist,BRD-A65767837,"0.00, 0.00","ANXA1, NOS2, NR3C1, NR3C2"
CP,homosalate,68.07,HSP activator,"0.73, 0.31",,BRD-A34751532,"10.00, 10.00",
CP,hyperforin,67.97,"cyclooxygenase inhibitor, dopamine reuptake inhibitor, interleukin receptor antagonist, lipoxygenase inhibitor, serotonin uptake inhibitor","1.53, 0.48",,BRD-A80775386,"0.00, 0.00","NR1I2, ALOX5, PTGS1, TRPC6"
CP,SB-203186,67.9,serotonin receptor antagonist,"1.80, 0.59",,BRD-K27141178,"0.00, 0.00",HTR4
CP,mestranol,-70.51,estrogen receptor agonist,"0.48, 0.06",,BRD-K31920458,"0.00, 0.00",ESR1
CP,valproic-acid,-70.55,"HDAC inhibitor, ABAT inhibitor, GABA receptor agonist, GABAergic transmission enhancer, voltage-gated sodium channel blocker","0.66, 0.19",,BRD-K41260949,"0.00, 0.00","ABAT, HDAC1, SCN1A, SCN3A, ACADSB, ALDH5A1, HDAC2, HDAC9, OGDH, SCN10A, SCN11A, SCN1B, SCN2A, SCN2B, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A"
CP,resveratrol,-70.72,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor","0.88, 0.31",,BRD-K25591257,"0.00, 0.00","PTGS1, PTGS2, SIRT1, APOA1, BACE1, CSNK2A1, MAOA, NQO2, SCN5A, TXNRD1, TXNRD2, XDH"
CP,dexamethasone,-70.73,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant","1.20, 0.67",,BRD-A10188456,"0.00, 0.00","ANXA1, CYP3A4, CYP3A5, NOS2, NR0B1, NR3C1, NR3C2"
CP,orphenadrine,-70.81,acetylcholine receptor antagonist,"0.95, 0.28",,BRD-A53576514,"0.00, 0.00","CYP2B6, GRIN1, GRIN2D, GRIN3A, GRIN3B, HRH1, SCN10A, SLC6A2"
CP,ABT-737,-70.86,BCL inhibitor,"1.83, 0.67",BCL inhibitor,BRD-K56301217,"0.00, 0.00","BCL2, BCL2L1, BCL2L2"
CP,niguldipine,-70.88,"adrenergic receptor antagonist, calcium channel blocker, calcium channel antagonist, calcium channel inhibitor","2.22, 0.72",,BRD-A43331270,"0.00, 0.00","ADRA1A, CACNA1C, ADRA1B, ADRA1D"
CP,WH-4023,-70.98,src inhibitor,"1.25, 0.47",SRC inhibitor,BRD-U44618005,"0.00, 0.00","ABL1, LCK, SRC"
CP,BMS-191011,-71.12,"large conductance calcium activated potassium channel opener, large conductance potassium channel activator","1.52, 0.33",Potassium channel activator,BRD-K95609758,"0.00, 0.00",KCNMA1
CP,avrainvillamide-analog-6,-71.12,nucleophosmin inhibitor,"0.51, 0.22",Nucleophosmin inhibitor,BRD-K50324045,"11.11, 11.11",NPM1
CP,verrucarin-a,67.77,protein synthesis inhibitor,"2.76, 0.81",Protein synthesis inhibitor,BRD-A26002865,"10.00, 10.00",
CP,testosterone,67.69,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist","1.01, 0.40",,BRD-K84036904,"0.00, 0.00","AR, CYP19A1, CYP2C19, CYP2C8, CYP3A5"
CP,KIN001-244,67.6,phosphoinositide dependent kinase inhibitor,"1.56, 0.55",,BRD-K09186807,"10.00, 10.00",PDPK1
CP,velnacrine,67.5,calcium channel activator,"0.89, 0.18",,BRD-A98299281,"11.11, 11.11",ACHE
CP,sulpiride,67.5,"carbonic anhydrase inhibitor, dopamine receptor, dopamine receptor antagonist","2.13, 0.63",,BRD-A10715913,"0.00, 0.00","DRD2, CA7, DRD3, CA1, CA12"
CP,procainamide,67.49,"sodium channel blocker, voltage-gated sodium channel blocker","0.63, 0.13",,BRD-K75089421,"10.00, 10.00","SCN5A, DNMT1"
CP,arachidonamide,67.44,cannabinoid receptor agonist,"1.13, 0.35",,BRD-K29555132,"10.00, 0.00","CNR1, CNR2"
CP,BRD-A51929314,67.41,"prostanoid receptor antagonist, thromboxane receptor antagonist","1.25, 0.40",,BRD-A51929314,"0.00, 0.00",
CP,noscapine,67.21,"bradykinin receptor antagonist, tubulin polymerization inhibitor, apoptosis stimulant, microtubule inhibitor, tubulin inhibitor","0.63, 0.10",,BRD-A51393488,"10.00, 10.00","BDKRB2, SIGMAR1"
CP,fludrocortisone,67.2,"glucocorticoid receptor agonist, mineralocorticoid receptor agonist","1.64, 0.57",Glucocorticoid receptor agonist,BRD-A38749782,"0.00, 0.00","NR3C2, AR, NR3C1"
CP,BRD-K52640952,-69.89,topoisomerase inhibitor,"0.68, 0.23",,BRD-K52640952,"0.00, 0.00",TOP1
CP,"7,8-dihydro-L-biopterin",-69.89,dihydroneopterin aldolase inhibitor,"0.86, 0.26",,BRD-A01317026,"0.00, 0.00","NOS2, TPH1"
CP,QL-XI-92,-69.91,DDR1 inhibitor,"1.31, 0.35",,BRD-U73238814,"0.00, 0.00",DDR1
CP,cefatrizine,-69.94,cell wall synthesis inhibitor,"0.83, 0.25",,BRD-M47937986,"0.00, 0.00",
CP,PF-543,-70,sphingosine kinase inhibitor,"0.60, 0.36",,BRD-K79877282,"0.00, 0.00",SPHK1
CP,AC-55649,-70.21,"RAR agonist, retinoid receptor agonist","1.35, 0.26",Retinoid receptor agonist,BRD-K93176058,"0.00, 0.00","RARB, RARA"
CP,L-733060,-70.22,tachykinin antagonist,"1.56, 0.66",Tachykinin antagonist,BRD-K15791587,"0.00, 0.00",TACR1
CP,tunicamycin,-70.24,GLCNAC phosphotransferase inhibitor,"2.39, 0.75",,BRD-K10573841,"0.00, 0.00",GNPTAB
CP,fludarabine,-70.34,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor","0.98, 0.33","DNA synthesis inhibitor, Ribonucleotide reductase inhibitor",BRD-K66788707,"0.00, 0.00","ADA, DCK, POLA1, RRM1, RRM2"
CP,GW-441756,-70.44,"growth factor receptor inhibitor, leucine rich repeat kinase inhibitor","1.23, 0.33",,BRD-K04146668,"10.00, 0.00","LRRK2, NTRK1"
CP,gelsemine,67.06,"acetylcholine receptor antagonist, glycine receptor antagonist","0.97, 0.31",,BRD-A17535965,"11.11, 0.00",GLRA3
CP,TW-37,67.04,"BCL inhibitor, MCL1 inhibitor","2.60, 0.72",BCL inhibitor,BRD-K28360340,"10.00, 10.00","BCL2, BCL2L1, MCL1"
CP,pentylenetetrazol,66.96,GABA receptor antagonist,"1.01, 0.26",GABA receptor antagonist,BRD-K57718010,"0.00, 0.00",
CP,PI-103,66.87,"PI3K inhibitor, mTOR inhibitor","1.93, 0.66","MTOR inhibitor, PI3K inhibitor",BRD-K67868012,"20.00, 10.00","PIK3CA, PIK3CG, MTOR, PIK3CB, PIK3CD, PRKDC"
CP,vorinostat,66.8,"HDAC inhibitor, cell cycle inhibitor","1.66, 0.57",HDAC inhibitor,BRD-K81418486,"0.00, 0.00","HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, HDAC10, HDAC11, HDAC5, HDAC9"
CP,protopine,66.77,"acetylcholinesterase inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor","0.68, 0.18",,BRD-K83302049,"11.11, 11.11","ACHE, SLC6A2, SLC6A4"
CP,SQ-22536,66.74,adenylyl cyclase inhibitor,"1.06, 0.40",,BRD-A56987319,"0.00, 0.00","ADCY1, ADCY5"
CP,ascorbic-acid,66.7,"vitamin C, antioxidant","1.89, 0.52",,BRD-A79237180,"0.00, 0.00",AKR1B1
CP,fostamatinib,66.65,"syk inhibitor, FLT3 inhibitor","2.07, 0.75",,BRD-K20285085,"0.00, 0.00","SYK, FLT3, RET"
CP,dehydroisoandosterone,66.47,GABA receptor modulator,"0.83, 0.22",,BRD-K96527333,"10.00, 0.00",
CP,ataluren,-69.52,"CFTR channel agonist, coagulation stimulant, dystrophin stimulant","1.92, 0.58",,BRD-K94830329,"0.00, 0.00","CFTR, DMD, F8, F9"
CP,TTNPB,-69.56,"RAR agonist, retinoid receptor agonist","1.40, 0.33",Retinoid receptor agonist,BRD-K68246049,"0.00, 0.00","RARB, RARA, RARG"
CP,BML-ST330,-69.61,"phospholipase inhibitor, DNA inhibitor, RNA synthesis inhibitor","0.82, 0.33",,BRD-A77118605,"0.00, 0.00",
CP,norgestimate,-69.63,progesterone receptor agonist,"0.41, 0.15",Progesterone receptor agonist,BRD-A04756508,"0.00, 0.00","PGR, ESR1"
CP,BMS-345541,-69.63,IKK inhibitor,"0.90, 0.55",,BRD-K13566078,"0.00, 0.00","IKBKB, CHUK"
CP,taurocholic-acid,-69.63,bile acid,"0.78, 0.30",Bile acid,BRD-K81062487,"0.00, 0.00","CEL, FXR, NR1H4, FABP6, SLCO1C1"
CP,"methyl-2,5-dihydroxycinnamate",-69.75,"EGFR inhibitor, tyrosine kinase inhibitor","1.06, 0.33",,BRD-K88741031,"10.00, 0.00",EGFR
CP,butylparaben,-69.76,antimicrobial preservative,"0.50, 0.10",,BRD-K08287586,"0.00, 0.00",
CP,piperine,-69.86,"monoamine oxidase inhibitor, ACAT inhibitor","0.70, 0.17",,BRD-K59522102,"10.00, 10.00","MAOA, MAOB, TRPV1"
CP,SU-11274,-69.87,"hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor","1.42, 0.56",,BRD-K02965346,"0.00, 0.00",MET
CP,triclosan,66.41,"DNA methyltransferase inhibitor, enoyl-(acyl-carrier protein) reductase Fabl inhibitor, enoyl-[acyl-carrier-protein] reductase [NADH] inhibitor","1.36, 0.30",,BRD-K41731458,"0.00, 0.00",DNMT1
CP,PJ-34,66.34,PARP inhibitor,"0.83, 0.23",PARP inhibitor,BRD-K11853856,"0.00, 0.00","EEF2, PARP1, PARP15, PARP3"
CP,Y-27632,66.1,"ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor","0.36, 0.13",,BRD-A58280226,"0.00, 0.00","ROCK1, ROCK2, LRRK2, PKIA, PKN2, PRKACA, PRKCE"
CP,DCEBIO,65.98,intermediate conductance potassium channel activator,"0.80, 0.24",Potassium channel activator,BRD-K32526544,"0.00, 0.00","KCNN2, KCNN3, KCNN4"
CP,emetine,65.97,protein synthesis inhibitor,"1.86, 0.60",,BRD-K01976263,"20.00, 10.00",RPS2
CP,safinamide,65.88,"dopamine reuptake inhibitor, glutamate release inhibitor, monoamine oxidase inhibitor, calcium channel antagonist, calcium channel modulator, Sodium Channel  Blockers, sodium channel blocker","1.69, 0.50",,BRD-K84639753,"10.00, 10.00","MAOB, SLC6A3"
CP,SKF-81297,65.81,dopamine receptor agonist,"0.83, 0.23",,BRD-A09828896,"10.00, 0.00","DRD1, DRD5"
CP,herniarin,65.65,acetylcholinesterase inhibitor,"1.57, 0.36",,BRD-K81209159,"10.00, 0.00","ACHE, CA1, CA12, CA14, CA4, CA6, CA9"
CP,flufenamic-acid,65.58,calcium activated chloride channel inhibitor,"1.31, 0.34",,BRD-K44067360,"10.00, 0.00","AKR1C3, AR, PTGS1, PTGS2, ANO1, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3, PKD2L1, TRPC5, TRPM2, TRPM5"
CP,genipin,65.58,"aglycone, nitric oxide production inhibitor","2.50, 0.86",,BRD-A04308630,"11.11, 0.00",
CP,6-aminochrysene,-69.13,inhibitor of transferase activity,"0.65, 0.15",,BRD-K00656370,"0.00, 0.00",
CP,triacsin-c,-69.23,adrenergic receptor antagonist,"1.22, 0.30",,BRD-K80527266,"0.00, 0.00",ACSL1
CP,androstenol,-69.23,GABA receptor modulator,"1.14, 0.36",,BRD-K24994810,"0.00, 0.00",NR1I3
CP,prednisolone,-69.32,glucocorticoid receptor agonist,"1.53, 0.75",Glucocorticoid receptor agonist,BRD-A78391468,"0.00, 0.00","NR3C1, NR3C2, SERPINA6"
CP,indatraline,-69.33,"norepinephrine transporter inhibitor, dopamine transporter inhibitor, dopamine uptake inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor","1.58, 0.47",,BRD-K01649396,"0.00, 0.00","SLC6A2, SLC6A3, SLC6A4"
CP,GW-6471,-69.38,PPAR receptor antagonist,"0.81, 0.17",,BRD-A72596465,"10.00, 0.00",PPARA
CP,oxantel,-69.41,fumarate reductase inhibitor,"0.78, 0.15",,BRD-K66019333,"0.00, 0.00",
CP,BRD-K63954456,-69.44,"macrophage migration inhibiting factor inhibitor, nitric oxide production inhibitor, tumor necrosis factor production inhibitor","2.57, 1.06",,BRD-K63954456,"0.00, 0.00","MIF, TNF"
CP,cladribine,-69.49,"adenosine deaminase inhibitor, antimetabolite, DNA synthesis inhibitor, immunosuppressant, ribonucleotide reductase inhibitor","1.42, 0.52",Ribonucleotide reductase inhibitor,BRD-K93034159,"0.00, 0.00","ADA, PNP, POLA1, POLE, POLE2, POLE3, POLE4, RRM1, RRM2, RRM2B"
CP,NSC-663284,-69.5,CDC inhibitor,"1.94, 0.48",,BRD-K03109492,"0.00, 0.00","CDC25A, CDC25B, CDC25C"
CP,aloisine,65.56,"CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor","0.94, 0.31","CDK inhibitor, Glycogen synthase kinase inhibitor",BRD-K93658967,"10.00, 0.00","CDK2, CDK5, CDK1, CDK5R1, CFTR, PTK2B, ZAP70"
CP,solifenacin,65.41,acetylcholine receptor antagonist,"1.32, 0.39",,BRD-A54596827,"11.11, 11.11","CHRM3, CHRM1, CHRM2, CHRM4, CHRM5"
CP,TPCA-1,65.13,IKK inhibitor,"1.81, 0.59",IKK inhibitor,BRD-K51575138,"0.00, 0.00",IKBKB
CP,dydrogesterone,65.11,progesterone receptor agonist,"0.98, 0.32",,BRD-K68620903,"10.00, 0.00",PGR
CP,theophylline,65.02,"adenosine receptor antagonist, chitinase inhibitor, GABA receptor antagonist, phosphodiesterase inhibitor","1.84, 0.49",,BRD-K97799481,"11.11, 11.11","ADORA1, ADORA2A, ADORA2B, ADORA3, CHIA, CYP2E1, CYP3A4, HDAC2, PDE3A, PDE4A, PDE4B, PDE5A"
CP,irilin-a,64.89,isoflavone,"0.70, 0.23",,BRD-K92678294,"20.00, 10.00",
CP,tamibarotene,64.88,"retinoid receptor agonist, RAR agonist","0.98, 0.31",Retinoid receptor agonist,BRD-K36627727,"10.00, 10.00","RARA, RARB"
CP,hydrocortisone,64.66,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist","1.36, 0.50",,BRD-K93568044,"0.00, 0.00","ANXA1, NOS2, NR3C1, NR3C2"
CP,BI-2536,64.58,"PLK inhibitor, apoptosis stimulant, cell cycle inhibitor, protein kinase inhibitor","1.49, 0.56",Bromodomain Inhibitor,BRD-K64890080,"20.00, 10.00","PLK1, BRD4, PLK2, PLK3"
CP,rifampicin,64.52,"DNA directed RNA polymerase inhibitor, enzyme inducer","1.26, 0.34",,BRD-A83892713,"0.00, 0.00","NR1I2, ABCB1, CYP2B6, CYP2C19, CYP2C8, CYP3A4, CYP3A5, SLCO1A2, SLCO1B1, SLCO1B3"
CP,sulfinpyrazone,-68.75,platelet aggregation inhibitor,"0.36, 0.06",,BRD-A36217750,"0.00, 0.00","ABCC1, ABCC2, FPR1, SLC22A12"
CP,CAY-10618,-68.76,"NAMPT inhibitor, niacinamide phosphoribosyltransferase inhibitor","1.57, 0.45",,BRD-K83289131,"0.00, 0.00",NAMPT
CP,niacin,-68.76,vitamin agonist,"1.23, 0.31",,BRD-K61993165,"0.00, 0.00","HCAR2, HCAR3, ACHE, DGAT2, HCAR1, NNMT, PTGDR, QPRT"
CP,BMY-45778,-68.84,IP1 prostacyclin receptor agonist,"1.58, 0.56",,BRD-K84895041,"11.11, 11.11",PTGIR
CP,quipazine,-68.84,serotonin receptor agonist,"0.84, 0.26",,BRD-K77925998,"0.00, 0.00","HTR2A, HTR3A, HTR3B, HTR1A, HTR1D, HTR2B, HTR2C, HTR6, SLC6A4"
CP,nomegestrol,-68.99,progesterone receptor agonist,"1.19, 0.25",Progesterone receptor agonist,BRD-K27351809,"0.00, 0.00",PGR
CP,hydrastine,-69.04,GABA receptor antagonist,"1.48, 0.45",,BRD-K02715688,"0.00, 0.00",
CP,LE-135,-69.05,retinoid receptor agonist,"0.53, 0.05",,BRD-K06593056,"0.00, 0.00",RARB
CP,coumarin,-69.06,vitamin antagonist,"0.68, 0.25",,BRD-K23913458,"0.00, 0.00","CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP2A6"
CP,reserpine,-69.11,vesicular monoamine transporter inhibitor,"1.59, 0.30",,BRD-K95921201,"0.00, 0.00","SLC18A2, SLC18A1"
CP,LY-294002,64.5,"PI3K inhibitor, mTOR inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor","1.16, 0.51","Bromodomain Inhibitor, MTOR inhibitor, PI3K inhibitor",BRD-K27305650,"0.00, 0.00","MTOR, PIK3CD, PIK3CG, PIK3CA, PIK3CB, PLK1, PRKDC, AKT1, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PDE2A, PRKCA, ROCK1, RPS6KB1, SGK1"
CP,depomedrol,64.43,glucocorticoid receptor agonist,"1.47, 0.75",Glucocorticoid receptor agonist,BRD-K94070024,"11.11, 0.00",
CP,ZSTK-474,64.42,PI3K inhibitor,"1.91, 0.60",PI3K inhibitor,BRD-K63068307,"0.00, 0.00","PIK3CG, PIK3CA, PIK3CB, PIK3CD"
CP,diethylstilbestrol,64.29,"estrogen receptor agonist, chloride channel blocker","0.41, 0.31",Estrogen receptor agonist,BRD-K45330754,"20.00, 0.00","ESR1, ESR2, ESRRG, ESRRB"
CP,dibutyrylcyclic-gmp,64.26,cGMP analog,"0.98, 0.30",,BRD-A06726973,"10.00, 0.00",
CP,lysergol,64.22,ergoline alkaloid,"1.22, 0.39",,BRD-K27871032,"0.00, 0.00","HTR1B, HTR1D, HTR1E"
CP,meclocycline,64.08,tetracycline antibiotic,"0.55, 0.11",Bacterial 30S ribosomal subunit inhibitor,BRD-A45140972,"0.00, 0.00",
CP,bumetanide,64,"diuretic, solute carrier family member inhibitor","1.00, 0.23",,BRD-K38197229,"0.00, 0.00","SLC12A1, SLC12A2, CFTR, GPR35, SLC12A4, SLC12A5"
CP,ecopipam,63.92,dopamine receptor antagonist,"0.76, 0.11",,BRD-K94270326,"20.00, 10.00","DRD1, DRD5, DRD2"
CP,nicardipine,63.79,"calcium channel blocker, L-type calcium channel blocker","0.55, 0.06",,BRD-A26711594,"0.00, 0.00","CACNA1C, ADORA3, ADRA1A, ADRA1B, ADRA1D, CACNA1D, CACNA2D1, CACNB2, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, PDE1A, PDE1B"
CP,U-0126,-67.91,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor","1.06, 0.43",MEK inhibitor,BRD-K18787491,"0.00, 0.00","AKT1, CHEK1, GSK3B, JAK2, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1"
CP,HDAC1-selective,-67.95,HDAC inhibitor,"0.35, 0.22",,BRD-K85133207,"11.11, 11.11",
CP,pirlindole,-68.29,monoamine oxidase inhibitor,"0.98, 0.24",,BRD-A54490543,"0.00, 0.00","MAOA, SLC6A2, SLC6A4"
CP,BRD-K30351863,-68.3,APEX inhibitor,"1.64, 0.51",,BRD-K30351863,"0.00, 0.00",APEX1
CP,floxuridine,-68.48,"DNA synthesis inhibitor, MDCK inhibitor, PEPT1 inhibitor, pyrimidine antagonist","1.30, 0.31",,BRD-K47832606,"0.00, 0.00",TYMS
CP,PSB-11,-68.49,adenosine receptor antagonist,"1.27, 0.49",,BRD-K10177585,"0.00, 0.00","ADORA3, ADORA1, ADORA2A"
CP,raltegravir,-68.5,HIV integrase inhibitor,"0.99, 0.31",,BRD-K05658747,"0.00, 0.00",
CP,norethindrone,-68.58,"ovulation inhibitor, progesterone receptor agonist","1.01, 0.34",Progesterone receptor agonist,BRD-K96037667,"11.11, 11.11",PGR
CP,tadalafil,-68.64,phosphodiesterase inhibitor,"0.43, 0.08",,BRD-K93645900,"20.00, 20.00","PDE5A, PDE11A"
CP,PD-0325901,-68.72,"MEK inhibitor, MAP kinase inhibitor, protein kinase inhibitor","1.34, 0.64",MEK inhibitor,BRD-K49865102,"0.00, 0.00","MAP2K1, MAP2K2"
CP,bisoprolol,63.77,adrenergic receptor antagonist,"0.41, 0.05",,BRD-A89175223,"10.00, 10.00","ADRB1, ADRB2"
CP,xaliproden,63.66,"serotonin receptor agonist, nerve growth factor agonist, neurotrophic factor enhancer","0.72, 0.27",,BRD-K88358234,"10.00, 10.00",HTR1A
CP,phorbol-12-myristate-13-acetate,63.64,"PKC activator, CD antagonist","2.48, 0.49",PKC activator,BRD-A15079084,"0.00, 0.00","CD4, KCNT2, PRKCA, TRPV4"
CP,docetaxel,63.61,"tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane","1.02, 0.39",Tubulin inhibitor,BRD-K63265447,"12.50, 12.50","TUBB, BCL2, MAP2, MAP4, MAPT, NR1I2, TUBB1"
CP,nalbuphine,63.53,"opioid receptor agonist, opioid receptor antagonist","1.23, 0.38",,BRD-K66404838,"44.44, 22.22","OPRD1, OPRK1, OPRM1"
CP,elvitegravir,63.31,"HIV integrase inhibitor, HIV inhibitor","1.10, 0.33",,BRD-K54472332,"10.00, 10.00",
CP,tetrahydrocannabinol-7-oic-acid,63.29,"analgesic, anti-inflammatory","1.08, 0.25",,BRD-A42831637,"11.11, 0.00",
CP,KU-C103885,63.26,cystic fibrosis transmembrane conductance regulator inhibitor,"1.35, 0.26",,BRD-K36153907,"11.11, 11.11",
CP,gatifloxacin,63.23,"topoisomerase inhibitor, DNA gyrase inhibitor","1.95, 0.56",Bacterial DNA gyrase inhibitor,BRD-A74980173,"0.00, 0.00",
CP,EMD-66684,63.23,angiotensin receptor antagonist,"1.19, 0.43",,BRD-K88759641,"10.00, 10.00",AGTR1
CP,FR-122047,-67.22,cyclooxygenase inhibitor,"0.48, 0.23",,BRD-K30990140,"10.00, 10.00",
CP,eugenitol,-67.43,"androgen receptor (AR) inhibitor, free radical scavenger, monoamine oxidase inhibitor, quorum sensing signaling modulator","1.18, 0.30",,BRD-K46068882,"0.00, 0.00","AR, MAOA"
CP,vecuronium,-67.44,acetylcholine receptor antagonist,"0.75, 0.28",,BRD-K61341215,"0.00, 0.00",CHRNA2
CP,moxonidine,-67.47,"imidazoline receptor agonist, adrenergic receptor agonist","0.56, 0.11",,BRD-K77771411,"10.00, 10.00","NISCH, ADRA2A, ADRA2B, ADRA2C"
CP,OM-137,-67.47,Aurora kinase inhibitor,"0.95, 0.15",Aurora kinase inhibitor,BRD-K21971034,"0.00, 0.00",
CP,pioglitazone,-67.49,"PPAR receptor agonist, insulin sensitizer, adiponectin expression enhancer, thiazolidinedione","0.41, 0.10",PPAR receptor agonist,BRD-A48430263,"10.00, 10.00","PPARG, INS, TRPM3"
CP,RITA,-67.58,"MDM inhibitor, thioredoxin reductase inhibitor","0.65, 0.14",MDM inhibitor,BRD-K00317371,"0.00, 0.00","MDM2, TXNRD1, TXNRD2"
CP,chloroquine,-67.64,antimalarial agent,"0.83, 0.11",,BRD-A91699651,"0.00, 0.00","CYP2C8, GSTA2, MRGPRX1, TLR9, TNF"
CP,periplocymarin,-67.88,apoptosis inducer,"2.74, 0.73",,BRD-A45333398,"0.00, 0.00",
CP,ifenprodil,-67.9,"adrenergic receptor antagonist, glutamate receptor antagonist","0.90, 0.16",,BRD-A24191444,"0.00, 0.00","GRIN1, GRIN2B"
CP,tetrindole,63.14,monoamine oxidase inhibitor,"1.74, 0.63",,BRD-A52660433,"11.11, 0.00",MAOA
CP,amperozide,63.1,"dopamine receptor antagonist, FAAH inhibitor, serotonin receptor antagonist","0.45, 0.09",,BRD-K52397688,"10.00, 0.00","HTR2A, DRD2, FAAH"
CP,hinokitiol,63.05,tyrosinase inhibitor,"1.36, 0.45",,BRD-K37691127,"0.00, 0.00",TYR
CP,cytochalasin-d,63,"actin polymerization inhibitor, actin stabilizer","1.82, 0.44",,BRD-K25504083,"0.00, 0.00",ACTB
CP,sulmazole,62.98,"calcium sensitizer, phosphodiesterase inhibitor","0.52, 0.11",,BRD-A41722204,"10.00, 10.00",
CP,bepridil,62.86,"calcium channel blocker, L-type calcium channel blocker","0.27, 0.05",,BRD-A91008255,"10.00, 10.00","ATP1A1, CACNA1A, CACNA1C, CACNA1H, CACNA2D2, CALM1, KCNQ1, KCNQ4, PDE1A, PDE1B, SCN5A, TNNC1"
CP,EBPC,62.86,aldose reductase inhibitor,"0.77, 0.24",,BRD-A96485169,"0.00, 0.00",AKR1B1
CP,"2',5'-dideoxyadenosine",62.84,adenylyl cyclase inhibitor,"1.40, 0.35",,BRD-A20131130,"0.00, 0.00",
CP,trazodone,62.74,"adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor, histamine receptor antagonist, serotonin uptake inhibitor","0.77, 0.15",,BRD-K70778732,"10.00, 10.00","HTR2A, HTR2C, SLC6A4, ADRA1A, ADRA2A, HRH1, HTR1A, HTR2B"
CP,1-monopalmitin,62.7,P glycoprotein inhibitor,"1.44, 0.56",,BRD-A80928489,"0.00, 0.00",ABCB1
CP,cercosporin,-66.3,"photoactivated to produce toxic reactive oxygen species, PKC inhibitor","2.96, 0.78",,BRD-A78360835,"0.00, 0.00",
CP,mepyramine,-66.38,histamine receptor antagonist,"0.50, 0.14",,BRD-K97564742,"0.00, 0.00",HRH1
CP,PTB1,-66.55,"AMPK activator, tyrosine phosphatase inhibitor","0.93, 0.32",,BRD-K16554956,"0.00, 0.00",PTPN1
CP,sunitinib,-66.69,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist","1.50, 0.52","FLT3 inhibitor, PDGFR/KIT inhibitor, RAF inhibitor, VEGFR inhibitor",BRD-M64432851,"10.00, 10.00","FLT3, KDR, KIT, FLT4, FLT1, PDGFRA, PDGFRB, RET, CSF1R, FGFR1"
CP,BRD-K13872703,-66.78,"chlorine/bicarbinate exchanger inhibitor, purinergic receptor antagonist","1.48, 0.40",,BRD-K13872703,"16.67, 0.00","ANO1, CLCN6, CLCN7, CLCNKA, CLCNKB, P2RY2"
CP,bendroflumethiazide,-66.85,"sodium/potassium/chloride transporter inhibitor, thiazide diuretic","0.55, 0.09",,BRD-A80017228,"0.00, 0.00","SLC12A3, CA1, CA2, CA4, KCNMA1, SLC12A1"
CP,noreleagnine,-66.96,"imidazoline receptor ligand, serotonin receptor ligand","1.11, 0.23",,BRD-K32696739,"10.00, 0.00","ADRA2A, ADRA2B, ADRA2C, HTR2A, MAOA, MAOB"
CP,alrestatin,-67.14,aldose reductase inhibitor,"1.06, 0.25",,BRD-K35498378,"0.00, 0.00",AKR1B1
CP,metixene,-67.17,acetylcholine receptor antagonist,"0.91, 0.25",,BRD-A33711280,"11.11, 0.00","CHRM5, CHRM1, CHRM2, CHRM3, CHRM4"
CP,amsacrine,-67.21,"topoisomerase inhibitor, DNA intercalating drug","2.77, 0.68",Topoisomerase inhibitor,BRD-K98490050,"0.00, 0.00","TOP2A, KCNH2"
CP,HLI-373,62.67,MDM inhibitor,"0.85, 0.25",MDM inhibitor,BRD-K17349619,"20.00, 20.00",MDM2
CP,KIN001-127,62.57,ITK inhibitor,"1.63, 0.50",,BRD-A29901043,"0.00, 0.00",ITK
CP,ZM-447439,62.53,Aurora kinase inhibitor,"0.55, 0.18",Aurora kinase inhibitor,BRD-K72703948,"10.00, 10.00","AURKA, AURKB"
CP,N6-cyclopentyladenosine,62.47,adenosine receptor agonist,"1.27, 0.39",Adenosine receptor agonist,BRD-A85234536,"0.00, 0.00","ADORA1, ADORA2A, ADORA2B, ADORA3, SLC29A1"
CP,ropivacaine,62.44,"membrane integrity inhibitor, potassium channel antagonist, sodium channel blocker","1.15, 0.35",,BRD-K50938786,"0.00, 0.00","SCN10A, SCN9A"
CP,arecaidine,62.35,acetylcholine receptor agonist,"0.78, 0.23",,BRD-K63792901,"10.00, 0.00","CHRM1, CHRM2, CHRM3, CHRM4"
CP,phenoxybenzamine,62.3,adrenergic receptor antagonist,"0.77, 0.15",,BRD-A67799922,"20.00, 20.00","ADRA2B, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2C, ADRB2, CALM1"
CP,HC-toxin,62.2,HDAC inhibitor,"1.55, 0.53",HDAC inhibitor,BRD-A39646320,"10.00, 10.00",HDAC1
CP,devazepide,62.13,"CCK receptor antagonist, gastrin inhibitor","1.43, 0.45",CCK receptor antagonist,BRD-K31238592,"20.00, 10.00","CCKAR, CCKBR, GAST"
CP,IB-MECA,62.1,"adenosine receptor agonist, granulocyte colony stimulating factor agonist","0.94, 0.30",,BRD-A20527803,"10.00, 0.00","ADORA3, ADORA1, ADORA2A, ADORA2B"
CP,YM-155,-65.74,"survivin inhibitor, XIAP expression inhibitor","2.30, 0.64",,BRD-K24681473,"0.00, 0.00",BIRC5
CP,terconazole,-65.74,"cell wall synthesis inhibitor, sterol demethylase inhibitor","0.58, 0.15",Sterol demethylase inhibitor,BRD-K86204871,"10.00, 10.00",
CP,3-amino-benzamide,-65.87,PARP inhibitor,"0.92, 0.16",,BRD-K08703257,"0.00, 0.00",PARP1
CP,rimcazole,-65.95,"sigma receptor antagonist, dopamine reuptake inhibitor","1.45, 0.64",,BRD-A63346720,"0.00, 0.00",SIGMAR1
CP,veratridine,-65.98,sodium channel activator,"1.07, 0.30",,BRD-K60923938,"0.00, 0.00","SCN1A, SCN3A, SCN8A, SCN9A"
CP,diphenoxylate,-66.03,opoid receptor agonist,"0.99, 0.19",,BRD-K41903098,"0.00, 0.00","OPRM1, OPRD1"
CP,flecainide,-66.04,"sodium channel blocker, sodium channel inhibitor, voltage-gated sodium channel blocker","0.55, 0.09",,BRD-A09472452,"0.00, 0.00","SCN5A, KCNA5, KCNA7, SCN4A"
CP,ciclacillin,-66.12,cell wall synthesis inhibitor,"1.22, 0.27",,BRD-K89046952,"0.00, 0.00",
CP,econazole,-66.13,"cell wall synthesis inhibitor, lanosterol demethylase inhibitor, sterol demethylase inhibitor","0.51, 0.15",Sterol demethylase inhibitor,BRD-A51820102,"0.00, 0.00","CYP51A1, NPY1R, NPY2R, TRPM2, TRPV5"
CP,tranilast,-66.16,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor","0.76, 0.17",,BRD-K19533706,"0.00, 0.00","HPGDS, HRH1, IDO1, IFNG, IL10, IL2, IL4, SLC22A12, TGFB1, TNF, TRPV2"
CP,MAPP-D-erythro,62,ceramidase inhibitor,"1.14, 0.49",,BRD-K76274772,"20.00, 20.00",
CP,maprotiline,61.98,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)","1.05, 0.35","Norepinephrine reuptake inhibitor, Tricyclic antidepressant",BRD-K03319035,"11.11, 0.00","SLC6A2, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2C, HTR7"
CP,azelastine,61.9,"histamine receptor antagonist, histamine release inhibitor, immunosuppressant","1.81, 0.68",,BRD-A68888262,"12.50, 0.00","HRH1, CYP2C19"
CP,BRD-K26947839,61.88,NADPH oxidase inhibitor,"0.69, 0.17",,BRD-K26947839,"0.00, 0.00",NOX1
CP,scopolamine,61.68,acetylcholine receptor antagonist,"1.14, 0.47",,BRD-A14566392,"0.00, 0.00","CHRM2, CHRM1, CHRM3, CHRM4, CHRM5, SI"
CP,phentermine,61.66,"adrenergic transmitter uptake inhibitor, dopamine transmitter uptake inhibitor, serotonin uptake inhibitor","0.49, 0.08",,BRD-K96319534,"20.00, 0.00","MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4"
CP,paclitaxel,61.53,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane","1.08, 0.30",,BRD-A23723433,"20.00, 10.00","TUBB, NR1I2, ABCB1, BCL2, CYP2C8, MAP2, MAP4, MAPT, TLR4, TUBB1"
CP,piretanide,61.48,"diuretic, glucocorticoid receptor agonist","1.20, 0.41",,BRD-K87990216,"20.00, 10.00","SLC12A1, SLC12A2"
CP,SB-225002,61.4,"CC chemokine receptor antagonist, Chemokine CXCR2  (IL-8 beta Receptor) Antagonists","1.27, 0.60",,BRD-K61323504,"10.00, 0.00",CXCR2
CP,AG-14361,61.32,PARP inhibitor,"0.64, 0.20",PARP inhibitor,BRD-K00615600,"20.00, 10.00",PARP1
CP,gefitinib,-65.26,EGFR inhibitor,"1.10, 0.50",EGFR inhibitor,BRD-K64052750,"0.00, 0.00","EGFR, CYP2C19"
CP,fluocinonide,-65.28,"corticosteroid agonist, corticosteroid hormone receptor agonist","1.74, 0.78",Glucocorticoid receptor agonist,BRD-A15297126,"0.00, 0.00","NR3C1, SERPINA6, SMO"
CP,TTNPB,-65.3,"RAR agonist, retinoid receptor agonist","0.66, 0.27",,BRD-K49685476,"0.00, 0.00","RARB, RARA, RARG"
CP,LM-1685,-65.36,cyclooxygenase inhibitor,"0.82, 0.22",,BRD-K51941867,"11.11, 0.00",PTGS2
CP,BRD-K60218670,-65.53,lipoxygenase inhibitor,"1.28, 0.23",,BRD-K60218670,"0.00, 0.00",
CP,esmolol,-65.56,adrenergic receptor antagonist,"0.56, 0.15",,BRD-A07395371,"12.50, 12.50",ADRB1
CP,pramipexole,-65.56,dopamine receptor agonist,"1.11, 0.22",,BRD-K06388322,"0.00, 0.00","DRD3, DRD2, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C"
CP,mecillinam,-65.61,cell wall synthesis inhibitor,"1.16, 0.34",,BRD-K41051431,"12.50, 12.50",
CP,U-18666A,-65.61,oxidosqualene cyclase inhibitor,"1.19, 0.26",,BRD-A81795050,"0.00, 0.00",
CP,etodolac,-65.63,"cyclooxygenase inhibitor, TRPV agonist","1.28, 0.34",,BRD-K99260425,"10.00, 10.00","PTGS2, PTGS1, RXRA, TRPV1"
CP,betahistine,61.29,"histamine receptor agonist, histamine receptor antagonist","1.58, 0.39",,BRD-K91315211,"10.00, 10.00","HRH3, HRH1"
CP,calcitriol,61.24,"vitamin D receptor agonist, hypercalcaemic agent","0.84, 0.27",Vitamin D receptor agonist,BRD-A84327315,"0.00, 0.00","VDR, CYP3A5"
CP,hymecromone,61.22,monoamine oxidase inhibitor,"0.81, 0.25",,BRD-K46424862,"0.00, 0.00",MAOA
CP,AG-494,61.18,"epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor","0.85, 0.26",,BRD-K81209512,"0.00, 0.00",EGFR
CP,ibuprofen,61.18,"cyclooxygenase inhibitor, NFkB pathway inhibitor","0.92, 0.19",,BRD-A17655518,"0.00, 0.00","PTGS2, PTGS1, ASIC1, BCL2, CFTR, CYP2C8, FABP2, PLAT, PPARG, SLC5A8, THBD"
CP,warfarin,61.18,"cytochrome P450 inhibitor, vitamin inhibitor, vitamin K epoxide reductase inhibitor","0.85, 0.22",,BRD-A24514565,"0.00, 0.00","VKORC1, CYP2C19, CYP2C8, CYP4F2"
CP,chloroxine,61.18,opioid receptor inhibitor,"1.31, 0.13",,BRD-K17075857,"0.00, 0.00",OPRK1
CP,paclitaxel,61.17,"tubulin inhibitor, microtubule stabilizing agent, microtubule stimulant, P glycoprotein inhibitor, taxane","0.64, 0.27",Tubulin inhibitor,BRD-A28746609,"20.00, 10.00","TUBB, NR1I2, ABCB1, BCL2, CYP2C8, MAP2, MAP4, MAPT, TLR4, TUBB1"
CP,niflumic-acid,61.09,cyclooxgenase inhibitor,"1.09, 0.39",,BRD-K98763141,"11.11, 11.11","CLCNKA, PTGS2, ANO1, CLCN1, CLCNKB, KCNQ1, PLA2G1B, PLA2G4A, PTGS1, UGT1A9"
CP,ibuprofen,61.03,"cyclooxygenase inhibitor, NFkB pathway inhibitor","0.76, 0.26",,BRD-K14965640,"20.00, 20.00","PTGS2, PTGS1, ASIC1, BCL2, CFTR, CYP2C8, FABP2, PLAT, PPARG, SLC5A8, THBD"
CP,CAY-10577,-64.85,casein kinase inhibitor,"1.09, 0.41",,BRD-K32836707,"10.00, 0.00",
CP,3-methyl-GABA,-64.87,GABA aminotransferase activator,"2.52, 0.88",,BRD-A62890442,"0.00, 0.00",
CP,xanthohumol,-64.91,"aromatase inhibitor, diacylglycerol O acyltransferase inhibitor, valosin containing protein inhibitor","1.35, 0.38",,BRD-K77390737,"0.00, 0.00","CYP19A1, VCP"
CP,dilazep,-64.93,"adenosine reuptake inhibitor, calcium channel antagonist, platelet aggregation inhibitor","1.32, 0.44",,BRD-K48722258,"0.00, 0.00","SLC29A1, CACNA1C"
CP,ketoconazole,-65.08,"14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor","0.83, 0.18",Sterol demethylase inhibitor,BRD-K29113274,"0.00, 0.00","AR, CYP19A1, CYP21A2, CYP2C19, CYP3A5, CYP3A7, KCNA10"
CP,kynuramine,-65.11,aryl hydrocarbon receptor activator,"0.94, 0.28",,BRD-A31227688,"0.00, 0.00",
CP,RK-682,-65.12,"heparanase inhibitor, tyrosine phosphatase inhibitor","0.58, 0.30",,BRD-A77349281,"0.00, 0.00","HPSE, PTPN1"
CP,mycophenolic-acid,-65.19,"dehydrogenase inhibitor, immunosuppressant, IMPDH inhibitor, inosine monophosphate dehydrogenase inhibitor","0.92, 0.33",IMPDH inhibitor,BRD-K31542390,"0.00, 0.00","IMPDH1, IMPDH2"
CP,PKCbeta-inhibitor,-65.21,PKC inhibitor,"0.83, 0.27",,BRD-K89687904,"0.00, 0.00",PRKCB
CP,BRD-K57954781,-65.23,"apoptosis stimulant, DNA inhibitor","1.10, 0.58",,BRD-K57954781,"0.00, 0.00",
CP,foliosidine,60.94,anticonvulsant,"0.94, 0.30",,BRD-A49734948,"0.00, 0.00",
CP,BRD-K20168484,60.85,"lipoxygenase inhibitor, leukotriene synthesis inhibitor, PPAR receptor modulator","1.44, 0.35",,BRD-K20168484,"12.50, 0.00",ALOX5AP
CP,oxotremorine,60.84,acetylcholine receptor agonist,"1.61, 0.50",,BRD-K21936341,"11.11, 11.11","CHRM2, CHRM1, CHRM3, CHRM4"
CP,buspirone,60.77,"serotonin receptor agonist, serotonin receptor partial agonist","0.68, 0.15",,BRD-K93461745,"0.00, 0.00","HTR1A, DRD2"
CP,tyrphostin-47,60.75,"EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor","1.05, 0.30",,BRD-K96778649,"0.00, 0.00",EGFR
CP,CGS-20625,60.67,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor partial agonist","0.89, 0.23",,BRD-K68103045,"0.00, 0.00","GABRA1, GABRA2, GABRA3, GABRA5"
CP,palonosetron,60.58,serotonin receptor antagonist,"1.28, 0.34",,BRD-K08924299,"0.00, 0.00",HTR3A
CP,honokiol,60.58,"AKT inhibitor, neurotrophic agent","1.67, 0.49",,BRD-K98493452,"0.00, 0.00","ALOX5, PTGS1, PTGS2"
CP,pyridine-2-aldoxime,60.4,acetylcholinesterase inhibitor,"1.45, 0.59",,BRD-K10016611,"11.11, 11.11","ACHE, BCHE"
CP,torin-2,60.39,mTOR inhibitor,"1.56, 0.48",MTOR inhibitor,BRD-K68174511,"20.00, 20.00",MTOR
CP,indirubin,-63.74,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor","1.08, 0.34",,BRD-K17894950,"11.11, 11.11","CDK1, CDK5, CCNE1, CDK2, CDK4, CDK5R1, CDK9, GSK3A, GSK3B, LCK, LRRK1, LRRK2"
CP,deferiprone,-63.89,"chelating agent, cytochrome P450 inhibitor, iron absorption inhibitor, reducing agent","0.51, 0.17",,BRD-K06878038,"0.00, 0.00",CYP4F2
CP,CGP-53353,-64.11,"EGFR inhibitor, PKC inhibitor","0.67, 0.11",PKC inhibitor,BRD-K32292990,"0.00, 0.00","EGFR, PRKCB"
CP,KUC104502N,-64.18,opioid receptor antagonist,"0.95, 0.19",,BRD-K24538644,"0.00, 0.00",OPRK1
CP,GSK-3-inhibitor-IX,-64.19,"glycogen synthase kinase inhibitor, lipoxygenase inhibitor, PKC inhibitor","1.55, 0.44","Glycogen synthase kinase inhibitor, PKC inhibitor",BRD-K04923131,"0.00, 0.00","ALOX5, GSK3A, GSK3B"
CP,tamoxifen,-64.29,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor","1.98, 0.59",Estrogen receptor antagonist,BRD-K04210847,"0.00, 0.00","ESR1, ESR2, CYP3A5, EBP, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ"
CP,latrepirdine,-64.53,"glutamate receptor antagonist, histamine receptor antagonist, serotonin receptor antagonist","1.57, 0.36",,BRD-K55703048,"0.00, 0.00","HTR6, GRIN2B, HRH1"
CP,dihydrexidine,-64.64,dopamine receptor agonist,"1.25, 0.32",,BRD-A99164655,"0.00, 0.00","DRD1, DRD2, DRD3, DRD4, DRD5"
CP,olanzapine,-64.77,"dopamine receptor antagonist, serotonin receptor antagonist","0.57, 0.17",,BRD-K18895904,"12.50, 0.00","DRD2, HTR2A, HTR2C, DRD1, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR6, HTR7, ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C8, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH2, HRH4, HTR1F, HTR2B, HTR3A, HTR5A"
CP,BRD-K61106942,-64.8,pyruvate kinase isozyme activator,"1.02, 0.26",,BRD-K61106942,"10.00, 10.00",PKM
CP,deltaline,60.25,acetylcholine receptor antagonist,"0.77, 0.28",,BRD-A99177642,"20.00, 10.00",CHRNA7
CP,ipratropium,60.21,acetylcholine receptor antagonist,"1.26, 0.40",,BRD-A07029265,"0.00, 0.00","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
CP,riluzole,60.15,"glutamate release inhibitor, dopamine receptor agonist, glutamate receptor antagonist, potassium channel blocker, Sodium Channel  Blockers, sodium channel blocker","0.35, 0.05",,BRD-K21283037,"0.00, 0.00","KCND3, KCNK10, KCNK2, KCNK4, KCNN4, SCN5A, SLC7A11"
CP,profenamine,60.13,"butyrylcholinesterase inhibitors, cholinergic receptor antagonist, glutamate receptor antagonist","1.26, 0.40",,BRD-A16311756,"0.00, 0.00","CHRM1, BCHE, CHRM2, GRIN3A"
CP,NCS-382,60.12,GABA receptor antagonist,"0.91, 0.31",,BRD-A67433117,"0.00, 0.00","GABBR1, GABBR2, SLC52A2"
CP,BRD-K71726959,60.11,CDK inhibitor,"0.63, 0.30",,BRD-K71726959,"0.00, 0.00","CDK1, CDK5"
CP,kenpaullone,60.05,"CDK inhibitor, glycogen synthase kinase inhibitor, src inhibitor","0.88, 0.39","CDK inhibitor, Glycogen synthase kinase inhibitor",BRD-K37312348,"0.00, 0.00","GSK3B, CDK1, CDK5, CCNB1, CDK2, LCK"
CP,procyclidine,60.02,anticholinergic,"1.05, 0.30",,BRD-A31800922,"0.00, 0.00","CHRM1, CHRM2, CHRM3, CHRM4"
CP,sitagliptin,60,"dipeptidyl peptidase inhibitor, HMGCR inhibitor, insulin secretagogue, tumor necrosis factor expression inhibitor","2.65, 0.89",,BRD-K19416115,"0.00, 0.00","DPP4, CYP2C8, FASLG, HMGCR, SLC22A8"
CP,benzydamine,59.85,"membrane integrity inhibitor, prostanoid receptor inhibitor","0.93, 0.26",,BRD-K76133116,"0.00, 0.00","PRSS1, PRSS2"
CP,GBR-13069,-62.71,dopamine uptake inhibitor,"2.94, 1.12",,BRD-K92577649,"0.00, 0.00",SLC6A3
CP,NTNCB,-62.87,neuropeptide receptor antagonist,"1.69, 0.73",,BRD-A94413429,"0.00, 0.00",NPY5R
CP,sirolimus,-63.11,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor","1.42, 0.40",,BRD-A23770159,"0.00, 0.00","MTOR, FKBP1A, CCR5, FGF2"
CP,CO-101244,-63.12,ionotropic glutamate receptor antagonist,"0.97, 0.23",,BRD-K55677650,"0.00, 0.00",GRIN2B
CP,PD-98059,-63.17,"MEK inhibitor, MAP kinase inhibitor","0.90, 0.23",MEK inhibitor,BRD-K62810658,"0.00, 0.00","MAP2K1, AKT1, CHEK1, GSK3B, LCK, MAP2K2, MAPK1, MAPK11, MAPK12, MAPK14, MAPK3, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1"
CP,capsazepine,-63.3,"TRPV agonist, TRPV antagonist","1.49, 0.49",,BRD-K44849676,"0.00, 0.00","TRPV1, TRPV4"
CP,BRD-K01265221,-63.41,BCL inhibitor,"1.01, 0.25",,BRD-K01265221,"10.00, 10.00",BCL2
CP,calcifediol,-63.42,vitamin D receptor agonist,"0.88, 0.28",Vitamin D receptor agonist,BRD-K77175907,"10.00, 0.00",VDR
CP,CG-930,-63.53,JNK inhibitor,"0.86, 0.28",,BRD-K84085265,"0.00, 0.00",MAPK8
CP,dienestrol,-63.72,estrogen receptor agonist,"0.34, 0.25",Estrogen receptor agonist,BRD-K95309561,"0.00, 0.00",ESR1
CP,S-14506,59.71,serotonin receptor agonist,"0.92, 0.26",Serotonin receptor agonist,BRD-K46766488,"22.22, 11.11","HTR1A, DRD2, HTR2C"
CP,deoxycholic-acid,59.66,"biliverdin reductase A activator, G protein coupled receptor agonist, unidentified pharmacological activity","0.91, 0.28",,BRD-K41170226,"10.00, 10.00","GPBAR1, EFTUD1, FPR1"
CP,acetylcholine,59.61,neurotransmitter of the peripheral and central nervous systems,"2.52, 0.67",,BRD-K82381502,"0.00, 0.00","ACHE, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2"
CP,EI-231,59.61,casein kinase inhibitor,"1.39, 0.43",,BRD-A74904029,"20.00, 10.00","CSNK2A1, CSNK2A2, CSNK2B"
CP,tyrphostin-AG-1296,59.61,FLT3 inhibitor,"0.65, 0.23",,BRD-K76064317,"10.00, 10.00",FLT3
CP,bisacodyl,59.56,stimulant laxative,"0.64, 0.26",,BRD-K39987650,"0.00, 0.00",
CP,indinavir,59.55,HIV protease inhibitor,"1.13, 0.28",HIV protease inhibitor,BRD-K33226500,"25.00, 0.00",CYP3A5
CP,BRD-A18279961,59.54,pyruvate kinase isozyme activator,"0.95, 0.18",,BRD-A18279961,"11.11, 0.00",PKM
CP,cerivastatin,59.53,HMGCR inhibitor,"0.95, 0.18",HMGCR inhibitor,BRD-K81169441,"0.00, 0.00","HMGCR, CYP2C8, CYP3A5"
CP,splitomycin,59.49,SIRT inhibitor,"1.26, 0.49",,BRD-K27710560,"0.00, 0.00","SIRT1, SIRT2"
CP,BRD-K75430629,-61.92,PI3K inhibitor,"1.33, 0.44",,BRD-K75430629,"0.00, 0.00",PIK3CD
CP,BRD-A61189834,-62.02,XIAP inhibitor,"1.20, 0.36",,BRD-A61189834,"0.00, 0.00",XIAP
CP,dexamethasone,-62.21,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant","1.47, 0.68",,BRD-A69951442,"0.00, 0.00","ANXA1, CYP3A4, CYP3A5, NOS2, NR0B1, NR3C1, NR3C2"
CP,radicicol,-62.34,"HSP inhibitor, ATP citrase lyase inhibitor, MAP kinase inhibitor, opioid receptor ligand, pyruvate dehydrogenase kinase inhibitor","2.09, 0.76",HSP inhibitor,BRD-K33551950,"0.00, 0.00","ACLY, DLAT, HSP90AB1, HSP90B1, MAP3K7, OPRM1, PDK3"
CP,articaine,-62.42,local anesthetic,"1.18, 0.34",,BRD-A70514680,"0.00, 0.00",
CP,cyclosporin-a,-62.46,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor","1.84, 0.53",,BRD-A69815203,"0.00, 0.00","PPIA, ABCB11, CAMLG, CYP3A5, CYP3A7, FPR1, PPID, PPIF, PPP3CA, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3"
CP,indapamide,-62.48,"carbonic anhydrase inhibitor, thiazide diuretic","1.00, 0.23",Na-K-Cl transporter inhibitor,BRD-A95869247,"11.11, 11.11","KCNQ1, CA7, KCNE1, SLC12A3"
CP,mycophenolate-mofetil,-62.66,"dehydrogenase inhibitor, hydroxycarboxylic acid receptor agonist, immunosuppressant, IMPDH inhibitor, inosine monophosphate dehydrogenase inhibitor","1.16, 0.33",IMPDH inhibitor,BRD-K92428153,"0.00, 0.00","IMPDH1, IMPDH2, HCAR2"
CP,perospirone,-62.69,"dopamine receptor antagonist, serotonin receptor antagonist","0.90, 0.18",,BRD-K85503079,"0.00, 0.00","DRD2, HTR2A, DRD3, DRD4, HTR2C"
CP,SA-792728,-62.71,"sphingosine kinase inhibitor, ATPase inhibitor","1.88, 0.68",,BRD-K20755323,"10.00, 0.00","SPHK1, VCP"
CP,E-4031,59.25,"polarization inhibitor, potassium channel antagonist, potassium channel blocker","0.72, 0.18",,BRD-K41713976,"0.00, 0.00","KCNH2, KCNH1"
CP,calcipotriol,59.24,vitamin D receptor agonist,"1.07, 0.26",Vitamin D receptor agonist,BRD-K56429665,"11.11, 11.11",VDR
CP,psoromic-acid,59.17,Rab-Prenylation Inhibitor,"1.73, 0.28",,BRD-K04170657,"0.00, 0.00",
CP,nalbuphine,59.01,"opioid receptor agonist, opioid receptor antagonist","1.08, 0.34",,BRD-A92651262,"20.00, 10.00","OPRD1, OPRK1, OPRM1"
CP,nadolol,58.94,adrenergic receptor antagonist,"0.72, 0.11",,BRD-A87606379,"10.00, 0.00","ADRB1, ADRB2, ADRB3"
CP,VX-702,58.92,p38 MAPK inhibitor,"1.49, 0.30",P38 MAPK inhibitor,BRD-K07736136,"0.00, 0.00","MAPK14, MAPK11, MAPK12"
CP,cabergoline,58.87,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor","1.43, 0.36",,BRD-A63043573,"10.00, 10.00","DRD2, ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, ADRA1B, ADRA1D, ADRB1, ADRB2, HTR7, PRL"
CP,JWE-035,58.81,Aurora kinase inhibitor,"1.50, 0.56",Aurora kinase inhibitor,BRD-K83972459,"0.00, 0.00",AURKA
CP,NU-7441,58.78,"DNA dependent protein kinase, DNA dependent protein kinase inhibitor, P glycoprotein inhibitor","1.41, 0.63",DNA dependent protein kinase inhibitor,BRD-K00337317,"0.00, 0.00","PRKDC, ABCB1"
CP,droperidol,58.76,"dopamine receptor antagonist, dopamine receptor","0.52, 0.11",Dopamine receptor antagonist,BRD-K97158071,"0.00, 0.00","DRD2, ADRA1A"
CP,cimaterol,-61.24,adrenergic receptor agonist,"0.82, 0.26",Beta-adrenergic receptor agonist,BRD-A65440446,"0.00, 0.00",
CP,SB-590885,-61.27,RAF inhibitor,"0.90, 0.41",RAF inhibitor,BRD-K01253243,"0.00, 0.00",BRAF
CP,mibefradil,-61.29,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker","1.25, 0.33",,BRD-A48631911,"0.00, 0.00","CACNA1G, CACNA1H, CACNA1C, CACNA1I, ANO1, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP3A5, CYP3A7, SCN2A, SCN4A, SCN5A, SCN9A"
CP,amlexanox,-61.3,"histamine release inhibitor, mediator release inhibitor","1.24, 0.34",,BRD-K29530284,"0.00, 0.00","FGF1, IL3, S100A12, S100A13"
CP,fillalbin,-61.34,increases arterial blood pressure,"0.75, 0.22",,BRD-K28667196,"0.00, 0.00",
CP,zuclopenthixol,-61.34,dopamine receptor antagonist,"0.95, 0.25",,BRD-K28761384,"10.00, 10.00","DRD2, DRD1, ADRA1A, ADRA2A, DRD5, HRH1, HTR2A"
CP,VUF-5681,-61.57,histamine receptor antagonist,"0.89, 0.35",,BRD-K62206109,"0.00, 0.00",HRH3
CP,troglitazone,-61.66,"PPAR receptor agonist, insulin sensitizer, CCK ligand expression inhibitor, EGR1 expression enhancer, glycogen synthase kinase stimulant","0.83, 0.27",PPAR receptor agonist,BRD-A13084692,"0.00, 0.00","PPARG, ACSL4, AKR1B1, CCL2, CYP3A4, ESRRA, ESRRG, INS, SERPINE1, SLC29A1, TRPM3"
CP,KF-38789,-61.7,P selectin inhibitor,"2.00, 0.59",,BRD-A54927599,"0.00, 0.00",SELP
CP,L-689560,-61.77,glutamate receptor antagonist,"1.13, 0.25",,BRD-K74284736,"0.00, 0.00","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D"
CP,ozagrel,58.71,"thromboxane synthase inhibitor, platelet aggregation inhibitor, selective thromboxane synthetase inhibitor","1.06, 0.34",,BRD-K19525698,"10.00, 0.00",TBXAS1
CP,VU-0418947-2,58.7,hypoxia inducible factor activator,"1.82, 0.63",HIF activator,BRD-K76907295,"11.11, 0.00",
CP,5'-guanidinonaltrindole,58.67,opioid receptor antagonist,"1.44, 0.57",,BRD-A33084410,"11.11, 11.11",
CP,amodiaquine,58.61,histamine N-methyltransferase inhibitor,"1.06, 0.34",,BRD-K91290917,"0.00, 0.00","HNMT, CYP2C8"
CP,iocetamic-acid,58.54,molecule used as a contrast medium,"0.77, 0.35",,BRD-A37492983,"0.00, 0.00",
CP,L-655708,58.46,GABA receptor inverse agonist,"0.99, 0.30",,BRD-A84389091,"0.00, 0.00","GABRA5, GABRA1, GABRA2, GABRA3, GABRG2"
CP,cyproheptadine,58.32,"histamine receptor antagonist, serotonin receptor antagonist","1.19, 0.47",,BRD-K28143534,"0.00, 0.00","HRH1, ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HTR2A, HTR2B, HTR2C, HTR6, HTR7"
CP,nisoxetine,58.27,"dopamine transporter inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor","0.66, 0.16",,BRD-A95696066,"0.00, 0.00","SLC6A2, SLC6A3, SLC6A4"
CP,vinpocetine,58.26,"phosphodiesterase inhibitor, sodium channel blocker, voltage-sensitive sodium channel inhibitor","0.94, 0.38",,BRD-A19374631,"0.00, 0.00","PDE1A, PDE1C, SCN10A"
CP,meropenem,58.23,cell wall synthesis inhibitor,"0.94, 0.31",,BRD-K01612348,"11.11, 11.11",
CP,osthol,-60.67,"ACAT inhibitor, GABA receptor modulator","0.73, 0.13",,BRD-K78294846,"0.00, 0.00",
CP,podophyllotoxin,-60.73,"caspase activator, insulin growth factor receptor inhibitor, microtubule inhibitor, tubulin inhibitor","1.50, 0.43",Tubulin inhibitor,BRD-K47869605,"0.00, 0.00","IGF1R, CASP3, TOP2A, TUBA4A, TUBB"
CP,TAK-715,-60.73,"p38 MAPK inhibitor, tumor necrosis factor production inhibitor","0.60, 0.20",P38 MAPK inhibitor,BRD-K52751261,"10.00, 0.00","MAPK14, TNF"
CP,medrysone,-60.75,"corticosteroid hormone receptor agonist, glucocorticoid receptor agonist","0.80, 0.24",,BRD-K56515112,"0.00, 0.00",NR3C1
CP,TCPOBOP,-60.75,constitutive androstane receptor (CAR) agonist,"1.01, 0.31",,BRD-K30743633,"10.00, 10.00",NR1I3
CP,treprostinil,-60.87,prostacyclin analog,"0.99, 0.23",,BRD-A67438293,"11.11, 0.00","PTGIR, CYP2C8, P2RY12, PPARD, PTGDR, PTGER1, PTGER2, PTGER3, PTGER4"
CP,BRD-K16604360,-60.89,"antiamyloidogenic agent, dopamine receptor agonist","0.63, 0.16",,BRD-K16604360,"10.00, 0.00",
CP,tyrphostin-AG-1295,-60.97,"FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor","1.66, 0.44",,BRD-K57926513,"0.00, 0.00","FLT3, KDR, PDGFRA, PDGFRB"
CP,ramipril,-60.97,angiotensin converting enzyme inhibitor,"1.52, 0.49",,BRD-A65739223,"0.00, 0.00",ACE
CP,isogedunin,-61.07,HSP inhibitor,"1.13, 0.20",,BRD-A52326238,"0.00, 0.00",
CP,everolimus,58.23,"mTOR inhibitor, angiogenesis inhibitor, cell cycle inhibitor, immunosuppressant, protein kinase inhibitor, rotamase inhibitor","1.93, 0.51",,BRD-K13514097,"10.00, 0.00","MTOR, CYP3A5, FKBP1A"
CP,metyrapone,58.2,"cytochrome P450 inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, mineralocorticoid receptor antagonist","0.67, 0.19",,BRD-K46862739,"0.00, 0.00","CYP11B1, HSD11B1, NR3C2"
CP,AR-A014418,58,glycogen synthase kinase inhibitor,"0.88, 0.19",Glycogen synthase kinase inhibitor,BRD-K67860401,"0.00, 0.00",GSK3B
CP,pemoline,57.97,non-narcotic dopaminergic compound,"0.68, 0.18",,BRD-A80793822,"0.00, 0.00",
CP,tenoxicam,57.95,"cyclooxygenase inhibitor, prostanoid receptor inhibitor","0.67, 0.11",,BRD-A22844106,"0.00, 0.00","PTGS2, PTGS1"
CP,tizanidine,57.9,adrenergic receptor agonist,"1.50, 0.47",,BRD-K06335600,"11.11, 11.11","ADRA2A, ADRA2B, ADRA2C, CYP1A2, NISCH"
CP,ropinirole,57.82,"dopamine receptor agonist, dopamine receptor modulator","0.89, 0.31",,BRD-K15933101,"0.00, 0.00","DRD2, DRD3, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C"
CP,dichloroacetic-acid,57.72,"pyruvate dehydrogenase kinase inhibitor, pyruvate dehydrogenase stimulant","1.33, 0.38",,BRD-K13664374,"12.50, 12.50",PDK1
CP,prednisolone,57.66,glucocorticoid receptor agonist,"0.86, 0.39",Glucocorticoid receptor agonist,BRD-A01643550,"10.00, 10.00","NR3C1, NR3C2, SERPINA6"
CP,tyrphostin-1,57.66,epidermal growth factor receptor (EGFR) inhibitor,"0.55, 0.13",,BRD-K41996876,"0.00, 0.00",EGFR
CP,L-701324,-60.19,glutamate receptor antagonist,"0.68, 0.17",,BRD-K08109516,"10.00, 10.00","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D"
CP,memantine,-60.2,"glutamate receptor antagonist, glutamate release inhibitor","1.42, 0.47",,BRD-K91938660,"12.50, 12.50","GRIN1, CHRFAM7A, CYP2E1, DRD2, GRIN2A, GRIN2B, GRIN3A, HTR3A"
CP,pyrvinium-pamoate,-60.25,"AKT inhibitor, androgen receptor (AR) inhibitor, androgen receptor antagonist","2.96, 0.81",,BRD-M86331534,"0.00, 0.00",AR
CP,thiotepa,-60.26,cytochrome P450 inhibitor,"1.48, 0.39",,BRD-K09631521,"0.00, 0.00",CYP2B6
CP,2-aminopurine,-60.44,serine/threonine protein kinase inhibitor,"1.43, 0.39",,BRD-K35128472,"0.00, 0.00",
CP,MRS-1845,-60.45,calcium channel blocker,"1.08, 0.34",,BRD-A32949107,"0.00, 0.00",ORAI1
CP,leu-enkephalin,-60.46,opioid receptor agonist,"1.40, 0.56",,BRD-A32836748,"11.11, 11.11","OPRD1, OPRM1"
CP,tacrolimus,-60.56,"calcineurin inhibitor, FK506-binding protein inhibitor, immunosuppressant, insulin expression inhibitor, interleukin receptor antagonist, macrolide calcineurin inhibitor, rotamase inhibitor, T cell inhibitor","1.22, 0.44",,BRD-K44094599,"0.00, 0.00","FKBP1A, CYP3A5, CYP3A7"
CP,BAS-09104376,-60.62,HIV integrase inhibitor,"1.69, 0.53",,BRD-K55991774,"0.00, 0.00",
CP,Y-27632,-60.63,"ROCK inhibitor, calcium sensitizer, leucine rich repeat kinase inhibitor","1.06, 0.25",Rho associated kinase inhibitor,BRD-K44084986,"11.11, 11.11","ROCK1, ROCK2, LRRK2, PKIA, PKN2, PRKACA, PRKCE"
CP,L-670596,57.55,prostanoid receptor antagonist,"1.40, 0.35",,BRD-A85472596,"11.11, 11.11",
CP,cyclophosphamide,57.52,"alkylating agrent, BCL inhibitor, galectin inhibitor","1.06, 0.41",,BRD-A09722536,"0.00, 0.00","BCL2, CYP2B6, CYP2C19, CYP3A5, LGALS1"
CP,citalopram,57.5,"serotonin reuptake inhibitor, serotonin uptake inhibitor","1.09, 0.23",,BRD-A47598013,"10.00, 10.00","SLC6A4, SLC6A2"
CP,venlafaxine,57.5,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, norepinephrine reputake inhibitor, serotonin uptake inhibitor","0.63, 0.15",,BRD-A51714012,"10.00, 0.00","SLC6A2, SLC6A4, CYP2C19, SLC6A3"
CP,SA-1478088,57.5,metalloproteinase inhibitor,"2.35, 0.81",,BRD-K73395020,"10.00, 0.00","MMP12, MMP14, MMP2, MMP8, MMP9"
CP,byssochlamic-acid,57.35,mycotoxin,"1.36, 0.40",,BRD-K43468059,"11.11, 11.11",
CP,hyoscyamine,57.32,acetylcholine receptor inhibitor,"0.85, 0.27",,BRD-K40530731,"10.00, 0.00","CHRM1, CHRM2, CHRM3, CHRM4"
CP,clotrimazole,57.3,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, imidazole inhibitor, intermediate conductance potassium channel activator, intermediate conductance potassium channel blocker, lanosterol demethylase inhibitor, sterol demethylase inhibitor","1.44, 0.69",,BRD-K15916496,"0.00, 0.00","KCNN4, CYP3A4, CYP51A1, NR1I2, NR1I3, TRPM2, TRPM4, TRPM8"
CP,PHCCC,57.25,"glutamate receptor agonist, glutamate receptor modulator","1.11, 0.30",,BRD-A48257147,"22.22, 22.22","GRM1, GRM4"
CP,protriptyline,57.15,tricyclic antidepressant (TCA),"1.17, 0.33",Tricyclic antidepressant,BRD-K42098891,"0.00, 0.00","SLC6A2, SLC6A4"
CP,GW-9662,-59.47,PPAR receptor antagonist,"1.00, 0.25",,BRD-K93258693,"0.00, 0.00","PPARG, NCOA2, RXRA"
CP,bicalutamide,-59.48,androgen receptor antagonist,"0.67, 0.17",,BRD-A29485665,"10.00, 10.00","AR, CYP2C19"
CP,NF-449,-59.54,purinergic receptor antagonist,"1.60, 0.48",,BRD-K36324071,"0.00, 0.00",P2RX1
CP,sappanone-a,-59.59,"melanogenesis inhibitor, tyrosinase inhibitor","1.13, 0.48",,BRD-K03557653,"0.00, 0.00",
CP,alfaxalone,-59.69,"11-beta hydroxysteroid dehydrogenase inhibitor, chloride channel agonist, general pump inhibitor","1.35, 0.51",,BRD-K41445866,"0.00, 0.00",HSD11B1
CP,BRD-K48974000,-59.79,CDC inhibitor,"0.70, 0.22",,BRD-K48974000,"11.11, 0.00",
CP,mepivacaine,-59.82,"potassium channel antagonist, voltage-gated sodium channel blocker","1.41, 0.36",,BRD-A03216249,"0.00, 0.00","SCN10A, SCN9A"
CP,prestwick-559,-59.95,dopamine receptor agonist,"0.68, 0.16",,BRD-K17378184,"10.00, 0.00","DRD3, ADRA1A, ADRA1D, ADRA2A, DRD1, DRD2, DRD4, HTR1A, HTR2B"
CP,primaquine,-59.98,"antimalarial agent, DNA inhibitor","0.57, 0.14",,BRD-A55913614,"0.00, 0.00","KRT7, NQO2"
CP,pipamperone,-60.01,"dopamine receptor, dopamine receptor antagonist, serotonin receptor antagonist","1.05, 0.34",Dopamine receptor antagonist,BRD-K26801045,"0.00, 0.00","DRD2, HTR2A, HRH1, HTR1A, HTR1B, HTR1D"
CP,flupirtine,57.13,"glutamate receptor antagonist, apoptosis inhibitor, opioid receptor agonist, potassium channel agonist","1.90, 0.58",,BRD-K50720187,"10.00, 0.00","KCNQ2, ADRA2A, KCNQ1, KCNQ3"
CP,aloisine,57.12,"CDK inhibitor, CFTR channel activator, glycogen synthase kinase inhibitor, JNK inhibitor","0.74, 0.28",,BRD-K51276371,"20.00, 10.00","CDK2, CDK5, CDK1, CDK5R1, CFTR, PTK2B, ZAP70"
CP,amonafide,57.1,"topoisomerase inhibitor, DNA intercalating drug","1.61, 0.44",Topoisomerase inhibitor,BRD-K56334280,"10.00, 10.00","TOP2A, TOP2B"
CP,tropisetron,56.98,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker","0.90, 0.24",,BRD-A79226577,"11.11, 0.00","HTR3A, GLRA1, GLRA2, GLRB, HTR4"
CP,quercetin,56.97,"aldose reductase inhibitor, cytokine production inhibitor, EGFR inhibitor, glucosidase inhibitor, monoamine oxidase inhibitor, polar auxin transport inhibitor, quorum sensing signaling modulator, SIRT activator, sodium channel blocker, tyrosine phosphatase inhibitor, xanthine oxidase inhibitor","0.98, 0.30",,BRD-K97399794,"0.00, 0.00","PIK3CG, AKR1B1, ATP5A1, ATP5B, ATP5C1, CYP2C8, EGFR, GAA, HCK, HIBCH, MAOA, PIM1, PTPN1, SCN5A, SIRT1, STK17B, UGT3A1, XDH"
CP,tozasertib,56.97,"Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor, Abl kinase inhibitor, mitotic inhibitor","1.70, 0.50",,BRD-K87947369,"10.00, 10.00","AURKA, AURKB, ABL1, AURKC, BCR, FLT3, JAK2, DDR2, LCK"
CP,berbamine,56.95,calmodulin antagonist,"1.76, 0.69",Calmodulin antagonist,BRD-K50464341,"0.00, 0.00",CALM1
CP,GW-9508,56.94,"Free Fatty Acid Receptor 1 (FFAR1;  GPR40) Agonists, G protein coupled receptor agonist, G-protein coupled receptor agonist","0.51, 0.08",,BRD-K71534238,"30.00, 20.00","FFAR4, FFAR1"
CP,brefeldin-a,56.9,"antibiotic that disrupts Golgi function, brefeldin A inhibited guanine nucleotide exchange protein inhibitors, golgi-specific brefeldin A-resistance guanine nucleotide exchange factor inhibitor, protein synthesis inhibitor","2.14, 0.78",Protein synthesis inhibitor,BRD-A17065207,"0.00, 0.00","ARF1, ARFGEF1, ARFGEF2, CYTH2, GBF1, SAR1A"
CP,latanoprost,56.84,prostanoid receptor agonist,"1.78, 0.70",,BRD-K10961822,"0.00, 0.00",PTGFR
CP,perphenazine,-58.74,"dopamine receptor, dopamine receptor antagonist","1.30, 0.53",Dopamine receptor antagonist,BRD-K10995081,"0.00, 0.00","DRD2, CALM1, DRD1, HRH1, HTR2A, HTR2C, HTR6, HTR7"
CP,BIBX-1382,-58.77,"EGFR inhibitor, tyrosine kinase inhibitor","1.45, 0.41",EGFR inhibitor,BRD-K70914287,"0.00, 0.00","EGFR, ERBB2"
CP,triclabendazole,-58.84,"acetylcholinesterase inhibitor, DNA methyltransferase inhibitor, microtubule inhibitor","0.83, 0.25",,BRD-K81916719,"0.00, 0.00",DNMT1
CP,tenidap,-58.85,"cyclooxygenase inhibitor, lipoxygenase inhibitor, prostanoid receptor antagonist","0.78, 0.24",,BRD-A87479750,"0.00, 0.00","ALOX5, KCNJ4, PTGS1"
CP,CAY-10415,-58.93,insulin sensitizer,"0.77, 0.24",PPAR receptor agonist,BRD-A61858259,"0.00, 0.00",INS
CP,topotecan,-59.12,topoisomerase inhibitor,"2.99, 0.69",,BRD-K55696337,"0.00, 0.00","TOP1, TOP1MT"
CP,tyrphostin-AG-112,-59.2,protein tyrosine kinase inhibitor,"1.78, 0.49",,BRD-K01192156,"0.00, 0.00",EGFR
CP,BRD-K32656671,-59.29,mannose-6-phosphate isomerate inhibitor,"1.67, 0.41",,BRD-K32656671,"0.00, 0.00",
CP,VX-222,-59.34,"HCV inhibitor, RNA-directed RNA polymerase inhibitor","0.59, 0.25",,BRD-K81783531,"0.00, 0.00",
CP,piroxicam,-59.45,cyclooxygenase inhibitor,"0.58, 0.16",,BRD-A57382968,"0.00, 0.00","PTGS2, PTGS1"
CP,dephostatin,56.81,tyrosine phosphatase inhibitor,"1.38, 0.31",,BRD-K60274257,"0.00, 0.00","PTPN1, PTPN6"
CP,metoclopramide,56.81,"dopamine receptor antagonist, serotonin receptor antagonist, serotonin receptor agonist","0.95, 0.27",,BRD-K75641298,"0.00, 0.00","DRD2, HTR3A, HTR4, CHRM1, HTR3B"
CP,mesna,56.76,sulfhydryl compound that inactivates toxic metabolites of some chemotherapeutics,"0.85, 0.32",,BRD-M40783228,"0.00, 0.00",
CP,tyrphostin-51,56.73,EGFR inhibitor,"1.35, 0.39",,BRD-K47943470,"0.00, 0.00",
CP,siguazodan,56.68,"histamine receptor antagonist, phosphodiesterase inhibitor","1.00, 0.30",,BRD-A62071884,"0.00, 0.00",PDE3A
CP,torin-1,56.68,"mTOR inhibitor, PI3K inhibitor","1.67, 0.61","MTOR inhibitor, PI3K inhibitor",BRD-K40175214,"10.00, 10.00","MTOR, PIK3CA"
CP,minoxidil,56.63,"antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant","1.34, 0.35",,BRD-K14888893,"10.00, 0.00","KCNJ8, ABCC9, KCNJ1, KCNJ10, KCNJ11, PTGS1, REN"
CP,homatropine,56.54,acetylcholine receptor antagonist,"1.42, 0.52",,BRD-A09539288,"0.00, 0.00","CES1, CHRM1"
CP,naltrexone,56.54,"opioid receptor antagonist, opioid receptor ligand","1.51, 0.63",,BRD-A83855350,"11.11, 11.11","OPRK1, OPRM1, OPRD1, SIGMAR1"
CP,nitrendipine,56.51,"calcium channel blocker, L-type calcium channel blocker","1.74, 0.41",Calcium channel blocker,BRD-A12560204,"0.00, 0.00","CACNA1C, CACNA1D, CACNA2D1, CACNA1H, CACNA1S, CACNA2D2, CACNB2, CACNG1, KCNN4"
CP,IRL-2500,-58.18,endothelin receptor antagonist,"1.14, 0.35",,BRD-A54029483,"10.00, 10.00",EDNRB
CP,avrainvillamide-analog-2,-58.25,nucleophosmin inhibitor,"0.59, 0.16",Nucleophosmin inhibitor,BRD-K42573370,"0.00, 0.00",NPM1
CP,androstanol,-58.27,constitutive androstane receptor (CAR) inhibitor,"0.99, 0.40",,BRD-U66370498,"0.00, 0.00",NR1I3
CP,emodic-acid,-58.47,"laxative, free radical generator","0.76, 0.18",,BRD-K94841585,"0.00, 0.00",
CP,STO-609,-58.47,"calcium/calmodulin dependent protein kinase inhibitor, calmodulin inhibitor","1.22, 0.38",,BRD-K52620403,"10.00, 0.00","CAMKK1, CAMKK2"
CP,cyclosporin-a,-58.56,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor","1.15, 0.44",,BRD-K13533483,"0.00, 0.00","PPIA, ABCB11, CAMLG, CYP3A5, CYP3A7, FPR1, PPID, PPIF, PPP3CA, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3"
CP,diclofenamide,-58.59,carbonic anhydrase inhibitor,"0.74, 0.23",,BRD-K71499074,"10.00, 0.00","CA1, CA2, CA4, CA12, CA7"
CP,danazol,-58.6,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator","0.77, 0.20",,BRD-K48970916,"0.00, 0.00","ESR1, GNRHR, AR, CCL2, CYP2C8, GNRHR2, PGR, TNF"
CP,SA-94315,-58.66,caspase inhibitor,"0.63, 0.11",,BRD-K20197062,"10.00, 10.00",CASP3
CP,menadione,-58.72,"CDC inhibitor, mitochondrial DNA polymerase inhibitor, phosphatase inhibitor, pyruvate kinase isozyme inhibitor","2.21, 0.41",,BRD-K78126613,"0.00, 0.00","AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PKM, PROC, PROS1, PROZ, VKORC1, VKORC1L1"
CP,atracurium,56.39,acetylcholine receptor antagonist,"1.17, 0.34",,BRD-A75935363,"12.50, 0.00",CHRNA2
CP,flumetasone,56.33,glucocorticoid receptor agonist,"1.31, 0.76",Glucocorticoid receptor agonist,BRD-A01346607,"10.00, 10.00","NR3C1, PLA2G1B"
CP,bucladesine,56.28,"adenosine receptor agonist, cAMP stimulant, vasodilator","1.34, 0.39",,BRD-A94624445,"0.00, 0.00",PRKACA
CP,BRD-K00313977,56.26,APEX inhibitor,"1.91, 0.59",,BRD-K00313977,"10.00, 0.00",APEX1
CP,bromocriptine,56,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor","0.88, 0.26",,BRD-A60274948,"11.11, 11.11","DRD2, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, ADRA1A, ADRA1B, ADRA1D, HTR6, HTR7, PRL"
CP,oxyphenonium,55.99,acetylcholine receptor antagonist,"1.41, 0.40",,BRD-A14208071,"10.00, 10.00",CHRM1
CP,norethindrone,55.92,"ovulation inhibitor, progesterone receptor agonist","1.01, 0.27",,BRD-A09349126,"0.00, 0.00",PGR
CP,veliparib,55.82,"PARP inhibitor, DNA repair enzyme inhibitor","1.06, 0.25",PARP inhibitor,BRD-K87142802,"30.00, 20.00","PARP1, PARP2"
CP,olvanil,55.82,TRPV agonist,"0.86, 0.20",Cannabinoid receptor agonist,BRD-K86958018,"10.00, 0.00","TRPV1, CNR1, GPR119"
CP,epothilone-a,55.79,microtubule stabilizing agent,"1.02, 0.40",,BRD-K71823332,"10.00, 10.00",
CP,ritonavir,-57.46,"HIV protease inhibitor, cytochrome P450 inhibitor","1.03, 0.26",,BRD-A03323675,"0.00, 0.00","CYP3A4, CYP1A2, CYP2B6, CYP2C19, CYP3A5, CYP3A7"
CP,BRD-A89049230,-57.53,thyroid-stimulating hormone receptor agonist,"0.94, 0.27",,BRD-A89049230,"0.00, 0.00",TSHR
CP,doxazosin,-57.55,adrenergic receptor antagonist,"1.22, 0.38",,BRD-A13188892,"11.11, 11.11","ADRA1D, ADRA1A, ADRA1B, CYP2C19, KCNH2, KCNH6, KCNH7"
CP,exemestane,-57.61,aromatase inhibitor,"1.02, 0.35",Aromatase inhibitor,BRD-A73741725,"0.00, 0.00",CYP19A1
CP,phentolamine,-57.61,adrenergic receptor antagonist,"1.24, 0.47",,BRD-K21317336,"0.00, 0.00","ADRA1A, ADRA2A, ADRA1B, ADRA1D, ADRA2B, ADRA2C"
CP,acetyl-farnesyl-cysteine,-57.62,inhibitor of methylation of endogenous isoprenylated proteins,"1.23, 0.43",,BRD-K79437791,"0.00, 0.00",PPARG
CP,GW-405833,-57.86,cannabinoid receptor agonist,"0.10, 0.01",Cannabinoid receptor agonist,BRD-K10705233,"0.00, 0.00",CNR2
CP,tyrphostin-AG-825,-57.93,receptor tyrosine protein kinase inhibitor,"1.22, 0.33",,BRD-K87919739,"10.00, 10.00",ERBB2
CP,camptothecin,-58.1,"topoisomerase inhibitor, beta amyloid synthesis inhibitor, hypoxia inducible factor inhibitor","2.19, 0.69",Topoisomerase inhibitor,BRD-A30437061,"0.00, 0.00","TOP1, HIF1A"
CP,olmesartan,-58.12,"angiotensin receptor antagonist, angiotensin antagonist","1.99, 0.48",,BRD-K83144676,"0.00, 0.00",AGTR1
CP,Ala-Ala-Phe-CMK,55.73,tripeptidyl peptidase inhibitor,"1.13, 0.43",,BRD-K93080877,"11.11, 0.00",TPP2
CP,protein-tyrosine-phosphatase-inhibitor-IV,55.72,tyrosine phosphatase inhibitor,"1.25, 0.42",,BRD-K02581333,"10.00, 10.00","PTPN1, PTPN11"
CP,simvastatin,55.68,HMGCR inhibitor,"1.15, 0.24",,BRD-K22134346,"10.00, 10.00","HMGCR, CYP2C8, CYP3A4, CYP3A5, ITGB2"
CP,NU-7026,55.68,"DNA dependent protein kinase inhibitor, mTOR inhibitor, PI3K inhibitor","1.02, 0.35","DNA dependent protein kinase inhibitor, MTOR inhibitor, PI3K inhibitor",BRD-K09537769,"20.00, 20.00",PRKDC
CP,fasudil,55.63,"ROCK inhibitor, calcium sensitizer, PKA inhibitor, protein kinase inhibitor, rho associated kinase inhibitor","0.91, 0.25","PKA inhibitor, Rho associated kinase inhibitor",BRD-K76617868,"0.00, 0.00","ROCK1, ROCK2, PKIA, PRKACA"
CP,GW-1929,55.44,"PPAR receptor agonist, insulin sensitizer","1.10, 0.28",PPAR receptor agonist,BRD-A15415227,"0.00, 0.00","INS, PPARG"
CP,MAZ-51,55.42,VEGFR inhibitor,"2.05, 0.74",,BRD-K95655893,"11.11, 0.00",FLT4
CP,cilastatin,55.39,dehydropeptidase inhibitor,"0.95, 0.34",,BRD-A90311807,"0.00, 0.00",DPEP1
CP,JNJ-38877605,55.37,"hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor","1.05, 0.27",,BRD-K02123250,"0.00, 0.00",MET
CP,estradiol-cypionate,55.17,estrogen receptor agonist,"1.38, 0.34",Estrogen receptor agonist,BRD-A91452556,"10.00, 10.00",ESR1
CP,altretamine,-56.96,DNA synthesis inhibitor,"0.41, 0.07",,BRD-K67043667,"0.00, 0.00",
CP,oligomycin-c,-57.06,"ATP synthase inhibitor, regulatory volume decrease inhibitor","1.44, 0.43","ATP synthase inhibitor, ATPase inhibitor",BRD-K05350981,"0.00, 0.00",ATP5A1
CP,depudecin,-57.11,HDAC inhibitor,"2.21, 0.53",HDAC inhibitor,BRD-K07888107,"0.00, 0.00","HDAC1, HDAC2"
CP,dantrolene,-57.11,calcium channel antagonist,"0.70, 0.14",,BRD-K81272440,"0.00, 0.00","RYR1, RYR3"
CP,fluprostenol,-57.22,prostaglandin F receptor agonist,"0.72, 0.15",,BRD-K31611373,"0.00, 0.00","PTGER3, PTGFR, TBXA2R"
CP,fluoxetine,-57.32,"selective serotonin reuptake inhibitor (SSRI), serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, Sodium Channel  Blockers","1.32, 0.30",,BRD-A31159102,"0.00, 0.00","SLC6A4, ANO1, CYP2C19, HTR2B"
CP,tyrphostin-AG-835,-57.32,protein tyrosine kinase inhibitor,"0.81, 0.25",,BRD-K17415526,"0.00, 0.00",EGFR
CP,ODQ,-57.34,"guanylyl cyclase inhibitor, inhibitor of soluble guanylyl cyclase, potassium channel blocker","1.08, 0.33",,BRD-K26015241,"0.00, 0.00","GUCY1A2, GUCY1A3, GUCY1B3"
CP,benzbromarone,-57.38,"calcium-activated chloride channel blocker, uric acid diuretic","0.52, 0.11",,BRD-K11717138,"0.00, 0.00","ABCC1, SLC22A12"
CP,SRC-kinase-inhibitor-I,-57.46,src inhibitor,"0.85, 0.39",,BRD-K50495309,"11.11, 11.11","CSK, LCK, RIPK2"
CP,decitabine,55.14,"DNA methyltransferase inhibitor, antimetabolite, DNA methylase inhibitor","0.89, 0.24",,BRD-K79254416,"20.00, 10.00",DNMT1
CP,vecuronium,55.14,acetylcholine receptor antagonist,"1.81, 0.50",,BRD-K20168442,"0.00, 0.00",CHRNA2
CP,scopolamine,55.11,acetylcholine receptor antagonist,"0.82, 0.25",,BRD-A49906757,"10.00, 10.00","CHRM2, CHRM1, CHRM3, CHRM4, CHRM5, SI"
CP,isorotenone,55.09,"mitochondrial complex I inhibitor, NADH-ubiquinone oxidoreductase (Complex I) inhibitor","1.10, 0.23",,BRD-K06198550,"10.00, 0.00",MT-ND1
CP,ITE,55.06,"aryl hydrocarbon receptor agonist, aryl hydrocarbon receptor ligand","1.24, 0.36",,BRD-K60298136,"0.00, 0.00",AHR
CP,GR-32191,55.06,"thromboxane receptor antagonist, prostanoid receptor antagonist","0.80, 0.28",Thromboxane receptor antagonist,BRD-K02283807,"30.00, 10.00",TBXA2R
CP,INCA-6,55.01,"calcineurin inhibitor, Inhibitor of interaction between calcineurin and its substrate nuclear factor of activated T cells (NFAT)","0.63, 0.18",,BRD-K33308633,"10.00, 0.00",NFATC1
CP,norethisterone,54.93,ovulation inhibitor,"0.67, 0.20",,BRD-K92073408,"0.00, 0.00",PGR
CP,palmitoylethanolamide,54.9,"cannabinoid receptor agonist, Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, unidentified pharmacological activity","0.83, 0.24",Cannabinoid receptor agonist,BRD-K68095457,"0.00, 0.00","CNR2, GPR119, GPR55"
CP,BD-1047,54.88,"alpha receptor antagonist, sigma receptor antagonist","0.76, 0.19",,BRD-K36864847,"10.00, 0.00",SIGMAR1
CP,EXO-1,-56.63,ARF inhibitor,"0.30, 0.06",,BRD-K78633253,"0.00, 0.00",
CP,estriol,-56.63,"estrogen receptor agonist, estrogen receptor antagonist","0.40, 0.35",,BRD-K17016787,"20.00, 20.00","ESR1, ESR2"
CP,paroxetine,-56.7,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor","1.34, 0.36",,BRD-A62326914,"0.00, 0.00","SLC6A4, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2"
CP,avrainvillamide-analog-4,-56.81,nucleophosmin inhibitor,"0.49, 0.15",Nucleophosmin inhibitor,BRD-K25079130,"0.00, 0.00",NPM1
CP,vinpocetine,-56.83,"phosphodiesterase inhibitor, sodium channel blocker, voltage-sensitive sodium channel inhibitor","0.94, 0.25",,BRD-K53318339,"0.00, 0.00","PDE1A, PDE1C, SCN10A"
CP,tolazoline,-56.84,adrenergic receptor antagonist,"0.48, 0.09",,BRD-K46211610,"0.00, 0.00","ADRA2A, ADRA2B, ADRA2C, ADRA1A, HRH1, HRH2"
CP,pyrrolidine-dithiocarbamate,-56.84,NFkB pathway inhibitor,"1.64, 0.73",NFkB pathway inhibitor,BRD-K80970344,"10.00, 10.00","HSD11B1, RELA"
CP,piceatannol,-56.9,"syk inhibitor, cyclooxygenase inhibitor, nitric oxide synthase inhibitor, SIRT activator, tyrosinase inhibitor, tyrosine kinase inhibitor","1.05, 0.30",,BRD-K26241953,"0.00, 0.00","ATP5A1, ATP5B, ATP5C1, IRF3, PTGS2, SIRT1, SYK, TYR"
CP,BRD-K76211160,-56.92,cytochrome P450 inhibitor,"0.94, 0.32",,BRD-K76211160,"0.00, 0.00",CYP11B2
CP,stiripentol,-56.92,"GABA aminotransferase inhibitor, GABA reuptake inhibitor, sodium channel blocker","1.07, 0.35",,BRD-A72441487,"0.00, 0.00","ABAT, SCN1A, SCN3A"
CP,tremorine,54.7,acetylcholine receptor agonist,"1.05, 0.24",,BRD-K08619838,"20.00, 10.00",
CP,HDAC3-selective,54.65,HDAC inhibitor,"0.56, 0.36",,BRD-K29313308,"0.00, 0.00",HDAC3
CP,pirenperone,54.57,serotonin receptor antagonist,"0.50, 0.07",,BRD-K25224017,"10.00, 0.00","HTR2A, HTR7"
CP,NBI-27914,54.43,CRF receptor antagonist,"0.73, 0.13",,BRD-K61177364,"0.00, 0.00",CRHR1
CP,PAC-1,54.33,caspase activator,"1.80, 0.50",,BRD-K92991072,"20.00, 10.00",CASP3
CP,XMD-892,54.31,"MAP kinase inhibitor, BMK inhibitor, leucine rich repeat kinase inhibitor","1.06, 0.53","Bromodomain Inhibitor, Leucine rich repeat kinase inhibitor",BRD-K50387473,"0.00, 0.00","MAPK7, DCLK2, LRRK2, PLK4, TNK1"
CP,MK-5108,54.27,Aurora kinase inhibitor,"1.05, 0.53",Aurora kinase inhibitor,BRD-K53665955,"11.11, 0.00","AURKA, AURKB, AURKC"
CP,SA-792541,54.22,"caspase activator, CDC inhibitor","0.84, 0.23",,BRD-K68143200,"20.00, 10.00","CASP3, CDC25A, CDC25B"
CP,meclofenamic-acid,54.14,"cyclooxygenase inhibitor, prostanoid receptor antagonist","0.53, 0.06",,BRD-K50398167,"10.00, 0.00","PTGS1, PTGS2, ALOX5, CNR1, KCNQ2, KCNQ3"
CP,anastrozole,54.1,aromatase inhibitor,"1.05, 0.39",,BRD-K52172416,"0.00, 0.00",CYP19A1
CP,VEGF-receptor-2-kinase-inhibitor-IV,-56.04,VEGFR inhibitor,"0.90, 0.31",,BRD-K61737877,"20.00, 0.00",KDR
CP,immepip,-56.12,histamine receptor agonist,"1.00, 0.33",,BRD-K25906698,"0.00, 0.00","HRH3, HRH4"
CP,D-4476,-56.12,"casein kinase inhibitor, TGF beta receptor inhibitor","1.18, 0.35",TGF beta receptor inhibitor,BRD-K09132007,"0.00, 0.00","CSNK1A1, CSNK1D, TGFB1"
CP,taurodeoxycholic-acid,-56.29,bile acid,"1.15, 0.38",Bile acid,BRD-K33572481,"0.00, 0.00",
CP,seneciphylline,-56.33,cytochrome P450 inhibitor,"0.83, 0.28",,BRD-K38449220,"0.00, 0.00",
CP,hydroxycholesterol,-56.38,"LXR agonist, ABC transporter expression enhancer, alpha secretase activator, beta secretase inhibitor, glutamate receptor modulator","0.92, 0.36",,BRD-A36707673,"0.00, 0.00","ABCA1, NR1H2, NR1H3"
CP,tacrine,-56.42,"acetylcholinesterase inhibitor, acetylcholine release stimulant, butyrylcholinesterase inhibitors, potassium channel antagonist","0.77, 0.17",,BRD-K81473089,"0.00, 0.00","ACHE, BCHE"
CP,indirubin,-56.43,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor","1.80, 0.53",Glycogen synthase kinase inhibitor,BRD-K53959060,"0.00, 0.00","CDK1, CDK5, CCNE1, CDK2, CDK4, CDK5R1, CDK9, GSK3A, GSK3B, LCK, LRRK1, LRRK2"
CP,nortriptyline,-56.48,"PI3K inhibitor, potassium channel blocker, tricyclic antidepressant (TCA)","1.60, 0.50",Tricyclic antidepressant,BRD-K91263825,"0.00, 0.00","KCNJ10, SLC6A2, SLC6A4, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C19, DRD2, HRH1, HTR1A, HTR2A, HTR2C, HTR6, PGRMC1, PIK3CD, SIGMAR1"
CP,SA-792709,-56.55,retinoid receptor agonist,"1.50, 0.55",,BRD-K51290057,"0.00, 0.00","RARA, RARB"
CP,KIN001-242,54.08,protein kinase inhiibor,"0.97, 0.26",,BRD-K24859147,"10.00, 10.00",RPS6KA3
CP,terbinafine,54.06,"fungal squalene monooxygenase inhibitor, squalene epoxidase inhibitor, steroid sulfatase inhibitor","0.82, 0.14",,BRD-K68132782,"0.00, 0.00","CYP2C19, CYP2C8, SQLE"
CP,omeprazole,54.04,"ATPase inhibitor, ABC transporter expression enhancer","1.30, 0.36",,BRD-A55962179,"0.00, 0.00","ATP4A, CLCN2, CYP1A2, CYP2C19"
CP,oxalomalic-acid,53.95,isocitrate dehydrogenase inhibitor,"1.95, 0.58",,BRD-A80574334,"0.00, 0.00","ACO1, IDH1"
CP,met-leu-phe,53.9,in touchstone,"1.18, 0.31",,BRD-A02189320,"0.00, 0.00",
CP,bromhexine,53.87,mucolytic,"0.56, 0.09",,BRD-K47631482,"10.00, 0.00",
CP,buddleoflavonoloside,53.86,acetylcholinesterase inhibitor,"1.34, 0.43",,BRD-K25905511,"10.00, 0.00",
CP,THM-I-94,53.86,"HDAC inhibitor, apoptosis stimulant, cell cycle inhibitor","1.81, 0.57",HDAC inhibitor,BRD-K12867552,"0.00, 0.00","HDAC1, HDAC10, HDAC2, HDAC3, HDAC6, HDAC8"
CP,chelidonine,53.85,tubulin polymerization inhibitor,"1.86, 0.72",Tubulin inhibitor,BRD-K32828673,"11.11, 0.00",
CP,BD-1063,53.68,sigma receptor antagonist,"1.31, 0.28",Sigma receptor antagonist,BRD-K29668683,"10.00, 10.00",SIGMAR1
CP,enalapril,-55.16,"angiotensin converting enzyme inhibitor, angiotensin receptor blocker","0.73, 0.19",,BRD-K57545991,"0.00, 0.00",ACE
CP,nicergoline,-55.19,adrenergic receptor antagonist,"0.76, 0.16",,BRD-K76810206,"0.00, 0.00",ADRA1A
CP,OMDM-2,-55.29,FAAH reuptake inhibitor,"1.06, 0.41",,BRD-A39522003,"0.00, 0.00",GPR119
CP,tacedinaline,-55.41,"HDAC inhibitor, cell cycle inhibitor","0.49, 0.28",,BRD-K52313696,"11.11, 11.11",HDAC1
CP,AVA,-55.64,nucleophosmin inhibitor,"0.59, 0.35",Nucleophosmin inhibitor,BRD-K10466330,"0.00, 0.00",
CP,erlotinib,-55.65,"EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor","1.18, 0.40",EGFR inhibitor,BRD-K70401845,"0.00, 0.00","EGFR, NR1I2"
CP,loxoprofen,-55.68,"cyclooxygenase inhibitor, platelet aggregation inhibitor, prostanoid receptor inhibitor","0.88, 0.30",,BRD-A43082555,"0.00, 0.00",PTGS2
CP,KUC103904N,-55.69,opioid receptor antagonist,"0.86, 0.15",,BRD-K65910366,"0.00, 0.00",
CP,BMS-182874,-55.93,endothelin receptor antagonist,"1.15, 0.31",,BRD-K56509348,"0.00, 0.00",EDNRA
CP,azacitidine,-55.94,"DNA methyltransferase inhibitor, antimetabolite, DNA methylase inhibitor, DNA synthesis inhibitor, RNA synthesis inhibitor","2.08, 0.81",,BRD-K03406345,"0.00, 0.00",DNMT1
CP,celecoxib,53.61,"cyclooxygenase inhibitor, caspase activator","0.74, 0.09",,BRD-K02637541,"0.00, 0.00","PTGS2, CA12, CASP3, CYP2C19, PDPK1"
CP,quizartinib,53.61,"FLT3 inhibitor, colony stimulating factor receptor inhibitor, KIT inhibitor, RET tyrosine kinase inhibitor","0.72, 0.17",,BRD-K93918653,"10.00, 10.00","FLT3, CSF1R, KIT, RET, PDGFRA, PDGFRB"
CP,BRD-K37940862,53.59,neuropeptide receptor antagonist,"2.22, 0.74",,BRD-K37940862,"11.11, 11.11",NPSR1
CP,RU-28318,53.58,cytochrome P450 antagonist,"0.86, 0.19",,BRD-A92585442,"11.11, 11.11",NR3C2
CP,PCO-400,53.53,"potassium channel activator, potassium channel agonist","1.10, 0.33",Potassium channel activator,BRD-K52721684,"0.00, 0.00","ABCC9, KCNJ8"
CP,homoharringtonine,53.27,"apoptosis stimulant, protein synthesis inhibitor","2.88, 0.75",Protein synthesis inhibitor,BRD-K76674262,"0.00, 0.00",RPL3
CP,ethambutol,53.22,bacterial arabinosyl transferase inhibitor,"1.17, 0.41",Bacterial cell wall synthesis inhibitor,BRD-A74500471,"0.00, 0.00",
CP,levomepromazine,53.2,dopamine receptor,"0.80, 0.26",Dopamine receptor antagonist,BRD-K35559145,"0.00, 0.00","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR2A, HTR2C"
CP,BX-795,53.15,"IKK inhibitor, PDK1 inhibitor, phosphoinositide dependent kinase inhibitor, serine/threonine kinase inhibitor, TBK1 inhibitor","2.16, 0.44",IKK inhibitor,BRD-K47983010,"0.00, 0.00","PDPK1, CDK2, CHEK1, GSK3B, IKBKE, KDR, PDK1, TBK1"
CP,fluspirilene,53.06,"dopamine receptor, dopamine receptor antagonist","0.94, 0.14",Dopamine receptor antagonist,BRD-K77947974,"10.00, 10.00","DRD2, HTR2A, CACNG1, HRH1, HTR1A, HTR1D, HTR1E"
CP,oxymetazoline,-54.21,"adrenergic receptor agonist, unidentified pharmacological activity","1.47, 0.35",,BRD-K16195444,"10.00, 10.00","ADRA1A, ADRA2A, ADRA1B, ADRA1D, ADRA2B, ADRA2C, CYP2C19, HTR1B, HTR1D, HTR2C"
CP,PIT,-54.31,purinergic receptor antagonist,"0.84, 0.32",,BRD-K43978949,"10.00, 10.00",P2RY1
CP,2-(4-methoxybenzylthio)-6-methylpyrimidin-4-ol,-54.57,matrix metalloprotease inhibitor,"0.84, 0.20",,BRD-K48115423,"0.00, 0.00",MMP13
CP,dexketoprofen,-54.63,cyclooxygenase inhibitor,"0.97, 0.20",,BRD-K43764301,"0.00, 0.00","CXCR1, PTGS1, PTGS2, SLC5A8"
CP,BRD-K36038115,-54.64,neuropeptide receptor antagonist,"1.09, 0.24",,BRD-K36038115,"0.00, 0.00",NPBWR1
CP,atovaquone,-54.87,"cytochrome b-c1 complex inhibitor, dihydroorotate dehydrogenase inhibitor, mitochondrial electron transport inhibitor","1.27, 0.34",,BRD-A84493640,"0.00, 0.00",DHODH
CP,lidocaine,-54.92,"histamine receptor agonist, voltage-gated sodium channel modulator","0.90, 0.19",,BRD-K52662033,"0.00, 0.00","SCN5A, EGFR, SCN10A, SCN9A"
CP,cinacalcet,-55.03,calcimimetic that activates calcium-sensing receptors,"1.19, 0.41",,BRD-K73838513,"10.00, 10.00",CASR
CP,necrostatin-1,-55.06,"RIPK inhibitor, indoleamine 2,3-dioxygenase inhibitor","0.58, 0.11",,BRD-A36318220,"0.00, 0.00","IDO1, KRR1, RIPK1"
CP,lupanine,-55.11,"ATP channel blocker, insulin secretagogue, Sodium Channel  Blockers, sodium channel blocker","0.91, 0.24",Sodium channel blocker,BRD-A92826379,"0.00, 0.00",INS
CP,AQ-RA741,52.95,acetylcholine receptor antagonist,"0.85, 0.20",,BRD-K81729199,"0.00, 0.00",
CP,sirolimus,52.95,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor","1.08, 0.47",,BRD-K84937637,"0.00, 0.00","MTOR, FKBP1A, CCR5, FGF2"
CP,thiocolchicoside,52.89,GABA receptor antagonist,"1.44, 0.57",,BRD-A11605036,"0.00, 0.00","GABRA1, GABRB2, GABRG2, GLRA1, GLRB"
CP,ceforanide,52.88,"cell wall synthesis inhibitor, penicillin binding protein inhibitor","0.76, 0.32",,BRD-K37848908,"0.00, 0.00",
CP,farnesol,52.88,"amine oxidase B inhibitor, FXR agonist","2.13, 0.48",,BRD-K24656285,"0.00, 0.00","MAOB, MVK, NR1H4"
CP,homoharringtonine,52.81,"apoptosis stimulant, protein synthesis inhibitor","2.46, 0.69",,BRD-A24643465,"0.00, 0.00",RPL3
CP,triptolide,52.74,RNA polymerase inhibitor,"1.92, 0.68",,BRD-A13122391,"10.00, 10.00","CYP2C19, RELA"
CP,ranolazine,52.69,"fatty acid oxidation partial inhibitor, Sodium Channel  Blockers, sodium channel blocker","0.36, 0.02",,BRD-A97674275,"0.00, 0.00","SCN9A, SCN10A, SCN5A, SLC22A2"
CP,cromoglicic-acid,52.64,immunosuppressant,"1.11, 0.34",,BRD-K20920669,"22.22, 11.11","KCNMA1, S100P"
CP,GR-89696,52.61,opioid receptor agonist,"0.76, 0.16",,BRD-A93659613,"10.00, 10.00",OPRK1
CP,mupirocin,-53.86,isoleucyl-tRNA synthetase inhibitor,"2.06, 0.55",,BRD-K15262564,"0.00, 0.00",
CP,KIN001-220,-53.94,Aurora kinase inhibitor,"0.97, 0.33",Aurora kinase inhibitor,BRD-K53561341,"0.00, 0.00",AURKA
CP,phylloquinone,-53.99,"antifibrinolytic agent, gamma carboxylase enzyme","1.17, 0.43",,BRD-A55815733,"0.00, 0.00","BGLAP, GGCX"
CP,heliotrine,-54.06,in touchstone,"1.08, 0.38",,BRD-A08709697,"0.00, 0.00",
CP,fenbendazole,-54.11,"cytochrome P450 inhibitor, tubulin inhibitor","0.88, 0.42",Tubulin inhibitor,BRD-K51318897,"20.00, 10.00","CYP2C19, CYP2D6, CYP2J2, CYP3A4, TUBB"
CP,oxybutynin,-54.12,acetylcholine receptor antagonist,"1.14, 0.34",,BRD-A65013509,"0.00, 0.00","CHRM3, CHRM1, CHRM2, CHRM4"
CP,PD-168077,-54.12,dopamine receptor agonist,"1.06, 0.20",,BRD-K47761761,"0.00, 0.00","DRD2, DRD4"
CP,lopinavir,-54.14,HIV protease inhibitor,"1.15, 0.41",HIV protease inhibitor,BRD-K99451608,"0.00, 0.00",
CP,topotecan,-54.15,topoisomerase inhibitor,"3.25, 0.84",Topoisomerase inhibitor,BRD-A59985574,"0.00, 0.00","TOP1, TOP1MT"
CP,alimemazine,-54.19,histamine receptor ligand,"1.67, 0.66",,BRD-A49225603,"0.00, 0.00",HRH1
CP,amcinonide,52.57,"corticosteroid agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant","1.53, 0.59",Glucocorticoid receptor agonist,BRD-A16478930,"11.11, 0.00","NR3C1, ANXA1"
CP,ergocryptine,52.57,dopamine agonist,"0.64, 0.14",,BRD-K74212935,"0.00, 0.00",
CP,demeclocycline,52.55,30S ribosomal subunit inhibitor,"1.13, 0.25",Bacterial 30S ribosomal subunit inhibitor,BRD-A75368507,"0.00, 0.00",
CP,diflunisal,52.51,"cyclooxygenase inhibitor, prostanoid receptor inhibitor","1.05, 0.19",,BRD-K22031190,"0.00, 0.00","PTGS2, PTGS1"
CP,MDL-73005EF,52.44,"serotonin receptor antagonist, serotonin receptor partial agonist","0.63, 0.07",,BRD-A50764878,"0.00, 0.00",HTR1A
CP,m-chlorophenylbiguanide,52.43,serotonin receptor agonist,"1.09, 0.35",,BRD-K36965586,"0.00, 0.00","HTR3A, HTR3B"
CP,OBAA,52.2,phospholipase inhibitor,"0.73, 0.30",,BRD-K85318537,"10.00, 10.00",PLA2G1B
CP,tramadol,52.18,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor","1.77, 0.44",,BRD-K04412738,"10.00, 10.00","OPRM1, SLC6A2, SLC6A4, CHRFAM7A, CHRM3, CYP2B6, GRIN3A, HTR2C, OPRD1, OPRK1"
CP,tubaic-acid,52.17,"mitochondrial complex I inhibitor, NADH-ubiquinone oxidoreductase (Complex I) inhibitor","1.09, 0.36",,BRD-A02176148,"10.00, 10.00",MT-ND1
CP,ganciclovir,52.14,"DNA directed DNA polymerase inhibitor, DNA polymerase inhibitor, DNA synthesis inhibitor","1.63, 0.35",DNA polymerase inhibitor,BRD-K22662435,"0.00, 0.00",
CP,PD-169316,-53.59,p38 MAPK inhibitor,"1.29, 0.28",P38 MAPK inhibitor,BRD-K77133231,"20.00, 0.00",ALOX5
CP,fludroxycortide,-53.59,"corticosteroid, glucocorticoid receptor agonist","1.34, 0.80",Glucocorticoid receptor agonist,BRD-A49765801,"0.00, 0.00","NR3C1, SERPINA6"
CP,triamcinolone,-53.64,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent","1.18, 0.77",Glucocorticoid receptor agonist,BRD-A92439610,"0.00, 0.00","NR3C1, CYP3A5, CYP3A7, SERPINA6"
CP,SA-63133,-53.65,"casein kinase inhibitor, tubulin inhibitor","1.23, 0.53",Tubulin inhibitor,BRD-K09638361,"0.00, 0.00","CSNK1E, CSNK1A1, CSNK1D, CSNK1G2"
CP,picotamide,-53.7,"prostanoid receptor antagonist, thromboxane receptor antagonist, thromboxane synthase inhibitor","0.80, 0.22",Thromboxane receptor antagonist,BRD-K67277431,"10.00, 10.00","TBXA2R, TBXAS1"
CP,FTI-276,-53.71,farnesyltransferase inhibitor,"0.58, 0.22",,BRD-K75532464,"0.00, 0.00","FNTA, FNTB"
CP,DL-PDMP,-53.72,"ceramide glucosyltransferase inhibitor, glucosyltransferase inhibitor","0.67, 0.05",,BRD-K05653692,"0.00, 0.00","ASAH1, UGCG"
CP,CGP-52432,-53.73,GABA receptor antagonist,"1.38, 0.45",GABA receptor antagonist,BRD-A04668240,"0.00, 0.00","GABBR1, GABBR2"
CP,equilin,-53.74,estrogen receptor agonist,"0.45, 0.36",Estrogen receptor agonist,BRD-K04046242,"10.00, 0.00",HSD17B1
CP,oligomycin-a,-53.78,"ATP synthase inhibitor, ATPase inhibitor","1.65, 0.45",,BRD-A81541225,"0.00, 0.00",ATP5A1
CP,hydroflumethiazide,51.98,sodium/potassium/chloride transporter inhibitor,"1.64, 0.39",,BRD-K36862742,"11.11, 11.11","SLC12A1, ATP1A1, CA1, CA12, CA2, CA4, CA9, KCNMA1"
CP,CNQX,51.97,"glutamate receptor antagonist, unidentified pharmacological activity","1.25, 0.32",,BRD-K53545112,"0.00, 0.00","GRIA1, GRIA2, GRIA3, GRIA4"
CP,nateglinide,51.89,"insulin secretagogue, ATP-sensitive potassium channel antagonist, meglitinide, sulphonylurea receptor activator","0.84, 0.27",,BRD-K84658672,"20.00, 10.00","ABCC8, KCNJ11, CYP3A4, INS, KCNJ10, PPARG"
CP,pinocembrin,51.82,"androgen receptor ligand, CYP1B1 inhibitor, reducing agent, steroid 5alpha-reductase inhibitor","0.90, 0.34",,BRD-K94689771,"0.00, 0.00","AR, CYP1B1, SRD5A1, SRD5A2"
CP,KU-0060648,51.75,"DNA dependent protein kinase, DNA dependent protein kinase inhibitor, PI3K inhibitor","1.84, 0.56","DNA dependent protein kinase inhibitor, PI3K inhibitor",BRD-K09499853,"10.00, 0.00","PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC"
CP,remoxipride,51.7,dopamine receptor antagonist,"0.72, 0.16",,BRD-K54094468,"10.00, 10.00","DRD2, DRD3, DRD4, HTR2A, SIGMAR1"
CP,BRD-K15107389,51.67,ribosomal protein inhibitor,"1.64, 0.42",,BRD-K15107389,"10.00, 0.00","RPS6KA1, RPS6KA2, RPS6KA3"
CP,sulfacetamide,51.61,antibiotic,"1.20, 0.33",,BRD-K21520694,"22.22, 0.00",
CP,palbociclib,51.57,CDK inhibitor,"2.00, 0.52",CDK inhibitor,BRD-K51313569,"0.00, 0.00","CDK4, CDK6, CCND3"
CP,tangeritin,51.49,cell cycle inhibitor,"0.98, 0.23",,BRD-K25186396,"10.00, 0.00",
CP,thiazolopyrimidine,-53.28,CDC inhibitor,"0.32, 0.08",,BRD-A75517195,"10.00, 0.00",
CP,loreclezole,-53.32,GABA receptor agonist,"0.78, 0.26",,BRD-K28137194,"0.00, 0.00","GABRB2, GABRB3"
CP,acitretin,-53.39,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor","1.64, 0.48",Retinoid receptor agonist,BRD-K62012036,"0.00, 0.00","RARA, RARB, RARG, RBP1, RXRA, RXRB, RXRG, STAT3"
CP,timolol,-53.39,adrenergic receptor antagonist,"0.59, 0.10",,BRD-K08806317,"0.00, 0.00","ADRB2, ADRB1"
CP,loteprednol,-53.4,"corticosteroid agonist, phospholipase inhibitor","1.67, 0.61",Glucocorticoid receptor agonist,BRD-K39983086,"0.00, 0.00",NR3C1
CP,acetyl-geranyl-cysteine,-53.41,Ras carboxyl methylation inhibitor,"1.15, 0.40",,BRD-U01690642,"0.00, 0.00",
CP,secoisolariciresinol,-53.41,antioxidant,"1.17, 0.33",,BRD-K91733562,"0.00, 0.00",
CP,tretinoin,-53.44,"RAR agonist, RAR receptor binder, retinoid receptor agonist, ROR ligand","0.84, 0.17",Retinoid receptor agonist,BRD-K06926592,"10.00, 10.00","RARG, RORB, ALDH1A1, ALDH1A2, GPRC5A, NR0B1, NR2C2, PPARD, RARA, RARB, RARRES1, RORC, RXRB, RXRG"
CP,clomifene,-53.47,"estrogen receptor antagonist, estrogen receptor modulator, selective estrogen receptor modulator (SERM), testosterone receptor agonist","0.50, 0.24",,BRD-K04218075,"0.00, 0.00","ESR1, AR"
CP,rhapontin,-53.52,apoptosis inducer,"1.17, 0.34",,BRD-K10098805,"22.22, 22.22",
CP,SB-205607,51.43,"delta 1 opioid receptor agonist, opioid receptor agonist","0.97, 0.34",,BRD-A11609859,"30.00, 30.00","OPRD1, OPRK1, OPRM1"
CP,wortmannin,51.35,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor","1.31, 0.38",,BRD-A75409952,"10.00, 0.00","PIK3CA, PIK3CG, PLK1, ATM, ATR, MTOR, PI4KA, PI4KB, PIK3CD, PIK3R1, PLK3, PRKDC"
CP,austricine,51.24,hypolipidemic,"1.40, 0.42",,BRD-K64236792,"0.00, 0.00",
CP,naphazoline,51.2,"adrenergic receptor agonist, peptide agonist","1.15, 0.33",,BRD-K77641333,"0.00, 0.00","ADRA1A, ADRA2A"
CP,balsalazide,51.19,"cyclooxygenase inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist","2.14, 0.53",,BRD-K41410256,"0.00, 0.00","PTGS1, PTGS2, ALOX5, PPARG"
CP,fenoldopam,51.13,dopamine receptor agonist,"0.40, 0.10",,BRD-A50684349,"0.00, 0.00","DRD1, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD4, DRD5"
CP,mocetinostat,51.13,"HDAC inhibitor, cell cycle inhibitor","1.90, 0.51",HDAC inhibitor,BRD-K16485616,"0.00, 0.00","HDAC1, HDAC2, HDAC3, HDAC11"
CP,isradipine,51.12,"calcium channel blocker, L-type calcium channel blocker","1.30, 0.35",,BRD-A90799790,"0.00, 0.00","CACNA1C, CACNA1D, CACNA2D1, CACNA1F, CACNA1H, CACNA1S, CACNA2D2, CACNB2"
CP,JAK3-inhibitor-VI,51.12,JAK inhibitor,"1.86, 0.65",JAK inhibitor,BRD-K04546108,"10.00, 10.00",JAK3
CP,O-2050,51.01,cannabinoid receptor antagonist,"1.14, 0.42",,BRD-K02590140,"0.00, 0.00",CNR1
CP,cefixime,-52.58,cell wall synthesis inhibitor,"1.49, 0.43",Bacterial cell wall synthesis inhibitor,BRD-K04993501,"0.00, 0.00",
CP,l-erythro-MAPP,-52.59,"ceramidase inhibitor, negative control for D-erythro-MAPP","0.80, 0.34",,BRD-K09635134,"0.00, 0.00",
CP,ZK-93426,-52.59,"benzodiazepine receptor agonist, benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist","1.15, 0.33",,BRD-K68392338,"0.00, 0.00","GABRA1, GABRA2, GABRA3, GABRA5"
CP,BRD-K70693222,-52.66,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor","0.75, 0.11",,BRD-K70693222,"0.00, 0.00","CLK1, CLK4, DYRK1A"
CP,BCI-hydrochloride,-52.81,"MAP kinase phosphatase inhibitor, protein phosphatase inhibitor","2.47, 0.52",,BRD-A11007541,"10.00, 0.00","DUSP1, DUSP6"
CP,alpha-estradiol,-52.86,estrogen receptor agonist,"0.41, 0.33",,BRD-A60070924,"11.11, 0.00","ESR1, ESR2, NR1I2, CYP2B6, CYP2C19, CYP2C8, CYP2E1, CYP3A5, CYP3A7, GPER1, KCNMA1"
CP,amiloride,-52.89,"sodium channel blocker, diuretic, epithelial sodium channel blocker, sodium/hydrogen exchanger inhibitor","0.32, 0.06",,BRD-K97181089,"0.00, 0.00","SCNN1A, ASIC1, ASIC2, SCNN1B, SCNN1G, AOC1, ASIC3, PKD2, PKD2L1, PLAU, SCNN1D, SLC9A1, TRPC7, TRPV2"
CP,fexofenadine,-53,histamine receptor antagonist,"0.72, 0.16",,BRD-A73368467,"0.00, 0.00",HRH1
CP,LY-320135,-53,cannabinoid receptor antagonist,"1.63, 0.51",,BRD-K78637815,"0.00, 0.00",CNR1
CP,zamifenacin,-53.14,acetylcholine receptor antagonist,"1.13, 0.31",,BRD-K80451230,"0.00, 0.00",CHRM3
CP,atorvastatin,51,"HMGCR inhibitor, dipeptidyl peptidase inhibitor, tumor necrosis factor expression inhibitor","1.50, 0.41",HMGCR inhibitor,BRD-U88459701,"0.00, 0.00","HMGCR, DPP4, AHR, CYP3A5, FASLG"
CP,BRD-A05680309,50.91,"caspase activator, XIAP inhibitor","1.26, 0.44",,BRD-A05680309,"0.00, 0.00","CASP8, XIAP"
CP,OSI-027,50.9,mTOR inhibitor,"1.35, 0.56",MTOR inhibitor,BRD-K94294671,"0.00, 0.00",MTOR
CP,tibolone,50.85,"estrogen receptor agonist, androgen receptor agonist, progesterone receptor agonist, selective estrogen receptor modulator (SERM), steryl sulfatase inhibitor","1.91, 0.58",Androgen receptor modulator,BRD-K10467831,"10.00, 0.00","AR, ESR1, PGR, STS"
CP,vincristine,50.83,"tubulin inhibitor, microtubule inhibitor, microtubule polymerization inhibitor, tubulin polymerisation inhibitor, vinca alkaloid","1.41, 0.49",,BRD-A60414806,"0.00, 0.00","TUBB, TUBA4A"
CP,losartan,50.8,angiotensin receptor antagonist,"1.78, 0.38",,BRD-K66198023,"12.50, 0.00",AGTR1
CP,raclopride,50.65,dopamine receptor antagonist,"0.45, 0.08",,BRD-K04111260,"20.00, 20.00","DRD2, DRD3, HTR1A"
CP,HO-013,50.51,PPAR receptor agonist,"1.10, 0.34",PPAR receptor agonist,BRD-K86465814,"0.00, 0.00",PPARG
CP,prednicarbate,50.51,"corticosteroid agonist, immunosuppressant, phospholipase activator","1.38, 0.64",Glucocorticoid receptor agonist,BRD-K46137903,"10.00, 0.00","NR3C1, PLA2G1B"
CP,doxylamine,50.44,histamine receptor antagonist,"0.36, 0.09",,BRD-A44008656,"10.00, 0.00","HRH1, CHRM1"
CP,PD-173074,-52.36,"FGFR inhibitor, VEGFR inhibitor","1.28, 0.40","FGFR inhibitor, VEGFR inhibitor",BRD-K97764662,"0.00, 0.00","FGFR1, FGFR3, FGFR2, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB"
CP,RS-17053,-52.37,adrenergic receptor antagonist,"1.68, 0.52",,BRD-K76840893,"0.00, 0.00","ADRA1A, ADRA1D"
CP,clioquinol,-52.45,"chelating agent, antiamyloidogenic agent, beta amyloid antagonist, carbonic anhydrase inhibitor","0.92, 0.15",,BRD-K09255212,"0.00, 0.00",OPRK1
CP,pantoprazole,-52.45,ATPase inhibitor,"0.58, 0.15",,BRD-A22380646,"0.00, 0.00","ATP4A, CYP2C19, CYP3A4"
CP,meloxicam,-52.47,"cyclooxygenase inhibitor, prostanoid receptor inhibitor","1.10, 0.35",,BRD-A84174393,"0.00, 0.00","PTGS2, PTGS1"
CP,fatostatin,-52.49,sterol regulatory element binding protein (SREBP) inhibitor,"0.88, 0.24",,BRD-K99696746,"10.00, 10.00","SREBF1, SREBF2"
CP,orantinib,-52.49,"PDGFR tyrosine kinase receptor inhibitor, FGFR inhibitor, VEGFR inhibitor, angiogenesis inhibitor, apoptosis stimulant, Aurora kinase inhibitor, FGFR antagonist, fibroblast growth factor receptor (FGFR) antagonist, fibroblast growth factor receptor inhibitor, kinase insert domain receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, serine/threonine kinase inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist","0.91, 0.41",FGFR inhibitor,BRD-K91696562,"0.00, 0.00","PDGFRB, AURKA, AURKB, KDR, EGFR, FGFR1, FGFR2, PDGFRA, TBK1"
CP,fulvestrant,-52.51,"estrogen receptor antagonist, DNA directed DNA polymerase inhibitor, soluble epoxide hydrolase inhibitor","0.74, 0.31",Estrogen receptor antagonist,BRD-A83237092,"0.00, 0.00","ESR1, EPHX2, ESR2, GPER1"
CP,MDL-72832,-52.55,serotonin receptor agonist,"0.91, 0.24",,BRD-A17453586,"0.00, 0.00",HTR1A
CP,mibefradil,-52.55,"T-type calcium channel blocker, angiogenesis inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker, sodium channel blocker","1.64, 0.48",T-type calcium channel blocker,BRD-K09549677,"0.00, 0.00","CACNA1G, CACNA1H, CACNA1C, CACNA1I, ANO1, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP3A5, CYP3A7, SCN2A, SCN4A, SCN5A, SCN9A"
CP,nafcillin,50.42,antibiotic,"0.88, 0.30",Bacterial cell wall synthesis inhibitor,BRD-K18574842,"10.00, 10.00",CYP3A4
CP,marbofloxacin,50.28,DNA gyrase inhibitor,"1.03, 0.36",Bacterial DNA gyrase inhibitor,BRD-K71926323,"11.11, 11.11",
CP,naringenin,50.26,"aromatase inhibitor, estrogen receptor agonist, quorum sensing signaling modulator, TRPM3 antagonist","1.16, 0.26",,BRD-A94669766,"30.00, 10.00","CYP19A1, ESR2, CYP1B1, GLO1, HSD17B1"
CP,MBCQ,50.26,phosphodiesterase inhibitor,"1.13, 0.39",,BRD-K64746805,"0.00, 0.00",PDE5A
CP,L-692585,50.19,"growth hormone releasing peptide ligand agonist, growth hormone secretagogue","1.06, 0.24",,BRD-K70241288,"10.00, 10.00","GH1, GHSR"
CP,chromanol,50.17,potassium channel blocker,"1.01, 0.31",Potassium channel blocker,BRD-A83695761,"22.22, 11.11",
CP,homatropine,50.1,acetylcholine receptor antagonist,"1.07, 0.39",,BRD-A74975734,"0.00, 0.00","CES1, CHRM1"
CP,carbenoxolone,50.08,11-beta hydroxysteroid dehydrogenase inhibitor,"0.97, 0.31",,BRD-A98702003,"0.00, 0.00","HSD11B1, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3"
CP,nifedipine,50.08,"calcium channel blocker, L-type calcium channel blocker","1.26, 0.40",,BRD-A30977374,"25.00, 25.00","CACNA1C, CACNA1D, CACNA1S, CACNA2D1, CACNA1F, CACNA1H, CACNB2, CALM1, CYP3A5, GLRA1, GLRA3, GLRB, KCNA1, KCNA5, NR1I2, TRPM3"
CP,dorsomorphin,50,"AMPK inhibitor, DNA damaging, TGF beta receptor inhibitor","1.16, 0.24",,BRD-K54233340,"0.00, 0.00","ACVR1, BMPR1A, BMPR1B, EPHA2, FKBP1A, FLT1, FLT3, KDR, LCK, MKNK1, PRKAA1, RPS6KA1, SRC"
CP,tegafur,-51.8,"DNA synthesis inhibitor, thymidylate synthase inhibitor","0.58, 0.20",,BRD-A79903587,"0.00, 0.00",TYMS
CP,actarit,-51.83,interleukin receptor agonist,"1.20, 0.30",,BRD-K33483813,"12.50, 0.00",
CP,azathioprine,-51.92,"dehydrogenase inhibitor, immunosuppressant, purine antagonist","0.22, 0.05",IMPDH inhibitor,BRD-K32821942,"0.00, 0.00","HPRT1, IMPDH1, PPAT"
CP,obatoclax,-51.92,"BCL inhibitor, MCL1 inhibitor","2.15, 0.70",BCL inhibitor,BRD-K15600710,"10.00, 10.00","BCL2, BCL2L1, MCL1"
CP,benidipine,-51.93,"calcium channel blocker, L-type calcium channel blocker","0.88, 0.27",,BRD-A35519318,"0.00, 0.00","CACNA1C, CACNA1G, CYP3A5"
CP,anandamide,-51.98,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist","0.73, 0.19",,BRD-K87905482,"0.00, 0.00","CNR1, CNR2, TRPV1, CACNA1G, CACNA1H, CACNA1I, GLRA1, GPR119, GPR18, GPR55, KCNA2, KCND3, KCNK3, KCNK9, TRPM8"
CP,phloretin,-52.03,"VCAM expression inhibitor, ICAM1 expression inhibitor","0.17, 0.02",,BRD-K15563106,"0.00, 0.00","AQP9, CLCN3, SLC23A1"
CP,proxyfan,-52.12,histamine receptor modulator,"0.90, 0.24",,BRD-K77171813,"0.00, 0.00",HRH3
CP,GSK-429286A,-52.17,ROCK inhibitor,"0.80, 0.28",,BRD-A10523515,"0.00, 0.00",ROCK1
CP,clofazimine,-52.19,GK0582 inhibitor,"0.64, 0.17",,BRD-K56614220,"0.00, 0.00",
CP,eprosartan,49.99,angiotensin receptor antagonist,"1.65, 0.47",,BRD-K67977190,"0.00, 0.00",AGTR1
CP,BRD-K14609189,49.96,PPAR receptor partial agonist,"1.17, 0.28",,BRD-K14609189,"0.00, 0.00",PPARG
CP,BRD-K58033748,49.92,acetylcholine receptor antagonist,"0.73, 0.18",,BRD-K58033748,"0.00, 0.00","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
CP,RHO-kinase-inhibitor-II,49.89,ROCK inhibitor,"0.91, 0.23",Rho associated kinase inhibitor,BRD-K46678324,"11.11, 11.11",
CP,6-benzylaminopurine,49.87,purinergic receptor activator,"0.53, 0.08",,BRD-K62929068,"22.22, 22.22",
CP,artesunate,49.85,DNA synthesis inhibitor,"1.72, 0.51",,BRD-A47829399,"10.00, 10.00",
CP,BRD-K51557114,49.73,GlyT-2 inhibitor,"0.81, 0.26",,BRD-K51557114,"0.00, 0.00","GPR18, LPAR5, SLC6A5"
CP,cucurbitacin-i,49.73,"inhibitor of STAT3/JAK2 signaling, JAK inhbitor, lipocortin synthesis stimulant, STAT inhibitor","2.92, 0.80",,BRD-A28105619,"0.00, 0.00","JAK2, STAT3"
CP,calpeptin,49.72,"calpain inhibitor, proteasome inhibitor, tyrosine phosphatase inhibitor","1.59, 0.51",,BRD-K26134695,"10.00, 0.00",
CP,ZD-2079,49.66,"adrenergic receptor agonist, insulin sensitizer","1.17, 0.34",,BRD-K64157027,"0.00, 0.00",ADRB3
CP,phenethyl-isothiocyanate,-51.35,"cancer cell growth inhibitor, unidentified pharmacological activity","0.93, 0.19",,BRD-K56700933,"0.00, 0.00",CYP2E1
CP,asiatic-acid,-51.42,antioxidant and antiinflammatory agent,"0.67, 0.16",,BRD-A72758037,"0.00, 0.00",PYGM
CP,ethisterone,-51.44,androgen receptor agonist,"0.73, 0.25",,BRD-K03981224,"0.00, 0.00",TYR
CP,phenylbutazone,-51.45,"cyclooxygenase inhibitor, platelet aggregation inhibitor, prostanoid receptor inhibitor","0.66, 0.13",,BRD-K10843433,"0.00, 0.00","PTGS2, PTGS1, PTGIS"
CP,acyclovir,-51.57,"DNA polymerase inhibitor, DNA directed DNA polymerase inhibitor","1.99, 0.50",,BRD-K32318651,"0.00, 0.00",PNP
CP,chlortalidone,-51.59,"carbonic anhydrase inhibitor, diuretic, sodium ion tranport inhibitor","0.86, 0.15",,BRD-A26384407,"10.00, 0.00","CA7, CA1, CA12, CA14, CA4, SLC12A1"
CP,carprofen,-51.64,"cyclooxygenase inhibitor, prostanoid receptor inhibitor","0.85, 0.24",,BRD-A17411484,"0.00, 0.00","PTGS2, PTGS1"
CP,15-delta-prostaglandin-j2,-51.67,"PPAR receptor agonist, FXR antagonist","3.07, 0.89",,BRD-K61033289,"0.00, 0.00","PPARG, NR1H4"
CP,sertraline,-51.67,"serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor","1.59, 0.59",Serotonin receptor antagonist,BRD-K82036761,"0.00, 0.00","SLC6A4, CYP2C19, SLC6A3"
CP,celastrol,-51.8,"anti-inflammatory agent, antioxidant, HSP90 Inhibitor, NFKB pathway inhibitor, topoisomerase inhibitor","1.88, 0.49",Topoisomerase inhibitor,BRD-A80960055,"0.00, 0.00","IL1B, TNF"
CP,benzonatate,49.55,non-narcotic cough suppressant thought to act as a local anesthetic,"0.69, 0.10",,BRD-K91699951,"0.00, 0.00",SCN5A
CP,ALW-II-49-7,49.55,ephrin inhibitor,"2.11, 0.55",,BRD-K22096725,"0.00, 0.00","DDR1, EPHA2, EPHA4, EPHA7, EPHB2, EPHB4, EPHB6"
CP,tenofovir,49.53,"reverse transcriptase inhibitor, nucleoside reverse transcriptase inhibitor, nucleotide reverse transcriptase inhibitor","3.25, 0.93",,BRD-K15891719,"10.00, 0.00",
CP,KU-C103443N,49.52,"CDC inhibitor, rho GTPase inhibitor","0.75, 0.23",,BRD-A81402010,"11.11, 0.00",
CP,norgestrel,49.51,progesterone receptor agonist,"1.06, 0.30",Progesterone receptor agonist,BRD-A50928468,"0.00, 0.00","CYP2E1, PGR"
CP,lenalidomide,49.33,"angiogenesis inhibitor, cereblon inhibitor, tumor apoptosis inducer, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist","1.30, 0.36",,BRD-K05926469,"0.00, 0.00","CRBN, TNF, CDH5, PTGS2, TNFSF11"
CP,givinostat,49.33,"HDAC inhibitor, interleukin receptor antagonist, interleukin synthesis inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor release inhibitor","1.35, 0.48",HDAC inhibitor,BRD-K13810148,"0.00, 0.00","HDAC2, HDAC1, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9, IL1B, IL1R2, IL6R, TNF"
CP,CGS-12066B,49.29,serotonin receptor agonist,"0.84, 0.18",,BRD-K18909381,"0.00, 0.00","HTR1B, HTR1A, HTR1D, HTR2A, HTR2B, HTR2C"
CP,fluphenazine,49.28,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist","1.01, 0.23",,BRD-K53987533,"10.00, 10.00","DRD2, DRD1, CALM1, CHRNA7, DRD5, HRH1, HTR2A, HTR6, HTR7"
CP,farnesylthiotriazole,49.23,prenylated protein methyltransferase (PPMTase) inhibitor,"1.00, 0.34",,BRD-K96402602,"0.00, 0.00",
CP,quinethazone,-50.74,diuretic,"1.09, 0.31",Na-K-Cl transporter inhibitor,BRD-A59303141,"0.00, 0.00","CA1, CA2, SLC12A1, SLC12A2, SLC12A3"
CP,RO-28-1675,-50.82,glucokinase activator,"0.66, 0.01",,BRD-K21672174,"0.00, 0.00",GCK
CP,BRD-K98404142,-50.96,"glucose 6 phosphate dehydrogenase inhibitor, immunostimulant","0.95, 0.34",,BRD-K98404142,"0.00, 0.00",G6PD
CP,mebeverine,-50.97,acetylcholine receptor antagonist,"0.85, 0.23",,BRD-A09467419,"0.00, 0.00","CHRM1, CHRM2, CHRM3, CHRM4"
CP,piperacetazine,-51.06,antipsychotic,"1.14, 0.31",,BRD-K16277217,"0.00, 0.00",
CP,lapatinib,-51.06,"EGFR inhibitor, EGFR antagonist, epidermal growth factor receptor (EGFR) inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor","0.85, 0.32",,BRD-M07438658,"11.11, 11.11","EGFR, ERBB2, CYP3A5"
CP,tropisetron,-51.07,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker","0.98, 0.26",,BRD-A83859836,"0.00, 0.00","HTR3A, GLRA1, GLRA2, GLRB, HTR4"
CP,bis-tyrphostin,-51.16,"EGFR inhibitor, dynamin GTPase inhibitor","0.93, 0.33",,BRD-K32906660,"20.00, 20.00","DNM1, EGFR"
CP,formoterol,-51.16,adrenergic receptor agonist,"1.72, 0.67",,BRD-K54006094,"12.50, 12.50","ADRB2, CYP2C19"
CP,fluvoxamine,-51.28,"selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor","1.60, 0.43",,BRD-K31534764,"0.00, 0.00","SLC6A4, CYP2C19"
CP,diflorasone,49.22,"corticosteroid agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant","1.47, 0.31",Glucocorticoid receptor agonist,BRD-K17674993,"0.00, 0.00","NR3C1, PLA2G1B"
CP,methantheline,49.1,acetylcholine receptor antagonist,"1.14, 0.23",,BRD-K09859624,"0.00, 0.00","CHRM1, HRH2"
CP,iobenguane,49.04,radiopharmaceutical and antineoplastic agent,"1.20, 0.38",,BRD-K43860855,"0.00, 0.00",
CP,tianeptine,48.98,"selective serotonin reuptake enhancer (SSRE), serotonin reuptake enhancer, serotonin uptake enhancer","1.05, 0.33",,BRD-A53077924,"11.11, 11.11",SLC6A4
CP,clopidogrel,48.94,"purinergic receptor antagonist, platelet aggregation inhibitor, purinergic receptor inhibitor","2.81, 0.70",,BRD-K27721098,"10.00, 0.00","P2RY12, CYP2B6, CYP2C19, CYP3A5"
CP,GR-135531,48.94,melatonin receptor agonist,"1.18, 0.34",,BRD-K83023055,"22.22, 22.22",
CP,cortisone,48.88,glucocorticoid receptor agonist,"1.11, 0.26",,BRD-K43736954,"20.00, 20.00",NR3C1
CP,trimidox,48.87,"antimetabolite, ribonucleoside reductase inhibitor, ribonucleotide reductase inhibitor","1.60, 0.43",,BRD-K11801786,"11.11, 0.00",RRM1
CP,penicillin,48.83,cell wall synthesis inhibitor,"1.33, 0.38",Bacterial cell wall synthesis inhibitor,BRD-A84702196,"10.00, 10.00",
CP,BRD-K91485395,48.82,dual specificity protein phosphatase inhibitors,"1.93, 0.38",,BRD-K91485395,"11.11, 0.00",
CP,iloperidone,-50.22,"dopamine receptor antagonist, serotonin receptor antagonist","1.19, 0.39",,BRD-K48722833,"10.00, 10.00","DRD2, HTR2A, HTR1A, HTR6, HTR7, ADRA1A, ADRA2C, DRD1, DRD3, DRD4, HRH1"
CP,cyclopiazonic-acid,-50.23,ATPase inhibitor,"1.99, 0.56",ATPase inhibitor,BRD-A10420615,"0.00, 0.00",ATP2A1
CP,GW-311616,-50.27,leukocyte elastase inhibitor,"1.43, 0.49",,BRD-A38898897,"0.00, 0.00",ELANE
CP,calcitriol,-50.39,"vitamin D receptor agonist, hypercalcaemic agent","0.93, 0.18",,BRD-K27316855,"0.00, 0.00","VDR, CYP3A5"
CP,MK-212,-50.42,serotonin receptor agonist,"2.21, 0.98",,BRD-K19554809,"0.00, 0.00","HTR2A, HTR2B, HTR2C"
CP,azasetron,-50.42,serotonin receptor antagonist,"0.66, 0.13",,BRD-A44133049,"10.00, 10.00","HTR3A, HTR3B"
CP,imperatorin,-50.43,"acetylcholinesterase inhibitor, nitric oxide production inhibitor, Sodium Channel  Blockers","0.82, 0.20",,BRD-K07117950,"10.00, 0.00","ACHE, HTR7"
CP,lisuride,-50.43,"dopamine receptor agonist, prolactin inhibitor, serotonin receptor antagonist, serotonin receptor ligand","1.01, 0.27",,BRD-K88871508,"0.00, 0.00","DRD2, HTR2B, HTR2C, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, ADRA1A, HRH1, HTR6"
CP,azithromycin,-50.51,"50S ribosomal subunit inhibitor, protein synthesis inhibitor","1.00, 0.33",,BRD-K74501079,"10.00, 10.00",MLNR
CP,galantamine,-50.59,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors","1.36, 0.45",,BRD-A49148672,"11.11, 11.11","ACHE, BCHE, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG"
CP,VU-0413807-2,48.79,calcium channel blocker,"1.13, 0.25",,BRD-A52172093,"22.22, 11.11","CACNA1G, CACNA1H, CACNA1I"
CP,estradiol-valerate,48.79,estrogen receptor agonist,"1.16, 0.43",Estrogen receptor agonist,BRD-A39747742,"0.00, 0.00",ESR1
CP,PCA-4248,48.79,platelet activating factor receptor antagonist,"0.76, 0.15",,BRD-A29289453,"10.00, 10.00",PTAFR
CP,3-matida,48.73,glutamate receptor antagonist,"1.87, 0.60",,BRD-A87125127,"0.00, 0.00",GRM1
CP,dihydroergocristine,48.65,"adrenergic receptor antagonist, prolactin inhibitor, adrenergic receptor partial agonist, dopamine receptor agonist, dopamine receptor partial agonist, dopamine receptor partial antagonist, serotonin receptor antagonist","0.55, 0.10",,BRD-K97440753,"0.00, 0.00","HTR2A, ADRA1A, ADRB1, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR3A, HTR4, HTR5A, HTR6, HTR7"
CP,U-0126,48.55,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor","1.67, 0.53",,BRD-K91701654,"10.00, 0.00","AKT1, CHEK1, GSK3B, JAK2, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1"
CP,BW-B70C,48.52,lipoxygenase inhibitor,"1.08, 0.33",,BRD-A55946879,"0.00, 0.00",ALOX5
CP,curcumin,48.49,"cyclooxygenase inhibitor, AP inhibitor, CCN expression inhibitor, DNA methyltransferase inhibitor, EGFR expression inhibitor, free radical scavenger, FtsZ inhibitor, glucose 6 phosphatase inhibitor, histone N-acetyltransferase inhibitor, HIV integrase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor, tau aggregation inhibitor, unidentified pharmacological activity","1.56, 0.32",,BRD-K69690935,"0.00, 0.00","PTGS1, PTGS2, APP, CA1, CA12, CA14, CA2, CA4, CA6, CA9, CCND1, CYP3A4, DNMT1, DNMT3B, EP300, G6PC, MAPT, MMP13, MMP9, NOS2, XDH"
CP,remacemide,48.48,"glutamate receptor antagonist, glutamate receptor agonist","0.93, 0.22",,BRD-A36074203,"10.00, 0.00",GRIN1
CP,YK-4279,48.47,"apoptosis stimulant, binding of RNA helicase A to the transcription factor EWS-FLI1 inhibitor, EWS-FLI1 inhibitor","1.40, 0.68",,BRD-A62182663,"10.00, 10.00","DHX9, EWSR1, FLI1"
CP,BAY-36-7620,-49.56,glutamate receptor antagonist,"1.14, 0.31",,BRD-K54704028,"0.00, 0.00",GRM1
CP,RS-102895,-49.61,"CC chemokine receptor antagonist, CCR antagonist","1.01, 0.33",,BRD-K83063356,"0.00, 0.00",CCR2
CP,AS-604850,-49.74,"Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor","1.13, 0.32",,BRD-K63915849,"0.00, 0.00","PIK3CG, PIK3CA"
CP,noscapine,-49.93,"bradykinin receptor antagonist, tubulin polymerization inhibitor, apoptosis stimulant, microtubule inhibitor, tubulin inhibitor","1.14, 0.39",,BRD-K66043364,"22.22, 11.11","BDKRB2, SIGMAR1"
CP,quinpirole,-49.96,dopamine receptor agonist,"0.86, 0.13",,BRD-K26548821,"0.00, 0.00","DRD2, DRD3, DRD4, DRD1, HTR1A, HTR2A, HTR2B, HTR2C"
CP,amlodipine,-50,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker","1.70, 0.73",,BRD-A22032524,"0.00, 0.00","CACNA1C, CACNA1D, CACNA2D1, ABCG2, CA1, CACNA1B, CACNA1S, CACNA2D3, CACNB1, CACNB2, SMPD1"
CP,kavain,-50.02,"calcium channel modulator, mTOR inhibitor, Sodium Channel  Blockers","0.56, 0.16",,BRD-A75455249,"0.00, 0.00",MTOR
CP,arcyriaflavin-a,-50.06,CDK inhibitor,"0.88, 0.23",,BRD-K72726508,"10.00, 10.00","CCND1, CCNE1, CDK2, CDK4"
CP,dasatinib,-50.09,"KIT inhibitor, src inhibitor, Bcr-Abl kinase inhibitor, ephrin receptor inhibitor, PDGFR tyrosine kinase receptor inhibitor, yes kinase inhibitor, Abl kinase inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, discoidin domain containing receptor Inhibitor, lymphocyte specific tyrosine kinase inhibitor, tyrosine kinase inhibitor","1.44, 0.53",SRC inhibitor,BRD-K49328571,"0.00, 0.00","ABL1, FYN, LCK, SRC, KIT, YES1, BCR, EPHA2, LYN, PDGFRB, ABL2, BTK, DDR1, DDR2, PDGFRA, STAT5B"
CP,mebendazole,-50.17,"acetylcholinesterase inhibitor, microtubule inhibitor, tubulin inhibitor","1.63, 0.59",Tubulin inhibitor,BRD-K77987382,"0.00, 0.00","TUBA1A, TUBB, TUBB4B"
CP,CAY-10470,48.43,NFKB pathway inhibitor,"0.98, 0.16",,BRD-K07403598,"11.11, 0.00","NFKB1, TNF"
CP,carbinoxamine,48.43,"histamine receptor antagonist, L-type calcium channel blocker","1.30, 0.38",,BRD-A29426959,"0.00, 0.00",HRH1
CP,RO-25-6981,48.41,"ionotropic glutamate receptor antagonist, monamine transporter modulator","1.07, 0.26",,BRD-K51541829,"0.00, 0.00","GRIN2B, SLC18A2"
CP,RO-15-4513,48.39,GABA benzodiazepine site receptor inverse agonist,"0.78, 0.16",,BRD-K82823076,"10.00, 10.00","GABRA1, GABRA2, GABRA3, GABRA5, GABRA4, GABRA6, GABRB2, GABRG2"
CP,fosinopril,48.38,"angiotensin converting enzyme inhibitor, breast cancer resistance protein inhibitor","1.51, 0.53",,BRD-A51382177,"11.11, 11.11","ACE, ABCG2"
CP,avrainvillamide-analog-5,48.38,nucleophosmin inhibitor,"0.40, 0.24",Nucleophosmin inhibitor,BRD-A70731303,"11.11, 11.11",NPM1
CP,BRD-A94297859,48.38,XIAP inhibitor,"1.56, 0.43",,BRD-A94297859,"0.00, 0.00",XIAP
CP,bongkrek-acid,48.34,"mitochondrial ADP, ATP translocase inhibitor","1.39, 0.41",,BRD-A41301928,"20.00, 10.00",SLC25A4
CP,clemastine,48.26,histamine receptor antagonist,"1.03, 0.26",HRH1 antagonist,BRD-K30240666,"0.00, 0.00",HRH1
CP,dolasetron,48.24,serotonin receptor antagonist,"1.38, 0.42",,BRD-K28029915,"0.00, 0.00",HTR3A
CP,dihydroergotamine,-49.12,"serotonin receptor agonist, adrenergic receptor partial agonist, dopamine receptor agonist","1.47, 0.50",,BRD-A54845972,"0.00, 0.00","HTR1D, HTR1B, ADRA2A, DRD2, HTR1E, HTR1F, HTR2B, HTR7"
CP,amcinonide,-49.12,"corticosteroid agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant","1.36, 0.45",,BRD-A36010170,"0.00, 0.00","NR3C1, ANXA1"
CP,clobenpropit,-49.17,"histamine receptor antagonist, histamine receptor inverse agonist","0.63, 0.18",,BRD-K71430621,"10.00, 10.00","HRH3, HRH4, HRH1, HRH2"
CP,rifapentine,-49.18,"DNA directed RNA polymerase inhibitor, DNA directed DNA polymerase inhibitor","1.13, 0.32",,BRD-K28346421,"10.00, 10.00","CYP2C8, CYP3A4"
CP,CP466722,-49.18,ATM kinase inhibitor,"2.06, 0.59",,BRD-K15592317,"0.00, 0.00",ATM
CP,SB-239063,-49.21,"p38 MAPK inhibitor, interleukin inhibitor, tumor necrosis factor production inhibitor","0.83, 0.35",P38 MAPK inhibitor,BRD-K82091397,"10.00, 0.00","MAPK11, MAPK14, PTGS2, TNF"
CP,rilmenidine,-49.23,"adrenergic receptor agonist, imidazoline receptor agonist","2.49, 0.59",Imidazoline ligand,BRD-K01638814,"0.00, 0.00",NISCH
CP,CFM-1571,-49.35,guanylate cyclase activator,"0.94, 0.24",,BRD-K64341947,"10.00, 10.00",
CP,antimycin-a,-49.37,"antibiotic, electron transfer inhibitor","1.50, 0.24",ATP synthase inhibitor,BRD-K56001384,"0.00, 0.00",CYCS
CP,gemfibrozil,-49.48,"lipase clearing factor inhibitor, lipoprotein lipase activator, PPAR receptor agonist","0.83, 0.24",,BRD-K11129031,"0.00, 0.00","PPARA, CYP2C8, LPL, SLCO1B1, SLCO1B3, SLCO2B1"
CP,ampicillin,48.22,cell wall synthesis inhibitor,"1.13, 0.38",,BRD-A16754160,"0.00, 0.00",SLC15A1
CP,WAY-629,48.22,serotonin receptor agonist,"1.16, 0.34",,BRD-K55430733,"11.11, 0.00",HTR2C
CP,thapsigargin,48.21,"ATPase inhibitor, calcium channel blocker, PKC activator","1.59, 0.48",,BRD-K69023402,"0.00, 0.00",ATP2A1
CP,methazolamide,48.18,"carbonic anhydrase inhibitor, insulin sensitizer","1.56, 0.56",,BRD-K13356952,"0.00, 0.00","CA1, CA2, CA4, CA7, CA12, CA14, INS"
CP,trichostatin-a,48.11,"HDAC inhibitor, CDK expression enhancer, ID1 expression inhibitor","1.69, 0.59",HDAC inhibitor,BRD-K68202742,"0.00, 0.00","HDAC7, HDAC8, HDAC1, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC9"
CP,mifobate,48.1,"cholesterol inhibitor, PPAR receptor antagonist, renin inhibitor","1.33, 0.49",,BRD-A72066420,"11.11, 11.11","PPARG, REN"
CP,valdecoxib,48.09,cyclooxygenase inhibitor,"0.34, 0.05",,BRD-K12994359,"0.00, 0.00","PTGS2, CA12, CYP2C19"
CP,nifedipine,48.04,"calcium channel blocker, L-type calcium channel blocker","0.86, 0.28",,BRD-K96354014,"0.00, 0.00","CACNA1C, CACNA1D, CACNA1S, CACNA2D1, CACNA1F, CACNA1H, CACNB2, CALM1, CYP3A5, GLRA1, GLRA3, GLRB, KCNA1, KCNA5, NR1I2, TRPM3"
CP,levofloxacin,47.99,"topoisomerase inhibitor, DNA gyrase inhibitor","1.83, 0.38",,BRD-K09471561,"0.00, 0.00",TOP2A
CP,yohimbine,47.97,adrenergic receptor antagonist,"1.49, 0.53",,BRD-A51410489,"0.00, 0.00","ADRA2A, ADRA2C, ADRA2B, HTR1A, HTR1B, HTR1D, HTR2B, DRD2, DRD3, HTR1E, HTR1F, HTR2A, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8"
CP,selumetinib,-48.7,"MEK inhibitor, MAP kinase inhibitor","0.89, 0.32",MEK inhibitor,BRD-K57080016,"0.00, 0.00","MAP2K1, MAP2K2"
CP,HG-6-64-01,-48.75,"RAF inhibitor, Abl kinase inhibitor, ephrin receptor inhibitor, KIT inhibitor, MAP kinase inhibitor, MEK inhibitor, p38 MAPK inhibitor, src inhibitor","1.82, 0.35","PDGFR/KIT inhibitor, RAF inhibitor",BRD-U37049823,"0.00, 0.00","ABL1, BRAF, CSF1R, EGFR, FGFR1, FLT3, KIT, MAPK11, PDGFRB, RET"
CP,escitalopram,-48.77,"selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor","0.45, 0.13",,BRD-K70301876,"0.00, 0.00","SLC6A4, ADRA1A, CHRM1, CYP2C19, HRH1, SLC6A2, SLC6A3"
CP,aripiprazole,-48.8,"serotonin receptor agonist, serotonin receptor antagonist, dopamine receptor agonist, dopamine receptor partial agonist, serotonin receptor partial agonist","0.97, 0.19",,BRD-K70358946,"0.00, 0.00","DRD2, HTR1A, HTR2A, HRH1, HTR1B, HTR1D, HTR2C, ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD3, DRD4, DRD5, HTR1E, HTR3A, HTR6, HTR7"
CP,HY-11007,-48.9,"Abl kinase inhibitor, Bcr-Abl kinase inhibitor","1.40, 0.35",,BRD-K97056771,"0.00, 0.00","ABL1, BCR"
CP,RHC-80267,-48.92,triacylglycerol lipase inhibitor,"0.72, 0.19",,BRD-K56047318,"0.00, 0.00","DAGLA, DAGLB, LIPC, LIPE, LIPG"
CP,ivachtin,-49,caspase inhibitor,"1.60, 0.39",,BRD-K64402243,"0.00, 0.00",CASP3
CP,desoxypeganine,-49,"acetylcholinesterase inhibitor, monoamine oxidase inhibitor","0.45, 0.10",,BRD-K13819402,"0.00, 0.00","ACHE, MAOA"
CP,perhexiline,-49.03,"carnitine palmitoyltransferase binder, carnitine palmitoyltransferase inhibitor","2.63, 0.72",,BRD-A19633847,"0.00, 0.00","CPT1A, CPT2"
CP,beclometasone,-49.1,"glucocorticoid receptor agonist, corticosteroid hormone receptor agonist, immunosuppressant","1.28, 0.67",Glucocorticoid receptor agonist,BRD-K97810537,"10.00, 10.00","NR3C1, CYP3A5, GPR97, SERPINA6"
CP,naloxone,47.86,opioid receptor antagonist,"0.55, 0.13",,BRD-K67511046,"0.00, 0.00","OPRM1, OPRK1, OPRD1, CREB1, ESR1, TLR4"
CP,vinblastine,47.85,"microtubule formation inhibitor, tubulin inhibitor, tubulin polymerisation inhibitor","1.72, 0.49",,BRD-A22783572,"0.00, 0.00","TUBB, JUN, TUBA1A, TUBD1, TUBE1, TUBG1"
CP,I-OMe-AG-538,47.84,inhibitor of insulin growth factor 1 receptor protein tyrosine kinase,"1.02, 0.26",,BRD-K35377380,"11.11, 0.00",
CP,NNC-711,47.83,GAT inhibitor,"0.90, 0.24",,BRD-K42221274,"10.00, 0.00","SLC6A1, SIGMAR1"
CP,riboflavin,47.78,"vitamin B2, required for flavoprotein enzyme reactions","0.76, 0.19",,BRD-K92760278,"10.00, 0.00",
CP,tetramethylsilane,47.72,organosilicon compound used as an internal standard in NMR spectroscopy,"1.18, 0.18",,BRD-K45988865,"0.00, 0.00",
CP,triciribine,47.68,AKT inhibitor,"1.44, 0.15",,BRD-K80431395,"0.00, 0.00","AKT1, AKT2, AKT3"
CP,staurosporine,47.68,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor","4.04, 1.01",,BRD-K17953061,"11.11, 0.00","CDK2, GSK3B, CAMK2B, CDK1, CDK5, CHEK1, CHRM1, CHRM2, CHRM4, CSK, DAPK1, GPR35, IKBKB, ITK, LCK, LRRK2, MAP2K4, MAP2K6, MAPKAPK2, PAK2, PDPK1, PHKG2, PIK3CG, PIM1, PKN1, PRKACB, PRKCI, PRKCQ, RPS6KA1, STK3, SYK, TNIK, ZAP70"
CP,JAK3-inhibitor-I,47.6,JAK inhibitor,"0.73, 0.20",JAK inhibitor,BRD-K72541103,"0.00, 0.00",JAK3
CP,flurofamide,47.52,bacterial urease inhibitor,"1.14, 0.33",,BRD-K67445247,"0.00, 0.00",
CP,hexamethyleneamiloride,-48.43,"gonadotropin releasing factor hormone receptor antagonist, sodium/hydrogen antiport inhibitor, sodium/hydrogen exchanger inhibitor, urokinase inhibitor","0.89, 0.19",,BRD-K40990712,"10.00, 10.00","GNRHR, ADRA2A, GNRH1, PLAU, SLC9A1"
CP,esomeprazole,-48.47,"ATPase inhibitor, ABC transporter expression enhancer","1.60, 0.34",,BRD-A56892734,"12.50, 12.50","ATP4A, CYP2C19, CYP3A4"
CP,canertinib,-48.49,"EGFR inhibitor, EGFR antagonist, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor","1.59, 0.39",EGFR inhibitor,BRD-K50168500,"0.00, 0.00","EGFR, ERBB2, ERBB4, AKT1"
CP,SJ-172550,-48.53,MDM inhibitor,"2.57, 0.65",MDM inhibitor,BRD-K93095519,"0.00, 0.00",MDM4
CP,lovastatin,-48.53,HMGCR inhibitor,"0.77, 0.16",HMGCR inhibitor,BRD-K09416995,"0.00, 0.00","HMGCR, CYP3A5, HDAC2, ITGAL, NR1I2"
CP,propofol,-48.54,"membrane integrity inhibitor, membrane permeability inhibitor, TRPV agonist","0.66, 0.17",,BRD-K82255054,"0.00, 0.00","CYP2B6, FAAH, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, SCN2A, SCN4A, TRPV1"
CP,alverine,-48.56,smooth muscle relaxant,"0.90, 0.28",,BRD-K89055274,"0.00, 0.00",HTR1A
CP,quinisocaine,-48.64,anesthetic,"0.63, 0.11",,BRD-K73391359,"10.00, 10.00",
CP,entecavir,-48.68,"DNA directed DNA polymerase inhibitor, DNA polymerase inhibitor, DNA replication inhibitor, reverse transcription inhibitor, transcription inhibitor","0.91, 0.33",Reverse transcriptase inhibitor,BRD-K08206212,"10.00, 0.00",
CP,dexbrompheniramine,-48.68,histamine receptor antagonist,"1.17, 0.30",,BRD-K22947005,"0.00, 0.00",HRH1
CP,somatostatin,47.47,"somatostatin receptor agonist, growth hormone receptor antagonist, growth hormone release inhibitor, somatostatin receptor ligand","0.93, 0.34",,BRD-K14681867,"10.00, 10.00","SSTR1, SSTR2, SSTR3, SSTR4, SSTR5, GH1, GHR, OPRD1, OPRM1"
CP,phenanthridone,47.46,PARP inhibitor,"1.27, 0.39",PARP inhibitor,BRD-K11163873,"0.00, 0.00",PARP1
CP,idarubicin,47.44,"topoisomerase inhibitor, radical formation stimulant, RNA synthesis inhibitor","2.64, 0.69",Topoisomerase inhibitor,BRD-K69650333,"0.00, 0.00",TOP2A
CP,dipropyl-dopamine,47.35,dopamine receptor agonist,"2.07, 0.69",,BRD-K82577285,"0.00, 0.00",
CP,tyrphostin-AG-1478,47.34,EGFR inhibitor,"1.60, 0.51",EGFR inhibitor,BRD-K68336408,"10.00, 10.00","EGFR, MAPK14"
CP,EI-273,47.31,PKC inhibitor,"2.13, 0.88",,BRD-K56064827,"0.00, 0.00","PRKCA, PRKCG"
CP,tivozanib,47.3,"VEGFR inhibitor, KIT inhibitor, tyrosine kinase inhibitor","1.91, 0.52","PDGFR/KIT inhibitor, VEGFR inhibitor",BRD-K53414658,"0.00, 0.00","FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB"
CP,dobutamine,47.16,adrenergic receptor agonist,"0.75, 0.14",Beta-adrenergic receptor agonist,BRD-A78322124,"10.00, 0.00","ADRB1, ADRB2, ADRA1A"
CP,dihydrexidine,47.13,dopamine receptor agonist,"1.32, 0.43",,BRD-K31471398,"0.00, 0.00","DRD1, DRD2, DRD3, DRD4, DRD5"
CP,coumaric-acid,47.1,antioxidant,"1.19, 0.32",,BRD-K96271548,"0.00, 0.00",
CP,rolipram,-48.11,"phosphodiesterase inhibitor, interleukin receptor antagonist","0.74, 0.10",,BRD-A34255068,"0.00, 0.00","PDE4A, PDE4B, PDE4D, PDE4C, PDE5A"
CP,CD-437,-48.13,"RAR agonist, retinoid receptor agonist","3.42, 0.89",,BRD-K28907958,"0.00, 0.00",RARG
CP,BRD-K55186349,-48.19,apelin receptor antagonist,"0.91, 0.32",,BRD-K55186349,"0.00, 0.00",APLNR
CP,mometasone,-48.2,"glucocorticoid receptor agonist, immunosuppressant","1.19, 0.64",Glucocorticoid receptor agonist,BRD-K60640630,"0.00, 0.00",NR3C1
CP,pregnenolone,-48.27,"acetylcholine release enhancer, dopamine release enhancer, GABA receptor negative allosteric modulator, glutamate receptor modulator, progesterone receptor agonist, steroid hormone inhibitor of CYP17A1 and SULT2B1","1.01, 0.36",,BRD-A35912562,"0.00, 0.00","CYP17A1, PGR, SULT2B1"
CP,ezetimibe,-48.32,"cholesterol absorption inhibitor, Niemann-Pick C1-like 1 protein antagonist, liver bile acid transporter inhibitor, Niemann-Pick C1-like 1 protein inhibitior","1.59, 0.44",,BRD-K42260897,"0.00, 0.00","NPC1L1, ANPEP, SOAT1"
CP,BRD-K07872006,-48.35,lipoxygenase inhibitor,"0.84, 0.17",,BRD-K07872006,"0.00, 0.00",
CP,fenbufen,-48.4,cyclooxygenase inhibitor,"0.89, 0.24",Cyclooxygenase inhibitor,BRD-K12513978,"10.00, 0.00","PTGS1, PTGS2"
CP,SDZ-NKT-343,-48.42,tachykinin antagonist,"0.82, 0.22",Tachykinin antagonist,BRD-A82590476,"0.00, 0.00",TACR1
CP,mepireserpate,-48.43,catecholamine depleting sympatholytic,"1.89, 0.67",,BRD-A71765365,"0.00, 0.00","SLC18A2, SLC18A1"
CP,L-694247,47.09,serotonin receptor agonist,"0.72, 0.08",,BRD-K18816859,"0.00, 0.00","HTR1D, HTR1A, HTR1B"
CP,BRD-K48969316,47.07,caspase inhibitor,"1.26, 0.34",,BRD-K48969316,"0.00, 0.00",CASP1
CP,TG100-115,47.01,PI3K inhibitor,"1.30, 0.34",,BRD-K64785675,"0.00, 0.00","PIK3CG, PIK3CA, PIK3CB, PIK3CD"
CP,zolpidem,46.97,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist, non-benzodiazepine hypnotic","0.75, 0.16",Benzodiazepine receptor agonist,BRD-K44876623,"22.22, 22.22","GABRA1, GABRA2, GABRA3"
CP,tolcapone,46.96,"catechol O methyltransferase inhibitor, transthyretin amyloid inhibitor","1.28, 0.36",,BRD-K10852020,"0.00, 0.00","COMT, TTR"
CP,cefpodoxime,46.89,cell wall synthesis inhibitor,"1.22, 0.39",,BRD-A87387433,"0.00, 0.00",
CP,tipifarnib,46.89,"farnesyltransferase inhibitor, angiogenesis inhibitor, apoptosis stimulant","0.66, 0.16",,BRD-K63195589,"10.00, 10.00","FNTA, FNTB"
CP,maraviroc,46.78,"CC chemokine receptor antagonist, CC chemokine receptor 5 (CCR5) antagonist, reverse transcriptase inhibitor","1.38, 0.50",,BRD-A04352665,"0.00, 0.00","CCR5, CYP3A5"
CP,CGP-57380,46.66,"MAP kinase inhibitor, MAPK-interacting kinase inhibitor","1.36, 0.49",,BRD-K42500029,"0.00, 0.00","AURKB, LCK, MKNK1, MKNK2, SGK1"
CP,pyroxamide,46.58,"HDAC inhibitor, cell cycle inhibitor","1.53, 0.64",HDAC inhibitor,BRD-K11663430,"10.00, 0.00",HDAC1
CP,ephedrine,-47.84,adrenergic receptor agonist,"1.33, 0.41",,BRD-A98431941,"0.00, 0.00","ACHE, ADRA1A, ADRB2, SLC18A2, SLC6A2"
CP,zileuton,-47.85,"leukotriene synthesis inhibitor, lipoxygenase inhibitor","0.57, 0.07",,BRD-A56359832,"10.00, 10.00",ALOX5
CP,enobosarm,-47.86,"androgen receptor modulator, androgen receptor agonist","0.81, 0.18","Androgen receptor modulator, Progesterone receptor antagonist",BRD-K16621777,"0.00, 0.00",AR
CP,phosphodiesterase-V-inhibitor-II,-47.86,phosphodiesterase inhibitor,"0.68, 0.23",,BRD-K68873215,"0.00, 0.00",PDE5A
CP,yohimbine,-47.88,adrenergic receptor antagonist,"0.36, 0.11",,BRD-A87445400,"10.00, 0.00","ADRA2A, ADRA2C, ADRA2B, HTR1A, HTR1B, HTR1D, HTR2B, DRD2, DRD3, HTR1E, HTR1F, HTR2A, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8"
CP,liquiritigenin,-47.9,aromatase inhibitor,"1.30, 0.45",,BRD-A68039575,"0.00, 0.00",CYP19A1
CP,thioperamide,-47.98,"histamine receptor antagonist, histamine receptor inverse agonist","0.66, 0.16",,BRD-K63874012,"0.00, 0.00","HRH3, HRH4"
CP,gingerol,-47.99,nitric oxide synthase inhibitor,"0.75, 0.14",,BRD-K26117720,"0.00, 0.00",
CP,irsogladine,-48.04,"diuretic, phosphodiesterase inhibitor","0.74, 0.16",,BRD-K74195153,"0.00, 0.00",PDE4A
CP,altrenogest,-48.07,progestogen steroid hormone,"0.70, 0.16",,BRD-A27554692,"0.00, 0.00",PGR
CP,daidzein,46.56,estrogen receptor agonist,"1.38, 0.39",Estrogen receptor agonist,BRD-K42095107,"11.11, 11.11","ESRRA, ESRRB, ESRRG, TRPC5"
CP,altizide,46.55,thiazide diuretic,"1.28, 0.43",Na-K-Cl transporter inhibitor,BRD-A56675431,"0.00, 0.00",
CP,purmorphamine,46.51,smoothened receptor agonist,"0.73, 0.19",,BRD-K73397362,"10.00, 10.00","SMO, DHH, IHH, PTCH1"
CP,acamprosate,46.49,"glutamate receptor antagonist, excitatory amino acid receptor antagonist, GABA receptor agonist, glutamate receptor modulator","1.35, 0.39",,BRD-M41783010,"0.00, 0.00","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM5"
CP,L-693403,46.45,"sigma receptor antagonist, sigma receptor ligand","1.06, 0.28",,BRD-K83322645,"0.00, 0.00","DRD2, SIGMAR1"
CP,XE-991,46.36,"acetylcholine release enhancer, potassium channel blocker, voltage-gated potassium channel blocker","0.73, 0.24",,BRD-K42748308,"10.00, 0.00","KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5"
CP,T-0901317,46.35,"LXR agonist, ABC transporter expression enhancer, ROR inverse agonist","0.77, 0.18",,BRD-K23383398,"10.00, 10.00","NR1H3, NR1H2, ABCA1, NCOA1, NCOA2, NR1I2, RORA, RORC, RXRB"
CP,KI-8751,46.34,"PDGFR alpha and c-Kit inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR inhibitor","2.49, 0.72",PDGFR/KIT inhibitor,BRD-K47150025,"11.11, 11.11",KDR
CP,nimodipine,46.32,"calcium channel blocker, L-type calcium channel blocker","1.00, 0.25",,BRD-A24891640,"10.00, 0.00","CACNA1C, NR3C2, AHR, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CFTR"
CP,diltiazem,46.24,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker","0.70, 0.19",,BRD-K24023109,"0.00, 0.00","CACNA1C, CACNA1S, CACNA2D1, CACNG1, CYP3A5, CYP3A7, HTR3A, KCNA5"
CP,BRD-K87426499,-47.45,caspase inhibitor,"2.01, 0.34",,BRD-K87426499,"0.00, 0.00",CASP3
CP,afatinib,-47.47,"EGFR inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor","1.34, 0.32",EGFR inhibitor,BRD-K66175015,"0.00, 0.00","EGFR, ERBB2, ERBB4"
CP,SU-4312,-47.49,"platelet-derived growth factor receptor (PDGFR) inhibitor, tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor","0.80, 0.24",,BRD-K60487568,"0.00, 0.00","KDR, PDGFRB"
CP,cinalukast,-47.53,leukotriene receptor antagonist,"1.88, 0.63",,BRD-K72816382,"0.00, 0.00",CYSLTR1
CP,neurodazine,-47.59,neurogenesis of non-pluripotent C2C12 myoblast inducer,"1.91, 0.64",,BRD-K22631935,"10.00, 0.00",
CP,indolophenanthridine,-47.61,"CALY activator, dopamine receptor agonist","1.11, 0.25",,BRD-K79353516,"0.00, 0.00","CALY, DRD1"
CP,KUC103420N,-47.68,"rho GTPase inhibitor, CDC inhibitor","1.64, 0.38",,BRD-A71009679,"0.00, 0.00",
CP,zalcitabine,-47.72,"nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor","0.81, 0.27",Nucleoside reverse transcriptase inhibitor,BRD-K85925969,"0.00, 0.00",
CP,helveticoside,-47.75,ATPase inhibitor,"2.44, 0.81",ATPase inhibitor,BRD-A63998256,"11.11, 11.11",ATP1A1
CP,L-168049,-47.83,"glucagon receptor antagonist, human glucagon receptor antagonist","1.31, 0.35",,BRD-K18036262,"0.00, 0.00",GCGR
CP,troxipide,46.18,glucosamine synthetase stimulant,"1.55, 0.52",,BRD-A68589262,"12.50, 12.50",
CP,naltrexone,46.17,"opioid receptor antagonist, opioid receptor ligand","0.51, 0.15",,BRD-K88172511,"10.00, 0.00","OPRK1, OPRM1, OPRD1, SIGMAR1"
CP,EI-247,46.11,insulin growth factor receptor inhibitor,"1.22, 0.30",,BRD-K32710582,"20.00, 20.00",INSR
CP,evoxine,46.06,antagonist of strychnine and pentylenetrazole; enhances effects of narcotics,"0.94, 0.32",,BRD-K47693913,"0.00, 0.00",
CP,NSC-632839,46.06,"ubiquitin hydrolase inhibitor, ubiquitin isopeptidase inhibitor","3.01, 0.78",,BRD-K74402642,"0.00, 0.00","USP2, USP7, SENP2, USP1"
CP,RO-16-6941,46.01,monoamine oxidase inhibitor,"1.00, 0.28",,BRD-K44899736,"20.00, 0.00",
CP,metoprolol,45.98,adrenergic receptor antagonist,"0.89, 0.38",,BRD-A03623303,"10.00, 10.00","ADRB1, ADRB2"
CP,ruxolitinib,45.94,"JAK inhibitor, tyrosine kinase inhibitor","0.56, 0.17",,BRD-K53972329,"0.00, 0.00","JAK1, JAK2, TYK2, JAK3"
CP,T-0070907,45.92,"PPAR receptor anatagonist, PPAR receptor antagonist","0.45, 0.10",,BRD-K31843556,"10.00, 10.00",PPARG
CP,artesunate,45.88,DNA synthesis inhibitor,"0.98, 0.23",,BRD-K79759031,"12.50, 0.00",
CP,chlorambucil,-47.13,"DNA damaging, DNA inhibitor","0.51, 0.16",,BRD-K29458283,"0.00, 0.00",
CP,bufalin,-47.14,"ATPase inhibitor, chloride channel activator","2.18, 0.60",ATPase inhibitor,BRD-K63606607,"10.00, 0.00",ATP1A1
CP,BRD-K16618170,-47.16,lysophospholipid receptor agonist,"1.07, 0.24",,BRD-K16618170,"0.00, 0.00",S1PR4
CP,gabazine,-47.22,GABA receptor antagonist,"1.08, 0.27",,BRD-K79905821,"11.11, 0.00","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRG2"
CP,tacrolimus,-47.24,"calcineurin inhibitor, FK506-binding protein inhibitor, immunosuppressant, insulin expression inhibitor, interleukin receptor antagonist, macrolide calcineurin inhibitor, rotamase inhibitor, T cell inhibitor","0.59, 0.07",,BRD-K69608737,"0.00, 0.00","FKBP1A, CYP3A5, CYP3A7"
CP,Y-27152,-47.25,"potassium channel activator, potassium channel agonist","0.83, 0.25",,BRD-K42679050,"10.00, 10.00","ABCC9, KCNJ8"
CP,thalidomide,-47.3,"angiogenesis inhibitor, cereblon inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist, tumor necrosis factor receptor inhibitor","1.03, 0.41",,BRD-A93255169,"0.00, 0.00","TNF, CRBN, CYP1A2, CYP2B6, CYP2C19, CYP3A5, FGFR2, NFKB1, ORM1, ORM2, PTGS2"
CP,"1,2-dichlorobenzene",-47.36,hepatotoxicant that induces oxidative stress and inflammatory response,"0.97, 0.27",,BRD-K74430258,"10.00, 0.00",
CP,L-690488,-47.4,nositol monophosphatase inhibitor,"1.00, 0.20",,BRD-K69328504,"0.00, 0.00",IMPA1
CP,eriochrome-black-t,-47.41,azo dye used in titrations to detect metal ions,"1.23, 0.38",,BRD-K16233984,"0.00, 0.00",
CP,cycloheximide,45.73,"glycogen synthase kinase inhibitor, protein synthesis inhibitor","1.01, 0.31",,BRD-A82329351,"10.00, 10.00","GSK3B, RPL3"
CP,iproniazid,45.68,monoamine oxidase inhibitor,"0.60, 0.25",,BRD-K88568253,"11.11, 11.11","MAOA, MAOB"
CP,genistein,45.57,"tyrosine kinase inhibitor, angiogenesis inhibitor, CFTR channel activator, EGFR inhibitor, estrogen receptor agonist, histidine kinase inhibitor, immunosuppressant, isoflavone agonist, protein tyrosine kinase inhibitor, reducing agent, topoisomerase inhibitor","0.38, 0.34",,BRD-K43797669,"0.00, 0.00","CFTR, ESR2, EGFR, ESR1, ESRRA, ESRRB, ESRRG, NCOA1, NCOA2, PPARG, PTK2B, TOP2A, TRPC5"
CP,tubocurarine,45.47,acetylcholine receptor antagonist,"1.13, 0.40",,BRD-K02607075,"0.00, 0.00","CHRNA2, HTR3A, ACHE, HTR3B, KCNN1, KCNN2, KCNN3, ZACN"
CP,CP-94253,45.21,serotonin receptor agonist,"1.03, 0.28",,BRD-K33860217,"0.00, 0.00",HTR1B
CP,BRD-K63784565,45.21,"beta amyloid synthesis inhibitor, topoisomerase inhibitor","1.88, 0.51",,BRD-K63784565,"0.00, 0.00",TOP1
CP,quinidine,45.15,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker","1.08, 0.32",,BRD-K70799801,"0.00, 0.00","SCN5A, ABCB1, CYP2D6, KCNA5, KCNA7, KCNH1, KCNH2, KCNH5, KCNK1, KCNK6, SLC29A4"
CP,BRD-A73929928,45.15,adenosine receptor agonist,"1.28, 0.32",,BRD-A73929928,"12.50, 12.50","ADORA1, ADORA2A"
CP,nemonapride,45.05,"dopamine receptor antagonist, serotonin receptor agonist","0.98, 0.38",,BRD-A66927094,"20.00, 10.00","DRD2, DRD3, DRD4"
CP,nicardipine,45.01,"calcium channel blocker, L-type calcium channel blocker","1.92, 0.56",,BRD-A63445921,"0.00, 0.00","CACNA1C, ADORA3, ADRA1A, ADRA1B, ADRA1D, CACNA1D, CACNA2D1, CACNB2, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, PDE1A, PDE1B"
CP,YC-1,-46.61,"activator of soluble guanylyl cyclase, guanylate cyclase activator, hypoxia inducible factor inhibitor","0.66, 0.16",,BRD-K60476892,"0.00, 0.00","HIF1A, GUCY1A2, GUCY1A3, GUCY1B3"
CP,diloxanide,-46.61,unidentified pharmacological activity,"0.47, 0.09",,BRD-K10974103,"0.00, 0.00",
CP,EMF-bca1-60,-46.64,caspase inhibitor,"0.66, 0.17",,BRD-K68437527,"0.00, 0.00",
CP,sumatriptan,-46.66,serotonin receptor agonist,"0.84, 0.25",,BRD-K50938287,"12.50, 12.50","HTR1D, HTR1B, HTR1A, HTR1F, HTR1E, HTR5A, HTR6, HTR7"
CP,AS-605240,-46.67,"Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor","1.70, 0.61",PI3K inhibitor,BRD-K41895714,"0.00, 0.00","MAOB, PIK3CA, PIK3CB, PIK3CD, PIK3CG"
CP,XAV-939,-46.78,"PARP inhibitor, TNKS inhibitor","0.88, 0.30",,BRD-K12762134,"20.00, 20.00","TNKS, TNKS2"
CP,PNU-120596,-46.79,"acetylcholine receptor modulator, acetylcholine receptor positive allosteric modulator","1.24, 0.47",,BRD-K71731651,"0.00, 0.00",CHRNA7
CP,benzyl-quinazolin-4-yl-amine,-46.96,epidermal growth factor receptor (EGFR) inhibitor,"0.90, 0.36",,BRD-K43796186,"11.11, 11.11",EGFR
CP,myricetin,-47.09,"androgen receptor ligand, cytochrome P450 inhibitor","0.74, 0.16",,BRD-K43149758,"0.00, 0.00","PIK3CG, AR, CYP3A4"
CP,SRC-kinase-inhibitor-II,-47.1,src inhibitor,"0.99, 0.26",,BRD-K97330509,"0.00, 0.00",
CP,SCH-28080,44.99,"ATPase inhibitor, potassium-competitive acid antagonist","0.70, 0.25",,BRD-K55748775,"0.00, 0.00",ATP4A
CP,benzamil,44.87,epithelial sodium channel blocker,"1.43, 0.50",,BRD-K97688263,"22.22, 11.11","PKD2L1, SCNN1A, SCNN1B, SCNN1G, ASIC1, SCNN1D, SLC8A1"
CP,oxiconazole,44.86,"cell wall synthesis inhibitor, sterol demethylase inhibitor","1.25, 0.40",,BRD-K23369905,"0.00, 0.00",
CP,LY-16350,44.78,"dopamine receptor agonist, dopamine receptor antagonist","1.34, 0.36",,BRD-K13261168,"0.00, 0.00","DRD2, DRD3"
CP,RU-24969,44.78,serotonin receptor agonist,"0.51, 0.15",,BRD-K00234327,"0.00, 0.00","HTR1A, HTR1B, HTR6, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A"
CP,BRD-K17693482,44.78,potassium channel activator,"0.69, 0.17",,BRD-K17693482,"0.00, 0.00",
CP,naproxen,44.75,cyclooxygenase inhibitor,"2.05, 0.53",,BRD-K59197931,"10.00, 10.00","PTGS2, PTGS1"
CP,quinapril,44.73,angiotensin converting enzyme inhibitor,"0.57, 0.11",,BRD-K72222507,"0.00, 0.00",ACE
CP,cephalotaxine,44.64,protein synthesis inhibitor,"1.22, 0.17",,BRD-A08877921,"0.00, 0.00",
CP,flumetasone,44.58,glucocorticoid receptor agonist,"1.30, 0.63",,BRD-K61496577,"0.00, 0.00","NR3C1, PLA2G1B"
CP,MRS-1754,-46.16,adenosine receptor antagonist,"0.80, 0.20",,BRD-K72024482,"0.00, 0.00","ADORA2B, ADORA1, ADORA2A, ADORA3"
CP,U0126,-46.17,"MEK inhibitor, JAK inhibitor, MAP kinase inhibitor","1.44, 0.51",,BRD-K46419649,"0.00, 0.00","JAK2, MAP2K1, MAP2K2, MAP3K1, MAP3K2"
CP,sertaconazole,-46.24,"sterol demethylase inhibitor, cell wall synthesis inhibitor","0.74, 0.25",,BRD-A95939040,"0.00, 0.00",
CP,GBR-13069,-46.28,dopamine uptake inhibitor,"0.97, 0.26",,BRD-K11634954,"0.00, 0.00",SLC6A3
CP,guanfacine,-46.39,"adrenergic receptor agonist, HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker","0.63, 0.09",,BRD-K32830106,"0.00, 0.00","ADRA2A, ADRA2B, ADRA2C, CYP3A5, HCN1, HCN2, HCN3, HCN4"
CP,oxybenzone,-46.45,lipase inhibitor,"1.25, 0.38",,BRD-K59037100,"10.00, 10.00",LIPE
CP,ALW-II-38-3,-46.54,ephrin inhibitor,"1.26, 0.52",,BRD-K68191783,"0.00, 0.00","DDR1, EPHA2, EPHA4, EPHB2, EPHB4, EPHB6"
CP,BRD-A83255679,-46.55,estrogen receptor antagonist,"0.50, 0.09",,BRD-A83255679,"10.00, 10.00",GPER1
CP,huperzine-a,-46.56,"acetylcholinesterase inhibitor, glutamate receptor antagonist","0.98, 0.39",,BRD-K15402119,"0.00, 0.00",ACHE
CP,auraptene,-46.6,"lipoxygenase inhibitor, monoamine oxidase inhibitor, nitric oxide production inhibitor, nitric oxide synthase expression inhibitor","1.27, 0.41",,BRD-K85013741,"0.00, 0.00",MAOB
CP,BRD-A38793261,44.55,ROR antagonist,"0.74, 0.19",,BRD-A38793261,"11.11, 0.00",RORC
CP,methysergide,44.44,serotonin receptor antagonist,"0.81, 0.24",,BRD-K35941380,"10.00, 10.00","HTR2C, HTR1B, HTR1E, HTR1F, HTR2A, HTR2B, HTR7, HTR1A, HTR1D, HTR5A, HTR6"
CP,NU-1025,44.42,"PARP inhibitor, DNA dependent protein kinase inhibitor","0.85, 0.18",,BRD-K48692744,"0.00, 0.00",PARP1
CP,BRD-K35133769,44.4,lipoxygenase inhibitor,"1.25, 0.43",,BRD-K35133769,"0.00, 0.00",
CP,NPC-15199,44.39,"ICAM 1 antagonist, increases intracellular calcium levels","0.97, 0.19",,BRD-A47633927,"0.00, 0.00","ICAM1, PPARG"
CP,ABT-751,44.36,"tubulin inhibitor, dihydropteroate synthase inhibitor, microtubule inhibitor, PABA antagonist, tubulin polymerisation inhibitor","1.51, 0.73",Tubulin inhibitor,BRD-K91623615,"0.00, 0.00",TUBB
CP,rhodomyrtoxin-b,44.27,"cytotoxic, DNA intercalator","1.80, 0.58",,BRD-A08003242,"0.00, 0.00",
CP,pifithrin-mu,44.26,HSP inhibitor,"1.05, 0.24",,BRD-K96799727,"0.00, 0.00","HSPA1A, TP53"
CP,nomifensine,44.19,norepinephrine-dopamine reuptake inhibitor,"1.27, 0.43",,BRD-A29644307,"0.00, 0.00","SLC6A2, SLC6A3, DRD2, MAOA, MAOB, MPO"
CP,NNC-05-2090,44.16,"GABA uptake inhibitor, GAT inhibitor","1.48, 0.51",,BRD-K85015012,"0.00, 0.00","SLC6A11, SLC6A12, SLC6A13"
CP,minoxidil,-45.62,"antialopecia agent, ATP channel activator, ATP-sensitive potassium channel agonist, KATP activator, Kir6 channel (KATP) activator, polarization activator, renin secretion stimulant","0.95, 0.23",,BRD-K06902185,"0.00, 0.00","KCNJ8, ABCC9, KCNJ1, KCNJ10, KCNJ11, PTGS1, REN"
CP,melperone,-45.71,"dopamine receptor antagonist, serotonin receptor antagonist","0.91, 0.20",,BRD-K92984783,"0.00, 0.00","DRD2, HTR1A, HTR2A"
CP,levonorgestrel,-45.72,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist","0.92, 0.31",,BRD-K35189033,"0.00, 0.00","PGR, AR, CYP2E1, ESR1, SRD5A1"
CP,prazosin,-45.85,"adrenergic receptor antagonist, adrenergic receptor blocker, CDK inhibitor","0.56, 0.13",,BRD-K49111258,"0.00, 0.00","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CDK1, KCNH2, KCNH6, KCNH7"
CP,retinol,-45.92,RAR receptor binder,"1.42, 0.49",,BRD-K22429181,"0.00, 0.00","ALDH1A1, ALDH1A2, ALDH1A3, DHRS3, DHRS4, LRAT, NR2C2, RBP1, RBP3, RDH11, RDH12, RDH13, RDH14, RDH5, RDH8, RETSAT, RHO, RLBP1, RXRA, RXRB, RXRG"
CP,rilmenidine,-45.98,"adrenergic receptor agonist, imidazoline receptor agonist","0.84, 0.20",,BRD-M62162320,"0.00, 0.00",NISCH
CP,cromakalim,-46.06,"ATP channel activator, potassium channel agonist","1.11, 0.28",,BRD-A76093993,"0.00, 0.00","KCNJ8, ABCC9, KCNJ5"
CP,BRD-K11757396,-46.06,neuropeptide receptor ligand,"0.76, 0.17",,BRD-K11757396,"10.00, 10.00",NPSR1
CP,forskolin,-46.08,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant","0.95, 0.41",,BRD-K03015355,"10.00, 10.00","ADCY2, ADCY5, GNAS"
CP,etomidate,-46.1,"membrane integrity inhibitor, membrane permeability inhibitor","0.56, 0.16",,BRD-A54880345,"0.00, 0.00","GABRA1, ADRA2B, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ"
CP,isoxsuprine,44.09,adrenergic receptor agonist,"0.77, 0.20",Beta-adrenergic receptor agonist,BRD-A16700644,"0.00, 0.00",ADRB2
CP,canrenoic-acid,44.09,aldosterone antagonist,"1.34, 0.40",,BRD-K46556543,"0.00, 0.00",
CP,rolitetracycline,44.08,antibiotic,"1.91, 0.49",,BRD-A27489425,"10.00, 0.00",
CP,erismodegib,43.9,"hedgehog pathway inhibitor, smoothened receptor antagonist","2.52, 0.73",,BRD-K19796430,"10.00, 10.00",SMO
CP,selinidin,43.9,cumarin derivative with antiallergic properties,"2.61, 0.97",,BRD-K07212038,"0.00, 0.00",
CP,tosyllysyl-chloromethyl-ketone,43.89,chymotrypsin inhibitor,"0.97, 0.38",,BRD-K10136726,"10.00, 0.00",
CP,"4,5,6,7-tetrabromobenzotriazole",43.84,casein kinase inhibitor,"0.66, 0.16",,BRD-K97118047,"0.00, 0.00","CSNK2A1, AKT1, CHEK1, CSNK2A2, CSNK2B, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1"
CP,estriol,43.82,"estrogen receptor agonist, estrogen receptor antagonist","1.24, 0.34",Estrogen receptor agonist,BRD-A18620900,"11.11, 11.11","ESR1, ESR2"
CP,esculin,43.82,"antioxidant, unidentified pharmacological activity","0.77, 0.30",,BRD-A99411506,"10.00, 10.00",
CP,K3644,43.82,"Kinesin-Like Spindle Protein  KIF11 (KSP, Eg5) Inhibitors, mitotic kinesin inhibitor","1.23, 0.36",,BRD-A67748489,"0.00, 0.00",KIF11
CP,danoprevir,-45.2,"HCV inhibitor, serine protease inhibitor","0.92, 0.30",,BRD-K17823458,"10.00, 10.00",
CP,acetyl-geranygeranyl-cysteine,-45.26,inhibitor of methyl esterification of geranylgeranylated proteins,"1.10, 0.38",,BRD-K75181824,"0.00, 0.00",
CP,cholic-acid,-45.31,"ferrochelatase inhibitor, unidentified pharmacological activity","1.40, 0.41",Bile acid,BRD-K43164539,"0.00, 0.00","CES1, FECH, PLA2G1B, ADH1C, COX4I1, COX5A, COX5B, COX6A2, COX6B1, COX6C, COX7A1, COX7B, COX7C, COX8A, ESRRG, FABP6, GPBAR1, MT-CO1, MT-CO2, MT-CO3"
CP,zidovudine,-45.35,"nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor","0.92, 0.39",Reverse transcriptase inhibitor,BRD-K72903603,"11.11, 11.11",TERT
CP,levetiracetam,-45.4,"acetylcholine receptor agonist, N-type calcium channel blocker, synaptic vesicle glycoprotein ligand","0.77, 0.24",,BRD-K49404994,"0.00, 0.00","SV2A, CACNA1B, SCN1A"
CP,etoposide,-45.45,"topoisomerase inhibitor, cell cycle inhibitor, DNA inhibitor, DNA intercalating drug, DNA repair enzyme inhibitor","2.66, 0.72",,BRD-A18419789,"0.00, 0.00","TOP2A, CYP2E1, CYP3A5, TOP2B"
CP,ZD-7155,-45.45,angiotensin receptor antagonist,"1.28, 0.45",Angiotensin receptor antagonist,BRD-K11373525,"0.00, 0.00",AGTR1
CP,apigenin,-45.52,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor","0.89, 0.16",,BRD-K12057390,"0.00, 0.00","AKR1B1, AR, CDK6, CFTR, CYP19A1, CYP1A2, CYP1B1, HSD17B1, MAOA, ODC1, XDH"
CP,FIT,-45.55,opioid receptor agonist,"1.44, 0.51",,BRD-K17896185,"0.00, 0.00",OPRD1
CP,alprazolam,-45.57,"GABA benzodiazepine site receptor agonist, benzodiazepine receptor agonist","1.10, 0.50",,BRD-K32398298,"0.00, 0.00","GABRA1, GABRA2, GABRA3, GABRA5, CYP3A5, GABRA4, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ"
CP,erythromycin,43.8,"NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor","1.73, 0.48",,BRD-A44827100,"0.00, 0.00","CYP3A4, MLNR"
CP,acarbose,43.79,glucosidase inhibitor,"0.75, 0.22",,BRD-K44276885,"10.00, 10.00","GAA, MGAM, AMY2A, SI"
CP,tosufloxacin,43.79,topoisomerase inhibitor,"1.20, 0.28",,BRD-A41450521,"0.00, 0.00",
CP,OBAA,43.78,phospholipase inhibitor,"1.43, 0.38",,BRD-K48029790,"20.00, 20.00",PLA2G1B
CP,BRD-A54632525,43.74,lipoxygenase inhibitor,"0.95, 0.32",,BRD-A54632525,"0.00, 0.00",ALOX12
CP,hydrocotarnine,43.72,non-narcotic opium alkaloid used in cancer pain treatment,"1.43, 0.45",,BRD-K37447567,"11.11, 11.11",
CP,CGP-54626,43.7,GABA receptor antagonist,"1.74, 0.64",,BRD-A55369275,"0.00, 0.00","GABBR1, GABBR2, KCTD12, KCTD16, KCTD8"
CP,physostigmine,43.66,"acetylcholinesterase inhibitor, cholinesterase inhibitor","0.57, 0.17",,BRD-K25650355,"10.00, 10.00","ACHE, BCHE"
CP,mestinon,43.64,cholinesterase inhibitor,"2.26, 0.53",,BRD-K69688083,"0.00, 0.00","ACHE, BCHE"
CP,SB-408124,43.61,"orexin receptor antagonist, orexin type 1 receptor antagonist","0.93, 0.22",,BRD-K53913732,"0.00, 0.00","HCRTR1, HCRTR2"
CP,BRD-K34608650,-44.83,cannabinoid receptor agonist,"1.24, 0.35",,BRD-K34608650,"0.00, 0.00",CNR2
CP,pimozide,-44.93,"dopamine receptor antagonist, dopamine receptor, opioid receptor antagonist, serotonin receptor antagonist","1.60, 0.57",Dopamine receptor antagonist,BRD-K01292756,"0.00, 0.00","DRD2, DRD3, CACNA1I, CALM1, HRH1, HTR1A, HTR2A, KCNA10, KCNH2"
CP,bethanechol,-44.98,acetylcholine receptor agonist,"1.18, 0.32",,BRD-A99833829,"0.00, 0.00","CHRM2, CHRM1, CHRM3, CHRM4"
CP,hydroquinidine,-44.98,anti-arrhythmia agent,"0.61, 0.22",,BRD-A06390036,"0.00, 0.00",
CP,metaxalone,-45,muscle relaxant,"0.88, 0.30",,BRD-A94709349,"0.00, 0.00",
CP,icariin,-45.07,"neuromedin receptor agonist, sorbitol dehydrogenase inhibitor","0.50, 0.07",,BRD-K65639003,"0.00, 0.00","NMUR2, PDE5A, SORD"
CP,pseudoephedrine,-45.1,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor","1.17, 0.32",,BRD-K84175871,"0.00, 0.00","ADRA1A, ADRA2A, ADRB1, ADRB2, ATF1, ATF2, ATF3, ATF4, ATF5, ATF6, ATF7, CXCL8, FOS, HRH1, IL2, JDP2, JUN, NFATC1, SLC6A2, SLC6A3, SLC6A4, TNF"
CP,triamcinolone,-45.11,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent","1.38, 0.73",,BRD-A37780065,"0.00, 0.00","NR3C1, CYP3A5, CYP3A7, SERPINA6"
CP,tomelukast,-45.14,leukotriene receptor antagonist,"0.76, 0.10",,BRD-K74765201,"0.00, 0.00",CYSLTR1
CP,irbesartan,-45.19,"angiotensin receptor antagonist, liver bile acid transporter inhibitor","0.58, 0.17",Angiotensin receptor antagonist,BRD-K60038276,"0.00, 0.00","AGTR1, JUN, SLC10A1"
CP,apoptosis-activator-II,43.6,carboxylesterase inhibitor,"1.08, 0.40",,BRD-K15164005,"0.00, 0.00","BCHE, CES1"
CP,wortmannin,43.57,"PI3K inhibitor, ATM kinase inhibitor, ATR kinase inhibitor, DNA dependent protein kinase inhibitor, mTOR inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PLK inhibitor","1.52, 0.50",PI3K inhibitor,BRD-A11678676,"0.00, 0.00","PIK3CA, PIK3CG, PLK1, ATM, ATR, MTOR, PI4KA, PI4KB, PIK3CD, PIK3R1, PLK3, PRKDC"
CP,oxfendazole,43.55,anthelmintic agent,"0.48, 0.13",,BRD-A33447119,"10.00, 10.00",
CP,M2-PK-activator,43.54,pyruvate kinase isozyme activator,"0.49, 0.08",,BRD-K80672993,"0.00, 0.00",PKM
CP,olmesartan,43.49,"angiotensin receptor antagonist, angiotensin antagonist","0.98, 0.26",Angiotensin receptor antagonist,BRD-K78485176,"0.00, 0.00",AGTR1
CP,loxapine,43.47,"dopamine receptor antagonist, serotonin receptor antagonist, dopamine receptor ligand","0.76, 0.16",,BRD-K39915878,"0.00, 0.00","DRD2, DRD3, DRD4, DRD1, HRH1, HTR2A, HTR2C, HTR6, ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD5, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR3A, HTR5A, HTR7, SLC6A2, SLC6A3, SLC6A4"
CP,prima-1-met,43.43,"thioredoxin inhibitor, TP53 activator","1.36, 0.39",,BRD-K49456190,"0.00, 0.00",TP53
CP,AM-281,43.31,"cannabinoid receptor antagonist, cannabinoid receptor inhibitor","0.94, 0.30",,BRD-K59419204,"11.11, 11.11","CNR1, CNR2, GPR55"
CP,SIB-1757,43.18,glutamate receptor antagonist,"1.11, 0.28",,BRD-K98157055,"20.00, 20.00",GRM5
CP,ketanserin,43.16,"serotonin receptor antagonist, collagen stimulant","0.76, 0.25",,BRD-K49671696,"0.00, 0.00","HTR2A, HTR2C, ADRA1A, ADRA1B, ADRA1D, DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR2B, HTR5A, HTR7, SLC18A1, SLC18A2"
CP,17-hydroxyprogesterone-caproate,-44.43,progesterone receptor agonist,"0.80, 0.18",Progesterone receptor agonist,BRD-A29731977,"0.00, 0.00","CYP1A2, CYP2B6, CYP3A5, PGR"
CP,cycloserine,-44.45,"glutamate receptor agonist, glutamate receptor modulator","0.73, 0.23",,BRD-K87226815,"0.00, 0.00",GRIN1
CP,tetrahydrobiopterin,-44.49,"nitric oxide stimulant, nitric oxide synthase stimulant, phenylalanine 4-hydroxylase stimulant, nitric oxide synthase activator","1.30, 0.36",,BRD-A67605442,"0.00, 0.00","PAH, TH, DBH, NOS3, TPH1"
CP,"3,3'-diindolylmethane",-44.5,"androgen receptor antagonist, aryl hydrocarbon receptor agonist, beta glucuronidase inhibitor, CHK inhibitor, cytochrome P450 activator, indoleamine 2,3-dioxygenase inhibitor","1.33, 0.39",,BRD-K37846922,"0.00, 0.00","AHR, AR, CYP1A2, GUSB, IDO1"
CP,aminolevulinic-acid,-44.51,oxidizing agent,"1.47, 0.42",,BRD-K57631554,"0.00, 0.00",ALAD
CP,n-arachidonyl-GABA,-44.6,arachidonyl amino acid that inhibits pain,"1.06, 0.38",,BRD-K06024458,"0.00, 0.00",
CP,naltrexone,-44.7,"opioid receptor antagonist, opioid receptor ligand","1.40, 0.47",,BRD-A66559694,"0.00, 0.00","OPRK1, OPRM1, OPRD1, SIGMAR1"
CP,boldine,-44.73,"acetylcholine receptor inhibitor, dopamine receptor antagonist","0.75, 0.24",,BRD-K03440695,"0.00, 0.00","CHRNA4, CHRNB2, DRD1, DRD2"
CP,U-0124,-44.77,MEK inhibitor,"1.41, 0.60",,BRD-K48427617,"0.00, 0.00",
CP,thioperamide,-44.81,"histamine receptor antagonist, histamine receptor inverse agonist","1.02, 0.32",,BRD-A85424553,"0.00, 0.00","HRH3, HRH4"
CP,ZM-241385,43.14,adenosine receptor antagonist,"0.63, 0.23",,BRD-K19605405,"20.00, 0.00","ADORA2A, ADORA2B, ADORA1, ADORA3"
CP,karakoline,42.88,phytotoxin,"1.60, 0.55",,BRD-A43849199,"0.00, 0.00",
CP,LY-344864,42.88,serotonin receptor agonist,"1.18, 0.20",,BRD-K95899059,"0.00, 0.00","HTR1F, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR7"
CP,pravastatin,42.88,HMGCR inhibitor,"1.28, 0.39",,BRD-A11170096,"0.00, 0.00","HMGCR, SLCO1B1"
CP,GSK-0660,42.8,PPAR receptor inhibitor,"1.11, 0.32",,BRD-K98684188,"20.00, 20.00",PPARD
CP,VU-0415374-1,42.8,glutamate receptor modulator,"1.07, 0.32",,BRD-K83010055,"0.00, 0.00",GRM4
CP,propantheline,42.78,acetylcholine receptor antagonist,"1.42, 0.36",,BRD-K90885812,"0.00, 0.00","CHRM1, CHRM2, CHRM3, CHRM4"
CP,ER-27319,42.78,"mediator release inhibitor, syk inhibitor","3.42, 1.16",,BRD-K11927976,"0.00, 0.00",SYK
CP,purvalanol-a,42.74,"CDK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor","2.88, 0.41",CDK inhibitor,BRD-K50836978,"0.00, 0.00","CDK1, CDK2, CDK4, CDK5, CCND1, CCNE1, CSNK1G3, RPS6KA1, SRC"
CP,zeranol,42.6,estrogen receptor agonist,"1.49, 0.59",,BRD-A24381660,"0.00, 0.00",
CP,BRD-K77681376,-43.85,"casein kinase inhibitor, FLT3 inhibitor","2.38, 0.72",,BRD-K77681376,"0.00, 0.00",
CP,thiothixene,-43.85,"dopamine receptor, dopamine receptor antagonist","1.48, 0.45",Dopamine receptor antagonist,BRD-K97309399,"0.00, 0.00","HTR2A, DRD1, DRD2, HRH1"
CP,SKF-77434,-43.88,"dopamine receptor agonist, dopamine receptor partial agonist","0.84, 0.34",,BRD-A64227845,"0.00, 0.00",DRD1
CP,tyrphostin-AG-556,-44.02,"epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor","1.13, 0.40",,BRD-K14441456,"0.00, 0.00",EGFR
CP,beclometasone,-44.12,"glucocorticoid receptor agonist, corticosteroid hormone receptor agonist, immunosuppressant","1.57, 0.56",Glucocorticoid receptor agonist,BRD-A17448384,"0.00, 0.00","NR3C1, CYP3A5, GPR97, SERPINA6"
CP,bifonazole,-44.12,"cell wall synthesis inhibitor, sterol demethylase inhibitor","1.10, 0.36",,BRD-A94543220,"0.00, 0.00",CYP2B6
CP,ergometrine,-44.19,"adrenergic receptor stimulatant, serotonin receptor stimulant","0.98, 0.39",,BRD-A73581086,"0.00, 0.00","ADRA1A, HTR1E, HTR2A"
CP,etodolac,-44.21,"cyclooxygenase inhibitor, TRPV agonist","0.91, 0.24",Cyclooxygenase inhibitor,BRD-A74667430,"0.00, 0.00","PTGS2, PTGS1, RXRA, TRPV1"
CP,NS-3694,-44.25,glutamate receptor antagonist,"1.36, 0.32",,BRD-K26979635,"0.00, 0.00",GRIK1
CP,hydrocortisone,-44.41,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist","1.34, 0.39",,BRD-A75172220,"0.00, 0.00","ANXA1, NOS2, NR3C1, NR3C2"
CP,resmethrin,42.58,cytochrome P450 inhibitor,"0.97, 0.31",,BRD-A83431637,"11.11, 0.00",
CP,motesanib,42.58,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, RET tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist","0.64, 0.17",PDGFR/KIT inhibitor,BRD-K99616396,"0.00, 0.00","FLT1, FLT4, KDR, KIT, PDGFRA, RET"
CP,digoxigenin,42.51,ATPase inhibitor,"1.19, 0.38",,BRD-K18619710,"10.00, 0.00",ATP1A1
CP,KIN001-055,42.44,"EGFR inhibitor, JAK inhibitor, leukotriene synthesis inhibitor, mediator release inhibitor","1.02, 0.31",,BRD-K68407802,"0.00, 0.00","EGFR, JAK3"
CP,MW-STK33-3B,42.43,large conductance potassium channel activator,"1.39, 0.25",,BRD-K64310881,"0.00, 0.00",
CP,rufloxacin,42.41,topoisomerase inhibitor,"1.00, 0.24",Bacterial DNA gyrase inhibitor,BRD-K62374253,"0.00, 0.00",
CP,noretynodrel,42.4,progestogen steroid hormone,"0.88, 0.20",,BRD-K80334323,"10.00, 10.00",PGR
CP,CGP-55845,42.32,GABA receptor antagonist,"1.06, 0.30",,BRD-A89672324,"0.00, 0.00","GABBR1, GABBR2, KCTD12, KCTD16, KCTD8"
CP,SC-68376,42.2,p38 MAPK inhibitor,"0.84, 0.26",,BRD-K85871428,"10.00, 10.00",MAPK14
CP,griseofulvin,42.19,"microtubule inhibitor, microtubule stabilizing agent, mitosis inhibitor","1.07, 0.24",,BRD-K08273968,"0.00, 0.00",KRT12
CP,acadesine,-43.62,"adenosine release stimulant, AMPK activator, AMPK stimulant","2.15, 0.51",,BRD-A95696820,"0.00, 0.00",
CP,AZ-628,-43.65,RAF inhibitor,"1.76, 0.56",RAF inhibitor,BRD-K05804044,"0.00, 0.00","BRAF, RAF1"
CP,gliquidone,-43.69,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulin secretagogue","0.72, 0.24",KCNJ11 modulator,BRD-K80396088,"0.00, 0.00","ABCC8, KCNJ10, KCNJ11, KCNJ8"
CP,SB-202190,-43.71,"p38 MAPK inhibitor, interleukin inhibitor, stress activated protein kinase inhibitor","1.02, 0.23","Bromodomain Inhibitor, P38 MAPK inhibitor",BRD-K54330070,"0.00, 0.00","MAPK14, AKT1, ALOX5, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1"
CP,pirfenidone,-43.76,"FGFR antagonist, p38 MAPK inhibitor, TGF beta receptor antagonist, TGF beta receptor inhibitor, tumor necrosis factor production inhibitor, tumor necrosis factor receptor antagonist","1.26, 0.27",,BRD-K96862998,"0.00, 0.00","TNF, FURIN, MAPK14, TNFRSF1A"
CP,clonidine,-43.77,adrenergic receptor agonist,"0.95, 0.27",,BRD-K98530306,"0.00, 0.00","ADRA2A, ADRA2B, ADRA2C, ADRA1A, ADRA1B, ADRA1D"
CP,BRD-K73709114,-43.79,glucosylceramidase inhibitor,"0.76, 0.15",,BRD-K73709114,"0.00, 0.00",GBA
CP,PF-562271,-43.79,"focal adhesion kinase inhibitor, angiogenesis inhibitor, apoptosis stimulant","2.69, 1.02",,BRD-K99545815,"0.00, 0.00","PTK2, PTK2B"
CP,hydralazine,-43.79,smooth muscle relaxant,"0.98, 0.30",,BRD-A77722753,"0.00, 0.00","AOC3, P4HA1"
CP,thiostrepton,-43.83,"downregulates FOXM1 expression, FOXM1 expression inhibitor, protein synthesis inhibitor","1.86, 0.31",Protein synthesis inhibitor,BRD-A20697603,"0.00, 0.00",FOXM1
CP,JLK-6,42.15,"gamma secretase inhibitor, antiamyloidogenic agent","1.88, 0.56",Gamma secretase inhibitor,BRD-K22010301,"0.00, 0.00",PSEN1
CP,tranilast,42.1,"angiogenesis inhibitor, histamine receptor antagonist, histamine release inhibitor, indoleamine 2,3-dioxygenase activator, interferon gamma synthesis inhibitor, interleukin receptor modulator, interleukin synthesis enhancer, interleukin synthesis inhibitor, TGF beta receptor antagonist, TRPV antagonist, tumor necrosis factor production inhibitor, urate transporter inhibitor","1.45, 0.63",,BRD-K17849083,"0.00, 0.00","HPGDS, HRH1, IDO1, IFNG, IL10, IL2, IL4, SLC22A12, TGFB1, TNF, TRPV2"
CP,ampiroxicam,42.09,cyclooxygenase inhibitor,"1.59, 0.52",,BRD-A39172021,"12.50, 0.00","PTGS1, PTGS2"
CP,tetracycline,42.05,"30S ribosomal protein inhibitor, 30S ribosomal subunit inhibitor, protein arginine deiminase inhibitor","2.18, 0.53",Bacterial 30S ribosomal subunit inhibitor,BRD-A15493168,"0.00, 0.00",PRNP
CP,4-hydroxy-2-nonenal,42.01,cytotoxic lipid peroxidation product,"1.76, 0.58",,BRD-A15914070,"0.00, 0.00",IKBKB
CP,IKK-2-inhibitor-V,42,"IKK inhibitor, NFkB pathway inhibitor, protein kinase inhibitor","1.99, 0.72","IKK inhibitor, NFkB pathway inhibitor",BRD-K74305673,"0.00, 0.00",IKBKB
CP,papaverine,42,phosphodiesterase inhibitor,"0.84, 0.20",,BRD-K15567136,"0.00, 0.00","PDE10A, PDE4B, PDE5A"
CP,acebutolol,41.96,adrenergic receptor antagonist,"1.13, 0.31",,BRD-A29260609,"0.00, 0.00","ADRB1, ADRB2"
CP,lobelanidine,41.93,"acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand","1.27, 0.51",,BRD-A59215453,"0.00, 0.00","SLC18A2, CHRNA10, CHRNA4, CHRNA9, CHRNB2, OPRM1"
CP,canrenoic-acid,41.86,aldosterone antagonist,"0.70, 0.19",,BRD-A29322418,"0.00, 0.00",
CP,PNU-96415E,-43.1,dopamine receptor antagonist,"0.91, 0.20",,BRD-A95096829,"10.00, 10.00",
CP,amiodarone,-43.14,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker","1.08, 0.25",,BRD-K87555556,"0.00, 0.00","KCNH2, ADRB1, CACNA1H, CACNA2D2, CHRM3, CYP2C8, KCNA7, SCN5A"
CP,GSK-1904529A,-43.18,"insulin growth factor receptor inhibitor, insulin receptor ligand","1.94, 0.52",,BRD-K04833372,"0.00, 0.00","IGF1R, INSR"
CP,BRD-K70751730,-43.35,histone lysine demethylase inhibitor,"1.35, 0.32",,BRD-K70751730,"0.00, 0.00","EGLN1, KDM3A, KDM4A, KDM4C, KDM6B"
CP,harpagoside,-43.43,acetylcholinesterase inhibitor,"0.94, 0.26",,BRD-K07996107,"0.00, 0.00",ACHE
CP,farnesylthioacetic-acid,-43.44,inhibitor of methyl esterification of farnesylated proteins,"1.24, 0.35",,BRD-K63089472,"0.00, 0.00",
CP,aspirin,-43.46,"cyclooxygenase inhibitor, nitric oxide donor, platelet aggregation inhibitor, thromboxane synthase inhibitor, TP53 expression enhancer","1.47, 0.43",,BRD-K11433652,"0.00, 0.00","PTGS1, PTGS2, TP53, AKR1C1, ASIC3, EDNRA, HSPA5, IKBKB, NFKB1, NFKB2, NFKBIA, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3, RPS6KA3"
CP,AY-9944,-43.53,hedgehog pathway inhibitor,"1.05, 0.19",,BRD-K03642198,"0.00, 0.00",
CP,zafirlukast,-43.57,leukotriene receptor antagonist,"0.97, 0.27",,BRD-K71289571,"0.00, 0.00","CYSLTR1, CYSLTR2"
CP,cinchonine,-43.59,antimalarial agent,"0.74, 0.19",,BRD-K14693417,"0.00, 0.00",CYP2D6
CP,famotidine,41.75,histamine receptor antagonist,"1.61, 0.40",,BRD-K00673382,"0.00, 0.00",HRH2
CP,tiaprofenic-acid,41.74,cyclooxygenase inhibitor,"1.32, 0.48",,BRD-A72988804,"0.00, 0.00","PTGS2, PTGS1"
CP,phenylbutyrate,41.73,"HDAC inhibitor, cell cycle inhibitor, pharmacological chaperone, pyruvate dehydrogenase kinase inhibitor","0.95, 0.33",,BRD-K67102207,"11.11, 11.11","CYP3A5, HDAC1"
CP,mosapride,41.68,"serotonin receptor agonist, serotonin receptor antagonist","2.30, 0.74",,BRD-A39052811,"0.00, 0.00","HTR4, HTR3A"
CP,nizatidine,41.67,histamine receptor antagonist,"1.34, 0.35",,BRD-K46652470,"0.00, 0.00",HRH2
CP,GR-79236,41.62,adenosine receptor agonist,"1.09, 0.34",Adenosine receptor agonist,BRD-K40578143,"20.00, 0.00","ADORA1, ADORA2A"
CP,SNS-314,41.6,Aurora kinase inhibitor,"0.99, 0.30",Aurora kinase inhibitor,BRD-K71512533,"20.00, 20.00","AURKA, AURKB, AURKC"
CP,mianserin,41.6,"serotonin receptor antagonist, tetracyclic antidepressant","1.14, 0.30",,BRD-A19661776,"0.00, 0.00","HTR2A, HTR2C, ADRA1A, ADRA1B, ADRA1D, HRH1, HTR2B, HTR6, HTR7, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD5, HRH2, HRH4, HTR1A, HTR1F, OPRK1, SLC6A2, SLC6A3, SLC6A4"
CP,granisetron,41.59,serotonin receptor antagonist,"1.49, 0.36",,BRD-K10860596,"0.00, 0.00","HTR3A, CYP3A5"
CP,ambelline,41.59,plant alkaloid,"0.69, 0.16",,BRD-A10969569,"11.11, 11.11",
CP,moxifloxacin,-42.82,"DNA gyrase inhibitor, topoisomerase inhibitor","0.51, 0.09",Bacterial DNA gyrase inhibitor,BRD-K66615216,"0.00, 0.00",TOP2A
CP,dibenzepin,-42.83,norepinephrine reuptake inhibitor,"0.90, 0.27",,BRD-K79145749,"0.00, 0.00",
CP,metanephrine,-42.83,"epinephrine metabolite, levels are diagnostic for the neoplasm pheochromocytoma","1.57, 0.50",,BRD-A42346008,"11.11, 0.00",
CP,CAY-10585,-42.84,hypoxia inducible factor inhibitor,"1.76, 0.75",,BRD-K88551539,"0.00, 0.00",HIF1A
CP,ranitidine,-42.91,histamine receptor antagonist,"1.24, 0.33",,BRD-K14204120,"0.00, 0.00","HRH2, SLC22A2"
CP,isotretinoin,-42.95,"retinoid receptor agonist, microbial collagenase inhibitor, protein synthesis inhibitor, RAR agonist","0.82, 0.27",Retinoid receptor agonist,BRD-K76723084,"0.00, 0.00","CYP2B6, CYP2C19, CYP2C8, CYP3A5, CYP3A7, NR2C2, PPARD, RARA, RARB, RARG, RORB, RORC"
CP,felodipine,-42.96,"calcium channel blocker, L-type calcium channel blocker","0.97, 0.16",,BRD-A30815329,"0.00, 0.00","CACNA1C, CACNA1D, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CALM1, CFTR, NR3C2, PDE1A, PDE1B, TNNC1, TNNC2"
CP,GSK-461364,-42.98,PLK inhibitor,"1.40, 0.31",,BRD-K92428232,"0.00, 0.00",PLK1
CP,phenformin,-43.02,AMPK activator,"0.83, 0.18",,BRD-K11399644,"0.00, 0.00","KCNJ8, PRKAA1"
CP,risperidone,-43.03,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist","0.63, 0.11",,BRD-K53857191,"10.00, 10.00","DRD2, HTR2A, ADRA1A, ADRA1B, DRD3, HRH1, HTR1A, HTR1D, HTR2C, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CYP3A5, DRD1, DRD4, HTR1B, HTR1E, HTR1F, HTR6, HTR7"
CP,fraxetin,41.59,anti-oxidative and anti-apoptotic agent,"0.65, 0.08",,BRD-K76587808,"10.00, 0.00",
CP,MDL-28170,41.56,"calpain inhibitor, cathepsin inhibitor","1.06, 0.32",,BRD-K43245338,"0.00, 0.00","CAPN1, CTSB, CTSL"
CP,nialamide,41.55,monoamine oxidase inhibitor,"1.83, 0.55",,BRD-K12102668,"20.00, 0.00","COMT, MAOA, MAOB"
CP,UBP-302,41.53,glutamate receptor antagonist,"0.94, 0.34",,BRD-A45499626,"0.00, 0.00",GRIK1
CP,eticlopride,41.39,dopamine receptor antagonist,"1.05, 0.25",,BRD-K50417881,"0.00, 0.00","DRD2, DRD3, DRD4"
CP,proadifen,41.37,"nitric oxide synthase inhibitor, cytochrome P450 inhibitor, potassium channel blocker","0.60, 0.16",,BRD-K46317332,"10.00, 10.00",NOS1
CP,QW-BI-011,41.37,histone lyinse methyltransferase inhibitor,"1.02, 0.31",,BRD-K72264770,"0.00, 0.00",EHMT2
CP,luzindole,41.34,melatonin receptor antagonist,"1.06, 0.34",,BRD-K67013324,"0.00, 0.00","MTNR1B, MTNR1A"
CP,parachlorophenol,41.31,disinfectant,"1.11, 0.33",,BRD-K40992116,"0.00, 0.00",
CP,digoxin,41.23,"ATPase inhibitor, ROR antagonist","2.18, 0.59",ATPase inhibitor,BRD-A94756469,"0.00, 0.00","ATP1A1, ABCB1, RORC, SLCO1B3"
CP,BRD-K78883024,-42.25,neuropeptide receptor antagonist,"0.82, 0.16",,BRD-K78883024,"22.22, 22.22",NPSR1
CP,pizotifen,-42.4,serotonin receptor antagonist,"0.60, 0.09",Serotonin receptor antagonist,BRD-K75958195,"0.00, 0.00","HTR2A, HTR1A, HTR2C"
CP,probucol,-42.41,"atherogenesis inhibitor, cholesterol inhibitor, reducing agent","1.40, 0.43",,BRD-K72029282,"10.00, 0.00","ABCA1, ABCB11, CES1"
CP,clobetasol,-42.44,glucocorticoid receptor agonist,"1.44, 0.73",Glucocorticoid receptor agonist,BRD-A26095496,"0.00, 0.00","NR3C1, PLA2G1B"
CP,VER-155008,-42.44,HSP inhibitor,"0.98, 0.36",,BRD-K32330832,"0.00, 0.00",HSPA1A
CP,linoleamide,-42.47,ACAT inhibitor,"1.16, 0.32",,BRD-K64044582,"0.00, 0.00","SOAT1, SOAT2"
CP,BRD-K73285375,-42.5,lipoxygenase inhibitor,"1.57, 0.51",,BRD-K73285375,"10.00, 0.00",
CP,cyclopamine,-42.56,"smoothened receptor antagonist, hedgehog pathway inhibitor","1.39, 0.55",,BRD-A02333338,"0.00, 0.00","SMO, DHH, IHH, PTCH1"
CP,fenpiverinium,-42.66,acetylcholine receptor antagonist,"1.18, 0.35",,BRD-K84566043,"0.00, 0.00",
CP,ketoconazole,-42.73,"14-alpha demethylase inhibitor, androgen receptor ligand, aromatase inhibitor, cell wall synthesis inhibitor, cortisol synthesis inhibitor, P glycoprotein inhibitor, sterol demethylase inhibitor","1.42, 0.35",,BRD-A76019558,"0.00, 0.00","AR, CYP19A1, CYP21A2, CYP2C19, CYP3A5, CYP3A7, KCNA10"
CP,ZD-7288,41.23,"HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker, HCN channel antagonist, potassium channel antagonist, sodium channel blocker","1.08, 0.36",,BRD-K18678457,"0.00, 0.00","HCN1, HCN2, HCN3, HCN4"
CP,fluvoxamine,41.07,"selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor","0.50, 0.10",,BRD-K72676686,"0.00, 0.00","SLC6A4, CYP2C19"
CP,mevastatin,40.97,HMGCR inhibitor,"1.23, 0.18",HMGCR inhibitor,BRD-K94441233,"20.00, 10.00",HMGCR
CP,dofetilide,40.95,"polarization inhibitor, potassium channel antagonist, potassium channel blocker","1.25, 0.40",,BRD-K86887724,"12.50, 0.00","KCNH2, KCNH1, KCNJ12, KCNK2"
CP,nomilin,40.93,HSP inhibitor,"2.02, 0.62",,BRD-A09161221,"20.00, 20.00",
CP,PHA-793887,40.91,CDK inhibitor,"1.55, 0.68",CDK inhibitor,BRD-K64800655,"0.00, 0.00","CDK1, CDK2, CDK4, CDK5, CCND1, CCNE1, CDK7, CDK9"
CP,lobeline,40.86,"acetylcholine receptor antagonist, dopamine receptor modulator, opioid receptor antagonist, vesicular monoamine transporter ligand","0.76, 0.28",,BRD-K66206289,"0.00, 0.00","SLC18A2, CHRNA10, CHRNA4, CHRNA9, CHRNB2, OPRM1"
CP,NVP-AUY922,40.83,HSP inhibitor,"1.22, 0.41",HSP inhibitor,BRD-K41859756,"10.00, 10.00","HSP90AA1, HSP90AA2, HSP90AB1"
CP,nelfinavir,40.78,"HIV protease inhibitor, proteasome inhibitor","1.51, 0.41",,BRD-K74117820,"0.00, 0.00","CYP2C19, CYP3A5, CYP3A7"
CP,mesulergine,40.78,dopamine receptor agonist,"0.94, 0.19",,BRD-K91336023,"0.00, 0.00","HTR2A, HTR2C, HTR7, HTR2B, HTR3A, HTR3B, HTR6"
CP,bisindolylmaleimide,-41.87,"CDK inhibitor, PKC inhibitor, leucine rich repeat kinase inhibitor","0.73, 0.14",PKC inhibitor,BRD-K49448285,"0.00, 0.00","CCND1, CDK4, LRRK2, PDPK1, PIM1, PRKCA, PRKCB, PRKCI, PRKCZ"
CP,SB-216763,-41.92,glycogen synthase kinase inhibitor,"0.36, 0.17",Glycogen synthase kinase inhibitor,BRD-K59184148,"0.00, 0.00","GSK3B, CCNA2, CDK2, GSK3A"
CP,TUL-XXI039,-41.94,serine/threonine kinase inhibitor,"1.26, 0.35",,BRD-K22828899,"0.00, 0.00",
CP,beta-CCP,-42.05,"indoleamine 2,3-dioxygenase inhibitor","0.94, 0.25",,BRD-K85242180,"0.00, 0.00","GABRA1, GABRG2, IDO1"
CP,P-1075,-42.15,"ATP channel activator, potassium channel agonist","1.06, 0.25","KCNJ11 modulator, Potassium channel activator",BRD-K00206590,"0.00, 0.00",KCNJ8
CP,SR-95639A,-42.16,acetylcholine receptor agonist,"0.89, 0.15",,BRD-K19309090,"0.00, 0.00",CHRM1
CP,bosutinib,-42.22,"src inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, apoptosis stimulant, STAT inhibitor","1.28, 0.45",SRC inhibitor,BRD-K99964838,"0.00, 0.00","ABL1, SRC, BCR, CAMK2G, LYN, CAMK1D, CDK2, FRK, FYN, HCK, MAP2K1, MAP2K2, MAP3K2, MAP4K5, STK10, STK24, STK4, TNK2, TXK"
CP,parthenolide,-42.23,"NFkB pathway inhibitor, adiponectin receptor agonist","1.10, 0.26",,BRD-A66395008,"10.00, 10.00","ADIPOR2, IKBKB, RELA"
CP,ioxaglic-acid,-42.24,iodine contrast agent,"1.26, 0.44",,BRD-K79124250,"0.00, 0.00",
CP,BRD-K28452084,-42.25,opioid receptor agonist,"0.92, 0.22",,BRD-K28452084,"0.00, 0.00",OPRK1
CP,mirtazapine,40.73,"adrenergic receptor antagonist, serotonin receptor antagonist","0.50, 0.14",,BRD-A64977602,"0.00, 0.00","ADRA2A, HTR2A, HTR2C, ADRA2C, HTR3A, ADRA1A, ADRA1B, ADRA1D, ADRA2B, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD5, HRH1, HRH3, HTR2B, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4"
CP,erastin,40.67,"anion channel modulator, ion channel antagonist","0.59, 0.35",,BRD-A25004090,"0.00, 0.00",VDAC2
CP,SKF-83566,40.56,dopamine receptor antagonist,"0.19, 0.01",,BRD-A52588987,"0.00, 0.00","DRD1, DRD5"
CP,myriocin,40.51,sphingolipid biosynthesis inhibitor,"0.90, 0.24",,BRD-A76279427,"0.00, 0.00","AKT1, SPTLC1, SPTLC2, SPTLC3"
CP,XMD-885,40.49,"leucine rich repeat kinase inhibitor, MAP kinase inhibitor","1.08, 0.56",Leucine rich repeat kinase inhibitor,BRD-K64857848,"10.00, 10.00","LRRK2, MAPK7"
CP,GDC-0879,40.47,RAF inhibitor,"1.20, 0.40",RAF inhibitor,BRD-K67578145,"10.00, 0.00",BRAF
CP,ticlopidine,40.47,"purinergic receptor antagonist, platelet aggregation inhibitor","1.24, 0.18",,BRD-K00603606,"10.00, 10.00","P2RY12, CYP2B6, CYP2C19"
CP,CDC,40.38,lipoxygenase inhibitor,"1.05, 0.38",,BRD-K10870738,"0.00, 0.00","ALOX12, ALOX5"
CP,tolazamide,40.3,ATP channel blocker,"0.97, 0.33",,BRD-K32164935,"0.00, 0.00","KCNJ1, KCNJ10"
CP,dihydroxyphenylglycine,40.3,glutamate receptor agonist,"1.77, 0.52",,BRD-A20589515,"0.00, 0.00",GRM1
CP,U-74389F,-41.4,lipid peroxidase inhibitor,"0.85, 0.34",,BRD-A96897502,"0.00, 0.00",
CP,hydroquinine,-41.43,anti-arrhythmia agent,"1.10, 0.39",,BRD-A78295502,"11.11, 11.11",
CP,mexiletine,-41.47,"sodium channel blocker, potassium channel blocker","0.61, 0.13",Sodium channel blocker,BRD-A64092382,"0.00, 0.00","SCN5A, AHR, CYP2B6, CYP2E1, KCNK2, KCNK3, SCN4A"
CP,DMEOB,-41.48,glutamate receptor modulator,"1.68, 0.51",,BRD-K31699485,"0.00, 0.00",
CP,cobalt(II)-chloride,-41.58,HSP agonist,"1.67, 0.59",HIF activator,BRD-K90864987,"0.00, 0.00",HIF1A
CP,temozolomide,-41.64,"DNA alkylating drug, DNA damage inducer, DNA inhibitor, topoisomerase inhibitor","0.50, 0.16",,BRD-K32107296,"0.00, 0.00",TOP2A
CP,GR-235,-41.67,"FXR antagonist, cholesterol inhibitor, estrogen receptor agonist, IKK inhibitor, progesterone receptor agonist, PXR agonist","1.27, 0.40",FXR antagonist,BRD-K26674531,"0.00, 0.00","ESR1, IKBKB, NR1H4, NR1I2, PGR"
CP,zolantidine,-41.78,histamine receptor antagonist,"1.06, 0.39",,BRD-K08996725,"0.00, 0.00",
CP,urapidil,-41.8,"adrenergic receptor antagonist, serotonin receptor agonist","1.93, 0.51",,BRD-K73196317,"0.00, 0.00",HTR1A
CP,sorafenib,-41.86,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist","1.83, 0.52","FLT3 inhibitor, PDGFR/KIT inhibitor, RAF inhibitor, VEGFR inhibitor",BRD-K49810818,"0.00, 0.00","RET, BRAF, FLT3, KDR, RAF1, FLT1, FLT4, KIT, DDR2, FGFR1, PDGFRB, CYP2B6, CYP2C8, CYP3A5, PDGFB, SLCO1B3"
CP,MT-21,40.28,"adenine nucleotide translocase inhibitor, caspase activator, neurotrophic agent","0.67, 0.20",,BRD-A99449986,"10.00, 10.00","CYCS, SLC25A4"
CP,disulfiram,40.27,"aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPA1 agonist","1.80, 0.52",,BRD-K32744045,"0.00, 0.00","ALDH2, ALDH1A2, ALDH5A1, ALDH7A1, CYP2E1, DBH, DNMT1, TRPA1"
CP,NSC-632839,40.27,"ubiquitin hydrolase inhibitor, ubiquitin isopeptidase inhibitor","2.25, 0.61",,BRD-K37392901,"0.00, 0.00","USP2, USP7, SENP2, USP1"
CP,dicyclohexylurea,40.26,epoxide hydolase inhibitor,"1.08, 0.45",,BRD-K81521265,"10.00, 10.00",EPHX2
CP,MK-1775,40.23,wee1 kinase inhibitor,"1.75, 0.60",,BRD-K54256913,"20.00, 10.00",WEE1
CP,AS-601245,40.19,JNK inhibitor,"1.81, 0.65",,BRD-A60245366,"0.00, 0.00","GSK3B, MAPK10, MAPK8, MAPK9, PIM1"
CP,thioridazine,40.19,"acetylcholine receptor ligand, dopamine receptor, dopamine receptor antagonist, mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor","1.84, 0.60",Dopamine receptor antagonist,BRD-A84481105,"0.00, 0.00","DRD1, DRD2, HTR2A, ADRA1A, ADRA1B, CHRNA7, DRD5, HRH1, HTR1A, HTR2C, HTR6, HTR7, KCNH2, MALT1"
CP,PIK-75,40.15,"DNA protein kinase inhibitor, P110 inhibitor, Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor","1.86, 0.69",PI3K inhibitor,BRD-M16762496,"0.00, 0.00","PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC"
CP,BIIB021,40.1,HSP inhibitor,"1.28, 0.52",HSP inhibitor,BRD-K51967704,"0.00, 0.00","AOX1, HSP90AA1"
CP,DPO-1,40.09,potassium channel blocker,"1.20, 0.36",Potassium channel blocker,BRD-K99922388,"0.00, 0.00",KCNA5
CP,flutamide,-41.08,androgen receptor antagonist,"0.97, 0.23",,BRD-K28307902,"0.00, 0.00","AR, AHR, CYP2C19"
CP,VU-0366037-2,-41.09,glutamate receptor modulator,"0.86, 0.16",,BRD-K39823328,"0.00, 0.00",GRM4
CP,cefaclor,-41.18,cell wall synthesis inhibitor,"0.98, 0.34",,BRD-K20338176,"0.00, 0.00",
CP,BRD-K79511609,-41.2,adenosine receptor agonist,"1.13, 0.27",,BRD-K79511609,"0.00, 0.00","ADORA1, ADORA2A, ADORA2B"
CP,nocodazole,-41.21,"tubulin inhibitor, Tubulin Polymerization Inhibitors","1.52, 0.57",Tubulin inhibitor,BRD-K12539581,"0.00, 0.00",HPGDS
CP,chlorpromazine,-41.26,"dopamine receptor, dopamine receptor antagonist, Kinesin-Like Spindle Protein  KIF11 (KSP, Eg5) Inhibitors","1.59, 0.63",Dopamine receptor antagonist,BRD-K89997465,"0.00, 0.00","DRD2, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, ADRA1A, ADRA1B, ADRA1D, CALM1, CHRM1, CHRM3, HRH4, HTR2B, KCNH2, KIF11, ORM1, ORM2, SMPD1, TRPC5"
CP,zebularine,-41.27,"DNA methyltransferase inhibitor, cytidine deaminase inhibitor","0.63, 0.20",,BRD-A01145011,"0.00, 0.00","CDA, DNMT1"
CP,lawsone,-41.32,coloring agent,"0.91, 0.26",,BRD-K66707493,"0.00, 0.00",
CP,tolterodine,-41.36,acetylcholine receptor antagonist,"1.59, 0.44",,BRD-K54316499,"0.00, 0.00","CHRM2, CHRM3, CHRM1, CHRM4, CHRM5"
CP,dinoprostone,-41.36,prostanoid receptor agonist,"0.90, 0.27",,BRD-K26521938,"0.00, 0.00","PTGER2, PTGER1, PTGER3, PTGER4, CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGDR2, PTGFR, TBXA2R"
CP,lypressin,40.09,vasopressin receptor agonist,"0.77, 0.24",,BRD-K93331255,"0.00, 0.00","AVPR1A, AVPR1B, AVPR2"
CP,BMS-299897,40.04,"gamma secretase inhibitor, antiamyloidogenic agent","1.18, 0.15",Gamma secretase inhibitor,BRD-K02950022,"0.00, 0.00",
CP,emetine,39.85,protein synthesis inhibitor,"3.28, 0.78",,BRD-K03067624,"12.50, 0.00",RPS2
CP,toltrazuril,39.83,anti-protozoal,"0.67, 0.16",,BRD-K64514229,"0.00, 0.00",
CP,methimazole,39.79,antithyroid Drugs,"0.90, 0.34",,BRD-K54416256,"22.22, 11.11",TPO
CP,rhamnetin,39.76,"aldose reductase inhibitor, JNK inhibitor, lipoxygenase inhibitor, nitric oxide production inhibitor, p38 MAPK inhibitor","0.80, 0.28",,BRD-K37206356,"10.00, 0.00","ALOX5, MAPK8"
CP,thiorphan,39.64,membrane metalloendopeptidase inhibitor,"1.03, 0.25",,BRD-A56012032,"0.00, 0.00",MME
CP,homochlorcyclizine,39.61,antihistamine,"0.95, 0.22",,BRD-A22769835,"11.11, 11.11",HRH1
CP,itraconazole,39.58,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, sterol demethylase inhibitor, VEGFR inhibitor","0.97, 0.13",,BRD-A34817987,"10.00, 0.00","CYP3A5, CYP3A7, CYP51A1, KDR"
CP,VAMA-37,39.57,"DNA dependent protein kinase, DNA dependent protein kinase inhibitor, PI3K inhibitor","1.39, 0.48",DNA dependent protein kinase inhibitor,BRD-K51018020,"0.00, 0.00",PRKDC
CP,H-89,-40.63,"AKT inhibitor, cAMP dependent protein kinase inhibitor, PKA inhibitor, voltage-gated potassium channel blocker","1.58, 0.55",PKA inhibitor,BRD-K27737647,"0.00, 0.00","PRKACA, GSG2, KCNA2, KCNA3, KCNA5, KCNAB2, KCNC1, KCNC2, KCNC3, KCNE1, KCNE2, KCNE3, KCNE4, KCNH1, KCNH2, KCNQ1, KCNQ2, KCNQ3, KCNQ5, KCNS3, PKIA"
CP,halcinonide,-40.72,glucocorticoid receptor agonist,"1.38, 0.75",Glucocorticoid receptor agonist,BRD-K81709173,"0.00, 0.00",NR3C1
CP,RS-102221,-40.72,serotonin receptor antagonist,"1.13, 0.25",,BRD-K87048468,"10.00, 10.00","HTR2C, HTR2A, HTR2B"
CP,brazilin,-40.76,"nitric oxide production inhibitor, nitric oxide synthase expression inhibitor, telomerase inhibitor","1.50, 0.50",,BRD-A83326220,"0.00, 0.00",
CP,diphencyprone,-40.78,immunostimulant,"1.84, 0.66",,BRD-K51730347,"0.00, 0.00",
CP,salbutamol,-40.83,adrenergic receptor agonist,"1.44, 0.41",,BRD-A88254928,"0.00, 0.00","ADRB2, ADRB1"
CP,guggulsterone,-40.84,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist","1.39, 0.27",FXR antagonist,BRD-A59808129,"0.00, 0.00","NR1H4, PGR, AR, ESR1, IKBKB, NR1I2, NR3C1, NR3C2"
CP,calpeptin,-40.92,"calpain inhibitor, proteasome inhibitor, tyrosine phosphatase inhibitor","1.36, 0.52",,BRD-A84045418,"0.00, 0.00",
CP,JNJ-16259685,-41.02,glutamate receptor antagonist,"1.05, 0.33",,BRD-K64670467,"0.00, 0.00",GRM1
CP,forskolin,-41.07,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant","1.24, 0.48",,BRD-A70449690,"0.00, 0.00","ADCY2, ADCY5, GNAS"
CP,triptolide,39.56,RNA polymerase inhibitor,"1.88, 0.72",,BRD-K39484304,"0.00, 0.00","CYP2C19, RELA"
CP,vardenafil,39.55,phosphodiesterase inhibitor,"0.99, 0.28",,BRD-K13926615,"0.00, 0.00","PDE5A, CYP2C19, CYP2C8, CYP3A5, PDE6G, PDE6H"
CP,BAY-K8644,39.5,L-type calcium channel activator,"1.02, 0.26",,BRD-K14329163,"0.00, 0.00",CACNA1C
CP,LE-300,39.42,"dopamine receptor antagonist, dopamine receptor ligand, serotonin receptor ligand","0.65, 0.20",,BRD-K01648091,"0.00, 0.00","DRD5, DRD1, HTR2A"
CP,5-iodotubercidin,39.41,"adenosine kinase inhibitor, nucleoside transporter inhibitor","4.91, 1.55",,BRD-A18497530,"0.00, 0.00","MAPK3, ADK, CSNK1G2, GSG2, LRRK2"
CP,BRD-A81377415,39.4,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor","1.41, 0.33",,BRD-A81377415,"0.00, 0.00","CLK1, CLK4, DYRK1A, DYRK1B"
CP,ormetoprim,39.4,antibiotic,"1.85, 0.74",,BRD-K25310650,"0.00, 0.00",
CP,puromycin,39.4,"adenosine receptor agonist, protein synthesis inhibitor","2.40, 0.51",Protein synthesis inhibitor,BRD-A28970875,"0.00, 0.00","NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1"
CP,HU-211,39.39,"glutamate receptor antagonist, apoptosis stimulant, NFkB pathway inhibitor, reducing agent","2.10, 0.49",,BRD-A15010982,"11.11, 0.00","CNR1, CNR2, GLRA1, GLRA2, GLRA3, GPR55, GRIN1, NFKB1"
CP,evodiamine,39.38,"ATPase inhibitor, TRPV agonist","0.84, 0.34",,BRD-A68631409,"10.00, 10.00",TRPV1
CP,SC-19220,-40.41,prostanoid receptor antagonist,"1.01, 0.36",,BRD-K52512893,"0.00, 0.00",PTGER1
CP,ginsenoside,-40.41,steroidal receptor agonist,"1.13, 0.31",,BRD-A65550283,"10.00, 10.00",
CP,montelukast,-40.45,leukotriene receptor antagonist,"0.89, 0.22",,BRD-K69470111,"12.50, 12.50","CYSLTR1, ALOX5, CYP2C8"
CP,parthenolide,-40.45,"NFkB pathway inhibitor, adiponectin receptor agonist","1.69, 0.69",,BRD-K28120222,"0.00, 0.00","ADIPOR2, IKBKB, RELA"
CP,alaproclate,-40.47,"serotonin receptor antagonist, serotonin reuptake inhibitor","0.58, 0.13",,BRD-A14966924,"0.00, 0.00",SLC6A4
CP,raltitrexed,-40.49,"thymidylate synthase inhibitor, pyrimidine antagonist","0.86, 0.26",Thymidylate synthase inhibitor,BRD-K89839824,"0.00, 0.00","TYMS, FPGS"
CP,westcort,-40.52,corticosteroid,"1.26, 0.47",Glucocorticoid receptor agonist,BRD-A23290232,"0.00, 0.00",
CP,mepacrine,-40.56,"NFkB pathway inhibitor, cytokine production inhibitor, TP53 expression enhancer, acetylcholinesterase inhibitor, AKT inhibitor, apoptosis stimulant, DNA inhibitor, mTOR inhibitor, phospholipase inhibitor, PI3K inhibitor, secretory phospholipase inhibitor, TP53 activator","1.22, 0.24",NFkB pathway inhibitor,BRD-A45889380,"0.00, 0.00","TP53, AKT1, MTOR, NFKB1, PLA2G1B, PLA2G2A, PLA2G2D, PLA2G4A, PLA2G6, PLCL1"
CP,entacapone,-40.56,catechol O methyltransferase inhibitor,"1.48, 0.48",,BRD-K83636919,"0.00, 0.00",COMT
CP,wiskostatin,-40.59,neural Wiskott-Aldrich syndrome protein inhibitor,"1.68, 0.72",,BRD-A18579359,"10.00, 0.00","WAS, WASL"
CP,galantamine,39.36,"acetylcholinesterase inhibitor, acetylcholine receptor agonist, butyrylcholinesterase inhibitors","1.66, 0.57",,BRD-K49481516,"12.50, 0.00","ACHE, BCHE, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG"
CP,BRD-K24127443,39.34,lipoxygenase inhibitor,"1.28, 0.31",,BRD-K24127443,"0.00, 0.00",
CP,"4,5-dianilinophthalimide",39.33,"EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor","0.84, 0.35",EGFR inhibitor,BRD-K13087974,"10.00, 0.00",EGFR
CP,chromomycin-a3,39.32,DNA binding,"1.43, 0.64",,BRD-A11702965,"0.00, 0.00",
CP,metformin,39.29,"insulin sensitizer, AMPK activator, biguanide, gluconeogenesis inhibitor","1.72, 0.47",,BRD-K79602928,"0.00, 0.00","ACACB, INS, PRKAB1"
CP,nitrendipine,39.28,"calcium channel blocker, L-type calcium channel blocker","0.77, 0.17",,BRD-A02006392,"0.00, 0.00","CACNA1C, CACNA1D, CACNA2D1, CACNA1H, CACNA1S, CACNA2D2, CACNB2, CACNG1, KCNN4"
CP,corticosterone,39.2,mineralocorticoid receptor agonist,"1.63, 0.55",,BRD-K73589401,"10.00, 10.00","HSD11B1, NR3C2, NCOA1"
CP,torasemide,39.14,"cytochrome P450 antagonist, diuretic, electrolyte reabsorption inhibitor, thromboxane receptor antagonist","0.84, 0.23",,BRD-K30480208,"0.00, 0.00","SLC12A1, CYP2C8, SLC12A2"
CP,diphemanil,38.9,acetylcholine receptor antagonist,"0.84, 0.31",,BRD-K93441486,"11.11, 0.00",CHRM3
CP,targinine,38.83,nitric oxide synthase inhibitor,"2.35, 0.69",,BRD-K22227508,"0.00, 0.00","NOS2, NOS3"
CP,naftidrofuryl,-39.99,adrenergic receptor antagonist,"1.30, 0.57",,BRD-A67862938,"10.00, 0.00",
CP,dioxybenzone,-40.01,topical sunscreen agent,"0.84, 0.14",,BRD-K22193694,"0.00, 0.00",
CP,pyrimethamine,-40.02,"dihydrofolate reductase inhibitor, hexosaminidase stimulant, pharmacological chaperone, STAT inhibitor","0.51, 0.06",Dihydrofolate reductase inhibitor,BRD-K88429204,"0.00, 0.00","DHFR, DHFRP1, HEXA, SLC47A1, STAT3"
CP,methoxsalen,-40.03,"acetylcholinesterase inhibitor, cytochrome P450 inhibitor, DNA damaging, DNA synthesis inhibitor, immunosuppressant","1.16, 0.31",,BRD-K63430059,"0.00, 0.00","ACHE, CYP1A2"
CP,desoxycortone,-40.03,mineralocorticoid receptor agonist,"1.17, 0.31",,BRD-K98521173,"0.00, 0.00","NR3C1, NR3C2"
CP,Y-134,-40.14,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","1.28, 0.23",Estrogen receptor antagonist,BRD-K94832621,"0.00, 0.00","ESR1, ESR2"
CP,L-152804,-40.27,neuropeptide receptor antagonist,"0.95, 0.26",,BRD-A42553870,"0.00, 0.00",NPY5R
CP,VU-0400071-3,-40.29,glutamate receptor modulator,"1.52, 0.31",,BRD-A57457122,"10.00, 10.00",GRM4
CP,PP-1,-40.36,"src inhibitor, Abl kinase inhibitor","1.75, 0.64",SRC inhibitor,BRD-K47598052,"0.00, 0.00","HCK, RET, SRC"
CP,phenelzine,-40.36,monoamine oxidase inhibitor,"0.74, 0.17",,BRD-K87024524,"10.00, 10.00","MAOB, AOC3, MAOA, ABAT, GAD2, GPT, GPT2, SLC6A2, SLC6A3, SLC6A4"
CP,HTMT,38.8,histamine receptor agonist,"1.00, 0.24",,BRD-A66435872,"0.00, 0.00",HRH4
CP,lestaurtinib,38.71,"FLT3 inhibitor, growth factor receptor inhibitor, JAK inhibitor, apoptosis stimulant","3.09, 0.86","FLT3 inhibitor, JAK inhibitor",BRD-K23192422,"0.00, 0.00","FLT3, NTRK1, JAK2, NTRK2, NTRK3"
CP,isoeugenol,38.68,nitric oxide production inhibitor,"1.83, 0.56",,BRD-K05737787,"0.00, 0.00",
CP,rotenonic-acid,38.65,RAR antagonist,"0.84, 0.23",,BRD-K34330170,"10.00, 0.00",
CP,brucine,38.63,glycine receptor antagonist,"0.60, 0.14",,BRD-A41995253,"0.00, 0.00","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
CP,SB-269970,38.61,serotonin receptor antagonist,"0.86, 0.31",,BRD-K24201553,"0.00, 0.00",HTR7
CP,calyculin,38.58,protein phosphatase inhibitor,"2.60, 0.66",,BRD-A47513740,"11.11, 11.11","PPP1CA, PPP1CC, PPP2CA"
CP,FG-7142,38.52,GABA benzodiazepine site receptor inverse agonist,"0.82, 0.26",,BRD-K61951118,"11.11, 0.00",
CP,ICI-89406,38.52,adrenergic receptor antagonist,"1.63, 0.44",,BRD-A03359064,"10.00, 10.00","ADRB1, ADRB2"
CP,fenobam,38.49,glutamate receptor antagonist,"0.82, 0.31",,BRD-K41160163,"10.00, 0.00",GRM5
CP,ondansetron,-39.63,serotonin receptor antagonist,"0.45, 0.02",,BRD-A19736161,"0.00, 0.00","HTR3A, CYP2D6, CYP3A5, HTR1A, HTR1B, HTR3B, HTR4, OPRM1"
CP,R-96544,-39.71,serotonin receptor antagonist,"1.30, 0.28",Serotonin receptor antagonist,BRD-K15588452,"0.00, 0.00",HTR2A
CP,SB-525334,-39.76,TGF beta receptor inhibitor,"1.60, 0.44",TGF beta receptor inhibitor,BRD-K37720887,"0.00, 0.00",TGFBR1
CP,epicatechin,-39.78,"beta amyloid protein neurotoxicity inhibitor, beta secretase inhibitor, cyclooxygenase inhibitor, DNA gyrase inhibitor, DNA polymerase beta inhibitor, fatty acid synthase inhibitor, HCV inhibitor, sodium/glucose cotransporter inhibitor","1.01, 0.33",,BRD-K50660797,"0.00, 0.00","FASN, APP, BACE1, SLC5A1"
CP,benzthiazide,-39.86,carbonic anhydrase inhibitor,"1.08, 0.26",,BRD-K21450440,"0.00, 0.00","CA2, CA1, CA12, CA4, CA9, SLC12A3"
CP,valsartan,-39.89,angiotensin receptor antagonist,"1.47, 0.63",,BRD-A14792000,"0.00, 0.00",AGTR1
CP,BML-257,-39.93,"AKT inhibitor, HCV NS5B RdRp inhibitor","0.93, 0.32",,BRD-K32584078,"10.00, 0.00",AKT1
CP,ZM-39923,-39.93,JAK inhibitor,"1.75, 0.43",,BRD-K40624912,"0.00, 0.00","JAK1, JAK3"
CP,BRD-K67258146,-39.94,mannose-6-phosphate isomerate inhibitor,"1.51, 0.43",,BRD-K67258146,"10.00, 0.00",
CP,lumicolchicine,-39.95,"colchicine isomer, non-binder of microtubules","0.51, 0.16",,BRD-K99411983,"0.00, 0.00",
CP,DMP-543,38.42,acetylcholine release enhancer,"0.77, 0.24",,BRD-K89274813,"0.00, 0.00",
CP,prostratin,38.38,"NFkB pathway activator, PKC activator","3.63, 1.03",PKC activator,BRD-K91145395,"0.00, 0.00","PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCH, PRKCQ"
CP,taxifolin,38.38,"apolipoprotein secretion inhibitor, beta amyloid aggregation inhibitor, cholesterol biosynthesis inhibitor, HMGCR inhibitor, NFkB pathway modulator, opioid receptor antagonist, reverse transcriptase inhibitor","2.00, 0.70",,BRD-K94649603,"0.00, 0.00","APOB, APP, HMGCR"
CP,triamterene,38.36,sodium channel blocker,"0.78, 0.23",Sodium channel blocker,BRD-K92049597,"0.00, 0.00","SCNN1A, SCNN1B, SCNN1G, SCNN1D"
CP,anisomycin,38.35,DNA synthesis inhibitor,"3.61, 0.86",,BRD-K91370081,"0.00, 0.00","NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1"
CP,SID-26681509,38.35,cathepsin inhibitor,"0.13, 0.02",,BRD-K08417745,"10.00, 0.00",CTSL
CP,SQ-29548,38.3,thromboxane receptor antagonist,"0.80, 0.14",,BRD-A91866971,"0.00, 0.00",
CP,bezafibrate,38.26,"PPAR receptor agonist, 11-beta hydroxysteroid dehydrogenase expression inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, lipase clearing factor inhibitor","0.83, 0.24",PPAR receptor agonist,BRD-K46018455,"0.00, 0.00","PPARA, PPARD, PPARG, HSD11B1, LPL"
CP,vicriviroc,38.25,"CC chemokine receptor antagonist, CC chemokine receptor 5 (CCR5) antagonist","0.97, 0.15",,BRD-M72442222,"0.00, 0.00",CCR5
CP,aminopurvalanol-a,38.17,"CDK inhibitor, tyrosine kinase inhibitor","1.91, 0.49",CDK inhibitor,BRD-K07762753,"0.00, 0.00","CDK1, CDK2, CDK5, CDK6"
CP,NGB-2904,-38.99,dopamine receptor antagonist,"0.70, 0.27",,BRD-K05181084,"0.00, 0.00",DRD3
CP,telmisartan,-38.99,"angiotensin receptor antagonist, PPAR receptor agonist, PPAR receptor modulator, PPAR receptor partial agonist","0.75, 0.19",,BRD-K73999723,"0.00, 0.00","AGTR1, PPARG, CYP2C19, CYP2J2, PPARA"
CP,JX-401,-39.1,p38 MAPK inhibitor,"1.08, 0.38",,BRD-K05464208,"0.00, 0.00",MAPK14
CP,fusaric-acid,-39.23,"chelating agent, dopamine beta hydroxylase inhibitor","1.02, 0.35",,BRD-K87049188,"0.00, 0.00",DBH
CP,RS-56812,-39.26,"serotonin receptor antagonist, serotonin receptor partial agonist","0.95, 0.38",,BRD-K20714604,"0.00, 0.00",HTR3A
CP,SA-792987,-39.41,PKC inhibitor,"1.32, 0.30",PKC inhibitor,BRD-K82823804,"0.00, 0.00",WEE1
CP,acetohydroxamic-acid,-39.47,inhibitor of bacterial and plant urease,"1.71, 0.42",,BRD-K74112339,"0.00, 0.00",
CP,SYK-inhibitor,-39.51,syk inhibitor,"0.99, 0.24",,BRD-K30189597,"0.00, 0.00",SYK
CP,goserelin,-39.55,"gonadotropin releasing factor hormone receptor agonist, luteinizing hormone releasing hormone agonist","1.14, 0.35",,BRD-A62434282,"0.00, 0.00","GNRHR, GNRH1, LHCGR"
CP,desoxycorticosterone,-39.57,mineralocorticoid receptor agonist,"1.09, 0.35",,BRD-A75402480,"0.00, 0.00",
CP,ketotifen,38.16,"histamine receptor ligand, leukotriene antagonist, phosphodiesterase inhibitor","0.52, 0.07",,BRD-K28936863,"0.00, 0.00","HRH1, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B, PGD"
CP,LY-456236,38.14,glutamate receptor antagonist,"0.98, 0.27",,BRD-K87696786,"0.00, 0.00",GRM1
CP,L-655240,38.11,"platelet aggregation inhibitor, prostanoid receptor antagonist, thromboxane receptor antagonist","0.91, 0.27",Thromboxane receptor antagonist,BRD-K89402695,"10.00, 0.00",PTGES
CP,metergoline,38.05,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor","1.22, 0.31",,BRD-K56699285,"0.00, 0.00","DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7"
CP,dexamethasone,38.04,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant","1.60, 0.86",,BRD-K38775274,"0.00, 0.00","ANXA1, CYP3A4, CYP3A5, NOS2, NR0B1, NR3C1, NR3C2"
CP,XMD-1150,38.04,leucine rich repeat kinase inhibitor,"1.33, 0.56",Leucine rich repeat kinase inhibitor,BRD-K01436366,"10.00, 0.00",LRRK2
CP,moexipril,38.03,"angiotensin converting enzyme inhibitor, phosphodiesterase inhibitor","1.23, 0.51",,BRD-K34441861,"0.00, 0.00","ACE, ACE2"
CP,RHO-kinase-inhibitor-III[rockout],37.98,ROCK inhibitor,"1.26, 0.76",,BRD-K23875128,"20.00, 20.00","IMPDH2, ROCK1"
CP,ethinylestradiol,37.95,"DNA directed DNA polymerase stimunlant, estrogen receptor agonist","1.73, 0.58",,BRD-K48195008,"0.00, 0.00","ESR1, CYP2C8, ESR2, NR1I2"
CP,cimetidine,37.91,"histamine receptor antagonist, histamine receptor inhibitor","0.72, 0.26",,BRD-K18618618,"0.00, 0.00","HRH2, SLC29A4, SLC47A1, SLC47A2"
CP,sirolimus,-38.39,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor","1.99, 0.56",MTOR inhibitor,BRD-K89626439,"11.11, 11.11","MTOR, FKBP1A, CCR5, FGF2"
CP,mafenide,-38.45,"carbonic anhydrase inhibitor, unidentified pharmacological activity","1.82, 0.47",,BRD-K30649484,"10.00, 0.00","CA6, CA12, CA14, CA2, CA4, CA9"
CP,thapsigargin,-38.52,"ATPase inhibitor, calcium channel blocker, PKC activator","1.76, 0.47",ATPase inhibitor,BRD-A62809825,"0.00, 0.00",ATP2A1
CP,rimexolone,-38.6,"glucocorticoid receptor agonist, immunosuppressant, mineralocorticoid receptor agonist","1.19, 0.47",Glucocorticoid receptor agonist,BRD-K31627533,"0.00, 0.00","NR3C1, SERPINA6"
CP,propylpyrazole,-38.72,estrogen receptor agonist,"1.33, 0.36",,BRD-K87573634,"0.00, 0.00",ESR1
CP,phenazone,-38.73,cyclooxygenase inhibitor,"0.56, 0.14",,BRD-K46937689,"0.00, 0.00","PTGS1, PTGS2"
CP,epigallocatechin,-38.79,"AP inhibitor, aromatase inhibitor, bacterial efflux pump inhibitor, beta amyloid aggregation inhibitor, beta amyloid protein neurotoxicity inhibitor, beta secretase inhibitor, DNA gyrase inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, enoyl-(acyl-carrier protein) reductase Fabl inhibitor, fatty acid synthase inhibitor, HCV inhibitor, indoleamine 2,3-dioxygenase inhibitor, NFkB pathway inhibitor, nitric oxide synthase inhibitor, PDGFR tyrosine kinase receptor inhibitor, PPAR receptor agonist, prolyl endopeptidase inhibitor, proteasome inhibitor, sodium/glucose cotransporter inhibitor, telomerase inhibitor, tumor NADH oxidase inhibitor, VEGFR inhibitor","0.55, 0.10",,BRD-K55591206,"0.00, 0.00","FASN, APP, BACE1, CYP19A1, DYRK1A, ELANE, ENOX2, EP300, IDO1, KAT2B, KDR, MMP14, MMP2, PPARA, PREP, SLC5A1"
CP,marmesin,-38.82,precursor in psoralen,"1.34, 0.44",,BRD-K36377456,"11.11, 11.11",
CP,noscapine,-38.92,"bradykinin receptor antagonist, tubulin polymerization inhibitor, apoptosis stimulant, microtubule inhibitor, tubulin inhibitor","0.91, 0.34",,BRD-K91301684,"10.00, 10.00","BDKRB2, SIGMAR1"
CP,etamivan,-38.95,respiratory stimulant,"1.30, 0.49",,BRD-K38055836,"0.00, 0.00",
CP,BRD-K66896231,37.88,acetylcholinesterase inhibitor,"1.90, 0.75",,BRD-K66896231,"0.00, 0.00",ACHE
CP,embelin,37.8,"HCV inhibitor, XIAP inhibitor","0.69, 0.23",,BRD-K86727142,"0.00, 0.00",XIAP
CP,ouabain,37.74,"ATPase inhibitor, alpha subunit binder","2.21, 0.51",,BRD-K35708212,"0.00, 0.00","ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, ATP1B4, FXYD2"
CP,nabumetone,37.68,"cyclooxygenase inhibitor, 3alpha hydroxysteroid dehydrogenase inhibitor","1.57, 0.33",Cyclooxygenase inhibitor,BRD-K65146499,"0.00, 0.00","PTGS2, AKR1C3, CYP2B6, CYP2C19, CYP2E1, PTGS1"
CP,testosterone,37.66,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist","0.82, 0.19",Androgen receptor modulator,BRD-A48720949,"0.00, 0.00","AR, CYP19A1, CYP2C19, CYP2C8, CYP3A5"
CP,mefenamic-acid,37.64,cyclooxygenase inhibitor,"1.11, 0.33",,BRD-K92778217,"0.00, 0.00","PTGS2, PTGS1, KCNQ1, TRPM3"
CP,WYE-125132,37.62,"mTOR inhibitor, PI3K inhibitor","1.59, 0.50",MTOR inhibitor,BRD-A45498368,"0.00, 0.00","MTOR, PIK3CA"
CP,staurosporine,37.57,"PKC inhibitor, AKT inhibitor, BMX inhibitor, CDK inhibitor, CHK inhibitor, G protein coupled receptor agonist, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, ribosomal protein inhibitor, sodium/hydrogen exchanger inhibitor","3.22, 0.84",,BRD-K70549064,"0.00, 0.00","CDK2, GSK3B, CAMK2B, CDK1, CDK5, CHEK1, CHRM1, CHRM2, CHRM4, CSK, DAPK1, GPR35, IKBKB, ITK, LCK, LRRK2, MAP2K4, MAP2K6, MAPKAPK2, PAK2, PDPK1, PHKG2, PIK3CG, PIM1, PKN1, PRKACB, PRKCI, PRKCQ, RPS6KA1, STK3, SYK, TNIK, ZAP70"
CP,BRD-K19059335,37.52,"runt-related transcription factor inhibitor, tyrosine aminotransferase inhibitor","1.36, 0.36",,BRD-K19059335,"0.00, 0.00",RUNX1
CP,linifanib,37.48,"PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, FLT3 inhibitor, macrophage colony stimulating factor antagonist, MAP kinase inhibitor, PARP inhibitor, receptor tyrosine kinase inhibitor, STAT inhibitor, VEGFR antagonist","1.02, 0.49",,BRD-K99749624,"0.00, 0.00","CSF1R, KDR, PDGFRB, FLT1, FLT3, FLT4, CSF1, KIT, PDGFRA, RET, TEK"
CP,carteolol,-37.75,adrenergic receptor antagonist,"0.70, 0.17",,BRD-A42167015,"0.00, 0.00","ADRB1, ADRB2"
CP,aristolochic-acid,-37.8,phospholipase inhibitor,"0.75, 0.11",,BRD-K17110974,"10.00, 10.00",
CP,alitretinoin,-37.88,"RXR agonist, ABC transporter expression enhancer, apoptosis stimulant, RAR agonist, retinoid receptor agonist","0.57, 0.24",Retinoid receptor agonist,BRD-K35483542,"0.00, 0.00","RARG, RARA, RARB, RXRA, RXRG, ABCA1, CYP2C8, CYP3A7, RXRB, VKORC1"
CP,GR-46611,-37.97,serotonin receptor agonist,"0.63, 0.13",,BRD-K68190965,"0.00, 0.00",HTR1D
CP,BRD-K85853281,-37.99,"radical formation stimulant, RNA synthesis inhibitor, topoisomerase inhibitor","2.38, 0.86",,BRD-K85853281,"0.00, 0.00",TOP2A
CP,diazoxide,-38.18,"ATP channel activator, potassium channel activator","1.05, 0.27",,BRD-K73109821,"0.00, 0.00","ATP1A1, CA1, CA2, KCNJ11, KCNMA1, SLC12A3"
CP,promazine,-38.2,"dopamine receptor, dopamine receptor antagonist","1.41, 0.49",Dopamine receptor antagonist,BRD-K06980535,"0.00, 0.00","CHRM5, DRD2, ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, DRD1, DRD3, DRD4, HRH1, HTR2A, HTR2C"
CP,deforolimus,-38.22,"mTOR inhibitor, angiogenesis inhibitor, cell cycle inhibitor, immunosuppressant, protein kinase inhibitor, serine/threonine kinase inhibitor, VEGFR antagonist","1.78, 0.55",MTOR inhibitor,BRD-K29733039,"10.00, 0.00",MTOR
CP,nefazodone,-38.22,"serotonin receptor antagonist, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor","0.60, 0.16",,BRD-K90789829,"10.00, 10.00","HTR2A, SLC6A4, HTR2C, SLC6A2, ADRA1A, ADRA1B, ADRA2A, CYP3A4, CYP3A5, CYP3A7, HTR1A, SLC6A3"
CP,triprolidine,-38.25,histamine receptor antagonist,"1.32, 0.41",,BRD-K56231354,"0.00, 0.00",HRH1
CP,ritodrine,37.44,adrenergic receptor agonist,"1.01, 0.30",,BRD-K51465424,"0.00, 0.00",ADRB2
CP,CL-82198,37.38,metalloproteinase inhibitor,"1.17, 0.40",,BRD-K00675675,"0.00, 0.00",MMP13
CP,PSB-1115,37.36,adenosine receptor antagonist,"1.13, 0.34",,BRD-K49027941,"11.11, 0.00","ADORA2B, ADORA1, ADORA3"
CP,rosmarinic-acid,37.27,antioxidant,"0.98, 0.19",,BRD-K20313525,"10.00, 10.00","MCL1, TYR"
CP,letrozole,37.24,"aromatase inhibitor, estrogen receptor antagonist","0.50, 0.11",,BRD-K88789588,"0.00, 0.00",CYP19A1
CP,naringin,37.14,cytochrome P450 inhibitor,"1.26, 0.47",,BRD-K02953697,"11.11, 11.11",SLCO1A2
CP,cardiogenol-c,37.06,"pyrimidine compound, induces embryonic stem cell ifferentiation into cardiomyocytes","0.99, 0.17",,BRD-K99174507,"0.00, 0.00",
CP,PG-9,37.01,presynaptic cholinergic modulator,"0.75, 0.31",,BRD-A70268693,"10.00, 10.00",
CP,emetine,36.96,protein synthesis inhibitor,"2.92, 0.68",Protein synthesis inhibitor,BRD-A25687296,"0.00, 0.00",RPS2
CP,BAPTA-AM,36.95,potassium channel blocker,"1.31, 0.26",,BRD-K40919711,"10.00, 10.00","KCNA3, KCNA5, KCNH2"
CP,EMF-bca1-57,-37.24,caspase inhibitor,"0.90, 0.17",,BRD-K64610608,"0.00, 0.00",CASP3
CP,sunitinib,-37.26,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, colony stimulating factor receptor antagonist, colony stimulating factor receptor inhibitor, platelet-derived growth factor receptor (PDGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 1 (VEGFR1) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR antagonist","1.27, 0.45",,BRD-K70511574,"0.00, 0.00","FLT3, KDR, KIT, FLT4, FLT1, PDGFRA, PDGFRB, RET, CSF1R, FGFR1"
CP,pindolol,-37.43,adrenergic receptor antagonist,"1.35, 0.31",,BRD-A97701745,"0.00, 0.00","ADRB1, ADRB2, HTR1A, HTR1B, HTR2A, HTR2B"
CP,amisulpride,-37.47,dopamine receptor antagonist,"0.55, 0.09",,BRD-A60197193,"0.00, 0.00","DRD2, DRD3, HTR2A, HTR7"
CP,ZK-164015,-37.48,estrogen receptor antagonist,"1.38, 0.18",Estrogen receptor antagonist,BRD-K05151076,"10.00, 0.00","ESR1, ESR2"
CP,rilmenidine,-37.55,"adrenergic receptor agonist, imidazoline receptor agonist","1.17, 0.38",,BRD-K52080565,"0.00, 0.00",NISCH
CP,KU-C103428N,-37.59,"CDC inhibitor, rho GTPase inhibitor","0.64, 0.17",,BRD-A82096673,"0.00, 0.00",NFE2
CP,CHEMBL-374350,-37.62,NFkB pathway inhibitor,"1.70, 0.33",,BRD-K59962020,"0.00, 0.00",
CP,GW-7647,-37.67,PPAR receptor agonist,"0.85, 0.20",PPAR receptor agonist,BRD-K96263742,"0.00, 0.00",PPARA
CP,SC-9,-37.72,protein kinase C activator,"1.23, 0.36",,BRD-K25875056,"10.00, 10.00",
CP,valsartan,36.93,angiotensin receptor antagonist,"0.73, 0.22",,BRD-K45158365,"10.00, 10.00",AGTR1
CP,epitestosterone,36.81,inactive testosterone analog,"0.53, 0.11",,BRD-K25836724,"0.00, 0.00","AKR1C1, AKR1C2, AR"
CP,SB-431542,36.8,"TGF beta receptor inhibitor, ALK inhibitor","1.23, 0.48",TGF beta receptor inhibitor,BRD-K67298865,"10.00, 0.00","TGFBR1, ACVR1C, ACVR1B"
CP,ciprofibrate,36.78,"PPAR receptor agonist, lipase clearing factor inhibitor","1.09, 0.34",,BRD-A49358627,"0.00, 0.00","PPARA, LPL"
CP,BVT-948,36.75,tyrosine phosphatase inhibitor,"2.32, 0.45",,BRD-A22713669,"0.00, 0.00","PTPN1, PTPN11, PTPN2"
CP,rifapentine,36.64,"DNA directed RNA polymerase inhibitor, DNA directed DNA polymerase inhibitor","0.81, 0.27",,BRD-K55889443,"25.00, 25.00","CYP2C8, CYP3A4"
CP,tienilic-acid,36.61,"sodium/potassium/chloride transporter inhibitor, uric acid diuretic","1.44, 0.52",,BRD-K34098590,"0.00, 0.00","CYP2C9, SLC12A1, SLC22A12"
CP,bemesetron,36.6,serotonin receptor antagonist,"0.69, 0.13",Serotonin receptor antagonist,BRD-A85587465,"0.00, 0.00","HTR3A, HTR3B"
CP,clofarabine,36.57,"ribonucleoside reductase inhibitor, DNA polymerase inhibitor, DNA repair enzyme inhibitor, DNA synthesis inhibitor, ribonucleotide reductase inhibitor","2.16, 0.52",Ribonucleotide reductase inhibitor,BRD-A82371568,"0.00, 0.00","RRM1, POLA1, RRM2, SLC22A8"
CP,aminoindazole,36.57,ionophore,"0.99, 0.36",,BRD-K51066026,"0.00, 0.00",
CP,pazopanib,-36.81,"VEGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, RAF inhibitor, tyrosine kinase inhibitor, VEGFR antagonist","0.81, 0.33","PDGFR/KIT inhibitor, VEGFR inhibitor",BRD-K74514084,"0.00, 0.00","KDR, KIT, FLT1, FLT4, PDGFRB, PDGFRA, BRAF, CSF1R, CYP2B6, CYP2C8, CYP2E1, DDR2, FGF1, FGFR1, FGFR3, ITK, SH2B3"
CP,prostaglandin,-36.89,prostanoid receptor antagonist,"1.19, 0.49",,BRD-K09436313,"0.00, 0.00","AKR1C3, PTGDR, PTGDR2, PTGER1, PTGER2, PTGER4, PTGFR"
CP,streptozotocin,-36.91,DNA alkylating drug,"1.32, 0.58",,BRD-A25576662,"11.11, 11.11",SLC2A2
CP,ML-7,-36.92,myosin light chain kinase inhibitor,"0.94, 0.22",,BRD-K93201660,"10.00, 10.00",MYLK
CP,BRD-K88761633,-36.96,glucosylceramidase inhibitor,"0.68, 0.22",,BRD-K88761633,"0.00, 0.00",GBA
CP,meptazinol,-36.97,opioid receptor agonist,"1.05, 0.41",,BRD-A02710418,"0.00, 0.00",BCHE
CP,diltiazem,-37,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker","0.91, 0.31",,BRD-A69636825,"10.00, 10.00","CACNA1C, CACNA1S, CACNA2D1, CACNG1, CYP3A5, CYP3A7, HTR3A, KCNA5"
CP,NSC-23766,-37.06,RAC1 GTPase inhibitor,"0.67, 0.17",,BRD-A80213327,"10.00, 10.00",
CP,betulinic-acid,-37.14,"apoptosis stimulant, caspase activator, diacylglycerol O acyltransferase inhibitor, HIV integrase inhibitor, NFkB pathway activator, NFKB pathway inhibitor, SARS coronavirus 3C-like protease inhibitor, topoisomerase inhibitor","0.89, 0.25",,BRD-K45401373,"0.00, 0.00","CASP3, CASP8, GPBAR1, TOP1"
CP,lapatinib,-37.23,"EGFR inhibitor, EGFR antagonist, epidermal growth factor receptor (EGFR) inhibitor, receptor tyrosine protein kinase inhibitor, tyrosine kinase inhibitor","1.16, 0.26",,BRD-K19687926,"10.00, 10.00","EGFR, ERBB2, CYP3A5"
CP,linopirdine,36.55,"acetylcholine release enhancer, acetylcholine release stimulant, neurotransmitter agonist, voltage-gated potassium channel blocker","0.66, 0.20",,BRD-K59332007,"0.00, 0.00","KCNQ2, KCNQ3, KCNQ4, KCNQ5"
CP,acarbose,36.46,glucosidase inhibitor,"0.84, 0.13",,BRD-A16444946,"0.00, 0.00","GAA, MGAM, AMY2A, SI"
CP,DPPE,36.45,histamine receptor antagonist,"0.92, 0.18",,BRD-K80315159,"10.00, 10.00","ABCB1, HRH1"
CP,spironolactone,36.45,"mineralocorticoid receptor antagonist, androgen receptor antagonist, potassium channel blocker","0.53, 0.15",,BRD-K90027355,"0.00, 0.00","NR3C2, AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, KCNA5, KCND3, NR3C1, PGR, SCNN1A, SHBG"
CP,SR-142948,36.39,neurotensin receptor antagonist,"1.27, 0.38",,BRD-K91243525,"10.00, 0.00",NTSR1
CP,REV-5901,36.39,"leukotriene receptor antagonist, lipoxygenase inhibitor","0.92, 0.35",,BRD-A68281735,"0.00, 0.00",ALOX5
CP,KI-16425,36.38,lysophosphatidic acid receptor antagonist,"1.16, 0.22",,BRD-A25569250,"0.00, 0.00","LPAR1, LPAR3"
CP,AM-251,36.36,"ACAT inhibitor, cannabinoid receptor antagonist, cannabinoid receptor inverse agonist","0.55, 0.14",,BRD-K92000912,"10.00, 10.00","CNR1, GPR18, GPR55"
CP,BRD-A69470004,36.31,XIAP inhibitor,"0.66, 0.13",,BRD-A69470004,"0.00, 0.00",XIAP
CP,buphenine,36.31,adrenergic receptor agonist,"0.68, 0.27",Beta-adrenergic receptor agonist,BRD-A36267905,"10.00, 10.00",ADRB2
CP,linsitinib,-36.59,"insulin growth factor receptor inhibitor, insulin receptor antagonist","1.02, 0.38",IGF-1 inhibitor,BRD-K08589866,"10.00, 0.00","IGF1R, INSR, INSRR"
CP,GR-55562,-36.6,serotonin receptor antagonist,"0.80, 0.25",Serotonin receptor antagonist,BRD-K46441700,"10.00, 10.00","HTR1B, HTR1D"
CP,cephalosporanic-acid,-36.61,core structure for synthesis of cephalosporin antibiotics,"1.76, 0.66",,BRD-A79314293,"0.00, 0.00",
CP,nifekalant,-36.66,"potassium channel antagonist, potassium channel blocker","0.98, 0.32",,BRD-K32311154,"0.00, 0.00",
CP,isoxsuprine,-36.67,adrenergic receptor agonist,"0.93, 0.30",,BRD-A74269027,"0.00, 0.00",ADRB2
CP,roxatidine,-36.68,histamine receptor antagonist,"0.94, 0.23",,BRD-K81855038,"0.00, 0.00",HRH2
CP,PK-11195,-36.69,"benzodiazepine receptor antagonist, constitutive androstane receptor (CAR) antagonist, PXR agonist, translocator protein antagonist","0.45, 0.03",,BRD-A41451487,"0.00, 0.00","TSPO, NR1I2, NR1I3"
CP,toremifene,-36.69,"selective estrogen receptor modulator (SERM), estrogen receptor antagonist","1.08, 0.33",,BRD-K51350053,"0.00, 0.00","ESR1, CYP3A5"
CP,pravastatin,-36.7,HMGCR inhibitor,"0.49, 0.17",,BRD-K60511616,"0.00, 0.00","HMGCR, SLCO1B1"
CP,idebenone,-36.74,"calcium channel modulator, reducing agent","0.86, 0.18",,BRD-K37516142,"0.00, 0.00",
CP,ingenol,36.3,PKC activator,"3.22, 0.82",PKC activator,BRD-A52650764,"10.00, 10.00","PRKCD, PRKCE"
CP,cirazoline,36.23,alpha receptor agonist,"1.07, 0.28",,BRD-K54142781,"0.00, 0.00",ADRA1A
CP,hydroxyfasudil,36.21,ROCK inhibitor,"1.35, 0.39",Rho associated kinase inhibitor,BRD-K77793136,"0.00, 0.00","ROCK1, PKIA, PRKACA, ROCK2"
CP,RO-60-0175,36.19,serotonin receptor agonist,"0.97, 0.23",Serotonin receptor agonist,BRD-A49370193,"0.00, 0.00","HTR2C, HTR2A, HTR2B"
CP,huperzine-a,36.19,"acetylcholinesterase inhibitor, glutamate receptor antagonist","1.06, 0.24",,BRD-A47065382,"11.11, 11.11",ACHE
CP,aniracetam,36.14,glutamate receptor agonist,"0.52, 0.08",,BRD-K88611939,"0.00, 0.00","DRD2, GRIA1, GRIA2, GRIA3, HTR2A, GRIA4"
CP,W-7,36.1,"calmodulin antagonist, potassium channel blocker, squalene monooxygenase channel blocker","1.80, 0.43",,BRD-K90259198,"0.00, 0.00","CALM1, CALM2, KCNA5, KCNH2, TNNC1, TNNI3"
CP,kinetin-riboside,36.1,apoptosis inducer,"2.90, 0.75",,BRD-K94325918,"0.00, 0.00",
CP,BRL-15572,36.08,serotonin receptor antagonist,"1.05, 0.30",,BRD-A51829654,"10.00, 10.00","HTR1D, HTR1A, HTR1B, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6"
CP,triamcinolone,36.08,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent","1.30, 0.67",,BRD-K77554836,"0.00, 0.00","NR3C1, CYP3A5, CYP3A7, SERPINA6"
CP,prilocaine,-36.4,anesthetic,"1.05, 0.44",,BRD-A53952395,"0.00, 0.00",SCN5A
CP,BRD-A61599461,-36.4,thyroid-stimulating hormone receptor inverse agonist,"1.10, 0.30",,BRD-A61599461,"11.11, 0.00",TSHR
CP,NSC-94258,-36.42,antitumor agent,"1.42, 0.42",,BRD-K56450366,"0.00, 0.00","AKR1B1, CYP19A1, HSD17B1"
CP,fluticasone,-36.42,glucocorticoid receptor agonist,"1.31, 0.69",Glucocorticoid receptor agonist,BRD-K62310379,"0.00, 0.00","NR3C1, CYP3A5, CYP3A7, NR3C2, PGR, PLA2G4A"
CP,cyclopenthiazide,-36.45,"diuretic, inhibitor of sodium chloride symporter","0.52, 0.18",,BRD-A41250306,"0.00, 0.00",
CP,cyclazosin,-36.47,adrenergic receptor antagonist,"0.94, 0.30",,BRD-A37837077,"0.00, 0.00","ADRA1B, ADRA1A, ADRA1D"
CP,resveratrol,-36.48,"apolipoprotein expression enhancer, beta-secretase inhibitor, cyclooxygenase inhibitor, cytochrome P450 inhibitor, lipid peroxidase inhibitor, MAP kinase inhibitor, monoamine oxidase inhibitor, NFkB pathway modulator, SIRT activator, SIRT pathway, SIRT stimulant, sodium channel blocker, thioredoxin reductase inhibitor, topoisomerase inhibitor, xanthine oxidase inhibitor","0.95, 0.20",,BRD-K80738081,"30.00, 30.00","PTGS1, PTGS2, SIRT1, APOA1, BACE1, CSNK2A1, MAOA, NQO2, SCN5A, TXNRD1, TXNRD2, XDH"
CP,RS-67506,-36.51,serotonin receptor partial agonist,"0.85, 0.16",,BRD-K50018155,"0.00, 0.00",HTR4
CP,SB-222200,-36.51,tachykinin antagonist,"1.33, 0.55",,BRD-K04414442,"0.00, 0.00",TACR3
CP,epibatidine,-36.57,acetylcholine receptor agonist,"1.85, 0.45",,BRD-A39268308,"0.00, 0.00","CHRFAM7A, CHRNA2, CHRNA3, CHRNA4, CHRNA7"
CP,nizatidine,35.98,histamine receptor antagonist,"0.59, 0.14",,BRD-K73589491,"0.00, 0.00",HRH2
CP,BRD-K66782112,35.95,histamine receptor antagonist,"1.41, 0.41",,BRD-K66782112,"10.00, 10.00",HRH2
CP,KN-62,35.94,"calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist, calmodulin antagonist","0.81, 0.14",,BRD-A81177136,"0.00, 0.00","AKT1, CAMK2A, CHEK1, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, P2RX7, PRKCA, ROCK1, RPS6KB1, SGK1"
CP,aminopentamide,35.9,anticholinergic agent,"0.72, 0.16",,BRD-A69917777,"10.00, 10.00",
CP,sulconazole,35.88,"sterol demethylase inhibitor, cell wall synthesis inhibitor","0.64, 0.11",,BRD-A70649075,"10.00, 10.00",
CP,flunisolide,35.76,"cytochrome P450 inhibitor, corticosteroid agonist, corticosteroid hormone receptor agonist, glucocorticoid receptor agonist, immunosuppressant","1.41, 0.75",,BRD-K49577446,"10.00, 0.00",NR3C1
CP,stavudine,35.72,"DNA directed DNA polymerase inhibitor, nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor","0.86, 0.26","Nucleoside reverse transcriptase inhibitor, Reverse transcriptase inhibitor",BRD-K93880783,"0.00, 0.00",
CP,danusertib,35.69,"Aurora kinase inhibitor, growth factor receptor inhibitor, Abl kinase inhibitor, Bcr-Abl kinase inhibitor, FGFR inhibitor, mitotic inhibitor, protein kinase inhibitor, RET tyrosine kinase inhibitor","2.02, 0.48",Aurora kinase inhibitor,BRD-K07881437,"0.00, 0.00","AURKA, AURKB, AURKC, FGFR1, NTRK1, RET, BCR, SLK"
CP,digoxin,35.55,"ATPase inhibitor, ROR antagonist","2.00, 0.58",,BRD-A75144621,"0.00, 0.00","ATP1A1, ABCB1, RORC, SLCO1B3"
CP,bucladesine,35.44,"adenosine receptor agonist, cAMP stimulant, vasodilator","0.68, 0.18",,BRD-A04706586,"20.00, 20.00",PRKACA
CP,cinobufagin,-35.98,"ATPase inhibitor, chloride channel activator","2.39, 0.55",ATPase inhibitor,BRD-A80502530,"0.00, 0.00","ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, ATP1B4, FXYD2"
CP,Cyclo-[Arg-Gly-Asp-D-Phe-Val],-36.1,integrin antagonist,"0.75, 0.14",,BRD-K95992530,"0.00, 0.00","ITGAV, ITGB3"
CP,naltrindole,-36.11,opioid receptor antagonist,"0.95, 0.22",,BRD-A47342814,"0.00, 0.00","OPRD1, OPRK1, OPRM1"
CP,UNC-0321,-36.11,"histone lyinse methyltransferase inhibitor, histone lysine methyltransferase inhibitor","0.76, 0.18",,BRD-K74236984,"0.00, 0.00",EHMT2
CP,levocetirizine,-36.19,"histamine receptor antagonist, interleukin expression inhibitor, tumor necrosis factor expression inhibitor","1.36, 0.36",,BRD-K27184429,"0.00, 0.00","HRH1, CXCL8"
CP,TAS-301,-36.27,voltage-independent calcium influx blocker,"1.10, 0.27",,BRD-K55454768,"0.00, 0.00",CAMK2A
CP,SB-366791,-36.28,TRPV antagonist,"0.92, 0.26",,BRD-K59331372,"0.00, 0.00",TRPV1
CP,SRT-1720,-36.29,SIRT activator,"1.06, 0.16",,BRD-K53855319,"0.00, 0.00",SIRT1
CP,cyanopindolol,-36.38,adrenergic receptor antagonist,"1.40, 0.47",,BRD-K40965114,"0.00, 0.00",HTR1D
CP,thiothixene,-36.39,"dopamine receptor, dopamine receptor antagonist","1.80, 0.45",,BRD-K55070890,"0.00, 0.00","HTR2A, DRD1, DRD2, HRH1"
CP,valaciclovir,35.39,"DNA directed DNA polymerase inhibitor, DNA polymerase inhibitor","1.90, 0.66",DNA polymerase inhibitor,BRD-K46435977,"12.50, 12.50",
CP,cucurbitacin-i,35.35,"inhibitor of STAT3/JAK2 signaling, JAK inhbitor, lipocortin synthesis stimulant, STAT inhibitor","2.09, 0.45",,BRD-A49680073,"0.00, 0.00","JAK2, STAT3"
CP,cyclosporin-a,35.3,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor","2.28, 0.90",,BRD-A38030642,"0.00, 0.00","PPIA, ABCB11, CAMLG, CYP3A5, CYP3A7, FPR1, PPID, PPIF, PPP3CA, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3"
CP,fludarabine,35.28,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor","1.49, 0.42",,BRD-A31374339,"0.00, 0.00","ADA, DCK, POLA1, RRM1, RRM2"
CP,larixinic-acid,35.27,comopund that interacts with metal centers,"1.18, 0.39",,BRD-K40619305,"0.00, 0.00",
CP,gibberellic-acid,35.27,NFkB pathway modulator,"0.84, 0.18",,BRD-K92758126,"0.00, 0.00",AADACL2
CP,tipifarnib-P2,35.22,"farnesyltransferase inhibitor, angiogenesis inhibitor, apoptosis stimulant","1.40, 0.33",,BRD-K62965247,"0.00, 0.00","FNTA, FNTB"
CP,H-7,35.19,PKA inhibitor,"1.09, 0.32",PKA inhibitor,BRD-A55756846,"0.00, 0.00","PKIA, PRKACA, PRKAR1A"
CP,nikkomycin,35.15,chitinase inhibitor,"1.15, 0.34",,BRD-A74771556,"11.11, 11.11",
CP,chenodeoxycholic-acid,35.11,"11-beta hydroxysteroid dehydrogenase inhibitor, FXR agonist","1.22, 0.45",,BRD-K18135438,"0.00, 0.00","HSD11B1, NR1H4"
CP,cefixime,-35.22,cell wall synthesis inhibitor,"0.83, 0.23",,BRD-K71059170,"0.00, 0.00",
CP,GR-113808,-35.28,serotonin receptor antagonist,"0.91, 0.32",,BRD-K49945136,"0.00, 0.00",HTR4
CP,III606050,-35.3,cytochrome P450 inhibitor,"1.08, 0.27",,BRD-K37194137,"0.00, 0.00",
CP,dexamethasone,-35.54,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant","1.20, 0.78",,BRD-K47635719,"10.00, 0.00","ANXA1, CYP3A4, CYP3A5, NOS2, NR0B1, NR3C1, NR3C2"
CP,CCCP,-35.55,mitochondrial oxidative phosphorylation uncoupler,"2.15, 0.60",,BRD-K15616905,"10.00, 0.00",
CP,roquinimex,-35.56,"T cell inhibitor, T cell stimulant, tumor necrosis factor receptor antagonist","0.91, 0.33",,BRD-K03384561,"0.00, 0.00",
CP,LY-83583,-35.57,"inhibitor of soluble guanylyl cyclase, leukotriene synthesis inhibitor","2.01, 0.45",,BRD-K62792802,"0.00, 0.00",GUCY1A2
CP,W-12,-35.76,calmodulin antagonist,"1.39, 0.38",,BRD-K78084463,"0.00, 0.00",
CP,fraxidin,-35.89,carbonic anhydrase inhibitor,"1.30, 0.40",,BRD-K66944906,"0.00, 0.00",CA1
CP,UCL-2077,-35.96,"potassium channel blocker, slow afterhyperpolarization channel blocker","0.83, 0.24",,BRD-K50325075,"0.00, 0.00",
CP,delcorine,35.1,"ganglioblocking, antiarrhythmic","1.53, 0.42",,BRD-A88282067,"0.00, 0.00",
CP,W-5,35.1,calmodulin antagonist,"1.07, 0.31",,BRD-K41868777,"11.11, 11.11",
CP,etifenin,35.09,compound used in hepatobiliary scans of the liver,"0.73, 0.20",,BRD-K63979671,"0.00, 0.00",
CP,ambroxol,35.07,"glucosylceramidase inhibitor, mucolytic agent, sodium channel blocker","0.84, 0.24",,BRD-K56558538,"10.00, 10.00",GBA
CP,YM-298198,35.07,glutamate receptor antagonist,"1.25, 0.25",,BRD-K48059230,"0.00, 0.00",GRM1
CP,ditolylguanidine,34.99,sigma receptor agonist,"1.27, 0.42",,BRD-K33459542,"0.00, 0.00","GRIN1, GRIN2A, GRIN2B, SIGMAR1"
CP,SB-203580,34.92,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor","0.82, 0.24",,BRD-A37704979,"10.00, 0.00","MAPK14, MAPK1, MAPK11, AKT1, ALOX5, CHEK1, CYP2D6, CYP3A4, GAK, GSK3B, LCK, MAPK10, MAPK12, MAPK8, MAPK9, PRKCA, RAF1, RIPK2, ROCK1, RPS6KB1, SGK1, SRC, TNF"
CP,ceramide,34.84,"nitric oxide production inhibitor, phosphoenolpyruvate carboxylase activator, serine/threonine protein phosphatase activator","0.91, 0.20",,BRD-A53416814,"0.00, 0.00",
CP,scriptaid,34.82,HDAC inhibitor,"1.80, 0.59",HDAC inhibitor,BRD-K22503835,"10.00, 0.00","HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
CP,imipramine,34.79,"norepinephrine reputake inhibitor, serotonin reuptake inhibitor, Sodium Channel  Blockers","0.58, 0.05",Norepinephrine reuptake inhibitor,BRD-K38436528,"0.00, 0.00","SLC6A2, SLC6A4, CHRM2, ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM3, CHRM4, CHRM5, CYP2C19, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, KCND2, KCND3, KCNH1, KCNH2, SLC6A3"
CP,"tropanyl-3,5-dimethylbenzoate",-34.85,serotonin receptor antagonist,"0.81, 0.18",,BRD-A84389633,"0.00, 0.00",
CP,AR-C133057XX,-34.87,nitric oxide synthase inhibitor,"1.27, 0.33",,BRD-K40892394,"0.00, 0.00","NOS2, NOS1"
CP,ofloxacin,-34.92,"antibiotic that inhibits DNA gyrase, topoisomerase inhibitor","1.72, 0.47",,BRD-A24228527,"0.00, 0.00",TOP2A
CP,moracizine,-34.95,sodium channel blocker,"1.08, 0.42",,BRD-K21548250,"0.00, 0.00",SCN5A
CP,alvespimycin,-35.01,"HSP inhibitor, HSP antagonist","1.89, 0.56",HSP inhibitor,BRD-K83988098,"0.00, 0.00",HSP90AA1
CP,vincristine,-35.02,"tubulin inhibitor, microtubule inhibitor, microtubule polymerization inhibitor, tubulin polymerisation inhibitor, vinca alkaloid","1.57, 0.50",Tubulin inhibitor,BRD-K82109576,"0.00, 0.00","TUBB, TUBA4A"
CP,BRD-K41143549,-35.05,glutamate receptor antagonist,"1.34, 0.43",,BRD-K41143549,"0.00, 0.00",
CP,CGP-71683,-35.17,neuropeptide receptor antagonist,"1.72, 0.61",,BRD-K31912990,"0.00, 0.00",NPY5R
CP,xanthoxyline,-35.21,plant-derived antifungal,"0.93, 0.28",,BRD-K12260308,"10.00, 10.00",
CP,scopolamine,-35.21,acetylcholine receptor antagonist,"0.86, 0.33",,BRD-A62035778,"10.00, 10.00","CHRM2, CHRM1, CHRM3, CHRM4, CHRM5, SI"
CP,busulfan,34.79,"DNA damaging, DNA inhibitor","1.14, 0.38",,BRD-K23204545,"0.00, 0.00",
CP,GW-501516,34.79,"PPAR receptor agonist, insulin sensitizer","0.93, 0.31",PPAR receptor agonist,BRD-K14880289,"0.00, 0.00","PPARD, INS, PPARA"
CP,ethotoin,34.68,anticonvulsant,"1.16, 0.38",,BRD-A30205217,"11.11, 0.00",SCN5A
CP,febuxostat,34.67,xanthine oxidase inhibitor,"0.91, 0.20",,BRD-K48367671,"10.00, 10.00",XDH
CP,diethyltoluamide,34.64,"DEET, activator of fly antenna ionotropic receptor IR40a","0.78, 0.18",,BRD-K94080537,"10.00, 10.00",
CP,noscapine,34.63,"bradykinin receptor antagonist, tubulin polymerization inhibitor, apoptosis stimulant, microtubule inhibitor, tubulin inhibitor","0.80, 0.13",,BRD-K89237706,"0.00, 0.00","BDKRB2, SIGMAR1"
CP,tubocurarine,34.6,acetylcholine receptor antagonist,"0.68, 0.24",,BRD-K99621550,"0.00, 0.00","CHRNA2, HTR3A, ACHE, HTR3B, KCNN1, KCNN2, KCNN3, ZACN"
CP,phenazopyridine,34.57,unidentified pharmacological activity,"0.52, 0.19",,BRD-K76304753,"20.00, 0.00",SCN1A
CP,gabazine,34.56,GABA receptor antagonist,"0.88, 0.17",,BRD-K93280214,"0.00, 0.00","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRG2"
CP,NCH-51,34.53,HDAC inhibitor,"2.09, 0.66",HDAC inhibitor,BRD-K52522949,"0.00, 0.00","HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
CP,NNC-55-0396,-34.43,T-type calcium channel blocker,"1.65, 0.48",T-type calcium channel blocker,BRD-K78122587,"0.00, 0.00","CATSPER1, CATSPER2, CATSPER3, CATSPER4"
CP,BRL-52537,-34.45,opioid receptor agonist,"1.23, 0.41",,BRD-A37347161,"11.11, 11.11",OPRK1
CP,EMF-BCA1-64,-34.45,caspase inhibitor,"0.66, 0.09",,BRD-K11540476,"0.00, 0.00",CASP3
CP,PPT,-34.52,estrogen receptor agonist,"0.85, 0.16",Estrogen receptor agonist,BRD-K00312224,"0.00, 0.00",ESR1
CP,biperiden,-34.57,anticholinergic,"0.88, 0.26",,BRD-A36471396,"0.00, 0.00","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2"
CP,LY-288513,-34.61,CCK receptor antagonist,"0.94, 0.19",,BRD-K24675965,"0.00, 0.00",CCKBR
CP,ipriflavone,-34.69,bone resorption inhibitor,"1.25, 0.25",,BRD-K93618743,"0.00, 0.00",
CP,fluoropyruvate,-34.75,PDH inhibitor,"1.27, 0.24",,BRD-K01779529,"0.00, 0.00",
CP,navitoclax,-34.78,"BCL inhibitor, apoptosis stimulant","1.28, 0.36",,BRD-K82746043,"0.00, 0.00","BCL2, BCL2L1, BCL2L2"
CP,AG-957,-34.84,"Abl kinase inhibitor, protein tyrosine kinase inhibitor","1.59, 0.56",,BRD-K36737713,"0.00, 0.00","ABL1, EGFR"
CP,bimatoprost,34.46,prostanoid receptor agonist,"1.51, 0.40",,BRD-A87848830,"0.00, 0.00","PTGFR, AKR1C3, PTGER1, PTGER3"
CP,mephenytoin,34.43,cytochrome P450 substrate,"1.45, 0.38",,BRD-A83937277,"11.11, 11.11","SCN5A, CYP2C19"
CP,brivanib,34.43,"alcohol dehydrogenase inhibitor, FGFR inhibitor, fibroblast growth factor receptor (FGFR) inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR inhibitor","0.83, 0.31",FGFR inhibitor,BRD-K28428262,"0.00, 0.00","FGFR1, KDR, FLT1, CYP3A4, FGFR2, FGFR3, FLT4, KCNH2"
CP,cefotaxime,34.39,cell wall synthesis inhibitor,"1.38, 0.35",Bacterial cell wall synthesis inhibitor,BRD-A67981824,"0.00, 0.00",
CP,BIX-01338,34.39,histone methyltransferase inhibitor,"1.50, 0.34",,BRD-K26863634,"0.00, 0.00",
CP,tropisetron,34.3,"serotonin receptor antagonist, polarization inhibitor, sodium channel blocker","1.88, 0.47",,BRD-K50866992,"0.00, 0.00","HTR3A, GLRA1, GLRA2, GLRB, HTR4"
CP,strophanthidin,34.3,ATPase inhibitor,"1.91, 0.48",ATPase inhibitor,BRD-K84595254,"0.00, 0.00","ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, ATP1B4, FXYD2"
CP,lamivudine,34.25,"nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor","0.59, 0.19",,BRD-K02992638,"0.00, 0.00",
CP,imiloxan,34.22,adrenergic receptor antagonist,"1.17, 0.44",,BRD-A10903566,"0.00, 0.00",ADRA2B
CP,scopoline,34.19,acetylcholine receptor antagonist,"0.73, 0.14",,BRD-A92161634,"11.11, 0.00",
CP,QL-XII-47,-34.17,"BMX inhibitor, Bruton's tyrosine kinase (BTK) inhibitor, bruton's tyrosine kinase inhibitor, cytoplasmic tyrosine protein kinase BMX inhibitor","2.59, 0.67",,BRD-U86922168,"0.00, 0.00","BMX, BTK"
CP,RS-100329,-34.18,adrenoceptor antagonist,"0.98, 0.36",,BRD-K08640512,"10.00, 10.00","ADRA1A, ADRA1D"
CP,r(-)-propylnorapomorphine,-34.19,"dopamine receptor agonist, antiamyloidogenic agent","0.68, 0.19",,BRD-K13544237,"0.00, 0.00","DRD2, DRD1, DRD3"
CP,triamcinolone,-34.21,"antiinflammatory agent, corticosteroid agonist, corticosteroid binding globulin binder, corticosteroid hormone receptor agonist, cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant, immunosuppressive agent","1.48, 0.52",Glucocorticoid receptor agonist,BRD-K53790871,"0.00, 0.00","NR3C1, CYP3A5, CYP3A7, SERPINA6"
CP,ibudilast,-34.33,"phosphodiesterase inhibitor, leukotriene receptor antagonist, toll-like receptor antagonist, macrophage migration inhibiting factor inhibitor, macrophage migration inhibiting factor modulator, mediator release inhibitor, nitric oxide synthase inhibitor","0.76, 0.13",,BRD-K16444452,"0.00, 0.00","PDE4A, PDE4B, PDE4C, MIF, PDE10A, PDE3A, PDE4D, TLR4, CYSLTR1, IL1B, IL6, PDE11A, PDE5A"
CP,SSR-69071,-34.35,leukocyte elastase inhibitor,"2.18, 0.52",,BRD-K72895815,"0.00, 0.00",ELANE
CP,glycocholic-acid,-34.38,cholesterol inhibitor,"0.50, 0.11",,BRD-K54771420,"0.00, 0.00",FABP6
CP,NSC-3852,-34.38,HDAC inhibitor,"2.16, 0.67",HDAC inhibitor,BRD-K13169950,"0.00, 0.00",HDAC1
CP,terbutaline,-34.4,adrenergic receptor agonist,"1.10, 0.42",Beta-adrenergic receptor agonist,BRD-A50157456,"0.00, 0.00",ADRB2
CP,prometon,-34.41,photosynthesis inhibitor,"2.05, 0.64",,BRD-K99029477,"0.00, 0.00",
CP,SB-334867,34.17,orexin receptor antagonist,"1.28, 0.47",,BRD-K41567364,"10.00, 0.00","HCRTR1, HCRTR2"
CP,fenretinide,34.13,"apoptosis stimulant, retinoid receptor agonist, RAR agonist","0.82, 0.16",Retinoid receptor agonist,BRD-K28168037,"0.00, 0.00","CYP2C8, CYP3A5, RARA, RARG"
CP,dicloxacillin,34.01,bacterial cell wall synthesis inhibitor,"0.85, 0.26",Bacterial cell wall synthesis inhibitor,BRD-K05673000,"0.00, 0.00",
CP,AG-592,34.01,tyrosine kinase inhibitor,"1.82, 0.48",,BRD-K89930444,"0.00, 0.00",
CP,modafinil,34.01,"adrenergic receptor agonist, dopamine receptor reuptake inhibitor","0.72, 0.18",,BRD-A16332958,"0.00, 0.00","ADRA1B, CYP1A2, CYP2B6, CYP2C19, CYP3A4, CYP3A5, SLC6A3"
CP,cefazolin,33.91,cell wall synthesis inhibitor,"1.34, 0.35",,BRD-A65282128,"0.00, 0.00","PON1, SLC22A8"
CP,chaetocin,33.88,"histone lyinse methyltransferase inhibitor, histone lysine N methyltransferase inhibitor","0.70, 0.05",,BRD-A85860691,"0.00, 0.00","EHMT2, SUV39H1"
CP,mofezolac,33.79,"cyclooxygenase inhibitor, cytochrome P450 inhibitor, platelet aggregation inhibitor","1.19, 0.30",,BRD-K49372556,"0.00, 0.00",
CP,enrofloxacin,33.7,topoisomerase inhibitor,"1.13, 0.36",Bacterial DNA gyrase inhibitor,BRD-K76534306,"0.00, 0.00",
CP,ZK-93423,33.68,benzodiazepine receptor agonist,"0.83, 0.20",,BRD-K33882852,"0.00, 0.00","GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2"
CP,HG-5-88-01,-33.69,protein kinase inhibitor,"2.00, 0.63",,BRD-U44700465,"0.00, 0.00","ADCK4, EGFR"
CP,GDC-0941,-33.75,PI3K inhibitor,"1.49, 0.70",PI3K inhibitor,BRD-K52911425,"0.00, 0.00","PIK3CG, PIK3CA, PIK3CB, PIK3CD"
CP,isoreserpine,-33.79,vesicular monoamine transporter inhibitor,"0.78, 0.17",,BRD-K37080523,"10.00, 0.00","SLC18A2, SLC18A1, SIAH1"
CP,nevirapine,-33.81,"non-nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor","0.91, 0.23",Reverse transcriptase inhibitor,BRD-K15502390,"0.00, 0.00","CYP2B6, CYP2C19, CYP3A4"
CP,manumycin-a,-33.83,"farnesyltransferase inhibitor, NFkB pathway inhibitor, ras farnesyltransferase inhibitor","2.32, 0.57",NFkB pathway inhibitor,BRD-K78599730,"0.00, 0.00","FNTA, IKBKB"
CP,clofibrate,-33.99,PPAR receptor agonist,"0.58, 0.24",,BRD-K45252063,"0.00, 0.00","PPARA, LPL"
CP,flubendazole,-34.03,"acetylcholinesterase inhibitor, microtubule inhibitor, tubulin inhibitor","0.89, 0.45",Tubulin inhibitor,BRD-K86003836,"12.50, 0.00",TUBB
CP,fluperlapine,-34.1,"dopamine receptor antagonist, serotonin receptor antagonist","0.52, 0.17",,BRD-K15715913,"0.00, 0.00","DRD2, HTR2A, HTR6, HTR7"
CP,rimcazole,-34.14,"sigma receptor antagonist, dopamine reuptake inhibitor","1.94, 0.53",,BRD-K70490179,"0.00, 0.00",SIGMAR1
CP,L-368899,-34.16,oxytocin receptor antagonist,"1.28, 0.47",,BRD-A43930669,"10.00, 0.00","OXTR, AVPR1A, AVPR2, OXT"
CP,QL-X-138,33.67,mTOR inhibitor,"1.47, 0.68",MTOR inhibitor,BRD-U33728988,"0.00, 0.00","BTK, JAK3, MKNK2, MTOR, PRKDC"
CP,flucloxacillin,33.61,antibiotic of the penicillin class,"1.03, 0.22",,BRD-A13650332,"10.00, 10.00",
CP,carbetocin,33.6,analogue of oxytocin,"1.08, 0.42",,BRD-A32161980,"10.00, 0.00",OXTR
CP,arctigenin,33.6,"adiponectin receptor agonist, AP inhibitor, aryl hydrocarbon receptor antagonist, HIV integrase inhibitor, MEK inhibitor, NFkB pathway inhibitor, topoisomerase inhibitor","0.69, 0.15",,BRD-K53523901,"0.00, 0.00","ADIPOR1, AHR, CHUK, MAP2K1"
CP,MDL-29951,33.6,"glutamate receptor antagonist, fructose biphosphate inhibitor, UDP/CysLT (GPR17, P2Y-like) Agonists","1.28, 0.45",,BRD-K59753853,"0.00, 0.00","FBP1, GPR17"
CP,WAY-161503,33.56,serotonin receptor agonist,"1.43, 0.45",,BRD-A62021152,"0.00, 0.00",HTR2C
CP,secnidazole,33.55,"acetylcholinesterase inhibitor, microtubule inhibitor","1.44, 0.48",,BRD-A70083328,"12.50, 12.50",
CP,heliomycin,33.54,"antibiotic, bacterial RNA synthesis inhibitor","2.15, 0.80",,BRD-K64517075,"11.11, 11.11",
CP,ST-638,33.54,tyrosine kinase inhibitor,"0.95, 0.25",,BRD-K51476772,"11.11, 0.00",
CP,BRD-K97951054,33.52,"Aurora kinase inhibitor, Pim kinase inhibitor, VEGFR inhibitor","1.41, 0.43",,BRD-K97951054,"0.00, 0.00","AURKB, KDR, PIM1"
CP,HEAT,-33.12,adrenergic receptor antagonist,"1.06, 0.27",,BRD-A24429032,"0.00, 0.00",ADRA1A
CP,HG-5-113-01,-33.12,protein kinase inhibitor,"1.97, 0.53",,BRD-U82589721,"0.00, 0.00","ABL1, LTK, STK10"
CP,isamoltan,-33.17,adrenergic receptor antagonist,"0.98, 0.34",,BRD-A26845397,"0.00, 0.00","ADRB1, ADRB2"
CP,xanthinol,-33.39,vasodilator,"1.31, 0.44",,BRD-A01826957,"0.00, 0.00",
CP,minaprine,-33.39,serotonin uptake inhibitor,"1.11, 0.28",,BRD-K02867583,"11.11, 11.11","HTR2B, SLC6A4, ACHE, CHRM1, DRD1, DRD2, HTR2A, HTR2C, MAOA"
CP,glimepiride,-33.43,"insulin secretagogue, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulinotropin agonist, sulfonylurea","0.68, 0.13",KCNJ11 modulator,BRD-K34776109,"0.00, 0.00","ABCC8, KCNJ11, KCNJ1"
CP,gestrinone,-33.44,"progesterone receptor antagonist, Estradiol 17 beta dehydrogenase stimulant, estrone sulfotransferase stimulant","1.31, 0.41","Androgen receptor modulator, Progesterone receptor antagonist",BRD-A94793051,"0.00, 0.00","PGR, AR, ESR1"
CP,KB-R7943,-33.56,sodium/calcium exchange inhibitor,"1.43, 0.42",T-type calcium channel blocker,BRD-K17743697,"0.00, 0.00","SLC8A1, TRPC3, TRPC5, TRPC6"
CP,terguride,-33.59,"adrenergic receptor antagonist, dopamine autoreceptor agonist, dopamine receptor agonist, dopamine receptor partial agonist, platelet aggregation inhibitor, prolactin secretion inhibitor, serotonin receptor antagonist","1.16, 0.42",,BRD-K05901394,"0.00, 0.00","DRD2, HTR2A, HTR2B, ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD3, DRD4, HTR1A, HTR1B, HTR1D, HTR2C, PRL"
CP,semaxanib,-33.61,"VEGFR inhibitor, angiogenesis inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, VEGFR antagonist","1.01, 0.31",,BRD-K63504947,"0.00, 0.00","KDR, FLT1, KIT, PDGFRB, FGFR1, FLT3, MET, PDGFRA, RET"
CP,ICI-199441,33.5,opioid receptor agonist,"1.42, 0.38",,BRD-K73290745,"10.00, 10.00","OPRK1, CYP2D6, OPRD1, OPRM1, UTS2R"
CP,BW-B70C,33.49,lipoxygenase inhibitor,"1.11, 0.35",,BRD-A68891053,"0.00, 0.00",ALOX5
CP,indole,33.45,"aryl hydrocarbon receptor agonist, indoleamine 2,3-dioxygenase inhibitor","0.92, 0.18",,BRD-K01815685,"0.00, 0.00","AHR, IDO1"
CP,dipropyl-5ct,33.43,serotonin receptor agonist,"0.89, 0.16",,BRD-K32645441,"10.00, 10.00","HTR1B, HTR1D, HTR1F, HTR7"
CP,formoterol,33.42,adrenergic receptor agonist,"0.57, 0.16",Beta-adrenergic receptor agonist,BRD-M00539986,"10.00, 0.00","ADRB2, CYP2C19"
CP,triciribine,33.4,AKT inhibitor,"0.97, 0.24",,BRD-A11706664,"0.00, 0.00","AKT1, AKT2, AKT3"
CP,propranolol,33.34,adrenergic receptor antagonist,"1.45, 0.47",,BRD-A10070317,"10.00, 10.00","ADRB2, ADRB3, ADRB1, CYP2C19, HTR1A, HTR1B"
CP,colforsin,33.33,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant","0.95, 0.47",,BRD-A55416093,"0.00, 0.00","ADCY2, ADCY5, GNAS"
CP,maackiain,33.29,"interleukin synthesis inhibitor, sodium/glucose cotransporter inhibitor","1.69, 0.55",,BRD-A95445494,"0.00, 0.00",SLC5A2
CP,mifepristone,33.28,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor","0.90, 0.16",Progesterone receptor antagonist,BRD-A44780397,"0.00, 0.00","PGR, NR3C1, AR, CYP2B6, CYP2C8, CYP3A5, CYP3A7, NR1I2"
CP,BRD-K30064966,-32.75,caspase activator,"0.91, 0.28",,BRD-K30064966,"0.00, 0.00",CASP3
CP,temsirolimus,-32.77,"mTOR inhibitor, cell cycle inhibitor, immunosuppressant, protein kinase inhibitor","1.08, 0.38",MTOR inhibitor,BRD-A62025033,"0.00, 0.00","MTOR, PTEN"
CP,bifemelane,-32.8,"acetylcholine release stimulant, adrenergic transmitter uptake inhibitor, reducing agent","0.88, 0.18",,BRD-K18779551,"0.00, 0.00",SLC6A2
CP,PD-102807,-32.89,acetylcholine receptor antagonist,"1.00, 0.10",,BRD-A89337244,"10.00, 10.00",CHRM4
CP,CMPD-1,-32.95,p38 MAPK inhibitor,"2.41, 0.70",,BRD-K54095730,"11.11, 11.11","GNRHR, MAPK14"
CP,daunorubicin,-32.96,"RNA synthesis inhibitor, topoisomerase inhibitor, DNA synthesis inhibitor, radical formation stimulant","1.73, 0.60",,BRD-A68009927,"0.00, 0.00","TOP2A, TOP2B"
CP,doxycycline,-33.04,"metalloproteinase inhibitor, 30S ribosomal protein inhibitor, matrix metalloprotease inhibitor, protein arginine deiminase inhibitor","0.78, 0.23",Bacterial 30S ribosomal subunit inhibitor,BRD-A88774919,"0.00, 0.00","MMP8, MMP1"
CP,GR-103691,-33.05,dopamine receptor antagonist,"1.63, 0.51",Dopamine receptor antagonist,BRD-K50891186,"11.11, 0.00",
CP,PRL-3-inhibitor-I,-33.05,"PRL phosphatase inhibitor, tyrosine phosphatase inhibitor","0.49, 0.07",,BRD-K09907482,"0.00, 0.00",PTP4A3
CP,rofecoxib,-33.11,cyclooxygenase inhibitor,"0.57, 0.15",,BRD-K21733600,"10.00, 0.00","PTGS2, CYP3A4, ELN"
CP,rucaparib,33.27,PARP inhibitor,"1.41, 0.26",PARP inhibitor,BRD-K88560311,"0.00, 0.00","PARP1, PARP2"
CP,nilotinib,33.15,"Bcr-Abl kinase inhibitor, Abl kinase inhibitor, discoidin domain containing receptor inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor","0.60, 0.17",FLT3 inhibitor,BRD-K81528515,"10.00, 10.00","ABL1, KIT, BCR, CYP2B6, CYP2C8, DDR1, DDR2, PDGFRA"
CP,SKF-86002,33.15,p38 MAPK inhibitor,"1.01, 0.36",P38 MAPK inhibitor,BRD-K96809896,"0.00, 0.00","ALOX5, MAPK14"
CP,MG-132,33.1,proteasome inhibitor,"2.30, 0.69",Proteasome inhibitor,BRD-K60230970,"10.00, 0.00",PSMB1
CP,eplerenone,33.07,"cytochrome P450 antagonist, mineralocorticoid receptor antagonist","1.35, 0.40",,BRD-A39969961,"20.00, 10.00","NR3C2, CYP3A5"
CP,hesperidin,33.07,free radical scavenger,"1.34, 0.50",,BRD-K38903228,"0.00, 0.00",CACNA1B
CP,naloxone,33.06,opioid receptor antagonist,"1.08, 0.28",,BRD-A37541666,"11.11, 0.00","OPRM1, OPRK1, OPRD1, CREB1, ESR1, TLR4"
CP,GR-127935,33.03,serotonin receptor antagonist,"1.34, 0.19",Serotonin receptor antagonist,BRD-K11911061,"0.00, 0.00","HTR1B, HTR1D, HTR1A, HTR2A, HTR2C, HTR1E, HTR1F, HTR2B, HTR6"
CP,tyrphostin-AG-527,33.03,protein tyrosine kinase inhibitor,"1.23, 0.41",,BRD-K43405658,"0.00, 0.00",EGFR
CP,synephrine,32.97,"adrenergic receptor agonist, L-type calcium channel activator","1.10, 0.23",,BRD-A04327189,"0.00, 0.00",ADRA1A
CP,TWS-119,-32.06,glycogen synthase kinase inhibitor,"1.14, 0.41",Glycogen synthase kinase inhibitor,BRD-K94176593,"0.00, 0.00","GSK3B, JUN, MYC"
CP,quinidine,-32.14,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker","1.06, 0.36",Sodium channel blocker,BRD-A64479082,"0.00, 0.00","SCN5A, ABCB1, CYP2D6, KCNA5, KCNA7, KCNH1, KCNH2, KCNH5, KCNK1, KCNK6, SLC29A4"
CP,sirolimus,-32.17,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor","0.92, 0.30",,BRD-A79768653,"0.00, 0.00","MTOR, FKBP1A, CCR5, FGF2"
CP,flumazenil,-32.21,"benzodiazepine receptor antagonist, GABA benzodiazepine site receptor antagonist","1.15, 0.22",,BRD-K98769987,"0.00, 0.00","GABRA1, GABRA2, GABRA3, GABRA5, GABRA4, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ"
CP,ICI-204448,-32.23,opioid receptor agonist,"0.93, 0.23",,BRD-A37776212,"0.00, 0.00",OPRK1
CP,BMY-14802,-32.26,"sigma receptor antagonist, glutamate receptor antagonist, serotonin receptor agonist","0.85, 0.31",Sigma receptor antagonist,BRD-A15435692,"0.00, 0.00","HTR1A, SIGMAR1"
CP,penfluridol,-32.47,"dopamine receptor antagonist, T-type calcium channel blocker","1.57, 0.35",T-type calcium channel blocker,BRD-K15409150,"0.00, 0.00","CACNA1G, DRD1, DRD2"
CP,LDN-193189,-32.48,"ALK inhibitor, serine/threonine protein kinase inhibitor","4.48, 1.43",,BRD-K04853698,"0.00, 0.00","ACVR1, BMPR1A"
CP,AT-7519,-32.5,"CDK inhibitor, cell cycle inhibitor","2.49, 0.85",CDK inhibitor,BRD-K13390322,"0.00, 0.00","CDK2, CDK5, CDK1, CDK4, CDK6, CDK9"
CP,cortisone,-32.61,glucocorticoid receptor agonist,"1.23, 0.40",,BRD-K86161929,"11.11, 11.11",NR3C1
CP,cymarin,32.9,ATPase inhibitor,"1.97, 0.57",ATPase inhibitor,BRD-A71459254,"0.00, 0.00",ATP1A1
CP,JNJ-10191584,32.83,"histamine receptor antagonist, histamine receptor silent antagonist","0.93, 0.32",,BRD-K15086322,"10.00, 0.00",HRH4
CP,fluconazole,32.73,"cell wall synthesis inhibitor, sterol demethylase inhibitor","0.53, 0.09",,BRD-K05977355,"10.00, 0.00","CYP3A5, CYP3A7"
CP,ebselen,32.65,"COX inihibitor, H+/K+-ATPase inhibitor, leukotriene receptor antagonist, NADPH oxidase inhibitor, nitric oxide synthase inhibitor, PKC inhibitor, prostanoid receptor antagonist, protein kinase C inhibitor, reducing agent","1.01, 0.25",,BRD-K29359156,"0.00, 0.00","ALB, LTB4R, NOX3"
CP,disopyramide,32.61,voltage-gated sodium channel blocker,"0.70, 0.20",,BRD-A29734509,"10.00, 0.00","SCN5A, CHRM1, CHRM2, CHRM3, KCND2, KCND3, KCNH2"
CP,puromycin,32.6,"adenosine receptor agonist, protein synthesis inhibitor","2.26, 0.58",,BRD-K36007650,"0.00, 0.00","NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1"
CP,coumestrol,32.59,"AGE inhibitor, estrogen receptor agonist, estrogen receptor ligand","1.31, 0.35",Estrogen receptor agonist,BRD-K97509413,"0.00, 0.00","ESR1, ESR2"
CP,hippeastrine,32.55,plant alkaloid with cytotoxic effects on some human tumor cell lines,"0.90, 0.28",,BRD-K71003802,"0.00, 0.00",
CP,benzatropine,32.5,anticholinergic,"1.56, 0.44",,BRD-A25067867,"0.00, 0.00","CHRM1, HRH1, SLC6A3"
CP,BML-190,32.47,cannabinoid receptor inverse agonist,"0.73, 0.10",,BRD-K94379058,"10.00, 10.00",CNR2
CP,eliprodil,-31.62,glutamate receptor antagonist,"0.95, 0.35",,BRD-A61392169,"0.00, 0.00","GRIN1, GRIN2B"
CP,ipratropium,-31.64,acetylcholine receptor antagonist,"1.15, 0.15",,BRD-A37432947,"0.00, 0.00","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
CP,ozagrel,-31.71,"thromboxane synthase inhibitor, platelet aggregation inhibitor, selective thromboxane synthetase inhibitor","1.00, 0.19",,BRD-K53061490,"0.00, 0.00",TBXAS1
CP,meprylcaine,-31.72,anesthetic,"0.45, 0.11",,BRD-K65417056,"10.00, 10.00",
CP,procarbazine,-31.8,"DNA alkylating drug, transmethylation inhibitor","0.78, 0.17",,BRD-K13032584,"0.00, 0.00",
CP,T-0156,-31.83,phosphodiesterase inhibitor,"1.10, 0.40",,BRD-K63516691,"0.00, 0.00",PDE5A
CP,FR-180204,-31.85,MAP kinase inhibitor,"0.89, 0.24",,BRD-K68756823,"0.00, 0.00","MAPK1, MAPK3"
CP,QX-314,-31.94,sodium channel blocker,"1.15, 0.30",,BRD-K56596464,"0.00, 0.00","MAPK14, TGFBR1"
CP,austricine,-31.97,hypolipidemic,"1.58, 0.44",,BRD-K78838262,"0.00, 0.00",
CP,hydrastinine,-31.97,alkaloid with hemostatic properties,"1.15, 0.42",,BRD-K92726801,"10.00, 0.00",
CP,chloramphenicol,32.38,"30S ribosomal protein inhibitor, 50S ribosomal subunit inhibitor, antibacterial agent","1.82, 0.47",,BRD-A51182606,"0.00, 0.00","CD55, CYP2C19"
CP,cinanserin,32.36,serotonin receptor antagonist,"0.48, 0.09",,BRD-K40901640,"0.00, 0.00",HTR2A
CP,thenoyltrifluoroacetone,32.34,PPAR receptor ligand,"1.36, 0.39",,BRD-K00959089,"10.00, 10.00","CES1, PPARA, SDHA"
CP,amoxapine,32.26,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine reputake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant","1.20, 0.32",Norepinephrine reuptake inhibitor,BRD-K02265150,"0.00, 0.00","SLC6A2, SLC6A4, HTR2A, HTR6, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH4, HTR1A, HTR1B, HTR2B, HTR2C, HTR3A, HTR7, SLC6A3"
CP,MK-2206,32.22,AKT inhibitor,"1.82, 0.36",,BRD-K68065987,"0.00, 0.00","AKT1, AKT2, AKT3"
CP,gossypol,32.17,"BCL inhibitor, MCL1 inhibitor, 11-beta hydroxysteroid dehydrogenase inhibitor, growth factor receptor modulator, lipid peroxidase inhibitor","1.26, 0.22",BCL inhibitor,BRD-K19295594,"0.00, 0.00","BCL2, BCL2L1, MCL1, BCL2L2, CTGF, EGF"
CP,tiabendazole,32.14,quinol-fumarate reductase inhibitor,"0.77, 0.14",,BRD-K77695569,"0.00, 0.00",
CP,AG-879,32.04,"angiogenesis inhibitor, EGFR inhibitor, tyrosine kinase inhibitor, VEGFR inhibitor","2.11, 0.65","EGFR inhibitor, VEGFR inhibitor",BRD-K59469039,"0.00, 0.00","ERBB2, KDR, NTRK1"
CP,mestranol,32.03,estrogen receptor agonist,"0.83, 0.28",Estrogen receptor agonist,BRD-A14798026,"0.00, 0.00",ESR1
CP,SB-205607,32.03,"delta 1 opioid receptor agonist, opioid receptor agonist","1.65, 0.52",,BRD-K22878149,"0.00, 0.00","OPRD1, OPRK1, OPRM1"
CP,eudesmic-acid,-31.17,in touchstone,"1.62, 0.36",,BRD-K15842202,"0.00, 0.00",
CP,itopride,-31.26,"dopamine receptor antagonist, acetylcholinesterase inhibitor","0.83, 0.28",,BRD-K96740444,"12.50, 12.50","DRD2, ACHE, CHRM3"
CP,atomoxetine,-31.27,"norepinephrine transporter inhibitor, adrenergic transmitter uptake inhibitor","0.63, 0.11",,BRD-K20141153,"0.00, 0.00","SLC6A2, SLC6A3, SLC6A4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B"
CP,fenoterol,-31.31,adrenergic receptor agonist,"0.97, 0.36",Beta-adrenergic receptor agonist,BRD-A97104540,"10.00, 0.00","ADRB2, ADRB1, ADRB3"
CP,BRD-K08438429,-31.32,"glucosylceramidase inhibitor, somatostatin receptor agonist","0.83, 0.16",,BRD-K08438429,"10.00, 0.00","GBA, SSTR4"
CP,penitrem-a,-31.33,potassium channel blocker,"0.89, 0.24",,BRD-K03842655,"0.00, 0.00",KCNMA1
CP,lamotrigine,-31.47,"glutamate release inhibitor, serotonin receptor inhibitor, Sodium Channel  Blockers, sodium channel blocker, voltage-gated sodium channel blocker","0.76, 0.11",,BRD-K93460210,"10.00, 0.00","SCN1A, SCN2A, SCN3A"
CP,pilocarpine,-31.52,acetylcholine receptor agonist,"1.15, 0.33",,BRD-K85090592,"0.00, 0.00","CHRM3, CHRM1, CHRM2, CHRM4, CHRM5"
CP,AG-490,-31.54,"epidermal growth factor receptor (EGFR) inhibitor, ErbB2 and JAK2 inhibitor, JAK inhibitor","0.70, 0.22",,BRD-K47105409,"0.00, 0.00","JAK2, JAK3, EGFR, STAT3"
CP,didanosine,-31.62,"nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor","0.86, 0.24",Nucleoside reverse transcriptase inhibitor,BRD-K99063460,"0.00, 0.00",PNP
CP,TCB2,31.98,serotonin receptor agonist,"1.26, 0.40",,BRD-A31195449,"10.00, 10.00",HTR2A
CP,tropicamide,31.97,"acetylcholine receptor antagonist, anticholinergic","1.06, 0.39",,BRD-A79672927,"11.11, 0.00","CHRM3, CHRM4, CHRM1, CHRM2"
CP,KU-14R,31.95,pancreatic ¦Â-cell I3 binding site antagonist,"0.89, 0.27",,BRD-A38747044,"50.00, 50.00",
CP,dehydrocholic-acid,31.87,gastrointestinal agent that stimulates bile production or the flow of bile into the duodenum,"0.50, 0.16",,BRD-A64125466,"10.00, 10.00",
CP,LFM-A13,31.76,Bruton's tyrosine kinase (BTK) inhibitor,"0.69, 0.13",,BRD-A30655177,"10.00, 0.00",BTK
CP,LY-364947,31.75,"TGF beta receptor inhibitor, p38 MAPK inhibitor","1.06, 0.28","P38 MAPK inhibitor, TGF beta receptor inhibitor",BRD-K06234293,"0.00, 0.00",TGFBR1
CP,fludarabine,31.75,"DNA synthesis inhibitor, DNA repair enzyme inhibitor, purine antagonist, ribonucleotide reductase inhibitor","3.44, 1.00",,BRD-K72238567,"0.00, 0.00","ADA, DCK, POLA1, RRM1, RRM2"
CP,eicosadienoic-acid,31.73,in touchstone,"1.49, 0.41",,BRD-K80325895,"11.11, 11.11",
CP,captopril,31.52,angiotensin converting enzyme inhibitor,"1.42, 0.42",,BRD-K54529596,"0.00, 0.00","ACE, LTA4H, MMP2, MMP9"
CP,butein,31.49,"angiotensin converting enzyme inhibitor, epidermal growth factor receptor (EGFR) inhibitor, interleukin synthesis inhibitor, NFkB pathway inhibitor, SIRT activator, Src tyrosine kinase inhibitor, steroid 5alpha-reductase inhibitor, tumor necrosis factor production inhibitor","1.52, 0.56",,BRD-K17497770,"0.00, 0.00","ACE, CXCL8, IL6, SIRT1, SRD5A1, SRD5A2, TNF"
CP,topiramate,-30.49,"carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist, GABA receptor agonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker","0.97, 0.22",,BRD-K29653726,"12.50, 12.50","CA2, CA4, GRIK1, CA1, CA12, CA7, CYP2C19, CYP3A4, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, SCN1A, SCN5A"
CP,AZ-10417808,-30.52,caspase inhibitor,"1.42, 0.40",,BRD-K36258877,"0.00, 0.00",CASP3
CP,naproxen,-30.54,cyclooxygenase inhibitor,"1.25, 0.35",,BRD-A87719232,"0.00, 0.00","PTGS2, PTGS1"
CP,nitrazepam,-30.57,GABA benzodiazepine site receptor agonist,"1.19, 0.33",Benzodiazepine receptor agonist,BRD-K57930253,"12.50, 12.50","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, SCN1A"
CP,FPL-64176,-30.59,"calcium channel agonist, L-type calcium channel activator","0.98, 0.39",,BRD-K78959463,"0.00, 0.00","CACNA1C, CACNA1S"
CP,monastrol,-30.59,kinesin-like spindle protein inhibitor,"0.77, 0.18",,BRD-A78377521,"10.00, 10.00",KIF11
CP,budesonide,-30.63,"glucocorticoid receptor agonist, glucocordicoid receptor antagonist, immunosuppressant","1.40, 0.80",,BRD-A34299591,"11.11, 0.00","NR3C1, CYP3A5, CYP3A7"
CP,lasalocid,-30.65,ionophore antibiotic,"1.80, 0.35",,BRD-K10207760,"0.00, 0.00",
CP,PHTPP,-30.65,estrogen receptor antagonist,"1.22, 0.45",,BRD-K76568384,"10.00, 10.00",ESR2
CP,cilostazol,-30.74,"phosphodiesterase inhibitor, platelet aggregation inhibitor","1.17, 0.38",,BRD-K67017579,"0.00, 0.00","PDE3A, CYP2C19, CYP3A5, PDE3B"
CP,SU-11652,31.44,"FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase receptor & angiogenic inhibitor, VEGFR inhibitor","3.73, 0.84",,BRD-K60623809,"0.00, 0.00","KDR, PDGFRB, CAMK1G, FGF2, FGFR1, FLT1, KIT, PDGFRA"
CP,YS-035,31.34,calcium channel blocker,"1.06, 0.41",,BRD-K06208435,"0.00, 0.00",
CP,mitoxantrone,31.27,"topoisomerase inhibitor, DNA intercalating drug, HCV inhibitor, immunosuppressant, Pim kinase inhibitor","2.56, 0.70",Topoisomerase inhibitor,BRD-K21680192,"0.00, 0.00","TOP2A, PIM1"
CP,diazepam,31.25,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist","0.45, 0.10",,BRD-K16508793,"0.00, 0.00","GABRA1, GABRA2, GABRA3, GABRA5, ADRA1A, CYP2C19, GABRA4, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO"
CP,norethisterone,31.24,ovulation inhibitor,"0.76, 0.27",Progesterone receptor agonist,BRD-A39415247,"0.00, 0.00",PGR
CP,ouabain,31.21,"ATPase inhibitor, alpha subunit binder","1.91, 0.52",,BRD-A46747628,"0.00, 0.00","ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, ATP1B4, FXYD2"
CP,tubacin,31.21,HDAC inhibitor,"0.88, 0.25",,BRD-K98426715,"10.00, 0.00",HDAC6
CP,dehydrocholic-acid,31.19,gastrointestinal agent that stimulates bile production or the flow of bile into the duodenum,"1.48, 0.41",,BRD-K90976994,"0.00, 0.00",
CP,RS-16566,31.11,(R)-zacopride ligand,"1.03, 0.33",,BRD-K80725821,"0.00, 0.00",
CP,carbidopa,30.89,"aromatic L-amino acid decarboxylase inhibitor, dopa decarboxylase (aromatic L-amino acid decarboxylase) inhibitor","2.07, 0.67",,BRD-A69512159,"0.00, 0.00",DDC
CP,SB-258585,-29.91,serotonin receptor antagonist,"0.99, 0.26",,BRD-K80639402,"11.11, 11.11",HTR6
CP,maprotiline,-30.06,"norepinephrine reputake inhibitor, tricyclic antidepressant (TCA)","1.39, 0.55",,BRD-K25433859,"0.00, 0.00","SLC6A2, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2C, HTR7"
CP,TER-14687,-30.07,inhibitor of translocation of PKCq in T cells,"1.09, 0.28",,BRD-A33833419,"10.00, 10.00",PRKCQ
CP,PT-630,-30.14,"dipeptidyl peptidase inhibitor, fibroblast activation protein inhibitor","1.68, 0.49",,BRD-A73680854,"0.00, 0.00","DPP4, FAP"
CP,RX-821002,-30.17,adrenergic receptor antagonist,"1.51, 0.50",,BRD-A65597028,"11.11, 0.00","ADRA2A, ADRA2B, ADRA2C, ADRA1A, ADRA1B, ADRA1D"
CP,MRS-1220,-30.18,adenosine receptor antagonist,"0.77, 0.31",,BRD-K37618799,"10.00, 0.00","ADORA2B, ADORA3"
CP,phenamil,-30.3,"acid sensing ion channel blocker, Sodium Channel  Blockers, TRPP3 channel inhibitor, TRPV modulator","0.80, 0.23",,BRD-K21350491,"11.11, 11.11",PKD2L1
CP,tremulacin,-30.34,5-lipoxygenase inhibitor,"1.53, 0.52",,BRD-A61856038,"10.00, 10.00",
CP,fluocinonide,-30.37,"corticosteroid agonist, corticosteroid hormone receptor agonist","1.57, 0.53",Glucocorticoid receptor agonist,BRD-K57886322,"11.11, 0.00","NR3C1, SERPINA6, SMO"
CP,thioproperazine,-30.46,dopamine receptor antagonist,"0.81, 0.30",Dopamine receptor antagonist,BRD-K08619574,"20.00, 20.00","ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A"
CP,brucine,30.88,glycine receptor antagonist,"1.51, 0.45",,BRD-K68077509,"0.00, 0.00","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
CP,midodrine,30.84,adrenergic receptor agonist,"0.78, 0.14",,BRD-A79981887,"0.00, 0.00","ADRA1A, ADRA1B, ADRA1D"
CP,mead-ethanolamide,30.82,cannabinoid receptor agonist,"0.76, 0.18",,BRD-K09764130,"0.00, 0.00",
CP,JAK3-Inhibitor-II,30.77,"JAK inhibitor, ALK tyrosine kinase receptor inhibitor, EGFR inhibitor","1.22, 0.42",JAK inhibitor,BRD-K52850071,"0.00, 0.00","EGFR, ALK, JAK1, JAK2, JAK3"
CP,norcyclobenzaprine,30.75,"adrenergic receptor ligand, serotonin receptor ligand","0.90, 0.20",Serotonin receptor antagonist,BRD-K63165456,"10.00, 10.00",HTR2A
CP,WT-171,30.61,HDAC inhibitor,"1.70, 0.59",,BRD-K74761218,"0.00, 0.00",HDAC6
CP,CP-93129,30.55,serotonin receptor agonist,"1.17, 0.32",,BRD-K81876028,"0.00, 0.00","HTR1A, HTR1B"
CP,YM-90709,30.53,"IL5 inhibitor, interleukin receptor antagonist","1.00, 0.31",,BRD-K06712146,"0.00, 0.00","CSF2RB, IL5RA"
CP,doconexent,30.51,"PPAR receptor agonist, unidentified pharmacological activity","0.77, 0.27",PPAR receptor agonist,BRD-K39965020,"0.00, 0.00","FFAR1, PPARA, PTGS1, PTGS2"
CP,icilin,30.5,"TRPA1 agonist, TRPM8 agonist","0.57, 0.14",,BRD-K48869804,"10.00, 0.00","TRPA1, TRPM8"
CP,alfuzosin,-29.35,adrenergic receptor antagonist,"0.57, 0.11",,BRD-A09056319,"0.00, 0.00","ADRA1A, ADRA1D, ADRA1B, KCNH2"
CP,RO-04-5595,-29.4,ionotropic glutamate receptor antagonist,"0.98, 0.31",,BRD-A63546914,"0.00, 0.00",
CP,WZ-4-145,-29.51,EGFR inhibitor,"1.70, 0.58",EGFR inhibitor,BRD-U25771771,"0.00, 0.00","CSF1R, DDR1, EGFR, PDGFRA, TIE1"
CP,repaglinide,-29.6,"insulin secretagogue, ATP-sensitive potassium channel antagonist, cytochrome P450 inhibitor, meglitinide","0.43, 0.09",,BRD-K82846253,"0.00, 0.00","ABCC8, CYP2C8, CYP3A5, INS, KCNJ11, PPARG"
CP,hydrocortisone,-29.65,"corticosteroid agonist, glucocorticoid receptor agonist, immunosuppressant, interleukin receptor antagonist","1.49, 0.48",Glucocorticoid receptor agonist,BRD-K73978287,"0.00, 0.00","ANXA1, NOS2, NR3C1, NR3C2"
CP,terazosin,-29.72,adrenergic receptor antagonist,"0.55, 0.11",,BRD-A22256192,"10.00, 10.00","ADRA1D, ADRA1A, ADRA1B, KCNH2, KCNH6, KCNH7"
CP,racecadotril,-29.75,"enkephalinase inhibitor, membrane metalloendopeptidase inhibitor, neprilysin inhibitor","0.98, 0.31",,BRD-A08187463,"0.00, 0.00",MME
CP,MEK1-2-inhibitor,-29.76,MEK inhibitor,"1.14, 0.49",MEK inhibitor,BRD-K12244279,"0.00, 0.00","MAP2K1, MAP2K2"
CP,LFM-A12,-29.81,"EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor","1.40, 0.35",,BRD-A44551378,"0.00, 0.00",EGFR
CP,carbamazepine,-29.87,"potassium channel modulator, Sodium Channel  Blockers, sodium channel blocker, voltage-gated sodium channel blocker","0.68, 0.16",,BRD-K71799949,"0.00, 0.00","ABCB1, CYP1A2, CYP3A4, SCN1A, SCN3A, SCN5A"
CP,bicuculline,30.47,GABA receptor antagonist,"1.27, 0.46",GABA receptor antagonist,BRD-A09495397,"0.00, 0.00","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, KCNN1"
CP,skimmianine,30.44,acetylcholinesterase inhibitor,"0.93, 0.18",,BRD-K25741894,"0.00, 0.00",
CP,dactinomycin,30.44,"DNA directed RNA polymerase inhibitor, nucleic acid syntheis inhibitor, protein synthesis inhibitor","2.80, 0.84",,BRD-K70578146,"0.00, 0.00",POLR2A
CP,oxybuprocaine,30.36,anesthetic,"0.92, 0.35",,BRD-K04185004,"10.00, 10.00",SCN10A
CP,syrosingopine,30.32,vesicular monoamine transporter inhibitor,"0.92, 0.30",,BRD-K14200658,"0.00, 0.00","SLC18A2, SLC18A1"
CP,dihydroergocristine,30.31,"adrenergic receptor antagonist, prolactin inhibitor, adrenergic receptor partial agonist, dopamine receptor agonist, dopamine receptor partial agonist, dopamine receptor partial antagonist, serotonin receptor antagonist","1.34, 0.35",,BRD-A65076780,"22.22, 11.11","HTR2A, ADRA1A, ADRB1, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR3A, HTR4, HTR5A, HTR6, HTR7"
CP,dactinomycin,30.24,"DNA directed RNA polymerase inhibitor, nucleic acid syntheis inhibitor, protein synthesis inhibitor","2.35, 0.80",,BRD-A73909368,"0.00, 0.00",POLR2A
CP,BJM-CSC-19,30.21,compound cytotoxic to breast cancer stem cells,"0.58, 0.14",,BRD-K92817986,"10.00, 10.00",
CP,sotalol,30.21,"adrenergic receptor antagonist, polarization inhibitor, potassium channel antagonist","0.82, 0.20",,BRD-A33168282,"11.11, 11.11","ADRB1, ADRB2, KCNH2"
CP,fluocinolone,30.18,"corticosteroid agonist, glucocorticoid receptor agonist","1.72, 0.78",Glucocorticoid receptor agonist,BRD-K94353609,"0.00, 0.00","NR3C1, SERPINA6"
CP,GBR-12783,-28.9,dopamine uptake inhibitor,"0.94, 0.19",,BRD-K92015269,"0.00, 0.00",
CP,RG-14620,-28.97,EGFR inhibitor,"1.09, 0.33",,BRD-K21853356,"0.00, 0.00",EGFR
CP,propylthiouracil,-28.99,thyroperoxidase inhibitor,"1.72, 0.64",,BRD-K48168960,"11.11, 0.00","TPO, DIO1"
CP,alclometasone,-29.02,"glucocorticoid receptor agonist, immunosuppressant","1.36, 0.61",Glucocorticoid receptor agonist,BRD-A90131694,"0.00, 0.00","NR3C1, SERPINA6"
CP,MNITMT,-29.04,lymphocyte inhibitor,"1.07, 0.26",,BRD-K63151507,"0.00, 0.00",
CP,GANT-58,-29.05,GLI antagonist,"0.66, 0.23",,BRD-K64451768,"0.00, 0.00","DHH, GLI1, IHH"
CP,ornidazole,-29.14,antiprotozoal agent,"0.88, 0.17",,BRD-A42759514,"0.00, 0.00",
CP,EI-346-erlotinib-analog,-29.18,epidermal growth factor receptor (EGFR) inhibitor,"1.74, 0.51",,BRD-U08759356,"0.00, 0.00",EGFR
CP,leflunomide,-29.25,"dihydroorotate dehydrogenase inhibitor, PDGFR tyrosine kinase receptor inhibitor, disease modifying antirheumatic drug, immunosuppressant, JAK inhibitor, STAT inhibitor","0.52, 0.18",,BRD-K78692225,"0.00, 0.00","DHODH, AHR, CYP2C19, JAK3, PTK2B, STAT6"
CP,capecitabine,-29.27,"dihydropyrimidine dehydrogenase inhibitor, DNA synthesis inhibitor, pyrimidine antagonist, RNA synthesis inhibitor, thymidylate synthase inhibitor","1.72, 0.45",Thymidylate synthase inhibitor,BRD-K61192372,"0.00, 0.00","TYMS, DPYD"
CP,BRD-K76425766,30.15,metalloproteinase inhibitor,"1.22, 0.26",,BRD-K76425766,"0.00, 0.00",
CP,BRD-K98297262,30.14,"1,3-beta-glucan synthase inhibitor","1.30, 0.36",,BRD-K98297262,"11.11, 11.11",CLC
CP,BH3I-1,30.14,BCL inhibitor,"0.98, 0.30",,BRD-A38913120,"0.00, 0.00",BCL2
CP,tyrphostin-AG-18,30.1,"epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor","0.65, 0.17",,BRD-K49657628,"0.00, 0.00",EGFR
CP,glimepiride,30.07,"insulin secretagogue, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulinotropin agonist, sulfonylurea","0.80, 0.24",,BRD-K42693031,"10.00, 10.00","ABCC8, KCNJ11, KCNJ1"
CP,apigenin,30.01,"casein kinase inhibitor, cell proliferation inhibitor, cytochrome P450 inhibitor, GABA receptor antagonist, glutamate receptor antagonist, monoamine oxidase inhibitor, nitric oxide production inhibitor, ornithine decarboxylase inhibitor, quorum sensing signaling modulator, VEGF expression inhibitor, xanthine oxidase inhibitor","0.91, 0.41",,BRD-K01493881,"0.00, 0.00","AKR1B1, AR, CDK6, CFTR, CYP19A1, CYP1A2, CYP1B1, HSD17B1, MAOA, ODC1, XDH"
CP,hexylcaine,29.97,sodium channel blocker,"0.56, 0.14",,BRD-A97730597,"0.00, 0.00","SCN5A, SCN10A"
CP,tolmetin,29.95,cyclooxygenase inhibitor,"0.64, 0.18",Cyclooxygenase inhibitor,BRD-K82562631,"20.00, 20.00","PTGS2, PTGS1"
CP,aliskiren,29.94,"renin inhibitor, peptidase inhibitor, protease inhibitor","0.56, 0.11",,BRD-K30020243,"10.00, 10.00",REN
CP,4-hydroxyretinoic-acid,29.78,retinoic acid metabolite,"1.15, 0.31",,BRD-A96799240,"0.00, 0.00",
CP,nimesulide,-28.55,"cyclooxygenase inhibitor, matrix metalloprotease inhibitor, prostanoid receptor inhibitor","1.30, 0.38",,BRD-K76775527,"0.00, 0.00","PTGS2, LTF, PLA2G2E, PTGS1"
CP,cefuroxime,-28.56,cell wall synthesis inhibitor,"1.75, 0.41",Bacterial cell wall synthesis inhibitor,BRD-K63641886,"0.00, 0.00",
CP,famciclovir,-28.57,"DNA polymerase inhibitor, DNA directed DNA polymerase inhibitor","0.38, 0.10",DNA polymerase inhibitor,BRD-K45033733,"0.00, 0.00",
CP,ivermectin,-28.66,"GABA receptor agonist, acetylcholine receptor allosteric modulator, GABA release stimulant, purinergic receptor allosteric modulator","1.89, 0.43",,BRD-A48570745,"0.00, 0.00","CHRNA7, GABRB3, GLRA3, P2RX7"
CP,FR-139317,-28.75,endothelin receptor antagonist,"1.18, 0.40",,BRD-A80641450,"0.00, 0.00",EDNRA
CP,BRD-K28680267,-28.78,CCK receptor antagonist,"0.89, 0.26",,BRD-K28680267,"0.00, 0.00","CCKAR, GABRA1, GABRB2, GABRG2"
CP,UB-165,-28.78,acetylcholine receptor agonist,"1.14, 0.43",,BRD-A14574269,"0.00, 0.00","CHRNA3, CHRNA4, CHRNB2"
CP,diethylcarbamazine,-28.86,lipoxygenase inhibitor,"0.70, 0.16",,BRD-K45542189,"10.00, 10.00","ALOX5, PTGS1"
CP,PD-158780,-28.86,"EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor","1.63, 0.51",EGFR inhibitor,BRD-K48735772,"0.00, 0.00",EGFR
CP,cinanserin,-28.89,serotonin receptor antagonist,"0.77, 0.28",,BRD-K15522385,"0.00, 0.00",HTR2A
CP,yohimbine,29.77,adrenergic receptor antagonist,"1.60, 0.52",,BRD-K35586044,"0.00, 0.00","ADRA2A, ADRA2C, ADRA2B, HTR1A, HTR1B, HTR1D, HTR2B, DRD2, DRD3, HTR1E, HTR1F, HTR2A, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8"
CP,QS-11,29.76,ARFGAP inhibitor,"1.27, 0.35",,BRD-K02526760,"10.00, 0.00",ARFGAP1
CP,fluocinolone,29.72,"corticosteroid agonist, glucocorticoid receptor agonist","1.51, 0.42",,BRD-A77824596,"0.00, 0.00","NR3C1, SERPINA6"
CP,lasalocid,29.7,ionophore antibiotic,"2.03, 0.66",,BRD-A72711497,"0.00, 0.00",
CP,verteporfin,29.7,"apoptosis stimulant, photosensitizing agent, radical formation stimulant","0.91, 0.30",,BRD-M45964048,"0.00, 0.00",
CP,isoflupredone,29.62,glucocorticoid receptor agonist,"1.57, 0.72",Glucocorticoid receptor agonist,BRD-K29173907,"0.00, 0.00",NR3C1
CP,ilomastat,29.6,matrix metalloprotease inhibitor,"0.91, 0.33",,BRD-K51662849,"0.00, 0.00","ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9"
CP,oxindole-I,29.52,"protein kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor","1.02, 0.25",,BRD-K51816706,"0.00, 0.00","AKT1, KDR, PDPK1, RET"
CP,saclofen,29.51,GABA receptor antagonist,"0.99, 0.32",GABA receptor antagonist,BRD-A24122750,"0.00, 0.00","GABBR1, GABBR2, KCTD12, KCTD16, KCTD8"
CP,L-803087,29.49,somatostatin receptor agonist,"1.28, 0.50",,BRD-A35511923,"10.00, 10.00",SSTR4
CP,GBR-12783,-28.24,dopamine uptake inhibitor,"0.70, 0.15",,BRD-K34034388,"0.00, 0.00",
CP,alvocidib,-28.26,"CDK inhibitor, apoptosis stimulant, BCL inhibitor, cell cycle inhibitor, MCL1 inhibitor, survivin inhibitor, XIAP inhibitor","2.16, 0.70",,BRD-K87909389,"0.00, 0.00","CDK2, CDK4, CDK1, CDK6, CDK7, CDK9, CDK5, CDK8, EGFR, PYGM, BCL2, BIRC5, CCNT1, MCL1, XIAP"
CP,pyrazinamide,-28.29,fatty acid synthase inhibitor,"1.74, 0.56",,BRD-K28667793,"0.00, 0.00",FASN
CP,verapamil,-28.3,"calcium channel blocker, L-type calcium channel blocker, dopamine receptor antagonist","0.84, 0.11",,BRD-A09533288,"0.00, 0.00","CACNA1C, CACNA1D, CACNA1G, CACNA1S, CACNA1A, CACNA1B, CACNA1F, CACNA1I, CACNB1, CACNB2, CACNB3, CACNB4, CYP2C8, CYP2E1, CYP3A4, CYP3A5, CYP3A7, DRD2, KCNA10, KCNA7, KCNH2, KCNJ11, NALCN, SCN5A, SLC29A4, SLC6A4"
CP,GW-583340,-28.3,"EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor, ErbB2 tyrosine kinase inhibitor, receptor tyrosine protein kinase inhibitor","0.94, 0.33",,BRD-K79930101,"0.00, 0.00","EGFR, ERBB2"
CP,KUC103898N,-28.39,G protein coupled receptor,"1.42, 0.42",,BRD-K34508425,"10.00, 10.00",
CP,lofexidine,-28.39,adrenergic receptor agonist,"1.19, 0.33",,BRD-A02990301,"0.00, 0.00",ADRA2A
CP,digoxin,-28.43,"ATPase inhibitor, ROR antagonist","2.17, 0.51",,BRD-K23478508,"0.00, 0.00","ATP1A1, ABCB1, RORC, SLCO1B3"
CP,PD-123319,-28.53,angiotensin antagonist,"0.80, 0.24",,BRD-A63836183,"0.00, 0.00",AGTR2
CP,floxuridine,-28.54,"DNA synthesis inhibitor, MDCK inhibitor, PEPT1 inhibitor, pyrimidine antagonist","1.23, 0.32",DNA synthesis inhibitor,BRD-A80638690,"11.11, 0.00",TYMS
CP,pirarubicin,29.45,topoisomerase inhibitor,"3.16, 0.95",Topoisomerase inhibitor,BRD-K83794624,"0.00, 0.00",TOP2A
CP,zonisamide,29.4,"GABA receptor agonist, Sodium Channel  Blockers, T-type calcium channel blocker","0.80, 0.19",,BRD-K48300629,"0.00, 0.00","CA1, CA12, CA7, SCN1A, CA10, CA11, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA8, CA9, CACNA1G, CACNA1H, CACNA1I, MAOA, MAOB, SCN11A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN9A"
CP,spiramide,29.32,"dopamine receptor antagonist, serotonin receptor antagonist","0.69, 0.23",Serotonin receptor antagonist,BRD-K94512704,"0.00, 0.00","DRD2, HTR1A, HTR2A, HTR2B, HTR2C"
CP,carbacyclin,29.25,"IP receptor activator, PPARbeta receptor activator","0.73, 0.19",,BRD-K27499107,"0.00, 0.00","PPARD, PTGDR, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, PTGIR, TBXA2R"
CP,roscovitine,29.19,"CDK inhibitor, apoptosis stimulant","0.91, 0.40",CDK inhibitor,BRD-K07691486,"10.00, 10.00","CDK2, CDK9, CDK7, CDK1, CDK5"
CP,propoxycaine,29.17,anesthetic,"0.56, 0.15",,BRD-K18250272,"10.00, 10.00",
CP,estropipate,29.06,estrogen receptor agonist,"0.61, 0.10",Estrogen receptor agonist,BRD-A22143024,"0.00, 0.00","ESR1, ESR2"
CP,diltiazem,29.05,"L-type calcium channel blocker, calcium channel antagonist, calcium channel blocker","0.90, 0.26",,BRD-K81029756,"0.00, 0.00","CACNA1C, CACNA1S, CACNA2D1, CACNG1, CYP3A5, CYP3A7, HTR3A, KCNA5"
CP,tamoxifen,29.02,"estrogen receptor antagonist, selective estrogen receptor modulator (SERM), estrogen receptor agonist, estrogen receptor modulator, PKC inhibitor","0.91, 0.18",,BRD-K43744935,"0.00, 0.00","ESR1, ESR2, CYP3A5, EBP, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ"
CP,NAS-181,28.99,serotonin receptor antagonist,"0.82, 0.19",,BRD-A23683907,"0.00, 0.00",HTR1B
CP,desmethylclozapine,-27.95,"acetylcholine receptor agonist, dopamine receptor agonist, dopamine receptor antagonist, dopamine receptor partial agonist, serotonin receptor antagonist, serotonin receptor inverse agonist","0.95, 0.25",,BRD-K10042277,"0.00, 0.00","CHRM1, DRD2, DRD3, HTR2A"
CP,WR-216174,-27.96,"CDK inhibitor, PFMRK inhibitor","1.34, 0.45",,BRD-K26669427,"10.00, 10.00",
CP,sirolimus,-27.97,"mTOR inhibitor, CCR expression inhibitor, cell cycle inhibitor, proteasome inhibitor, protein kinase inhibitor, T cell inhibitor","0.99, 0.43",,BRD-K99369265,"0.00, 0.00","MTOR, FKBP1A, CCR5, FGF2"
CP,NM-PP1,-27.98,"calcium/calmodulin dependent protein kinase inhibitor, growth factor receptor inhibitor, MAP kinase inhibitor, mutant kinase inhibitor","1.14, 0.35",,BRD-K78278890,"0.00, 0.00","CAMK2A, LCK, MAPK8, PRKACA, RIPK2, SRC"
CP,L-690330,-28.01,inositol monophophatase inhibitor,"1.70, 0.78",,BRD-K28470988,"0.00, 0.00",IMPA1
CP,SB-205384,-28.01,GABA receptor modulator,"0.75, 0.10",,BRD-A22707317,"0.00, 0.00","GABRA3, GABRA5, GABRA6"
CP,PLX-4720,-28.03,RAF inhibitor,"0.86, 0.30",RAF inhibitor,BRD-K16478699,"0.00, 0.00","BRAF, KDR"
CP,dimercaptosuccinic-acid,-28.05,"chelating agent, DNA methyltransferase inhibitor","1.56, 0.50",HIF activator,BRD-K88701661,"0.00, 0.00",DNMT1
CP,huperzine-a,-28.16,"acetylcholinesterase inhibitor, glutamate receptor antagonist","1.68, 0.48",,BRD-K45888792,"0.00, 0.00",ACHE
CP,cetirizine,-28.18,histamine receptor antagonist,"0.81, 0.11",,BRD-A42571354,"0.00, 0.00",HRH1
CP,VU-0404997-2,28.97,glutamate receptor modulator,"0.95, 0.26",,BRD-A34208323,"0.00, 0.00",GRM4
CP,IWR-1-ENDO,28.88,PARP inhibitor,"0.58, 0.15",PARP inhibitor,BRD-K61314889,"10.00, 10.00","TNKS, TNKS2"
CP,cilastatin,28.87,dehydropeptidase inhibitor,"1.33, 0.33",,BRD-K85518562,"0.00, 0.00",DPEP1
CP,L-701252,28.86,glutamate receptor antagonist,"1.18, 0.38",,BRD-K10176267,"10.00, 10.00",GRIN1
CP,BRD-K91691979,28.84,glucosylceramidase inhibitor,"0.89, 0.25",,BRD-K91691979,"0.00, 0.00",GBA
CP,belinostat,28.78,"HDAC inhibitor, cell cycle inhibitor","1.84, 0.53",HDAC inhibitor,BRD-K17743125,"0.00, 0.00","HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9"
CP,medrysone,28.71,"corticosteroid hormone receptor agonist, glucocorticoid receptor agonist","1.15, 0.48",Glucocorticoid receptor agonist,BRD-A20126139,"0.00, 0.00",NR3C1
CP,ochratoxin-a,28.71,phenylalanyl tRNA synthetase inhibitor,"1.39, 0.57",,BRD-K39944607,"0.00, 0.00",SLC22A6
CP,BRD-K52219182,28.61,phosphodiesterase inhibitor,"0.65, 0.14",,BRD-K52219182,"10.00, 10.00",
CP,corynanthine,28.59,alpha adrenergic receptor antagonist,"1.27, 0.38",,BRD-K06467078,"11.11, 0.00",
CP,MDM2-inhibitor,-27.56,MDM inhibitor,"1.22, 0.52",MDM inhibitor,BRD-K84987553,"10.00, 0.00",MDM2
CP,W-13,-27.56,calmodulin antagonist,"0.83, 0.13",Calmodulin antagonist,BRD-K45068323,"10.00, 0.00","CALM1, MYLK, PDE1A"
CP,propafenone,-27.58,"antiarrhythmic medication, potassium channel blocker, voltage-gated sodium channel blocker","0.89, 0.17",,BRD-A26334849,"0.00, 0.00","KCNH2, SCN5A, ADRB1, ADRB2, KCNA5, KCNK2, KCNK3"
CP,doxepin,-27.66,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant","0.86, 0.24",,BRD-K54462405,"10.00, 0.00","HRH1, HRH2, SLC6A2, SLC6A4, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C19, DRD2, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, KCNH2, SLC6A3"
CP,CA-074-Me,-27.68,"cathepsin inhibitor, antiamyloidogenic agent","2.63, 0.91",,BRD-A56020723,"0.00, 0.00",CTSB
CP,alosetron,-27.77,serotonin receptor antagonist,"1.31, 0.35",,BRD-K46742498,"0.00, 0.00",HTR3A
CP,asiaticoside,-27.84,possible antitumor agent,"1.50, 0.44",,BRD-A66199457,"0.00, 0.00",
CP,zardaverine,-27.88,phosphodiesterase inhibitor,"0.61, 0.11",,BRD-K37561857,"0.00, 0.00","PDE4D, PDE3A, PDE4A, PDE4B, PDE4C"
CP,GW-3965,-27.88,"LXR agonist, ABC transporter expression enhancer","0.90, 0.35",,BRD-K33818169,"0.00, 0.00","NR1H2, NR1H3, ABCA1"
CP,vinburnine,-27.89,adrenergic receptor antagonist,"0.76, 0.22",,BRD-K40227168,"0.00, 0.00","CHRM1, CHRM2, CHRM3, CHRM4"
CP,ZG-10,28.58,JNK inhibitor,"1.19, 0.61",,BRD-U51951544,"0.00, 0.00",MAPK8
CP,JW-7-24-1,28.57,LCK Inhibitor,"2.46, 0.67",,BRD-U68942961,"0.00, 0.00",LCK
CP,practolol,28.54,adrenergic receptor antagonist,"0.95, 0.31",,BRD-A41304429,"0.00, 0.00",ADRB1
CP,terreic-acid,28.54,Bruton's tyrosine kinase (BTK) inhibitor,"1.56, 0.52",,BRD-A64228451,"20.00, 10.00",BTK
CP,U-46619,28.52,thromboxane receptor agonist,"0.91, 0.20",,BRD-K18757346,"10.00, 10.00","PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, PTGIR, TBXA2R"
CP,sulfafurazole,28.51,"endothelin receptor antagonist, FOLP inhibitor","1.09, 0.25",Dihydrofolate reductase inhibitor,BRD-K50859149,"0.00, 0.00",
CP,oxibendazole,28.44,"DNA polymerase inhibitor, tubulin inhibitor","1.08, 0.47",Tubulin inhibitor,BRD-K52075715,"10.00, 0.00","TUBB, TUBB4B"
CP,glycodeoxycholic-acid,28.41,apoptosis activator,"1.36, 0.38",,BRD-K68144790,"0.00, 0.00",
CP,nefopam,28.39,"cyclooxygenase inhibitor, prostanoid receptor inhibitor","1.00, 0.24",,BRD-A78877355,"0.00, 0.00",
CP,H-9,28.36,"cAMP dependent protein kinase inhibitor, PKA inhibitor","0.57, 0.23",,BRD-K09790412,"0.00, 0.00",PRKACA
CP,MR-16728,-26.62,acetylcholine release enhancer,"0.59, 0.23",,BRD-A30590053,"0.00, 0.00",
CP,enzastaurin,-26.74,"PKC inhibitor, AKT inhibitor, angiogenesis inhibitor, apoptosis stimulant, PI3K inhibitor","0.86, 0.27",PKC inhibitor,BRD-K79404599,"10.00, 10.00","PRKCB, AKT1, GSK3B, PRKCA, PRKCD, PRKCG"
CP,perindopril,-26.89,angiotensin converting enzyme inhibitor,"0.61, 0.22",,BRD-K92731339,"0.00, 0.00",ACE
CP,RS-45041-190,-26.9,imidazoline receptor agonist,"0.84, 0.15",,BRD-K26160755,"10.00, 10.00",
CP,BRD-K49061529,-26.92,GABA benzodiazepine site receptor inverse agonist,"1.45, 0.33",,BRD-K49061529,"0.00, 0.00","GABRA1, GABRG2"
CP,nTZDpa,-26.98,PPAR receptor partial agonist,"0.97, 0.24",PPAR receptor agonist,BRD-K54708045,"0.00, 0.00",PPARG
CP,DY-131,-27.13,estrogen-related receptor agonist,"0.70, 0.22",,BRD-K62353524,"0.00, 0.00","ESR2, ESRRB, ESRRG"
CP,nitrocaramiphen,-27.36,acetylcholine receptor antagonist,"0.66, 0.20",,BRD-K28453807,"10.00, 0.00",
CP,procaterol,-27.44,adrenergic receptor agonist,"0.94, 0.36",Beta-adrenergic receptor agonist,BRD-A22684332,"0.00, 0.00",ADRB2
CP,calmidazolium,-27.51,"calcium channel blocker, calmodulin antagonist","2.27, 0.38",,BRD-A26199074,"0.00, 0.00","ATP2B1, PDE1A"
CP,azaperone,28.31,dopamine receptor antagonist,"0.59, 0.11",,BRD-K45861246,"10.00, 0.00","DRD2, DRD3"
CP,MLN-4924,28.2,nedd activating enzyme inhibitor,"2.53, 0.74",,BRD-K67844266,"0.00, 0.00","NAE1, UBA3"
CP,relcovaptan,28.07,vasopressin receptor antagonist,"1.09, 0.28",,BRD-K96720755,"10.00, 0.00","AVPR1A, AVPR1B, AVPR2, OXTR"
CP,glipizide,28.03,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, insulin secretagogue","0.94, 0.19",KCNJ11 modulator,BRD-K12219985,"0.00, 0.00","ABCC8, KCNJ10, KCNJ11, PPARG"
CP,SCH-79797,28.02,proteinase activated receptor antagonist,"3.38, 0.63",,BRD-K17140735,"0.00, 0.00",F2R
CP,parecoxib,27.99,cyclooxygenase inhibitor,"0.99, 0.30",,BRD-K13800121,"0.00, 0.00","LTF, PTGS2"
CP,AICA-ribonucleotide,27.93,"adenosine release stimulant, AMPK stimulant","2.41, 0.59",,BRD-A67373739,"0.00, 0.00","ATIC, PRKAA1"
CP,hypericin,27.86,"PKC inhibitor, tyrosine kinase inhibitor, unidentified pharmacological activity","0.75, 0.20",,BRD-K29673530,"0.00, 0.00",
CP,rhodomyrtoxin,27.86,"cytotoxic, DNA intercalator","1.24, 0.32",,BRD-K13725475,"0.00, 0.00",
CP,bemegride,27.86,chemoreceptor agonist,"0.85, 0.27",,BRD-K14993104,"10.00, 10.00",GABRA1
CP,NPI-2358,-26.23,"tubulin inhibitor, angiogenesis inhibitor, tubulin polymerisation inhibitor","1.63, 0.59",Tubulin inhibitor,BRD-K99498722,"0.00, 0.00",
CP,Ro-04-6790,-26.35,"serotonin receptor antagonist, serotonin receptor inhibitor","0.85, 0.27",,BRD-K43290182,"0.00, 0.00",HTR6
CP,zosuquidar,-26.39,"P glycoprotein inhibitor, P glycoprotein modulator","0.98, 0.31",,BRD-K70557564,"0.00, 0.00","ABCB1, ABCB4"
CP,CI-966,-26.41,"GABA uptake inhibitor, GAT inhibitor","0.90, 0.19",,BRD-K67680372,"0.00, 0.00",SLC6A1
CP,tyrphostin-B44,-26.43,EGFR inhibitor,"1.33, 0.44",,BRD-K11158509,"10.00, 10.00",
CP,ZD-7114,-26.46,adrenergic receptor agonist,"0.56, 0.18",,BRD-K45296539,"0.00, 0.00",ADRB3
CP,"16,16-dimethylprostaglandin-e2",-26.46,"15-hydroxyprostaglandin dehydrogenase inhibitor, unidentified pharmacological activity","1.40, 0.40",,BRD-K92301463,"0.00, 0.00",HPGD
CP,paroxetine,-26.48,"cyclophilin inhibitor, norepinephrine reputake inhibitor, selective serotonin reuptake inhibitor (SSRI), serotonin reuptake inhibitor, serotonin uptake inhibitor","1.65, 0.47",,BRD-K37991163,"0.00, 0.00","SLC6A4, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2"
CP,nobiletin,-26.51,"MEK phosphorylation inhibitor, nitric oxide synthase expression inhibitor, P glycoprotein inhibitor, tyrosinase inhibitor","0.42, 0.13",,BRD-K06753942,"0.00, 0.00","ABCB1, MAP2K1, TYR"
CP,SIB-1893,-26.59,glutamate receptor antagonist,"1.10, 0.41",,BRD-K67439147,"10.00, 0.00","GRM5, GRM4"
CP,tracazolate,27.86,"GABA receptor agonist, GABA receptor modulator","0.61, 0.17",,BRD-K34154330,"10.00, 10.00",GABRA1
CP,JZL-184,27.85,monoacylglucerol lipase inhibitor,"1.31, 0.39",,BRD-K45446451,"10.00, 10.00",MGLL
CP,trapidil,27.8,"calcium channel antagonist, PDGFR tyrosine kinase receptor inhibitor, platelet aggregation inhibitor, protein kinase activator","0.72, 0.22",,BRD-K95763993,"0.00, 0.00",PDGFRA
CP,sphingosine,27.79,ceramidase inhibitor,"0.88, 0.15",,BRD-K62959606,"10.00, 10.00","GLTP, PVR, TRPM3"
CP,J-104129,27.72,acetylcholine receptor antagonist,"1.17, 0.33",,BRD-K26429091,"0.00, 0.00",CHRM3
CP,vinorelbine,27.68,"tubulin inhibitor, apoptosis stimulant, microtubule inhibitor, mitosis inhibitor, mitotic inhibitor, tubulin polymerisation inhibitor, vinca alkaloid","2.16, 0.73",,BRD-K97514127,"0.00, 0.00",TUBB
CP,betaxolol,27.65,adrenergic receptor antagonist,"0.85, 0.17",,BRD-A02759312,"0.00, 0.00","ADRB1, ADRB2"
CP,cisapride,27.56,"acetylcholine receptor agonist, serotonin receptor agonist","0.73, 0.13",Serotonin receptor agonist,BRD-K06895174,"10.00, 0.00","HTR4, KCNH2, CYP2B6, CYP2C8, CYP3A5, CYP3A7, HTR2A, HTR3A"
CP,BNTX,27.54,opioid receptor antagonist,"2.36, 0.59",,BRD-A55484088,"0.00, 0.00","OPRD1, OPRK1, OPRM1"
CP,olomoucine,27.52,CDK inhibitor,"0.93, 0.22",,BRD-K82731415,"0.00, 0.00","CDK1, CDK2, CDK5, MAPK1"
CP,chlorphensin,-25.78,muscle relaxant,"0.85, 0.26",,BRD-A39230911,"0.00, 0.00",
CP,spiperone,-25.84,dopamine receptor antagonist,"0.64, 0.16",,BRD-K55468218,"0.00, 0.00","ADRA1A, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR7, ADRA1B, ADRA1D, DRD1, DRD5, HTR1D, HTR2B, HTR2C, HTR6"
CP,JTC-801,-25.84,opioid receptor antagonist,"2.92, 0.63",,BRD-K17705806,"0.00, 0.00",OPRL1
CP,reichstein,-25.86,androgen receptor antagonist,"1.27, 0.35",,BRD-A56245458,"0.00, 0.00",AR
CP,pifithrin-alpha,-25.95,TP53 inhibitor,"0.52, 0.11",,BRD-K66874953,"0.00, 0.00",TP53
CP,ispinesib,-25.96,"kinesin family member inhibitor, kinesin inhibitor, Kinesin-Like Spindle Protein  KIF11 (KSP, Eg5) Inhibitors","1.68, 0.51",,BRD-K64881305,"0.00, 0.00",KIF11
CP,methysergide,-26.05,serotonin receptor antagonist,"1.01, 0.30",,BRD-A98725278,"0.00, 0.00","HTR2C, HTR1B, HTR1E, HTR1F, HTR2A, HTR2B, HTR7, HTR1A, HTR1D, HTR5A, HTR6"
CP,droxinostat,-26.12,HDAC inhibitor,"0.93, 0.40",HDAC inhibitor,BRD-K11558771,"11.11, 11.11","HDAC6, HDAC8"
CP,efavirenz,-26.13,"HIV reverse transcriptase inhibitor, non-nucleoside reverse transcriptase inhibitor, reverse transcriptase inhibitor","0.74, 0.20",,BRD-K40758068,"0.00, 0.00","CYP2B6, CYP2C19, CYP2C8, CYP3A4, CYP3A5"
CP,niridazole,-26.2,"oogenesis inhibitor, spermatogenesis inhibitor","0.78, 0.26",,BRD-K53123955,"11.11, 0.00",
CP,AKT-inhibitor-1-2,27.49,"AKT inhibitor, PI3K inhibitor","1.42, 0.28",,BRD-K04887706,"0.00, 0.00","AKT1, AKT2, AKT3"
CP,chlorphenamine,27.45,histamine receptor antagonist,"0.45, 0.09",,BRD-K89595132,"10.00, 10.00","HRH1, SLC6A2, SLC6A3, SLC6A4"
CP,PIK-90,27.43,PI3K inhibitor,"1.57, 0.61",PI3K inhibitor,BRD-K99818283,"10.00, 0.00",
CP,NECA,27.4,adenosine receptor agonist,"0.91, 0.36",Adenosine receptor agonist,BRD-A35338386,"10.00, 10.00","ADORA1, ADORA2A, ADORA2B, ADORA3, HSP90B1"
CP,CGP-20712,27.37,adrenergic receptor antagonist,"0.88, 0.32",,BRD-A31575449,"10.00, 10.00","ADRB1, ADRB3"
CP,denbufylline,27.35,phosphodiesterase inhibitor,"0.76, 0.24",,BRD-K37792168,"10.00, 10.00","PDE4A, PDE4B, PDE4D"
CP,cotinine,27.32,nicotine metabolite,"1.89, 0.59",,BRD-K94144010,"0.00, 0.00",
CP,manumycin-a,27.23,"farnesyltransferase inhibitor, NFkB pathway inhibitor, ras farnesyltransferase inhibitor","3.15, 0.77",,BRD-A77216878,"10.00, 0.00","FNTA, IKBKB"
CP,penciclovir,27.22,DNA directed DNA polymerase inhibitor,"1.18, 0.31",,BRD-K47780086,"12.50, 12.50",
CP,IBC-293,27.21,hydroxycarboxylic acid receptor agonist,"1.02, 0.26",,BRD-K15196155,"10.00, 0.00",HCAR3
CP,robustic-acid,-25.03,cAMP inhibitor,"0.97, 0.15",,BRD-K54411430,"0.00, 0.00",
CP,aprepitant,-25.07,tachykinin antagonist,"1.22, 0.30",,BRD-K17306061,"0.00, 0.00","TACR1, CYP2C19"
CP,pterostilbene,-25.09,"cyclooxygenase inhibitor, FAAH inhibitor, MAP kinase inhibitor, PPAR receptor agonist","1.94, 0.63",,BRD-K92870997,"0.00, 0.00","FAAH, PPARA, PTGS1, PTGS2"
CP,SAL-1,-25.37,adenosine receptor antagonist,"0.72, 0.13",,BRD-K40213712,"0.00, 0.00","ADORA2B, ADORA2A"
CP,GSK-1070916,-25.39,Aurora kinase inhibitor,"1.24, 0.53",Aurora kinase inhibitor,BRD-K36740062,"0.00, 0.00","AURKB, AURKC, AURKA, CYP2D6, CYP3A4"
CP,rifaximin,-25.43,"50S ribosomal subunit inhibitor, DNA directed DNA polymerase inhibitor, PXR agonist, RNA synthesis inhibitor","1.88, 0.56",,BRD-K89708791,"12.50, 0.00","NR1I2, CYP3A4"
CP,atorvastatin,-25.52,"HMGCR inhibitor, dipeptidyl peptidase inhibitor, tumor necrosis factor expression inhibitor","0.97, 0.35",,BRD-A82307304,"0.00, 0.00","HMGCR, DPP4, AHR, CYP3A5, FASLG"
CP,lysylphenylalanyl-tyrosine,-25.55,heparin activation inhibitor,"1.41, 0.44",,BRD-K47328134,"0.00, 0.00",
CP,vitexin,-25.58,antioxidant,"1.34, 0.58",,BRD-A41941932,"10.00, 10.00",
CP,SR-27897,-25.69,CCK receptor antagonist,"0.99, 0.31",CCK receptor antagonist,BRD-K35629949,"0.00, 0.00",CCKAR
CP,CGP-60474,27.21,"CDK inhibitor, PKC inhibitor","3.50, 1.24",,BRD-K79090631,"0.00, 0.00","CDK1, CDK2"
CP,GBR-12935,27.19,dopamine uptake inhibitor,"1.25, 0.36",,BRD-K50135270,"10.00, 10.00","AGTR1, SLC6A3"
CP,DAPT-GSI-IX,27.13,"antiamyloidogenic agent, gamma secretase inhibitor","0.84, 0.23",Gamma secretase inhibitor,BRD-A68929948,"0.00, 0.00",
CP,PP-2,27.08,src inhibitor,"1.60, 0.53",SRC inhibitor,BRD-K95785537,"0.00, 0.00","SRC, LCK, ABL1, LYN, RIPK2"
CP,resorcinol,27.02,phosphodiesterase inhibitor,"1.27, 0.31",,BRD-K85603128,"0.00, 0.00","CA12, CA14, CA2, PTGS1"
CP,ZM-323881,26.95,"vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR inhibitor","0.82, 0.20",VEGFR inhibitor,BRD-K67831364,"0.00, 0.00",KDR
CP,azacyclonol,26.93,ataractive drug used to diminish hallucinations,"0.89, 0.14",,BRD-K97061094,"0.00, 0.00",HRH1
CP,bergenin,26.91,anti-arthritic compound that modulates Th1/Th2 cytokine balance,"1.19, 0.32",,BRD-A15034104,"11.11, 11.11",PTPN1
CP,trioxsalen,26.9,DNA synthesis inhibitor,"1.02, 0.31",,BRD-K54790157,"0.00, 0.00",
CP,pentoxifylline,26.88,"phosphodiesterase inhibitor, acetylcholinesterase inhibitor, chitinase inhibitor, tumor necrosis factor production inhibitor","0.63, 0.14",,BRD-K57569181,"0.00, 0.00","TNF, ACHE, ADORA1, ADORA2A, ADRA2B, CHIA, NT5E, PDE4A, PDE4B, PDE5A"
CP,estradiol,-24.15,estrogen receptor agonist,"0.52, 0.15",Estrogen receptor agonist,BRD-A18917088,"0.00, 0.00","ESR1, ESR2, NR1I2, CYP2B6, CYP2C19, CYP2C8, CYP2E1, CYP3A5, CYP3A7, GPER1, KCNMA1"
CP,icosapent,-24.17,"fatty acid with anti-inflammatory, antithrombotic and immunomodulatory properties","1.13, 0.30",,BRD-K47192521,"11.11, 0.00","PTGS1, PTGS2, ACSL3, ACSL4, FADS1, FFAR1, PPARD, PPARG, SLC8A1, TRPV1"
CP,MST-312,-24.18,telomerase inhibitor,"1.36, 0.32",,BRD-K19894101,"0.00, 0.00",TERT
CP,tyrphostin-46,-24.23,tyrosine kinase inhibitor,"0.92, 0.27",,BRD-K60184833,"0.00, 0.00",EGFR
CP,amiodarone,-24.4,"acetylcholine receptor ligand, adrenergic receptor antagonist, ATP-sensitive potassium channel inhibitor, HCN (hyperpolarization activated cyclic nucleotide gated) channel modulator, polarization inhibitor, potassium channel antagonist, Sodium Channel  Blockers, voltage-gated sodium channel blocker","1.55, 0.49",,BRD-K17561142,"0.00, 0.00","KCNH2, ADRB1, CACNA1H, CACNA2D2, CHRM3, CYP2C8, KCNA7, SCN5A"
CP,betamethasone,-24.57,"corticosteroid agonist, glucocorticoid receptor agonist","1.63, 0.90",Glucocorticoid receptor agonist,BRD-A02180903,"0.00, 0.00",NR3C1
CP,edrophonium,-24.57,acetylcholinesterase inhibitor,"0.90, 0.33",,BRD-K81128206,"0.00, 0.00","ACHE, BCHE"
CP,budesonide,-24.78,"glucocorticoid receptor agonist, glucocordicoid receptor antagonist, immunosuppressant","1.51, 0.75",,BRD-A60571864,"0.00, 0.00","NR3C1, CYP3A5, CYP3A7"
CP,BRD-K64835161,-24.78,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor, dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B inhibitor","1.14, 0.42",,BRD-K64835161,"20.00, 20.00","CLK1, CLK4, DYRK1B"
CP,DPN,-25,estrogen receptor agonist,"0.81, 0.28",Estrogen receptor agonist,BRD-A27143604,"0.00, 0.00",ESR2
CP,anabasine,26.85,acetylcholine receptor agonist,"1.10, 0.19",,BRD-K36638830,"0.00, 0.00",
CP,CGK-733,26.8,"ATM kinase inhibitor, ATR kinase inhibitor","2.44, 0.64",,BRD-A50737080,"0.00, 0.00","ATM, ATR"
CP,hyoscyamine,26.74,acetylcholine receptor inhibitor,"1.51, 0.40",,BRD-A78303415,"0.00, 0.00","CHRM1, CHRM2, CHRM3, CHRM4"
CP,BI-78D3,26.7,JNK inhibitor,"1.74, 0.51",,BRD-K73982490,"10.00, 0.00",MAPK8
CP,leucodin,26.66,melanin synthesis inhibitor,"0.83, 0.19",,BRD-K96119599,"0.00, 0.00",
CP,FCCP,26.64,mitochondrial oxidative phosphorylation uncoupler,"1.90, 0.72",,BRD-K14821540,"0.00, 0.00",
CP,AG-370,26.62,"PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase inhibitor","1.31, 0.40",,BRD-K33204703,"0.00, 0.00",PDGFRB
CP,loperamide,26.52,"opioid receptor agonist, atrial natriuretic peptide receptor antagonist","1.26, 0.56",,BRD-K61250553,"0.00, 0.00","OPRM1, OPRD1, CACNA1A, CALM1, CYP2B6, CYP2C8, NPR2, OPRK1, POMC"
CP,forskolin,26.48,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant","1.14, 0.35",,BRD-K09602097,"0.00, 0.00","ADCY2, ADCY5, GNAS"
CP,L-732138,26.39,tachykinin antagonist,"1.41, 0.35",,BRD-A96882008,"0.00, 0.00","TACR1, TACR2"
CP,U-99194,-23.83,dopamine receptor antagonist,"1.11, 0.27",,BRD-K70281171,"0.00, 0.00",DRD3
CP,rosiglitazone,-23.84,"PPAR receptor agonist, insulin sensitizer, thiazolidinedione","0.39, 0.11",PPAR receptor agonist,BRD-A97437073,"0.00, 0.00","PPARG, ACSL4, CYP2C8, FFAR1, INS, TRPC5, TRPM3"
CP,metergoline,-23.87,"dopamine receptor agonist, serotonin receptor antagonist, prolactin inhibitor","1.90, 0.58",Serotonin receptor antagonist,BRD-A30435184,"0.00, 0.00","DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7"
CP,docosatrienoic-acid,-23.89,inhibitor of LTB4 binding to neutrophils,"1.52, 0.59",,BRD-K01624546,"0.00, 0.00",
CP,BMS-641988,-23.89,androgen receptor antagonist,"2.52, 0.60",,BRD-K48923948,"0.00, 0.00",AR
CP,propentofylline,-23.93,"acetylcholinesterase inhibitor, adenosine reuptake inhibitor, adenosine uptake inhibitor, phosphodiesterase inhibitor","0.77, 0.18",,BRD-K59273480,"0.00, 0.00",ACHE
CP,praziquantel,-23.94,"membrane permeability enhancer, schistosomicide","0.72, 0.16",,BRD-A21858158,"0.00, 0.00",
CP,RS-39604,-23.97,serotonin receptor antagonist,"1.50, 0.55",Serotonin receptor antagonist,BRD-K20742498,"0.00, 0.00",HTR4
CP,eicosatrienoic-acid,-24.11,vasodilator,"1.28, 0.47",,BRD-K63913457,"10.00, 10.00",
CP,LY-165163,-24.13,serotonin receptor antagonist,"0.91, 0.23",Serotonin receptor antagonist,BRD-K14282469,"10.00, 10.00","HTR1A, HTR1D"
CP,flurbiprofen,26.35,cyclooxygenase inhibitor,"1.57, 0.39",,BRD-A86044036,"0.00, 0.00","PTGS1, PTGS2"
CP,quinoclamine,26.34,algicide,"2.48, 0.58",,BRD-K66792149,"0.00, 0.00",
CP,talampicillin,26.25,antibiotic,"0.80, 0.17",,BRD-A10303790,"0.00, 0.00",
CP,pyrazolanthrone,26.25,"JNK inhibitor, AP inhibitor, dual specificity protein kinase inhibitor, leucine rich repeat kinase inhibitor","0.68, 0.16",,BRD-K01567962,"0.00, 0.00","MAPK10, MAPK8, MAPK9, TTK, LRRK2, MAPK8IP1"
CP,picrotoxin,26.24,GABA receptor antagonist,"1.11, 0.36",,BRD-A37817666,"0.00, 0.00","GABRA1, GLRA2, GLRA3, GABRR1, GLRA1, GLRB, HTR3A, HTR3B"
CP,tebuthiuron,26.2,photosynthesis inhibitor,"0.59, 0.14",,BRD-K34820100,"0.00, 0.00",
CP,BMS-536924,26.05,"insulin growth factor receptor inhibitor, insulin receptor ligand","2.15, 0.73",IGF-1 inhibitor,BRD-K34581968,"0.00, 0.00","IGF1R, AKT1, CCNE1, CDK2, CYP3A4, ERBB2, INSR, KDR, LCK, MAPK1, MET, PDGFRA, PDGFRB"
CP,bithionol,25.97,autotaxin inhibitor,"1.89, 0.60",,BRD-K39120595,"0.00, 0.00","ESR1, ESR2, MCL1"
CP,MY-5445,25.94,"phosphodiesterase inhibitor, platelet aggregation inhibitor","0.70, 0.18",,BRD-K90524085,"0.00, 0.00",PDE5A
CP,zoxazolamine,25.91,IKCa channel activator,"0.56, 0.11",,BRD-K66353228,"0.00, 0.00",
CP,hemado,-23.28,adenosine receptor agonist,"0.85, 0.32",,BRD-A00267231,"0.00, 0.00","ADORA3, ADORA1, ADORA2A, ADORA2B"
CP,GR-206,-23.28,aryl hydrocarbon receptor ligand,"0.97, 0.31",,BRD-K00184207,"10.00, 10.00",
CP,ramipril,-23.39,angiotensin converting enzyme inhibitor,"0.77, 0.11",,BRD-K89348303,"0.00, 0.00",ACE
CP,voriconazole,-23.48,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, lanosterol demethylase inhibitor","1.43, 0.45",,BRD-K46212057,"0.00, 0.00","CYP2C19, CYP51A1"
CP,dextromethorphan,-23.63,"glutamate receptor antagonist, sigma receptor agonist","0.45, 0.15",,BRD-K24053527,"0.00, 0.00","SIGMAR1, CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, CYP3A5, GRIN1, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SLC6A2, SLC6A4"
CP,RS-504393,-23.65,CC chemokine receptor antagonist,"1.22, 0.15",,BRD-K87510569,"0.00, 0.00","CCR2, CCL2"
CP,AG-490,-23.65,"epidermal growth factor receptor (EGFR) inhibitor, ErbB2 and JAK2 inhibitor, JAK inhibitor","1.31, 0.45",,BRD-K12357156,"0.00, 0.00","JAK2, JAK3, EGFR, STAT3"
CP,SCH-23390,-23.65,dopamine receptor antagonist,"1.02, 0.28",,BRD-K45435259,"10.00, 10.00","DRD1, DRD5, HTR2C, KCNJ4, KCNJ6"
CP,AGK-2,-23.66,"SIRT inhibitor, SIRT pathway","0.83, 0.23",,BRD-K32536677,"10.00, 10.00",SIRT2
CP,SB-218078,-23.8,"CHK inhibitor, PKC inhibitor","1.43, 0.60",,BRD-A06352508,"0.00, 0.00",CHEK1
CP,gamma-linolenic-acid,25.9,"cyclooxygenase inhibitor, prostanoid receptor stimulant, thromboxane synthase stimulant","1.66, 0.52",,BRD-K18059238,"10.00, 0.00",TBXAS1
CP,noretynodrel,25.8,progestogen steroid hormone,"0.88, 0.28",,BRD-A00758722,"10.00, 10.00",PGR
CP,arecaidine,25.71,acetylcholine receptor agonist,"1.28, 0.36",,BRD-K23922020,"0.00, 0.00","CHRM1, CHRM2, CHRM3, CHRM4"
CP,narciclasine,25.66,"coflilin signaling pathway activator, LIM kinase activator, ROCK activator","3.52, 0.82",,BRD-K06792661,"0.00, 0.00",RHOA
CP,cabergoline,25.5,"dopamine receptor agonist, prolactin inhibitor, prolactin secretion inhibitor","0.84, 0.23",,BRD-K86882815,"0.00, 0.00","DRD2, ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, ADRA1B, ADRA1D, ADRB1, ADRB2, HTR7, PRL"
CP,BRD-A97035593,25.5,XIAP inhibitor,"0.83, 0.23",,BRD-A97035593,"0.00, 0.00",XIAP
CP,methylene-blue,25.49,"guanylate cyclase inhibitor, monoamine oxidase inhibitor, nitric oxide production inhibitor, tau aggregation inhibitor","2.94, 0.64",,BRD-K16406336,"0.00, 0.00","ACHE, MAPT"
CP,EO-1428,25.44,p38 MAPK inhibitor,"1.26, 0.32",,BRD-K42452249,"0.00, 0.00","MAPK11, MAPK14"
CP,JAK3-inhibitor-V,25.38,JAK inhibitor,"1.39, 0.28",,BRD-K95676198,"0.00, 0.00",JAK3
CP,miglitol,25.36,"glucosidase inhibitor, sodium/glucose cotransporter activator","1.74, 0.57",,BRD-K44779798,"0.00, 0.00","GAA, MGAM, GANAB, GANC, SLC5A4"
CP,lavendustin-a,-22.71,"EGFR inhibitor, tyrosine kinase inhibitor","1.42, 0.33",,BRD-K23583188,"10.00, 0.00","EGFR, LCK"
CP,rivaroxaban,-22.91,"coagulation factor inhibitor, coagulation inhibitor, serine protease inhibitor","0.91, 0.38",,BRD-K37130656,"0.00, 0.00","F10, CYP2J2, CYP3A5"
CP,tiagabine,-22.97,"GABA uptake inhibitor, GAT inhibitor","1.98, 0.76",,BRD-K60160658,"0.00, 0.00","SLC6A1, CYP2C19"
CP,scandenin,-22.98,plant compound with antimicrobiial activity,"0.79, 0.17",,BRD-K81847782,"0.00, 0.00",
CP,L-741626,-23.05,"dopamine receptor, dopamine receptor antagonist","1.27, 0.42",Dopamine receptor antagonist,BRD-K05181463,"0.00, 0.00","DRD2, DRD3, DRD4, HTR2A, HTR2B"
CP,daunorubicin,-23.11,"RNA synthesis inhibitor, topoisomerase inhibitor, DNA synthesis inhibitor, radical formation stimulant","2.84, 1.10",,BRD-K17210248,"0.00, 0.00","TOP2A, TOP2B"
CP,picrotoxin,-23.13,GABA receptor antagonist,"1.74, 0.64",,BRD-M47793593,"0.00, 0.00","GABRA1, GLRA2, GLRA3, GABRR1, GLRA1, GLRB, HTR3A, HTR3B"
CP,BRD-K14844937,-23.17,GABA benzodiazepine site receptor inverse agonist,"0.85, 0.24",,BRD-K14844937,"10.00, 10.00","GABRA1, GABRA2, GABRA3, GABRA5"
CP,n-(3-acetamidophenyl)-3-chlorobenzamide,-23.22,glutamate receptor inhibitor,"0.99, 0.22",,BRD-K61217870,"0.00, 0.00",GRM5
CP,methandriol,-23.23,androgenic horomone,"2.10, 0.76",Androgen receptor modulator,BRD-K88679075,"0.00, 0.00",
CP,sorafenib,25.32,"RAF inhibitor, FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor, angiogenesis inhibitor, VEGFR antagonist","1.13, 0.23",,BRD-K23984367,"10.00, 0.00","RET, BRAF, FLT3, KDR, RAF1, FLT1, FLT4, KIT, DDR2, FGFR1, PDGFRB, CYP2B6, CYP2C8, CYP3A5, PDGFB, SLCO1B3"
CP,BD-1008,25.31,sigma receptor antagonist,"1.15, 0.38",Sigma receptor antagonist,BRD-K17008822,"10.00, 10.00",
CP,estradiol-benzoate,25.26,contraceptive agent,"0.39, 0.10",Estrogen receptor agonist,BRD-A36066264,"10.00, 10.00",ESR1
CP,NSC-119889,25.24,"botulin neurotoxin inhibitor, mur synthetase inhibitor","1.03, 0.30",,BRD-K59637651,"0.00, 0.00",
CP,atenolol,25.23,adrenergic receptor antagonist,"1.47, 0.41",,BRD-A20239487,"0.00, 0.00","ADRB1, ADRB2"
CP,DR-2313,25.21,PARP inhibitor,"0.99, 0.15",,BRD-K94920105,"10.00, 10.00","PARP1, PARP3"
CP,racephedrine,25.19,adrenergic receptor agonist,"1.25, 0.33",,BRD-A54236247,"0.00, 0.00",
CP,pinacidil,25.16,"ATP channel activator, potassium channel agonist","0.66, 0.19",,BRD-A43882281,"0.00, 0.00","ABCC9, KCNJ8"
CP,amlodipine,25.14,"breast cancer resistance protein inhibitor, calcium channel blocker, calcium channel inhibitor, L-type calcium channel blocker","1.36, 0.33",Calcium channel blocker,BRD-A64297288,"0.00, 0.00","CACNA1C, CACNA1D, CACNA2D1, ABCG2, CA1, CACNA1B, CACNA1S, CACNA2D3, CACNB1, CACNB2, SMPD1"
CP,ATPA,25.13,glutamate receptor agonist,"1.16, 0.27",,BRD-A65145453,"0.00, 0.00","GRIK1, GRIA2"
CP,doxorubicin,-22.08,"topoisomerase inhibitor, DNA intercalating drug","1.56, 0.65",Topoisomerase inhibitor,BRD-K92093830,"0.00, 0.00",TOP2A
CP,epinephrine,-22.1,"carbonic anhydrase activator, hormone, neurotransmitter","1.24, 0.66",,BRD-A07765530,"0.00, 0.00","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, TNF"
CP,salubrinal,-22.14,"eukaryotic translation initiation factor inhibitor, GlyT-1 inhibitor","1.56, 0.45",,BRD-A77299732,"0.00, 0.00","EIF2S1, SLC6A9"
CP,metolazone,-22.27,"carbonic anhydrase inhibitor, quinazoline diuretic, inhibitor of sodium chloride symporters","0.48, 0.10",,BRD-A61793559,"10.00, 0.00","SLC12A3, CA2, CA7"
CP,BAY-11-7821,-22.4,NFkB pathway inhibitor,"1.55, 0.50",NFkB pathway inhibitor,BRD-K15025317,"0.00, 0.00",RELA
CP,biochanin-a,-22.64,estrogen receptor agonist,"1.30, 0.38",,BRD-K28075147,"10.00, 10.00",
CP,PSB-069,-22.65,NTPDase inhibitor,"0.90, 0.22",,BRD-K79366068,"0.00, 0.00","ENTPD1, ENTPD2, ENTPD3"
CP,triflupromazine,-22.65,"acetylcholine receptor ligand, dopamine receptor","1.53, 0.61",Dopamine receptor antagonist,BRD-K63675182,"0.00, 0.00","HTR2B, CHRM1, CHRM2, CHRNA7, DRD1, DRD2"
CP,WZ-4002,-22.69,EGFR inhibitor,"1.35, 0.40",EGFR inhibitor,BRD-K72420232,"0.00, 0.00","EGFR, ERBB2"
CP,cyproterone,-22.7,"androgen receptor antagonist, DNA directed DNA polymerase stimunlant, Estradiol 17 beta dehydrogenase stimulant, estrone sulfotransferase stimulant, progesterone receptor agonist, testosterone receptor antagonist","1.01, 0.23","Androgen receptor modulator, Progesterone receptor antagonist",BRD-A39290993,"0.00, 0.00","AR, ADORA1, ESR1"
CP,mephentermine,25.09,adrenergic receptor agonist,"0.98, 0.26",,BRD-K18194590,"0.00, 0.00","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3"
CP,angiogenesis-inhibitor,25.06,angiogenesis inhibitor,"1.67, 0.48",,BRD-K08502430,"0.00, 0.00",EGFR
CP,SEW-2871,25.06,lysophospholipid receptor agonist,"1.19, 0.39",,BRD-K15601958,"10.00, 0.00",S1PR1
CP,CP-724714,25.04,"receptor tyrosine protein kinase inhibitor, EGFR inhibitor, tyrosine kinase inhibitor","1.26, 0.22",,BRD-K76908866,"0.00, 0.00",ERBB2
CP,AM-630,24.97,"cannabinoid receptor antagonist, cannabinoid receptor inverse agonist","1.25, 0.43",,BRD-K63533170,"0.00, 0.00","CNR2, CNR1"
CP,ergocornine,24.97,dopamine receptor agonist,"1.14, 0.24",,BRD-K19360254,"10.00, 0.00",DRD2
CP,BRD-K68783079,24.94,"CLK inhibitor, dual specificity tyrosine-(Y)-phosphorylation regulated kinase inhibitor","1.11, 0.16",,BRD-K68783079,"0.00, 0.00","CLK1, CLK4, DYRK1A"
CP,selegiline,24.73,"monoamine oxidase inhibitor, superoxide dismutase stimulant","0.80, 0.26",,BRD-K86434416,"0.00, 0.00","MAOB, MAOA, CYP2B6, CYP2C19"
CP,carbofuran,24.67,cholinesterase inhibitor,"0.91, 0.31",,BRD-K53570330,"0.00, 0.00",
CP,mefexamide,24.66,psychostimulant,"0.80, 0.31",,BRD-K20655524,"10.00, 10.00",
CP,phenolphthalein,-21.56,weak acid used as a pH indicator,"1.25, 0.52",,BRD-K19227686,"0.00, 0.00",
CP,BRD-K84421793,-21.72,dopamine receptor agonist,"1.16, 0.23",,BRD-K84421793,"0.00, 0.00",DRD1
CP,quipazine,-21.76,serotonin receptor agonist,"1.32, 0.41",,BRD-K62056274,"0.00, 0.00","HTR2A, HTR3A, HTR3B, HTR1A, HTR1D, HTR2B, HTR2C, HTR6, SLC6A4"
CP,niguldipine,-21.83,"adrenergic receptor antagonist, calcium channel blocker, calcium channel antagonist, calcium channel inhibitor","1.43, 0.32",,BRD-A62336480,"0.00, 0.00","ADRA1A, CACNA1C, ADRA1B, ADRA1D"
CP,BRD-A41630653,-21.85,"glutamate receptor antagonist, sigma receptor agonist","0.51, 0.14",,BRD-A41630653,"0.00, 0.00","SIGMAR1, CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, CYP3A5, GRIN1, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SLC6A2, SLC6A4"
CP,CGP-37157,-21.91,"L-type calcium channel blocker, mitochondrial Na+/Ca2+ exchanger antagonist, sodium/calcium exchange inhibitor","0.78, 0.25",,BRD-A35623999,"0.00, 0.00",SLC8A1
CP,etoposide,-21.92,"topoisomerase inhibitor, cell cycle inhibitor, DNA inhibitor, DNA intercalating drug, DNA repair enzyme inhibitor","2.69, 0.78",Topoisomerase inhibitor,BRD-K37798499,"0.00, 0.00","TOP2A, CYP2E1, CYP3A5, TOP2B"
CP,SU-1498,-21.94,"receptor tyrosine protein kinase inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, VEGFR inhibitor","0.81, 0.25",,BRD-K34995470,"0.00, 0.00","ERBB2, KDR"
CP,ciglitazone,-22.01,"PPAR receptor agonist, insulin sensitizer","0.66, 0.22",PPAR receptor agonist,BRD-A93000692,"0.00, 0.00","PPARG, INS"
CP,zibotentan,-22.05,endothelin receptor antagonist,"1.49, 0.32",,BRD-K31553034,"0.00, 0.00",EDNRA
CP,clocortolone,24.64,glucocorticoid receptor agonist,"1.40, 0.59",Glucocorticoid receptor agonist,BRD-K38003476,"30.00, 20.00","NR3C1, PLA2G1B"
CP,tegaserod,24.6,"serotonin receptor partial agonist, serotonin receptor agonist","1.69, 0.63",,BRD-K21806131,"0.00, 0.00","HTR4, HTR2B, HTR2A, HTR2C"
CP,IKK-16,24.58,IKK inhibitor,"1.49, 0.32",IKK inhibitor,BRD-K14618467,"0.00, 0.00",IKBKB
CP,mefloquine,24.5,"acidifying agent non gastric, adenosine receptor antagonist, calmodulin antagonist, hemoglobin antagonist, pannexin inhibitor","1.34, 0.28",,BRD-K40645748,"11.11, 11.11","ADORA2A, HBA1, PANX1"
CP,thiazolidinecarboxylic-acid,24.49,"glutathione synthase stimulant, reducing agent","2.32, 0.82",,BRD-K92413528,"0.00, 0.00",
CP,cyclopentolate,24.49,acetylcholine receptor antagonist,"0.55, 0.11",,BRD-A77291778,"0.00, 0.00",CHRM1
CP,l-stepholidine,24.45,"dopamine receptor antagonist, dopamine receptor agonist","1.03, 0.30",,BRD-A71203467,"0.00, 0.00","DRD2, DRD1"
CP,YM-976,24.44,"phosphodiesterase inhibitor, tumor necrosis factor production inhibitor","0.73, 0.27",,BRD-K12932420,"0.00, 0.00","PDE4A, PDE4B, PDE4C, PDE4D, TNF"
CP,capsaicin,24.41,"TRPV agonist, NFkB pathway inhibitor, tumor NADH oxidase inhibitor","1.43, 0.47",,BRD-K16336526,"0.00, 0.00","TRPV1, CFTR, ENOX2"
CP,rutin,24.35,"aldose reductase inhibitor, antioxidant, capillary stabilizing agent, nitric oxide scavenger, prolyl 4-hydroxylase inhibitor","0.91, 0.31",,BRD-A34907681,"10.00, 10.00","AKR1C3, AKR1B1, F10"
CP,CGS-21680,-20.94,adenosine receptor agonist,"0.98, 0.35",Adenosine receptor agonist,BRD-A81866333,"0.00, 0.00","ADORA2A, ADORA1, ADORA2B, ADORA3"
CP,ryuvidine,-20.95,histone lyinse methyltransferase inhibitor,"1.86, 0.38",,BRD-K06426971,"0.00, 0.00","CDK4, CDK2"
CP,benzylpenicillin,-20.99,PBP3 inhibitor,"2.00, 0.72",,BRD-K55191674,"0.00, 0.00",
CP,tenovins,-21.15,"SIRT inhibitor, TP53 activator","1.14, 0.36",,BRD-K05977823,"0.00, 0.00","SIRT1, SIRT2"
CP,FPL-55712,-21.22,"leukotriene receptor antagonist, leukotriene synthesis inhibitor","1.09, 0.26",,BRD-A96456596,"20.00, 0.00",
CP,clofibric-acid,-21.26,PPAR receptor agonist,"1.40, 0.38",,BRD-K19111024,"0.00, 0.00",PPARA
CP,cefoxitin,-21.34,cell wall synthesis inhibitor,"1.06, 0.36",,BRD-K70976396,"0.00, 0.00",
CP,FGIN-1-27,-21.44,"benzodiazepine receptor agonist, inositol monophosphatase inhibitor","0.65, 0.13",,BRD-K09778810,"10.00, 10.00",TSPO
CP,lonidamine,-21.45,"glucokinase inhibitor, protein synthesis inhibitor","0.76, 0.18",,BRD-K96670504,"0.00, 0.00",GCK
CP,dosulepin,-21.47,"adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant","1.30, 0.30",,BRD-K54759182,"0.00, 0.00","SLC6A2, SLC6A4, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C19, HRH1"
CP,danazol,24.19,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator","1.02, 0.32",,BRD-A92537424,"10.00, 0.00","ESR1, GNRHR, AR, CCL2, CYP2C8, GNRHR2, PGR, TNF"
CP,5-methoxytryptamine,24.15,serotonin receptor agonist,"1.44, 0.44",,BRD-K30197592,"0.00, 0.00","HTR2A, HTR6, HTR1B, HTR1D, HTR1E, HTR1F, HTR2C, HTR4, HTR7, TRPM8"
CP,lofepramine,24.09,"adrenergic transmitter uptake inhibitor, norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, serotonin uptake inhibitor, tricyclic antidepressant","1.72, 0.57",,BRD-K82147103,"0.00, 0.00","SLC6A2, SLC6A4"
CP,reversine,24.08,"Aurora kinase inhibitor, adenosine receptor antagonist","1.58, 0.56",Aurora kinase inhibitor,BRD-K77286328,"0.00, 0.00","AURKB, ADORA3, AURKA, INCENP, MAP2K1"
CP,proguanil,24.08,dihydrofolate reductase inhibitor,"0.90, 0.27",,BRD-K28183345,"0.00, 0.00","CYP2C19, DHFR"
CP,clebopride,24.06,dopamine receptor antagonist,"1.03, 0.31",,BRD-K17294426,"0.00, 0.00","DRD2, ACHE"
CP,proxymetacaine,23.98,"membrane integrity inhibitor, potassium channel antagonist, sodium channel blocker","0.83, 0.20",,BRD-K79116891,"0.00, 0.00","SCN10A, SCN5A, SCN9A"
CP,LY-303511,23.97,"casein kinase inhibitor, mTOR inhibitor, PI3K inhibitor","0.97, 0.42",Bromodomain Inhibitor,BRD-K22385716,"0.00, 0.00","CSNK2A1, CSNK2A2, CSNK2B, MTOR"
CP,quinpirole,23.84,dopamine receptor agonist,"1.22, 0.32",,BRD-A85280935,"0.00, 0.00","DRD2, DRD3, DRD4, DRD1, HTR1A, HTR2A, HTR2B, HTR2C"
CP,10H-phenothiazin-10-yl)(p-tolyl)methanone,23.82,BCHE inhibitor,"0.89, 0.24",,BRD-K94919853,"11.11, 0.00",BCHE
CP,vesamicol,-20.42,acetylcholine transport inhibitor,"0.59, 0.17",,BRD-K14765469,"10.00, 10.00",SLC18A3
CP,pseudopelletierine,-20.47,stimulant reflex trigger used as an anthelmintic and anti-amoeboid,"0.86, 0.25",,BRD-A19053259,"0.00, 0.00",
CP,alfacalcidol,-20.56,"hypercalcaemic agent, vitamin D receptor agonist","1.53, 0.51",Vitamin D receptor agonist,BRD-K93433262,"0.00, 0.00","VDR, CYP27B1, CYP3A5"
CP,tramadol,-20.61,"opioid receptor agonist, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, OP3 receptor agonist, serotonin uptake inhibitor","0.81, 0.17",,BRD-K51033547,"10.00, 0.00","OPRM1, SLC6A2, SLC6A4, CHRFAM7A, CHRM3, CYP2B6, GRIN3A, HTR2C, OPRD1, OPRK1"
CP,tinidazole,-20.64,anti-protozoal,"0.77, 0.15",,BRD-K89125793,"0.00, 0.00",
CP,GYKI-52466,-20.65,"glutamate receptor antagonist, kainate receptor antagonist","1.10, 0.34",,BRD-K24240364,"0.00, 0.00","GRIA1, GRIA2, GRIA3, GRIA4"
CP,BRD-A32917072,-20.7,ROR antagonist,"0.67, 0.18",,BRD-A32917072,"0.00, 0.00",RORC
CP,levonorgestrel,-20.78,"estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist","1.13, 0.44",Progesterone receptor agonist,BRD-K90543092,"0.00, 0.00","PGR, AR, CYP2E1, ESR1, SRD5A1"
CP,tetramisole,-20.88,alkaline phosphatase inhibitor,"1.20, 0.38",,BRD-A46393198,"0.00, 0.00",
CP,BU-224,-20.92,imidazoline receptor ligand,"1.20, 0.35",Imidazoline ligand,BRD-K55344148,"0.00, 0.00","MAOA, MAOB"
CP,BRD-K21009077,23.81,dual specificity protein phosphatase inhibitors,"1.00, 0.26",,BRD-K21009077,"0.00, 0.00",
CP,bisphenol-a,23.67,synthetic compound with hormone-like properties,"0.36, 0.09",,BRD-A16694057,"0.00, 0.00","AR, ESR2, ESRRG, PPARG"
CP,ethylestrenol,23.61,"anabolic steroid, has some progesterone-like activity","1.59, 0.70","Progesterone receptor agonist, Progesterone receptor antagonist",BRD-K39391626,"0.00, 0.00",AR
CP,GSK-3-inhibitor-II,23.61,"glycogen synthase kinase inhibitor, PKC inhibitor, superoxide dismutase expression inhibitor","1.24, 0.44","Glycogen synthase kinase inhibitor, PKC inhibitor",BRD-K09991945,"0.00, 0.00",GSK3B
CP,fluorometholone,23.53,"corticosteroid agonist, glucocorticoid receptor agonist","1.45, 0.72",Glucocorticoid receptor agonist,BRD-A13133631,"0.00, 0.00",NR3C1
CP,VU-0400195-3,23.53,glutamate receptor modulator,"1.07, 0.27",,BRD-K30570479,"0.00, 0.00",GRM4
CP,RS-79948,23.47,adrenoreceptor antagonist,"0.88, 0.23",,BRD-K86600316,"0.00, 0.00",
CP,benazepril,23.47,angiotensin converting enzyme inhibitor,"0.78, 0.15",,BRD-A15131297,"0.00, 0.00",ACE
CP,AM-404,23.42,"FAAH transport inhibitor, anandamide transport inhibitor, nucelar factor of activated T-cells inhibitor, TRPV agonist","1.23, 0.27",,BRD-K21667562,"0.00, 0.00","TRPV1, CNR1, CNR2, FAAH"
CP,pepstatin,23.39,aspartic protease inhibitor,"2.32, 0.85",,BRD-K13571841,"0.00, 0.00","CTSB, CTSD, CTSL, REN"
CP,midostaurin,-19.81,"FLT3 inhibitor, KIT inhibitor, PKC inhibitor, angiogenesis inhibitor, cell cycle inhibitor, cyclin inhibitor, histamine release inhibitor, multi targeted kinase inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR antagonist, VEGFR inhibitor","1.35, 0.26","FLT3 inhibitor, PDGFR/KIT inhibitor, PKC inhibitor, VEGFR inhibitor",BRD-K13646352,"0.00, 0.00","FLT3, KIT, CCNB1, FLT1, KDR, PDGFRB, PRKCA, PRKCG, VEGFA"
CP,ricinine,-19.88,casein kinase inhibitor,"0.94, 0.19",,BRD-K82561139,"0.00, 0.00",
CP,erythromycin,-20.05,"NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor","1.31, 0.32",,BRD-K51677086,"10.00, 0.00","CYP3A4, MLNR"
CP,salsolinol,-20.09,"monoamine oxidase inhibitor, tyrosine hydroxylase inhibitor","1.18, 0.36",,BRD-K99595596,"10.00, 10.00",DRD2
CP,calmidazolium,-20.09,"calcium channel blocker, calmodulin antagonist","2.63, 0.69",,BRD-A98283014,"0.00, 0.00","ATP2B1, PDE1A"
CP,mesoridazine,-20.1,dopamine receptor antagonist,"0.33, 0.07",,BRD-A14395271,"10.00, 10.00","DRD2, HTR2A"
CP,U-54494A,-20.1,kappa opioid agonist,"1.33, 0.44",,BRD-K20995441,"0.00, 0.00",
CP,BCL2-inhibitor,-20.2,BCL inhibitor,"1.31, 0.45",BCL inhibitor,BRD-K39111395,"10.00, 10.00",BCL2
CP,daunorubicin,-20.32,"RNA synthesis inhibitor, topoisomerase inhibitor, DNA synthesis inhibitor, radical formation stimulant","2.67, 0.82",Topoisomerase inhibitor,BRD-K43389675,"0.00, 0.00","TOP2A, TOP2B"
CP,mead-acid,-20.34,KPL-1 tumor suppressor,"1.18, 0.35",,BRD-K96144918,"0.00, 0.00",
CP,ethoprop,23.34,acetylcholinesterase inhibitor,"1.47, 0.39",,BRD-K08556791,"0.00, 0.00",ACHE
CP,fluticasone,23.33,glucocorticoid receptor agonist,"1.30, 0.74",,BRD-A59943784,"0.00, 0.00","NR3C1, CYP3A5, CYP3A7, NR3C2, PGR, PLA2G4A"
CP,mitomycin-c,23.31,"DNA alkylating drug, DNA inhibitor, DNA synthesis inhibitor","1.31, 0.40",,BRD-K51418664,"0.00, 0.00",
CP,naltrindole,23.27,opioid receptor antagonist,"0.94, 0.36",,BRD-A82656074,"0.00, 0.00","OPRD1, OPRK1, OPRM1"
CP,ranitidine,23.2,histamine receptor antagonist,"1.10, 0.44",,BRD-K70505054,"10.00, 10.00","HRH2, SLC22A2"
CP,zolmitriptan,23.1,serotonin receptor agonist,"0.59, 0.14",,BRD-K54314721,"10.00, 0.00","HTR1B, HTR1D, HTR1A, HTR1F, HTR1E"
CP,lobaric-acid,23.09,tyrosine phosphatase inhibitor,"1.53, 0.39",,BRD-K88849294,"11.11, 0.00",PTPN1
CP,SB-415286,23.05,glycogen synthase kinase inhibitor,"0.70, 0.20",Glycogen synthase kinase inhibitor,BRD-K76805682,"0.00, 0.00","GSK3B, GSK3A, RPS6KB1"
CP,CGP-12177,23.03,adrenergic receptor agonist,"0.94, 0.32",,BRD-A34706053,"0.00, 0.00","ADRB1, ADRB2, ADRB3"
CP,SD-169,23.02,p38 MAPK inhibitor,"1.19, 0.34",,BRD-K91904471,"11.11, 11.11",MAPK14
CP,MLN-8054,-19.44,"Aurora kinase inhibitor, mitotic inhibitor, protein kinase inhibitor","1.11, 0.33",,BRD-K83963101,"0.00, 0.00",AURKA
CP,pitavastatin,-19.51,"HMGCR inhibitor, apolipoprotein expression enhancer, osteopontin expression inhibitor","2.19, 0.43",HMGCR inhibitor,BRD-K30097969,"0.00, 0.00","HMGCR, APOA1, CYP2C8"
CP,nicorandil,-19.66,"ATP channel activator, nitric oxide donor, potassium channel agonist","2.11, 0.73",,BRD-K97752965,"0.00, 0.00","ABCC9, KCNJ11, KCNJ8"
CP,PAC-1,-19.66,caspase activator,"2.34, 0.56",,BRD-K50841342,"0.00, 0.00",CASP3
CP,BAX-channel-blocker,-19.69,cytochrome C release inhibitor,"2.48, 0.57",,BRD-A18763547,"0.00, 0.00",BAX
CP,ZK-756326,-19.72,CC chemokine receptor ligand,"1.11, 0.35",,BRD-K56403959,"0.00, 0.00",CCR8
CP,piperlongumine,-19.76,glutathione transferase inhibitor,"2.11, 0.70",,BRD-K24132293,"0.00, 0.00",
CP,sinensetin,-19.76,cyclooxygenase inhibitor,"1.10, 0.38",,BRD-K84996949,"0.00, 0.00",
CP,BRL-50481,-19.77,phosphodiesterase inhibitor,"0.89, 0.26",,BRD-K84266862,"0.00, 0.00","PDE7A, PDE7B"
CP,hexylresorcinol,-19.81,polyphenol oxidase inhibitor,"1.05, 0.36",,BRD-K99946902,"22.22, 22.22",TYR
CP,JNK-9L,23.01,JNK inhibitor,"1.32, 0.67",,BRD-K19220233,"0.00, 0.00",MAPK8
CP,cimetidine,22.99,"histamine receptor antagonist, histamine receptor inhibitor","0.44, 0.13",,BRD-K34157611,"0.00, 0.00","HRH2, SLC29A4, SLC47A1, SLC47A2"
CP,doxapram,22.94,potassium channel blocker,"1.13, 0.48",Potassium channel blocker,BRD-A46179541,"10.00, 0.00","KCNK3, KCNK9"
CP,SB-221284,22.89,serotonin receptor antagonist,"0.81, 0.22",,BRD-K14807180,"10.00, 0.00","HTR2B, HTR2C, HTR2A"
CP,equilin,22.86,estrogen receptor agonist,"0.65, 0.18",,BRD-A88080608,"10.00, 10.00",HSD17B1
CP,tetradecylthioacetic-acid,22.86,lipid peroxidase inhibitor,"0.93, 0.40",,BRD-K47539947,"10.00, 0.00",
CP,SB-203580,22.65,"p38 MAPK inhibitor, calcium channel activator, interleukin inhibitor, stress activated protein kinase inhibitor","1.74, 0.34",P38 MAPK inhibitor,BRD-K99291625,"0.00, 0.00","MAPK14, MAPK1, MAPK11, AKT1, ALOX5, CHEK1, CYP2D6, CYP3A4, GAK, GSK3B, LCK, MAPK10, MAPK12, MAPK8, MAPK9, PRKCA, RAF1, RIPK2, ROCK1, RPS6KB1, SGK1, SRC, TNF"
CP,JNJ-7706621,22.61,"CDK inhibitor, Aurora kinase inhibitor","4.50, 1.56",CDK inhibitor,BRD-K11636097,"0.00, 0.00","CDK1, CDK2, AURKA, AURKB"
CP,DAU-5884,22.53,acetylcholine receptor antagonist,"1.02, 0.32",,BRD-K31633810,"10.00, 10.00","CHRM1, CHRM3"
CP,GW-441756,22.46,"growth factor receptor inhibitor, leucine rich repeat kinase inhibitor","1.40, 0.31",,BRD-K28178212,"10.00, 10.00","LRRK2, NTRK1"
CP,piperidolate,-18.78,acetylcholine receptor antagonist,"1.19, 0.31",,BRD-A97479839,"0.00, 0.00",CHRM1
CP,BMY-7378,-18.91,"serotonin receptor antagonist, adrenergic receptor antagonist","1.25, 0.47",,BRD-K31054881,"0.00, 0.00","HTR1A, ADRA1D, ADRA1A, ADRA1B"
CP,cilomilast,-18.92,"phosphodiesterase inhibitor, interleukin synthesis inhibitor, tumor necrosis factor production inhibitor","1.22, 0.35",,BRD-K62982419,"0.00, 0.00","PDE4A, PDE4B, PDE4D, IL12A, IL12B, IL1B, PDE4C, TNF"
CP,PD-198306,-18.93,"MAP kinase inhibitor, MEK inhibitor","1.14, 0.31",MEK inhibitor,BRD-K88677950,"10.00, 0.00","MAP2K1, MAP2K2, MAPK1, MAPK3"
CP,guaifenesin,-18.96,expectorant,"1.19, 0.38",,BRD-A90515964,"0.00, 0.00",
CP,immethridine,-19,histamine receptor agonist,"0.53, 0.11",,BRD-K49519092,"0.00, 0.00",HRH3
CP,retinyl,-19.13,vitamin analog,"1.38, 0.39",,BRD-K65331431,"0.00, 0.00",
CP,alfadolone,-19.24,GABA receptor agonist,"1.16, 0.34",,BRD-K51751936,"0.00, 0.00",
CP,cyclopiazonic-acid,-19.29,ATPase inhibitor,"0.97, 0.17",,BRD-A26787626,"11.11, 0.00",ATP2A1
CP,clomethiazole,-19.38,"GABA receptor agonist, GABA receptor antagonist, GABA receptor modulator, p38 MAPK inhibitor","0.74, 0.19",,BRD-K50422030,"10.00, 10.00",GABRA1
CP,chlorprothixene,22.38,"dopamine receptor, dopamine receptor antagonist","1.59, 0.57",Dopamine receptor antagonist,BRD-K59058766,"0.00, 0.00","DRD2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD3, HRH1, HTR2A, HTR2B, HTR2C"
CP,docetaxel,22.32,"tubulin inhibitor, microtubule depolymerization inhibitor, microtubule stabilizing agent, microtubule stimulant, taxane","1.26, 0.36",,BRD-K42125900,"20.00, 10.00","TUBB, BCL2, MAP2, MAP4, MAPT, NR1I2, TUBB1"
CP,methoprene-acid,22.22,RXR agonist,"1.06, 0.35",,BRD-A41145729,"0.00, 0.00","NCOA2, NR1H3, RXRA, RXRB"
CP,ML-9,21.98,myosin light chain kinase inhibitor,"1.17, 0.38",,BRD-K68402494,"0.00, 0.00","MLCK, TRPC6, PKA, PKC"
CP,"androsta-1,4-dien-3,17-dione",21.95,aromatase inhibitor,"0.66, 0.23",Aromatase inhibitor,BRD-A95513702,"0.00, 0.00",CYP19A1
CP,oleylethanolamide,21.9,"Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, potassium channel blocker","0.98, 0.31",,BRD-K31987754,"0.00, 0.00","GPR119, CNR1, GPR55, KCND3, PPARA"
CP,NCS-382,21.86,GABA receptor antagonist,"0.59, 0.10",GABA receptor antagonist,BRD-A85025557,"0.00, 0.00","GABBR1, GABBR2, SLC52A2"
CP,pifithrin,21.81,interleukin receptor antagonist,"0.73, 0.20",,BRD-K31792052,"0.00, 0.00",
CP,tetrabenazine,21.8,vesicular monoamine transporter inhibitor,"1.45, 0.44",,BRD-K95739795,"0.00, 0.00","SLC18A2, DRD2, SLC18A1"
CP,parbendazole,21.73,tubulin inhibitor,"0.89, 0.42",Tubulin inhibitor,BRD-K02407574,"0.00, 0.00",TUBB
CP,benperidol,-18.14,dopamine receptor antagonist,"1.01, 0.39",,BRD-K79425933,"0.00, 0.00",DRD2
CP,glibenclamide,-18.17,"sulfonylurea, ATP channel blocker, ATP-sensitive potassium channel antagonist, biguanide, gluconeogenesis inhibitor, insulin secretagogue, insulin sensitizer, TRPA1 agonist","0.88, 0.11",,BRD-K36927236,"10.00, 10.00","KCNJ11, ABCC8, CFTR, KCNJ5, KCNJ8, ABCA1, ABCB11, ABCC9, CPT1A, KCNJ1, SLCO2B1, TRPA1"
CP,moclobemide,-18.34,monoamine oxidase inhibitor,"0.95, 0.32",,BRD-K07237224,"0.00, 0.00","MAOA, CYP2C19, MAOB"
CP,PU-H71,-18.36,HSP inhibitor,"1.07, 0.36",HSP inhibitor,BRD-K36529613,"10.00, 10.00",HSP90AA1
CP,PSB-36,-18.4,adenosine receptor antagonist,"1.01, 0.23",,BRD-A70407468,"0.00, 0.00","ADORA1, ADORA2A, ADORA2B, ADORA3"
CP,daphnetin,-18.56,protein kinase inhibitor,"1.07, 0.32",,BRD-K61269089,"11.11, 11.11",
CP,DMAB-anabaseine,-18.56,alpha receptor partial agonist,"0.98, 0.41",,BRD-K26573499,"0.00, 0.00",CHRNA7
CP,suloctidil,-18.57,"adrenergic receptor antagonist, platelet aggregation inhibitor, vasodilator","2.07, 0.56",,BRD-A34205397,"0.00, 0.00",
CP,GR-159897,-18.7,tachykinin antagonist,"1.24, 0.28",Tachykinin antagonist,BRD-K52394958,"0.00, 0.00","TACR2, TAC1"
CP,cyclosporin-a,-18.72,"calcineurin inhibitor, cyclophilin inhibitor, immunosuppressant, insulin expression inhibitor, T cell inhibitor","1.56, 0.48",,BRD-A64290322,"0.00, 0.00","PPIA, ABCB11, CAMLG, CYP3A5, CYP3A7, FPR1, PPID, PPIF, PPP3CA, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3"
CP,etomoxir,21.73,"carnitine palmitoyltransferase inhibitor, carnitine O-palmitoyltransferase inhibitor, fatty acid oxidation inhibitor","1.90, 0.76",,BRD-A67552655,"12.50, 0.00","CPT1A, CPT1B"
CP,trimetozine,21.68,compound with mild tranquilizing effects,"1.00, 0.33",,BRD-K53220666,"0.00, 0.00",
CP,UK-356618,21.59,metalloproteinase inhibitor,"0.81, 0.19",,BRD-K57011718,"10.00, 0.00","MMP3, MMP13, MMP14, MMP2, MMP9"
CP,alpha-linolenic-acid,21.57,omega-3 fatty acid,"1.28, 0.33",,BRD-K33396764,"10.00, 0.00","ELOVL4, FADS1, FADS2, FFAR1, FFAR4, PTGS2, SLC8A1, TRPV1"
CP,ipratropium,21.54,acetylcholine receptor antagonist,"0.75, 0.27",,BRD-A05352148,"10.00, 10.00","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
CP,BRD-A53107311,21.54,"mitotic kinesin inhibitor, Tubulin Polymerization Inhibitors","0.99, 0.23",,BRD-A53107311,"0.00, 0.00",
CP,HSP90-inhibitor,21.52,"HSP inhibitor, HSP antagonist","0.94, 0.23",HSP inhibitor,BRD-K65503129,"0.00, 0.00","HSP90AA1, HSP90AB1"
CP,zimelidine,21.49,serotonin uptake inhibitor,"0.98, 0.25",,BRD-K47207162,"0.00, 0.00","SLC6A4, MAOA, MAOB"
CP,trimipramine,21.46,"adrenergic transmitter uptake inhibitor, dopamine receptor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor, tricyclic antidepressant, tricyclic antidepressant (TCA)","1.33, 0.50","Norepinephrine reuptake inhibitor, Tricyclic antidepressant",BRD-A19195498,"0.00, 0.00","SLC6A2, SLC6A4, SLC6A3, ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR1D, HTR2A, HTR2C, HTR3A"
CP,AG-99,21.46,tyrosine kinase inhibitor,"1.05, 0.27",,BRD-K51223576,"0.00, 0.00",EGFR
CP,cytarabine,-17.36,"antimetabolite, DNA polymerase inhibitor, DNA synthesis inhibitor, ribonucleotide reductase inhibitor","1.28, 0.45",Ribonucleotide reductase inhibitor,BRD-K33106058,"0.00, 0.00","POLB, POLA1"
CP,flavokavain-b,-17.5,"carcinoma cell growth inhibitor, hypoxia inducible factor inhibitor","1.49, 0.66",,BRD-K30296925,"0.00, 0.00",HIF1A
CP,arachidonyl-trifluoro-methane,-17.68,cytosolic phospholipase inhibitor,"1.40, 0.15",,BRD-K07303502,"0.00, 0.00",PLA2G4A
CP,GW-4064,-17.71,FXR agonist,"0.41, 0.08",,BRD-K64245000,"0.00, 0.00",NR1H4
CP,deracoxib,-17.82,cyclooxygenase inhibitor,"0.60, 0.18",,BRD-K68558722,"0.00, 0.00",PTGS2
CP,tyrphostin-AG-555,-17.89,"CDK inhibitor, epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor","1.20, 0.32",,BRD-K72783841,"0.00, 0.00","CDK2, EGFR"
CP,etazolate,-17.9,"phosphodiesterase inhibitor, alpha secretase activator, GABA receptor modulator","1.39, 0.44",,BRD-K64755930,"11.11, 11.11","GABRB3, PDE4A"
CP,nadolol,-18.06,adrenergic receptor antagonist,"1.47, 0.59",,BRD-A97454584,"0.00, 0.00","ADRB1, ADRB2, ADRB3"
CP,temefos,-18.06,cholinesterase inhibitor,"0.72, 0.23",,BRD-K51805276,"0.00, 0.00",
CP,rimantadine,-18.08,"acetylcholine channel inhibitor, unidentified pharmacological activity","1.86, 0.53",,BRD-A75479906,"0.00, 0.00",
CP,amoxicillin,21.38,"cell wall synthesis inhibitor, PBPA inhibitor","1.64, 0.45",,BRD-K55044200,"0.00, 0.00",SLC15A1
CP,NAN-190,21.32,serotonin receptor agonist,"1.16, 0.38",,BRD-K69195780,"0.00, 0.00","HTR1A, ADRA1A, ADRA1B, ADRA1D, HTR1F"
CP,oxcarbazepine,21.3,"voltage-gated sodium channel blocker, Sodium Channel  Blockers","1.35, 0.35",,BRD-K04196797,"0.00, 0.00","CYP2C19, CYP3A4, CYP3A5, SCN1A, SCN3A, SCN5A"
CP,hyperoside,21.28,"glucosidase inhibitor, free radical scavenger","2.08, 0.76",,BRD-K84955386,"12.50, 0.00","ACE, AKR1B1, GAA"
CP,imiquimod,21.24,"interferon inducer, toll-like receptor agonist, immunostimulant","1.31, 0.49",,BRD-K26657438,"0.00, 0.00","TLR7, TLR8"
CP,salmeterol,21.08,adrenergic receptor agonist,"0.56, 0.09",Beta-adrenergic receptor agonist,BRD-A01320529,"0.00, 0.00",ADRB2
CP,JTE-907,21.03,cannabinoid receptor inverse agonist,"1.17, 0.34",Cannabinoid receptor agonist,BRD-K63150726,"0.00, 0.00",CNR2
CP,buflomedil,20.97,"adrenergic receptor antagonist, calcium channel antagonist","1.24, 0.35",,BRD-K19462402,"0.00, 0.00",CACNA1C
CP,pheniramine,20.96,acetylcholine receptor antagonist,"0.61, 0.11",,BRD-A23072235,"10.00, 0.00",HRH1
CP,guanabenz,20.95,adrenergic receptor agonist,"0.84, 0.23",,BRD-K67847053,"10.00, 0.00","ADRA2A, ADRA2B, ADRA2C"
CP,BRD-K47448802,-16.88,acetylcholine receptor allosteric modulator,"1.60, 0.45",,BRD-K47448802,"0.00, 0.00",CHRM1
CP,IAA-94,-16.89,chloride channel blocker,"1.01, 0.19",,BRD-K85383046,"0.00, 0.00",
CP,ARC-239,-16.97,adrenergic receptor antagonist,"1.82, 0.45",,BRD-K93188295,"11.11, 0.00","ADRA2B, ADRA2A, ADRA2C"
CP,clobetasol,-16.98,glucocorticoid receptor agonist,"1.66, 0.70",,BRD-K10799896,"0.00, 0.00","NR3C1, PLA2G1B"
CP,digitoxin,-16.99,ATPase inhibitor,"2.18, 0.56",ATPase inhibitor,BRD-A93236127,"0.00, 0.00",ATP1A1
CP,exemestane,-17.02,aromatase inhibitor,"0.92, 0.28",,BRD-K33425534,"0.00, 0.00",CYP19A1
CP,BRD-K71427192,-17.09,XIAP inhibitor,"1.17, 0.19",,BRD-K71427192,"0.00, 0.00",XIAP
CP,estrone,-17.13,"estrogen receptor agonist, estrogenic hormone","0.68, 0.22",,BRD-A37959677,"0.00, 0.00","ESR1, ESR2"
CP,hexamethylenebisacetamide,-17.19,"differentiation inducer, NFKB inhibitor, AKT inhibitor","2.07, 0.75",,BRD-K04710043,"0.00, 0.00",
CP,halometasone,-17.26,"cytochrome P450 inhibitor, glucocorticoid receptor agonist, immunosuppressant","1.69, 0.53",Glucocorticoid receptor agonist,BRD-K33312228,"12.50, 12.50",NR3C1
CP,SC-560,20.9,cyclooxygenase inhibitor,"0.90, 0.25",,BRD-K14767410,"10.00, 10.00",PTGS1
CP,laudanosine,20.87,central nervous system agent,"1.32, 0.27",,BRD-A24817035,"0.00, 0.00",
CP,norepinephrine,20.85,"adrenergic receptor agonist, DNA inhibitor, free radical scavenger","1.61, 0.43",,BRD-A91555231,"0.00, 0.00","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB3, ADRB2, DRD1, DRD5, PAH, SLC18A1, SLC18A2"
CP,PQ-401,20.73,insulin growth factor receptor inhibitor,"0.66, 0.06",,BRD-K67537649,"10.00, 0.00",IGF1R
CP,iloprost,20.73,"platelet aggregation inhibitor, prostanoid receptor agonist, prostacyclin analog","0.84, 0.25",,BRD-A45664787,"20.00, 20.00","PTGIR, PTGER1, PTGER2, PDE4A, PDE4B, PDE4C, PDE4D, PLAT, PTGDR, PTGER3, PTGER4, PTGFR, TBXA2R"
CP,edaravone,20.66,free radical scavenger,"1.28, 0.38",,BRD-K35458079,"0.00, 0.00",BCL2
CP,mirtazapine,20.5,"adrenergic receptor antagonist, serotonin receptor antagonist","1.10, 0.35",,BRD-K83153774,"0.00, 0.00","ADRA2A, HTR2A, HTR2C, ADRA2C, HTR3A, ADRA1A, ADRA1B, ADRA1D, ADRA2B, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD5, HRH1, HRH3, HTR2B, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4"
CP,dihydrosamidin,20.39,"nitric oxide production inhibitor, phospholipase inhibitor, platelet activating factor receptor antagonist","0.44, 0.09",,BRD-K63945320,"0.00, 0.00",
CP,RO-19-4605,20.28,GABA benzodiazepine site receptor inverse agonist,"0.72, 0.19",,BRD-K80778372,"0.00, 0.00","GABRA1, GABRA2, GABRA3, GABRA5"
CP,mammea-a,20.26,"cytotoxic, antibacterial","0.55, 0.08",,BRD-K92138166,"20.00, 20.00",
CP,isoquercetin,-16.1,"aldose reductase inhibitor, falcipain inhibitor","1.64, 0.66",,BRD-K73991644,"0.00, 0.00","AKR1B1, ACE"
CP,fursultiamine,-16.1,thiamine deriviative,"1.40, 0.47",,BRD-A71157293,"0.00, 0.00",
CP,eriodictyol,-16.21,"cytochrome P450 inhibitor, TRPM3 antagonist, xanthine oxidase inhibitor","1.48, 0.51",,BRD-A35033682,"0.00, 0.00","CYP1B1, NFE2L2, XDH"
CP,finasteride,-16.28,"5 alpha reductase inhibitor, androgen receptor antagonist, steroid 5alpha-reductase inhibitor","1.23, 0.25",,BRD-A83081521,"10.00, 10.00","SRD5A2, SRD5A1, AKR1D1, AR"
CP,tiotidine,-16.44,histamine receptor antagonist,"0.97, 0.36",,BRD-K11107424,"10.00, 0.00",HRH2
CP,bosentan,-16.51,endothelin receptor antagonist,"1.00, 0.30",,BRD-K74763371,"0.00, 0.00","EDNRB, EDNRA, ABCB1, CYP2C19, CYP3A4"
CP,GS-39783,-16.56,"GABA receptor modulator, GABA receptor positive allosteric modulator","0.49, 0.17",,BRD-K75478907,"10.00, 0.00",GABBR1
CP,lylamine,-16.56,cannabinoid receptor agonist,"1.65, 0.63",,BRD-K62289640,"0.00, 0.00",CNR1
CP,duloxetine,-16.73,"norepinephrine reuptake inhibitor, serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine transporter inhibitor, serotonin transporter (SERT) inhibitor, serotonin uptake inhibitor","0.49, 0.14",,BRD-K71103788,"0.00, 0.00","SLC6A2, SLC6A4, SLC6A3, HTR2A, HTR2C, HTR6"
CP,VU-0420363-1,-16.88,SARS coronavirus 3C-like protease inhibitor,"1.59, 0.39",,BRD-K59633790,"0.00, 0.00",
CP,IKK-2-inhibitor,20.25,"IKK inhibitor, syk inhibitor","0.81, 0.20",,BRD-K26373640,"0.00, 0.00",IKBKB
CP,BRD-K55055802,20.06,"membrane integrity inhibitor, membrane permeability inhibitor","2.01, 0.53",,BRD-K55055802,"0.00, 0.00","GABRA1, ADRA2B, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ"
CP,dihydroergotamine,20.04,"serotonin receptor agonist, adrenergic receptor partial agonist, dopamine receptor agonist","0.65, 0.16",,BRD-K72166146,"0.00, 0.00","HTR1D, HTR1B, ADRA2A, DRD2, HTR1E, HTR1F, HTR2B, HTR7"
CP,GW-5074,19.96,"RAF inhibitor, leucine rich repeat kinase inhibitor","0.53, 0.17",,BRD-K07859598,"0.00, 0.00","LRRK1, LRRK2, NTRK1, RAF1"
CP,BRD-A17664363,19.94,steroidogenic factor antagonist,"0.78, 0.15",,BRD-A17664363,"10.00, 10.00",NR5A1
CP,SKF-96365,19.88,"calcium channel blocker, cytochrome P450 inhibitor","0.49, 0.23",,BRD-A72703248,"10.00, 10.00","CYP3A4, TRPC1, PKD2, TRPC3, TRPC4, TRPC5, TRPV2"
CP,bromocriptine,19.81,"dopamine receptor agonist, dopamine receptor antagonist, prolactin secretion inhibitor","0.98, 0.35",,BRD-A80151636,"0.00, 0.00","DRD2, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, ADRA1A, ADRA1B, ADRA1D, HTR6, HTR7, PRL"
CP,BRD-A12633378,19.81,voltage-gated potassium channel activator,"0.90, 0.18",,BRD-A12633378,"0.00, 0.00","KCNQ4, KCNQ2"
CP,cisapride,19.69,"acetylcholine receptor agonist, serotonin receptor agonist","0.98, 0.18",,BRD-K59163477,"0.00, 0.00","HTR4, KCNH2, CYP2B6, CYP2C8, CYP3A5, CYP3A7, HTR2A, HTR3A"
CP,BIBU-1361,19.66,EGFR inhibitor,"1.69, 0.69",EGFR inhibitor,BRD-K49294207,"0.00, 0.00",EGFR
CP,oleoylethanolamide,-15.36,"Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119)  Agonists, potassium channel blocker, PPAR receptor agonist","1.34, 0.52",,BRD-K66956375,"0.00, 0.00","CNR1, GPR119, GPR55, KCND3, PPARA"
CP,PF-04217903,-15.44,"c-Met inhibitor, hepatocyte growth factor receptor inhibitor","0.63, 0.16",,BRD-K73319509,"10.00, 10.00",MET
CP,brimonidine,-15.5,adrenergic receptor agonist,"0.86, 0.16",,BRD-K68264559,"0.00, 0.00","ADRA2A, ADRA2B, ADRA2C, AOX1"
CP,medroxyprogesterone,-15.53,progesterone receptor agonist,"1.18, 0.40",,BRD-K99615199,"0.00, 0.00","PGR, ESR1"
CP,PD-0325901,-15.64,"MEK inhibitor, MAP kinase inhibitor, protein kinase inhibitor","1.50, 0.58",,BRD-A50454580,"0.00, 0.00","MAP2K1, MAP2K2"
CP,quetiapine,-15.67,"dopamine receptor antagonist, serotonin receptor antagonist, adrenergic receptor antagonist, histamine receptor antagonist","1.34, 0.48",,BRD-K68867920,"0.00, 0.00","DRD2, HTR1A, HTR2A, DRD1, HRH1, HTR1D, HTR1E, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD3, DRD4, DRD5, HTR1B, HTR1F, HTR2C, HTR3A, HTR6, HTR7, SLC6A2"
CP,benzo(a)pyrene,-15.82,pro carcinogen that is metabolized to the DNA intercalating agent benzo(a)pyrene diol epoxide,"1.40, 0.43",,BRD-K09668667,"0.00, 0.00",
CP,methylprednisolone,-15.83,glucocorticoid receptor agonist,"1.44, 0.60",Glucocorticoid receptor agonist,BRD-K35240538,"0.00, 0.00",NR3C1
CP,piceid,-16.04,"glucosidase inhibitor, ICAM1 expression inhibitor, VCAM expression inhibitor, xanthine oxidase inhibitor","1.11, 0.41",,BRD-K14536225,"0.00, 0.00","GAA, XDH"
CP,CL-218872,-16.08,GABA receptor agonist,"1.31, 0.27",,BRD-K00662280,"0.00, 0.00","GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2"
CP,DH-97,19.62,melatonin receptor antagonist,"1.31, 0.50",,BRD-K06014311,"0.00, 0.00",MTNR1B
CP,KN-93,19.54,calcium/calmodulin dependent protein kinase inhibitor,"0.61, 0.08",,BRD-K93480852,"0.00, 0.00",CAMK2A
CP,L-755507,19.3,"adrenergic receptor agonist, adrenergic receptor partial agonist","0.58, 0.15",,BRD-A93206962,"0.00, 0.00","ADRB3, ADRB1, ADRB2"
CP,BRD-K72817452,19.25,lipoxygenase inhibitor,"1.63, 0.41",,BRD-K72817452,"0.00, 0.00",
CP,4-(2-Amino-ethyl)-benzenesulfonamide,19.2,carbonic anhydrase inhibitor,"1.06, 0.16",,BRD-K14643723,"0.00, 0.00","CA2, CA1, CA9, CA12, CA14, CA4"
CP,pravastatin,19.18,HMGCR inhibitor,"0.97, 0.33",,BRD-A71816415,"0.00, 0.00","HMGCR, SLCO1B1"
CP,hispidin,19.1,"beta secretase inhibitor, cyclooxygenase inhibitor, HIV integrase inhibitor, PKC inhibitor, prolyl endopeptidase inhibitor, xanthine oxidase inhibitor","1.05, 0.34",,BRD-K07325606,"0.00, 0.00","PREP, PRKCB, PTGS2, XDH"
CP,penicillic-acid,19.06,"bacterial quorum sensing inhibitor, caspase inhibitor","1.40, 0.55",,BRD-A43150328,"0.00, 0.00",
CP,mercaptopurine,19.02,"immunosuppressant, protein synthesis inhibitor, purine antagonist","1.15, 0.31",,BRD-K91601245,"0.00, 0.00","HPRT1, IMPDH1, IMPDH2, PPAT"
CP,epitestosterone,18.98,inactive testosterone analog,"0.63, 0.11",,BRD-A53131506,"0.00, 0.00","AKR1C1, AKR1C2, AR"
CP,erythrosine,-14.24,food coloring agent,"0.68, 0.19",,BRD-K14920963,"0.00, 0.00",
CP,iso-olomoucine,-14.3,cyclin-related kinase inhibitor,"1.30, 0.28",,BRD-K86509404,"0.00, 0.00",
CP,flavoxate,-14.38,acetylcholine receptor antagonist,"1.10, 0.34",,BRD-K47639036,"0.00, 0.00","CHRM1, CHRM2"
CP,BRD-K73610817,-14.44,apoptosis protein inhibitor,"1.99, 0.45",,BRD-K73610817,"0.00, 0.00",
CP,decafluorobutane,-14.53,ultrasound contrast agent,"1.15, 0.30",,BRD-K23623876,"0.00, 0.00",GRM5
CP,mesalazine,-14.89,"cyclooxygenase inhibitor, arylamine N-acetyltransferase inhibitor, beta catenin inhibitor, lipoxygenase inhibitor, prostanoid receptor inhibitor, protein phosphatase inhibitor, thromboxane receptor antagonist, thromboxane synthase inhibitor","1.17, 0.58",,BRD-K28849549,"0.00, 0.00","PTGS1, PPARG, PTGS2, ALOX5, CHUK, CTNNB1, IKBKB, MPO, NAT1"
CP,kitasamycin,-15.1,protein synthesis inhibitor,"1.08, 0.34",,BRD-K96134740,"0.00, 0.00",
CP,BRD-A89208012,-15.17,"prostanoid receptor antagonist, thromboxane receptor antagonist","1.56, 0.58",,BRD-A89208012,"0.00, 0.00",TBXA2R
CP,zaprinast,-15.24,"phosphodiesterase inhibitor, histamine release inhibitor","1.01, 0.34",,BRD-K12516989,"0.00, 0.00","PDE5A, GPR35, PDE1A, PDE4D, PDE9A"
CP,quinidine,-15.28,"cytochrome P450 inhibitor, P glycoprotein inhibitor, sodium current blocker","0.77, 0.24",,BRD-K59632282,"0.00, 0.00","SCN5A, ABCB1, CYP2D6, KCNA5, KCNA7, KCNH1, KCNH2, KCNH5, KCNK1, KCNK6, SLC29A4"
CP,JWH-015,18.95,cannabinoid receptor agonist,"1.25, 0.41",Cannabinoid receptor agonist,BRD-K17796732,"10.00, 10.00","CNR2, GPR55"
CP,NBQX,18.74,"glutamate receptor antagonist, kainate receptor antagonist","0.85, 0.19",,BRD-K47717570,"0.00, 0.00","GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIN1, GRIN2A, GRIN2B"
CP,voriconazole,18.74,"cell wall synthesis inhibitor, cytochrome P450 inhibitor, lanosterol demethylase inhibitor","1.18, 0.43",,BRD-K06557128,"0.00, 0.00","CYP2C19, CYP51A1"
CP,TFMPP,18.6,"serotonin receptor agonist, serotonin receptor antagonist","1.41, 0.39",,BRD-K94887716,"12.50, 0.00",
CP,cinnarizine,18.58,"calcium ion channel antagonist, histamine receptor antagonist","1.07, 0.45",,BRD-K07220430,"0.00, 0.00","HRH1, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5"
CP,MDL-11939,18.53,serotonin receptor antagonist,"1.39, 0.53",,BRD-A62057054,"0.00, 0.00","HTR2A, HTR2B, HTR2C"
CP,PETCM,18.51,caspase activator,"0.94, 0.27",,BRD-A93477898,"22.22, 22.22",CASP3
CP,PF-3845,18.47,FAAH inhibitor,"0.69, 0.28",,BRD-K68997413,"0.00, 0.00",FAAH
CP,testosterone,18.43,"androgen receptor (AR) agonist, androgen receptor agonist, testosterone receptor agonist","0.84, 0.31",Androgen receptor modulator,BRD-A55393291,"0.00, 0.00","AR, CYP19A1, CYP2C19, CYP2C8, CYP3A5"
CP,fananserin,18.17,"dopamine receptor antagonist, serotonin receptor antagonist","1.20, 0.42",,BRD-K08998509,"0.00, 0.00","HTR2A, DRD4"
CP,ICI-118551,-13.41,adrenergic receptor antagonist,"1.08, 0.27",,BRD-A78942461,"11.11, 11.11",
CP,siguazodan,-13.42,"histamine receptor antagonist, phosphodiesterase inhibitor","1.13, 0.35",,BRD-A91992993,"0.00, 0.00",PDE3A
CP,ranitidine,-13.5,histamine receptor antagonist,"1.02, 0.31",,BRD-K30816563,"10.00, 0.00","HRH2, SLC22A2"
CP,CO-102862,-13.56,sodium channel blocker,"0.98, 0.20",,BRD-K08890269,"0.00, 0.00","SCN2A, SCN4A, SCN9A"
CP,forskolin,-13.58,"adenylyl cyclase activator, Adenylate cyclase stimulant, growth hormone receptor agonist, phosphokinase stimulant","0.85, 0.43",,BRD-K77830450,"10.00, 10.00","ADCY2, ADCY5, GNAS"
CP,andarine,-13.83,androgen receptor modulator,"1.08, 0.30",Androgen receptor modulator,BRD-K82164249,"0.00, 0.00",AR
CP,tribenoside,-13.96,vasoprotective agent,"1.05, 0.33",,BRD-A60294240,"0.00, 0.00",
CP,progesterone,-13.98,progesterone receptor agonist,"0.45, 0.11",Progesterone receptor agonist,BRD-K64994968,"0.00, 0.00","PGR, CYP17A1, NR3C2, CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP2C19, ESR1, OPRK1, TRPC5"
CP,clozapine,-14.05,"serotonin receptor antagonist, dopamine receptor antagonist, adrenergic receptor antagonist","0.73, 0.14","Dopamine receptor antagonist, Serotonin receptor antagonist",BRD-K37289225,"0.00, 0.00","DRD2, DRD4, ADRA1A, ADRA1B, CHRM1, DRD1, DRD3, HRH1, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR6, HTR7, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALY, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C19, DRD5, HTR1F, HTR2B, HTR3A, HTR5A"
CP,SB-218795,-14.22,tachykinin antagonist,"1.00, 0.34",,BRD-K61097567,"0.00, 0.00",TACR3
CP,indometacin,18.14,cyclooxygenase inhibitor,"1.18, 0.33",,BRD-K57222227,"11.11, 0.00","PTGS1, PTGS2, PPARG, PTGDR2, GLO1, PLA2G2A, PPARA, PTGR2, SLC46A1"
CP,A-443644,18.13,AKT inhibitor,"2.41, 0.84",,BRD-K38615104,"0.00, 0.00","AKT1, AKT2, AKT3, CDC42BPB, GSK3B, PHKG1, PKIA, PRKACA"
CP,DNQX,18.12,glutamate receptor antagonist,"1.00, 0.22",,BRD-K85266041,"0.00, 0.00","GRIA1, GRIA2, GRIK1, GRIN1, GRIN2A, GRIN2B"
CP,sibutramine,18.11,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, dopamine reuptake inhibitor, norepinephrine reuptake inhibitor, norepinephrine transporter inhibitor, serotonin uptake inhibitor","0.98, 0.30",,BRD-A23359898,"0.00, 0.00","SLC6A2, SLC6A4, SLC6A3, CYP2B6, CYP2C19, CYP3A5"
CP,taxifolin,18.09,"apolipoprotein secretion inhibitor, beta amyloid aggregation inhibitor, cholesterol biosynthesis inhibitor, HMGCR inhibitor, NFkB pathway modulator, opioid receptor antagonist, reverse transcriptase inhibitor","1.88, 0.76",,BRD-K95808480,"0.00, 0.00","APOB, APP, HMGCR"
CP,tetryzoline,18.06,adrenergic receptor agonist,"1.32, 0.22",,BRD-A28856712,"0.00, 0.00",
CP,medetomidine,18.01,"adrenergic receptor agonist, MAP kinase inhibitor","1.22, 0.45",,BRD-A66563878,"0.00, 0.00","ADRA2A, ADRA2B, ADRA2C, ADRA1A, ADRA1B, ADRA1D"
CP,doxepin,17.93,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant","0.76, 0.17",,BRD-K36616567,"10.00, 10.00","HRH1, HRH2, SLC6A2, SLC6A4, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C19, DRD2, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, KCNH2, SLC6A3"
CP,tyrphostin-AG-494,17.87,"epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor","0.81, 0.25",,BRD-K34533029,"10.00, 10.00",EGFR
CP,estradiol,17.81,estrogen receptor agonist,"0.34, 0.25",,BRD-K18910433,"10.00, 10.00","ESR1, ESR2, NR1I2, CYP2B6, CYP2C19, CYP2C8, CYP2E1, CYP3A5, CYP3A7, GPER1, KCNMA1"
CP,eugenol,-12.32,"androgen receptor (AR) inhibitor, free radical scavenger, monoamine oxidase inhibitor, quorum sensing signaling modulator","0.91, 0.25",,BRD-K32977963,"11.11, 0.00","AR, MAOA"
CP,VU-0400193-3,-12.32,glutamate receptor modulator,"0.83, 0.27",,BRD-K84141129,"0.00, 0.00",GRM4
CP,suloctidil,-12.42,"adrenergic receptor antagonist, platelet aggregation inhibitor, vasodilator","0.72, 0.09",,BRD-K42635745,"0.00, 0.00",
CP,desoximetasone,-12.42,glucocorticoid receptor agonist,"1.03, 0.19",,BRD-A49447682,"0.00, 0.00","NR3C1, PLA2G1B"
CP,benproperine,-12.51,anti-tussive,"1.26, 0.35",,BRD-A42423104,"0.00, 0.00",
CP,zaldaride,-12.64,"calmodulin antagonist, calmodulin inhibitor","0.61, 0.16",,BRD-A26032986,"10.00, 10.00",CALM1
CP,talniflumate,-12.66,"cyclooxygenase inhibitor, calcium channel blocker, calcium-activated chloride channel blocker, mucin production inhibitor","1.20, 0.51",,BRD-A98378129,"10.00, 0.00",CLCA1
CP,dicycloverine,-12.71,"acetylcholine receptor antagonist, anticholinergic","0.75, 0.18",,BRD-K68507560,"10.00, 0.00","CHRM1, CHRM2, CHRM3"
CP,nalbuphine,-12.83,"opioid receptor agonist, opioid receptor antagonist","1.34, 0.40",,BRD-A16934955,"0.00, 0.00","OPRD1, OPRK1, OPRM1"
CP,M-3M3FBS,-13.07,phospholipase activator,"0.63, 0.10",,BRD-K09635314,"10.00, 0.00","PLCB2, PLCB3, PLCD1, PLCG1, PLCG2"
CP,BRD-K54331210,17.61,alkaline phosphatase inhibitor,"1.32, 0.35",,BRD-K54331210,"10.00, 10.00",ALPL
CP,prednisolone,17.57,glucocorticoid receptor agonist,"1.15, 0.44",Glucocorticoid receptor agonist,BRD-A27887842,"0.00, 0.00","NR3C1, NR3C2, SERPINA6"
CP,antimycin-a,17.56,"antibiotic, electron transfer inhibitor","1.01, 0.33",,BRD-A52886023,"10.00, 0.00",CYCS
CP,triciribine,17.5,AKT inhibitor,"1.63, 0.16",,BRD-A42649439,"10.00, 0.00","AKT1, AKT2, AKT3"
CP,lorazepam,17.49,"chloride channel agonist, GABA benzodiazepine site receptor agonist, GABA receptor agonist, potassium channel agonist","1.08, 0.33",Benzodiazepine receptor agonist,BRD-A11990600,"12.50, 12.50","GABRA1, GABRA2, GABRA3, GABRA5, GABRA4, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO"
CP,anpirtoline,17.44,"serotonin receptor agonist, serotonin receptor antagonist","1.08, 0.35",,BRD-K55424922,"0.00, 0.00","HTR1B, HTR3A"
CP,chlortetracycline,17.33,protein synthesis inhibitor,"1.30, 0.49",,BRD-A41555725,"0.00, 0.00",
CP,tranylcypromine,17.25,"cytochrome P450 inhibitor, histone lysine demethylase inhibitor, monoamine oxidase inhibitor","1.14, 0.30",,BRD-A43974575,"0.00, 0.00","MAOA, MAOB, KDM1A, CYP2A6"
CP,carpindolol,17.18,"adrenergic receptor antagonist, serotonin receptor antagonist","1.11, 0.32",Serotonin receptor antagonist,BRD-A15530910,"0.00, 0.00",
CP,WAY-170523,16.83,metalloproteinase inhibitor,"1.30, 0.38",,BRD-K36198571,"10.00, 0.00",MMP13
CP,sildenafil,-11,phosphodiesterase inhibitor,"0.58, 0.10",,BRD-K79759585,"0.00, 0.00","PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3"
CP,reserpic-acid,-11.09,norepinephrine transporter inhibitor,"0.93, 0.38",,BRD-K32755366,"0.00, 0.00",
CP,prochlorperazine,-11.1,"dopamine receptor antagonist, dopamine receptor","0.93, 0.16",Dopamine receptor antagonist,BRD-K19352500,"0.00, 0.00","DRD2, DRD1, DRD3, DRD4"
CP,BRD-K53780220,-11.35,"casein kinase inhibitor, FLT3 inhibitor","2.82, 0.91",,BRD-K53780220,"0.00, 0.00",
CP,FGIN-1-43,-11.58,benzodiazepine receptor ligand,"1.50, 0.53",,BRD-K66093087,"0.00, 0.00",TSPO
CP,limonin,-12.03,HIV protease inhibitor,"0.82, 0.22",,BRD-K05906022,"0.00, 0.00",
CP,calycanthine,-12.11,GABA release inhibitor,"0.83, 0.23",,BRD-K59851896,"0.00, 0.00",
CP,bromfenac,-12.12,cyclooxygenase inhibitor,"1.44, 0.48",,BRD-K47679368,"0.00, 0.00","PTGS1, PTGS2"
CP,ganglioside,-12.27,src activator,"0.86, 0.34",,BRD-K77998258,"0.00, 0.00",
CP,naltriben,-12.28,opioid receptor antagonist,"1.01, 0.31",,BRD-A21723284,"0.00, 0.00","OPRD1, OPRK1, OPRM1"
CP,masitinib,16.79,"KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, c-kit inhibitor, FGFR antagonist, FGFR inhibitor, tyrosine kinase inhibitor","0.80, 0.24",PDGFR/KIT inhibitor,BRD-K71035033,"0.00, 0.00","KIT, FGFR3, LYN, PDGFRA, PDGFRB"
CP,pidotimod,16.72,"interferon receptor agonist, interleukin receptor agonist, T cell stimulant","1.86, 0.65",,BRD-K44442813,"0.00, 0.00",
CP,benzoxiquine,16.62,topical anti-infective,"0.22, 0.07",,BRD-K70327191,"10.00, 10.00",
CP,"9-methyl-5H-6-thia-4,5-diaza-chrysene-6,6-dioxide",16.6,NFkB pathway inhibitor,"0.85, 0.25",,BRD-K14696368,"0.00, 0.00",RELA
CP,benzopurpurin-4b,16.51,binds HIV gp120 and inhibits HIV-1 entry into the neural cell line SK-N-MC,"1.14, 0.40",,BRD-K14221570,"10.00, 10.00",
CP,tyrphostin-AG-126,16.41,"ERK1 and ERK2 phosphorylation inhibitor, tyrosine kinase inhibitor","1.78, 0.40",,BRD-K67506692,"10.00, 10.00",
CP,BP-554,16.41,serotonin receptor agonist,"1.53, 0.40",,BRD-K45479396,"10.00, 10.00",HTR1A
CP,GW-0742,16.23,"PPAR receptor agonist, insulin sensitizer","1.32, 0.43",PPAR receptor agonist,BRD-K82983861,"0.00, 0.00","INS, PPARD"
CP,7b-cis,16.01,exportin antagonist,"2.61, 0.70",,BRD-K61829047,"0.00, 0.00",XPO1
CP,lidoflazine,15.89,calcium channel antagonist,"0.60, 0.09",,BRD-K62996583,"0.00, 0.00","SCN1A, SCN3A, SLC29A1"
CP,crotamiton,-9.41,"scabicidal, antipruritic","1.06, 0.17",,BRD-K57179821,"10.00, 10.00",
CP,methyllidocaine,-9.75,"antiarrhythmic, phosphatidyl-inositol activator","0.88, 0.19",,BRD-K60060639,"0.00, 0.00",
CP,brinzolamide,-9.87,carbonic anhydrase inhibitor,"0.66, 0.23",,BRD-K74913225,"10.00, 0.00","CA2, CA1, CA7, CA12, CA14, CA4, CA5A, CYP2B6, CYP2C8"
CP,lansoprazole,-9.88,ATPase inhibitor,"1.35, 0.30",,BRD-A49172652,"0.00, 0.00","ATP4A, CYP2C19, CYP3A4, CYP3A5"
CP,medroxyprogesterone,-9.94,progesterone receptor agonist,"1.81, 0.60",Progesterone receptor agonist,BRD-K82216340,"0.00, 0.00","PGR, ESR1"
CP,diclofenac,-9.99,cyclooxygenase inhibitor,"0.78, 0.19",,BRD-K08252256,"0.00, 0.00","PTGS1, PTGS2, AKR1C3, ALOX5, ASIC1, ASIC3, CYP2C8, KCNQ2, KCNQ3, PLA2G2A, PPARG, SCN4A"
CP,ALX-5407,-10.04,"glycine transporter inhibitor, GlyT-1 inhibitor","1.20, 0.44",,BRD-K53979406,"11.11, 11.11",SLC6A9
CP,saquinavir,-10.48,"HIV protease inhibitor, peptidase inhibitor","1.15, 0.35",,BRD-K09963420,"0.00, 0.00","CYP3A4, CYP3A5"
CP,pregnenolone,-10.76,"acetylcholine release enhancer, dopamine release enhancer, GABA receptor negative allosteric modulator, glutamate receptor modulator, progesterone receptor agonist, steroid hormone inhibitor of CYP17A1 and SULT2B1","0.77, 0.25",,BRD-K39356024,"0.00, 0.00","CYP17A1, PGR, SULT2B1"
CP,BH3I-1,-10.77,BCL inhibitor,"1.03, 0.19",,BRD-A71799696,"11.11, 0.00",BCL2
CP,danazol,15.86,"estrogen receptor antagonist, luteinizing hormone releasing hormone antagonist, progesterone receptor agonist, steroid derivative with antigonadotropic and anti-estrogenic activities, tumor necrosis factor modulator","0.89, 0.22",,BRD-A20243730,"0.00, 0.00","ESR1, GNRHR, AR, CCL2, CYP2C8, GNRHR2, PGR, TNF"
CP,EHNA,15.84,adenosine deaminase inhibitor,"0.70, 0.22",,BRD-K27450477,"0.00, 0.00","ADA, PDE2A, ADORA2A"
CP,linoleic-acid,15.7,oxidative stress inducer,"1.27, 0.38",,BRD-K08973992,"0.00, 0.00","FABP4, FFAR1, FFAR4, HNF4A, KCNB1, PPARG, TRPM8"
CP,gabexate,15.68,"serine protease inhibitor, AP inhibitor, NFkB pathway inhibitor, peptidase inhibitor, protease inhibitor","1.23, 0.36",,BRD-K59256312,"0.00, 0.00","PRSS1, TPSAB1"
CP,FTase-inhibitor-B581,15.63,"farnesyltransferase inhibitor, protein farnesyltransferase inhibitor","0.83, 0.30",,BRD-K04877770,"0.00, 0.00",
CP,H-8,15.61,PKA inhibitor,"1.00, 0.30",PKA inhibitor,BRD-K18742343,"0.00, 0.00","PKIA, PRKACA"
CP,nimodipine,15.59,"calcium channel blocker, L-type calcium channel blocker","0.64, 0.13",,BRD-A58048407,"0.00, 0.00","CACNA1C, NR3C2, AHR, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CFTR"
CP,nilutamide,15.58,"androgen receptor antagonist, RNA directed RNA polymerase inhibitor","0.66, 0.20",,BRD-K23566484,"0.00, 0.00","AR, CYP2C19"
CP,prothionamide,15.58,mycobacterium tuberculosis enoyl-[acyl-carrier-protein] reductase [NADH] (inhA) inhibitor,"1.07, 0.39",,BRD-K97863768,"10.00, 0.00",
CP,digitoxigenin,15.56,ATPase inhibitor,"2.61, 0.56",ATPase inhibitor,BRD-K18518344,"0.00, 0.00",ATP1A1
CP,azauridine,-8.81,"antiviral agent, blocks the conversion of orotic acid into UMP","1.30, 0.32",,BRD-K56745457,"10.00, 0.00",
CP,trifluoperazine,-8.85,"breast cancer resistance protein inhibitor, calcium/calmodulin dependent protein kinase inhibitor, dopamine receptor, dopamine receptor antagonist, sodium channel blocker","1.24, 0.32",Dopamine receptor antagonist,BRD-K89732114,"0.00, 0.00","DRD2, ABCG2, ADRA1A, CALM1, CALY, CAMK2A, DRD4, HRH1, HTR2A, HTR2C, S100A4, SCN4A, SCN9A, TNNC1"
CP,DCPIB,-8.9,"chloride channel blocker, gap junction modulator, glutamate transporter inhibitor, membrane permeability inhibitor","0.65, 0.24",,BRD-A39255369,"0.00, 0.00",SLC1A2
CP,trequinsin,-8.91,"phosphodiesterase inhibitor, platelet aggregation inhibitor, potassium channel blocker","0.55, 0.36",,BRD-K84663978,"0.00, 0.00","PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PTGIR"
CP,brompheniramine,-8.99,histamine receptor antagonist,"0.94, 0.28",,BRD-A68723818,"10.00, 10.00","HRH1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
CP,erythromycin,-9.04,"NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor","1.20, 0.44",,BRD-K63550407,"0.00, 0.00","CYP3A4, MLNR"
CP,RS-67333,-9.13,serotonin receptor partial agonist,"1.17, 0.35",,BRD-K46142322,"10.00, 0.00",HTR4
CP,flunarizine,-9.13,"calcium channel blocker, T-type calcium channel blocker","0.92, 0.23",,BRD-K29582677,"0.00, 0.00","CACNA1G, CACNA1H, CACNA1I, CALM1, CYP2J2, HRH1"
CP,BRD-K27074404,-9.21,solute carrier family member inhibitor,"0.93, 0.13",,BRD-K27074404,"0.00, 0.00",SLC12A5
CP,BRD-K98824517,-9.21,tyrosine phosphatase inhibitor,"2.49, 0.73",,BRD-K98824517,"0.00, 0.00",
CP,cefdinir,15.49,cell wall synthesis inhibitor,"1.60, 0.41",Bacterial cell wall synthesis inhibitor,BRD-K52735702,"0.00, 0.00",MPO
CP,D-64406,15.3,PDGFR tyrosine kinase receptor inhibitor,"1.03, 0.28",PDGFR/KIT inhibitor,BRD-K27665173,"10.00, 10.00","FLT3, PDGFRA, PDGFRB"
CP,CGS-15943,15.21,adenosine receptor antagonist,"1.56, 0.28",,BRD-K49049886,"11.11, 11.11","ADORA1, ADORA2A, ADORA2B, ADORA3"
CP,BRD-K91781484,15.21,"nuclear factor erythroid derived, like (NRF2) activator","1.51, 0.56",,BRD-K91781484,"0.00, 0.00",NFE2L2
CP,BIX-01294,15.18,"DNA methyltransferase inhibitor, histone lyinse methyltransferase inhibitor, histone lysine methyltransferase inhibitor","0.95, 0.15",,BRD-K26818574,"0.00, 0.00","EHMT1, EHMT2"
CP,iodoacetic-acid,15.15,cysteine peptidase inhibitor,"1.67, 0.34",,BRD-K88868628,"0.00, 0.00",
CP,tyrphostin,15.02,"epidermal growth factor receptor (EGFR) inhibitor, receptor tyrosine protein kinase inhibitor","1.00, 0.28",,BRD-K08132273,"0.00, 0.00",ERBB2
CP,AMN-082,14.98,glutamate receptor positive allosteric modulator,"1.10, 0.32",,BRD-K23335153,"0.00, 0.00",GRM7
CP,withaferin-a,14.61,"acetylcholinesterase inhibitor, butyrylcholinesterase inhibitors, IKK inhibitor, NFkB pathway inhibitor, PKC inhibitor","1.85, 0.40",IKK inhibitor,BRD-A52193669,"0.00, 0.00","ACHE, BCHE, IKBKB"
CP,CAY-10578,14.52,casein kinase inhibitor,"1.03, 0.23",,BRD-K54987996,"0.00, 0.00",
CP,LY-255283,-7.58,leukotriene receptor antagonist,"1.02, 0.32",,BRD-K92492521,"0.00, 0.00","LTB4R, LTB4R2"
CP,Y-26763,-7.66,"potassium channel activator, potassium channel agonist","0.83, 0.22",Potassium channel activator,BRD-K45117373,"0.00, 0.00","ABCC9, KCNJ8"
CP,pregnenolone,-7.82,"acetylcholine release enhancer, dopamine release enhancer, GABA receptor negative allosteric modulator, glutamate receptor modulator, progesterone receptor agonist, steroid hormone inhibitor of CYP17A1 and SULT2B1","1.89, 0.58",,BRD-K43880410,"10.00, 0.00","CYP17A1, PGR, SULT2B1"
CP,phentolamine,-7.94,adrenergic receptor antagonist,"0.94, 0.23",,BRD-K90333595,"0.00, 0.00","ADRA1A, ADRA2A, ADRA1B, ADRA1D, ADRA2B, ADRA2C"
CP,PNU-22394,-8.03,serotonin receptor agonist,"0.97, 0.28",,BRD-K16551401,"0.00, 0.00","MAOA, MAOB"
CP,tyrphostin-AG-538,-8.24,"insulin growth factor receptor inhibitor, tyrosine kinase inhibitor","0.94, 0.26",,BRD-K07888196,"0.00, 0.00",EGFR
CP,rottlerin,-8.41,"large conductance potassium channel activator, MAP kinase inhibitor, PKC inhibitor, protein kinase inhibitor, tissue transglutaminase inhibitor","1.28, 0.32",,BRD-K39256324,"0.00, 0.00","KCNH2, PRKCD, TGM2"
CP,fluphenazine,-8.41,"dopamine receptor antagonist, acetylcholine receptor ligand, dopamine receptor, histamine receptor antagonist, serotonin receptor antagonist","1.40, 0.49",Dopamine receptor antagonist,BRD-K55127134,"0.00, 0.00","DRD2, DRD1, CALM1, CHRNA7, DRD5, HRH1, HTR2A, HTR6, HTR7"
CP,SCH-58261,-8.6,adenosine receptor antagonist,"1.01, 0.42",,BRD-K81225797,"0.00, 0.00","ADORA2A, ADORA1, ADORA2B, ADORA3"
CP,guggulsterone,-8.68,"estrogen receptor agonist, FXR antagonist, progesterone receptor agonist, cholesterol inhibitor, IKK inhibitor, PXR agonist","0.94, 0.31",,BRD-A86109770,"10.00, 10.00","NR1H4, PGR, AR, ESR1, IKBKB, NR1I2, NR3C1, NR3C2"
CP,BU-239,14.48,"imidazoline receptor agonist, imidazoline receptor ligand","1.22, 0.47",Imidazoline ligand,BRD-K11696279,"10.00, 10.00",
CP,SB-200646,14.32,serotonin receptor antagonist,"0.74, 0.20",,BRD-K77677632,"10.00, 10.00","HTR2B, HTR2C"
CP,doxorubicin,14.26,"topoisomerase inhibitor, DNA intercalating drug","2.36, 0.74",,BRD-A76941896,"0.00, 0.00",TOP2A
CP,sulpiride,14.17,"carbonic anhydrase inhibitor, dopamine receptor, dopamine receptor antagonist","2.11, 0.84",Dopamine receptor antagonist,BRD-K51671335,"0.00, 0.00","DRD2, CA7, DRD3, CA1, CA12"
CP,prostaglandin-b2,14.07,cAMP inhibitor,"0.77, 0.26",,BRD-K82865713,"0.00, 0.00",
CP,trans-7-hydroxy-pipat,13.98,dopamine receptor ligand,"0.77, 0.33",,BRD-A01295252,"20.00, 10.00",
CP,BRD-K12401458,13.95,lysophospholipid receptor agonist,"0.76, 0.22",,BRD-K12401458,"11.11, 11.11",S1PR4
CP,metronidazole,13.92,DNA inhibitor,"1.66, 0.42",,BRD-K52020312,"0.00, 0.00","CYP2C8, CYP2E1, CYP3A5, CYP3A7"
CP,pazufloxacin,13.62,topoisomerase inhibitor,"1.58, 0.75",,BRD-K66412701,"0.00, 0.00",
CP,ritodrine,13.59,adrenergic receptor agonist,"1.26, 0.45",Beta-adrenergic receptor agonist,BRD-A59174698,"0.00, 0.00",ADRB2
CP,talipexole,-6.19,"adrenergic receptor agonist, dopamine receptor agonist, dopamine autoreceptor agonist, serotonin receptor antagonist","0.89, 0.22",,BRD-K75615183,"10.00, 0.00","DRD2, HTR3A"
CP,lavendustin-c,-6.61,epidermal growth factor receptor (EGFR) inhibitor,"1.09, 0.26",,BRD-K80725632,"0.00, 0.00","CAMK2A, EGFR, SRC"
CP,retrorsine,-6.82,"mutagenic, antimitotic, cytotoxic","0.97, 0.31",,BRD-K42142750,"0.00, 0.00",
CP,diphenidol,-7,acetylcholine receptor ligand,"1.07, 0.27",,BRD-K01663662,"0.00, 0.00","CHRM1, CHRM3, CHRM4, CHRM2"
CP,HA-14-1,-7.03,BCL inhibitor,"1.30, 0.26",BCL inhibitor,BRD-A13807286,"0.00, 0.00",BCL2
CP,betamethasone,-7.06,"corticosteroid agonist, glucocorticoid receptor agonist","1.60, 0.66",,BRD-K39188321,"0.00, 0.00",NR3C1
CP,pargyline,-7.3,monoamine oxidase inhibitor,"0.91, 0.28",,BRD-K83597974,"0.00, 0.00","MAOB, MAOA"
CP,nimetazepam,-7.32,"chloride channel agonist, GABA receptor agonist, potassium channel agonist","0.99, 0.27",,BRD-K70883034,"0.00, 0.00","GABRA1, GABRA2, GABRA3, GABRA5"
CP,L-689560,-7.35,glutamate receptor antagonist,"0.76, 0.18",,BRD-A28422058,"0.00, 0.00","GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D"
CP,dihydroergocristine,-7.56,"adrenergic receptor antagonist, prolactin inhibitor, adrenergic receptor partial agonist, dopamine receptor agonist, dopamine receptor partial agonist, dopamine receptor partial antagonist, serotonin receptor antagonist","1.11, 0.32",,BRD-A44701612,"0.00, 0.00","HTR2A, ADRA1A, ADRB1, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR3A, HTR4, HTR5A, HTR6, HTR7"
CP,aminomethyltransferase,13.53,nitric oxide synthase inhibitor,"1.30, 0.47",,BRD-A28318179,"0.00, 0.00",NOS2
CP,T-98475,13.52,gonadotropin releasing factor hormone receptor antagonist,"1.59, 0.49",,BRD-K62221994,"10.00, 0.00","GNRH1, GNRHR"
CP,megestrol,13.49,"progesterone receptor agonist, DNA inhibitor, HegG2 inhibitor","1.36, 0.45",Progesterone receptor agonist,BRD-K12002134,"0.00, 0.00",PGR
CP,XL-147,13.3,"Phosphatidylinositol 3-kinase (PI3K) inhibitor, PI3K inhibitor","2.02, 0.58",,BRD-K95901403,"0.00, 0.00","PIK3CA, PIK3CD, PIK3CG"
CP,labetalol,13.2,adrenergic receptor antagonist,"0.61, 0.19",,BRD-A07440155,"10.00, 10.00","ADRB1, ADRB2, ADRA1A, ADRA1D, ADRA1B"
CP,dexchlorpheniramine,13.2,histamine receptor antagonist,"1.17, 0.39",,BRD-K39462424,"10.00, 10.00",
CP,L-165041,13.16,PPAR receptor agonist,"0.86, 0.30",PPAR receptor agonist,BRD-K40656405,"10.00, 0.00",PPARD
CP,BU-226,13.02,imidazoline 2 receptor ligand,"1.64, 0.49",Imidazoline ligand,BRD-K56115039,"0.00, 0.00",
CP,NSC-693868,13.01,"CDK inhibitor, glycogen synthase kinase inhibitor","1.16, 0.28",,BRD-K31268420,"0.00, 0.00","CDK1, CDK5, GSK3A, GSK3B"
CP,catechin,12.9,"beta secretase inhibitor, fatty acid synthase inhibitor, free radical scavenger, immunostimulant, LDL antioxidants, quorum sensing signaling modulator, reducing agent, sodium channel blocker","1.31, 0.36",,BRD-K03600606,"0.00, 0.00","BACE1, CA1, CA12, CA14, CA2, CA4, CA6, CA9, FASN, PTGS1, SCN5A"
CP,chlordiazepoxide,-5.48,GABA benzodiazepine site receptor agonist,"1.38, 0.41",,BRD-K86595100,"0.00, 0.00","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ"
CP,progesterone,-5.49,progesterone receptor agonist,"0.44, 0.11",,BRD-A67479912,"0.00, 0.00","PGR, CYP17A1, NR3C2, CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP2C19, ESR1, OPRK1, TRPC5"
CP,SCH-442416,-5.69,adenosine receptor antagonist,"0.95, 0.22",,BRD-K46469693,"10.00, 10.00","ADORA1, ADORA2A, ADORA2B, ADORA3"
CP,vinorelbine,-5.86,"tubulin inhibitor, apoptosis stimulant, microtubule inhibitor, mitosis inhibitor, mitotic inhibitor, tubulin polymerisation inhibitor, vinca alkaloid","1.51, 0.51",,BRD-K10916986,"20.00, 10.00",TUBB
CP,ST-91,-5.93,adrenergic receptor agonist,"1.31, 0.35",,BRD-K18905250,"10.00, 0.00",
CP,prostaglandin-a1,-6,"HSP inducer, NFKB pathway inhibitor","0.63, 0.16",,BRD-K04010869,"0.00, 0.00",
CP,1-benzylimidazole,-6.09,thromboxane synthase inhibitor,"1.14, 0.38",,BRD-K32795028,"0.00, 0.00","CYP11B1, QPCT"
CP,formestane,-6.11,aromatase inhibitor,"0.95, 0.25",Aromatase inhibitor,BRD-A31801025,"0.00, 0.00",CYP19A1
CP,scopolamine,-6.14,acetylcholine receptor antagonist,"0.90, 0.19",,BRD-K89923877,"0.00, 0.00","CHRM2, CHRM1, CHRM3, CHRM4, CHRM5, SI"
CP,7-nitroindazole,-6.18,nitric oxide synthase inhibitor,"0.81, 0.19",,BRD-K04430056,"0.00, 0.00","NOS1, NOS2, NOS3"
CP,cilostamide,12.89,phosphodiesterase inhibitor,"0.36, 0.30",,BRD-K28578425,"10.00, 0.00","PDE3A, PDE3B"
CP,methylnorlichexanthone,12.85,"Aurora kinase inhibitor, Pim kinase inhibitor, VEGFR inhibitor","0.85, 0.25",,BRD-K33193182,"0.00, 0.00","AURKB, KDR, PIM1"
CP,KU-55933,12.82,ATM kinase inhibitor,"0.84, 0.26",,BRD-K25311561,"0.00, 0.00","ATM, PRKDC"
CP,selamectin,12.72,nematocide,"1.74, 0.50",,BRD-A58564983,"0.00, 0.00",
CP,midazolam,12.4,"benzodiazepine receptor agonist, GABA benzodiazepine site receptor agonist","1.90, 0.82",Benzodiazepine receptor agonist,BRD-K00532621,"0.00, 0.00","CYP3A5, CYP3A7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3"
CP,abiraterone,12.36,"17,20 lyase inhibitor, androgen biosynthesis inhibitor, cytochrome P450 inhibitor, steroid sulfatase inhibitor","1.34, 0.45",,BRD-K55301415,"0.00, 0.00","CYP17A1, CYP11B1"
CP,rizatriptan,12.07,serotonin receptor agonist,"0.34, 0.08",,BRD-K75699339,"0.00, 0.00","HTR1D, HTR1B, HTR1F, HTR1A, HTR1E"
CP,milnacipran,12.01,"serotonin reuptake inhibitor, adrenergic transmitter uptake inhibitor, norepinephrine reputake inhibitor, norepinephrine reuptake inhibitor, serotonin uptake inhibitor","1.49, 0.43",,BRD-K02227374,"0.00, 0.00","SLC6A2, SLC6A4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B"
CP,rifabutin,11.93,"DNA directed DNA polymerase inhibitor, DNA directed RNA polymerase inhibitor, protein synthesis inhibitor","1.76, 0.69",,BRD-K30563334,"0.00, 0.00","CYP3A4, HSP90AA1, HSP90B1"
CP,telenzepine,11.92,acetylcholine receptor antagonist,"0.53, 0.17",,BRD-K06147391,"0.00, 0.00",CHRM1
CP,tyrphostin-AG-82,-4.65,"EGFR inhibitor, epidermal growth factor receptor (EGFR) inhibitor, tyrosine kinase inhibitor","0.80, 0.15",,BRD-K03670461,"0.00, 0.00","EGFR, LCK"
CP,nonoxynol-9,-4.68,interacts with the lipids in the membranes of the acrosome and the midpiece of the sperm,"1.23, 0.22",,BRD-K88625236,"0.00, 0.00",
CP,donepezil,-4.77,acetylcholinesterase inhibitor,"1.13, 0.32",,BRD-A49160188,"0.00, 0.00","ACHE, HTR2A"
CP,trimethobenzamide,-4.77,histamine receptor antagonist,"0.81, 0.31",,BRD-K34415467,"20.00, 10.00",DRD2
CP,LY-278584,-4.82,serotonin receptor antagonist,"0.68, 0.18",,BRD-A12016240,"0.00, 0.00",HTR3A
CP,trimebutine,-4.84,"opioid receptor agonist, acetylcholine receptor antagonist, Sodium Channel  Blockers","1.00, 0.30",,BRD-A92630576,"0.00, 0.00","CHRM1, CHRM2, CHRM3, CHRM4"
CP,estrone,-4.94,"estrogen receptor agonist, estrogenic hormone","0.52, 0.35",Estrogen receptor agonist,BRD-K81839095,"10.00, 10.00","ESR1, ESR2"
CP,cefalexin,-4.97,cell wall synthesis inhibitor,"1.35, 0.28",Bacterial cell wall synthesis inhibitor,BRD-K90733503,"0.00, 0.00",
CP,umbelliferone,-5.24,"carbonic anhydrase inhibitor, cyclooxygenase inhibitor","0.61, 0.16",,BRD-K87991767,"0.00, 0.00","CA9, CA12, PTGS2"
CP,norketamine,-5.3,glutamate receptor antagonist,"1.31, 0.39",,BRD-A10355991,"0.00, 0.00","CYP2B6, CYP2C19, CYP3A5, GRIN1"
CP,iopanoic-acid,11.9,radiopaque medium,"1.26, 0.73",,BRD-A42628519,"0.00, 0.00",
CP,doxorubicin,11.8,"topoisomerase inhibitor, DNA intercalating drug","1.58, 0.51",,BRD-A52530684,"0.00, 0.00",TOP2A
CP,phenprobamate,11.36,skeletal muscle relaxant,"0.67, 0.23",,BRD-K22009844,"12.50, 0.00",
CP,BRD-K45031696,11.23,cytohesin inhibitor,"0.55, 0.10",,BRD-K45031696,"0.00, 0.00",
CP,PP-3,11.16,EGFR kinase inhibitor,"0.85, 0.35",,BRD-K16977723,"0.00, 0.00",
CP,benactyzine,10.89,acetylcholine receptor antagonist,"1.19, 0.39",,BRD-K85030058,"0.00, 0.00",
CP,proscillaridin,10.8,ATPase inhibitor,"2.23, 0.53",ATPase inhibitor,BRD-A34806832,"0.00, 0.00",ATP1A1
CP,ubenimex,10.74,"leukotriene hydrolase inhibitor, alanine aminopeptidase inhibitor, aminopeptidase B inhibitor, immunostimulant, peptidase inhibitor","0.56, 0.08",,BRD-K59574735,"0.00, 0.00","LTA4H, ANPEP, RNPEP"
CP,CGP-7930,10.18,"GABA receptor modulator, GABA receptor positive allosteric modulator","1.00, 0.22",,BRD-K65786282,"10.00, 10.00",GABBR1
CP,BW-723C86,10.05,serotonin receptor agonist,"0.78, 0.22",,BRD-A17428743,"0.00, 0.00","HTR2B, HTR2A, HTR2C"
CP,KU-C103871,-4.24,GSP agonist,"1.35, 0.42",,BRD-K51302260,"0.00, 0.00",SMAD3
CP,mestanolone,-4.24,androgenic steroid,"1.38, 0.44",Androgen receptor modulator,BRD-K18523449,"0.00, 0.00",
CP,anagrelide,-4.31,phosphodiesterase inhibitor,"0.98, 0.31",,BRD-K62200014,"10.00, 0.00",PDE3A
CP,BRD-K20401833,-4.32,ROR inverse agonist,"1.08, 0.23",,BRD-K20401833,"0.00, 0.00",RORA
CP,L-745870,-4.34,dopamine receptor antagonist,"0.74, 0.18",,BRD-K05528470,"0.00, 0.00","DRD4, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR6, HTR7"
CP,phenacetin,-4.38,cyclooxygenase inhibitor,"0.81, 0.15",Cyclooxygenase inhibitor,BRD-K38323065,"0.00, 0.00",PTGS1
CP,JTE-013,-4.4,lysophospholipid receptor antagonist,"0.72, 0.19",,BRD-K43330982,"20.00, 20.00","S1PR2, P2RY10"
CP,ebelactone-b,-4.48,pancreatic lipase inhibitor,"1.40, 0.40",,BRD-K64935403,"0.00, 0.00",PNLIP
CP,2-(biphenyl-4-ylsulfonamido)pentanedioic-acid,-4.5,matrix metalloprotease inhibitor,"0.60, 0.11",,BRD-A71657825,"22.22, 22.22","MMP13, MMP8, MMP9"
CP,bupropion,-4.61,"dopamine reuptake inhibitor, adrenergic transmitter uptake inhibitor, dopamine transporter inhibitor, norepinephrine transporter inhibitor, norepinephrine/dopamine dual reuptake inhibitor","0.61, 0.08",,BRD-A05186015,"0.00, 0.00","SLC6A2, SLC6A3, CHRNA3, CYP2B6"
CP,sulfasalazine,10,"cyclooxygenase inhibitor, disease modifying antirheumatic drug, lipoxygenase inhibitor, NFkB pathway inhibitor, prostanoid receptor inhibitor, thromboxane receptor antagonist","1.00, 0.25",,BRD-K10670311,"12.50, 0.00","PTGS1, PTGS2, ACAT1, ALOX5, CHUK, IKBKB, PLA2G1B, PPARG, SLC46A1, SLC7A11, TBXAS1"
CP,CPCCOEt,9.94,glutamate receptor antagonist,"0.74, 0.25",,BRD-A18202423,"0.00, 0.00",GRM1
CP,arvanil,9.9,"TRPV agonist, cannabinoid receptor agonist","0.99, 0.31",,BRD-K34092021,"10.00, 0.00","CNR1, TRPV1"
CP,butabindide,9.74,tripeptidyl peptidase inhibitor,"0.98, 0.26",,BRD-A58157837,"10.00, 10.00",TPP2
CP,tyrphostin-A9,9.71,"protein tyrosine kinase inhibitor, tyrosine kinase inhibitor","2.16, 0.70",,BRD-K40255344,"10.00, 10.00",
CP,enalapril,9.7,"angiotensin converting enzyme inhibitor, angiotensin receptor blocker","1.09, 0.33",,BRD-K44497846,"0.00, 0.00",ACE
CP,TC-2559,9.53,"acetylcholine receptor agonist, acetylcholine receptor ligand","1.17, 0.38",,BRD-K67352070,"10.00, 10.00",CHRNA4
CP,amylocaine,9.33,local anesthetic,"1.07, 0.43",,BRD-A09062839,"0.00, 0.00",
CP,amitriptyline,9.32,"norepinephrine inhibitor, serotonin receptor inhibitor, sigma receptor inhibitor","1.08, 0.27",Serotonin receptor antagonist,BRD-K53737926,"10.00, 10.00","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, HTR6, SLC6A2, SLC6A4, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRB1, ADRB2, ADRB3, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2C, HTR7, KCNA1, KCND2, KCND3, KCNQ2, KCNQ3, NTRK1, NTRK2, OPRD1, OPRK1, OPRM1, SIGMAR1"
CP,L-161982,9.27,"prostanoid receptor antagonist, angiotensin receptor antagonist","0.86, 0.34",,BRD-K39733634,"0.00, 0.00",PTGER4
CP,AZD-7762,-3.44,CHK inhibitor,"1.49, 0.57",,BRD-K46056750,"0.00, 0.00","CHEK1, CHEK2"
CP,biperiden,-3.54,anticholinergic,"0.61, 0.15",,BRD-A00546892,"0.00, 0.00","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2"
CP,erythromycin,-3.6,"NFkB pathway inhibitor, 50S ribosomal subunit inhibitor, motilin receptor agonist, RPLV inhibitor","0.74, 0.14",,BRD-K39746403,"10.00, 0.00","CYP3A4, MLNR"
CP,artemether,-3.71,"antimalarial, interacts with heme and with COX3","1.15, 0.26",,BRD-K39621635,"0.00, 0.00","ATP1A1, CYP2B6, CYP2C19, CYP3A5"
CP,desipramine,-3.76,"norepinephrine transporter inhibitor, Sodium Channel  Blockers, tricyclic antidepressant (TCA)","1.41, 0.42",Tricyclic antidepressant,BRD-K60762818,"0.00, 0.00","SLC6A2, SLC6A4, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, SMPD1"
CP,dextromethorphan,-4.02,"glutamate receptor antagonist, sigma receptor agonist","0.61, 0.14",,BRD-K33211335,"0.00, 0.00","SIGMAR1, CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, CYP3A5, GRIN1, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SLC6A2, SLC6A4"
CP,rescinnamine,-4.04,angiotensin converting enzyme inhibitor,"1.10, 0.27",,BRD-K52930707,"0.00, 0.00",ACE
CP,dopamine,-4.1,dopamine receptor agonist,"0.88, 0.34",,BRD-K43887077,"0.00, 0.00","DRD2, DRD1, DRD3, DRD4, DRD5, DBH, HTR1A, HTR7, SLC6A2, SLC6A3, SLC6A4"
CP,AKT-inhibitor-IV,-4.12,AKT inhibitor,"2.85, 0.60",,BRD-K28296557,"0.00, 0.00",AKT1
CP,clomipramine,-4.22,"serotonin transporter (SERT) inhibitor, dopamine transporter (DAT) inhibitor, norepinephrine transporter (NET) inhibitor","0.86, 0.22",Tricyclic antidepressant,BRD-K52989797,"10.00, 0.00","SLC6A4, SLC6A2, CYP2C19, GSTP1, HTR2A, HTR2B, HTR2C, SLC6A3"
CP,BRL-37344,9.26,adrenergic receptor agonist,"0.76, 0.25",,BRD-K07507905,"0.00, 0.00","ADRB3, ADRB1, ADRB2"
CP,flavanone,9.22,11-beta hydroxysteroid dehydrogenase inhibitor,"1.26, 0.28",,BRD-A07824748,"0.00, 0.00","ADORA3, HSD11B1"
CP,SKF-89976A,9.22,GABA uptake inhibitor,"0.89, 0.27",,BRD-A49046702,"20.00, 10.00",SLC6A1
CP,sulindac,9.12,"ABC transporter expression enhancer, cyclooxygenase inhibitor, NFkB pathway inhibitor","1.27, 0.35",,BRD-A13946108,"11.11, 0.00","AKR1B1, PTGS1, PTGS2, MAPK3, PPARD, PTGDR2"
CP,PRE-084,9.01,"alpha receptor agonist, sigma receptor agonist","0.73, 0.20",,BRD-K57304726,"20.00, 20.00",SIGMAR1
CP,ziprasidone,8.9,"dopamine receptor antagonist, serotonin receptor antagonist, norepinephrine reuptake inhibitor, serotonin receptor agonist, serotonin reuptake inhibitor","1.74, 0.64",,BRD-K29582115,"0.00, 0.00","DRD2, HTR2A, HTR1A, HTR1D, HRH1, HTR1B, HTR1E, HTR2C, HTR7, ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD3, DRD4, DRD5, HTR3A, HTR6, SLC6A4"
CP,mitotane,8.89,antineoplastic agent,"0.66, 0.11",,BRD-A31204924,"0.00, 0.00","CYP11B1, CYP11A1, CYP3A4, ESR1, FDX1"
CP,tubastatin-a,8.75,HDAC inhibitor,"0.35, 0.25",HDAC inhibitor,BRD-K00627859,"0.00, 0.00",HDAC6
CP,epirizole,8.65,cyclooxygenase inhibitor,"0.57, 0.10",,BRD-K39339537,"10.00, 10.00","PTGS1, PTGS2"
CP,otenzepad,8.63,acetylcholine receptor antagonist,"1.58, 0.58",,BRD-A00520476,"0.00, 0.00",
CP,dichlorobenzamil,-3.05,sodium/calcium exchange inhibitor,"1.47, 0.39",T-type calcium channel blocker,BRD-K12906962,"0.00, 0.00",
CP,CCMQ,-3.05,inhibitor of the binding of homoquinolinic acid to non-NMDA sensitive sites,"1.33, 0.48",,BRD-K06159959,"0.00, 0.00",
CP,tandutinib,-3.06,"FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor","0.97, 0.28",PDGFR/KIT inhibitor,BRD-K89162000,"0.00, 0.00","FLT3, KIT, PDGFRA, PDGFRB, CSF1R, PDGFD"
CP,pefloxacin,-3.07,topoisomerase inhibitor,"1.27, 0.40",,BRD-K55034111,"0.00, 0.00",TOP2A
CP,fluticasone,-3.11,glucocorticoid receptor agonist,"1.40, 0.78",Glucocorticoid receptor agonist,BRD-K14791739,"0.00, 0.00","NR3C1, CYP3A5, CYP3A7, NR3C2, PGR, PLA2G4A"
CP,trap-101,-3.22,"nociceptin/orphanin FQ (NOP) receptor antagonist, opioid receptor antagonist","0.89, 0.22",,BRD-K69837166,"10.00, 0.00",OPRL1
CP,RWJ-21757,-3.26,toll-like receptor ligand,"0.69, 0.20",,BRD-A29437505,"0.00, 0.00",TLR7
CP,elesclomol,-3.31,"apoptosis stimulant, HSP agonist, HSP inducer, oxidative stress inducer, topoisomerase inhibitor","1.14, 0.13",,BRD-K82135108,"0.00, 0.00",TOP2A
CP,DUP-697,-3.35,cyclooxygenase inhibitor,"0.72, 0.19",,BRD-K06221026,"0.00, 0.00",PTGS2
CP,naproxol,-3.41,antiinflammatory agent,"0.80, 0.20",,BRD-K34014345,"0.00, 0.00","PTGS1, PTGS2"
CP,z-prolyl-prolinal,8.5,prolyl endopeptidase inhibitor,"0.88, 0.26",,BRD-K60174629,"0.00, 0.00",PREP
CP,niclosamide,8.18,"DNA replication inhibitor, STAT inhibitor","2.25, 0.74",,BRD-K35960502,"0.00, 0.00",STAT3
CP,SB-216641,8.16,serotonin receptor antagonist,"0.78, 0.13",Serotonin receptor antagonist,BRD-K30867024,"10.00, 0.00","HTR1B, HTR1D, HTR1A, HTR2A, HTR2B, HTR2C"
CP,dextrorphan,7.82,"glutamate receptor antagonist, adrenergic transmitter release inhibitor, opioid receptor agonist, serotonin receptor antagonist","1.74, 0.72",,BRD-K88304388,"0.00, 0.00","OPRM1, OPRK1, OPRD1, GRIN1, HTR1A, SLC6A2"
CP,dipyridamole,7.75,"phosphodiesterase inhibitor, cyclooxygenase inhibitor, platelet aggregation inhibitor","0.55, 0.09",,BRD-K86301799,"0.00, 0.00","ADA, PDE5A, PDE10A, PDE4A, PDE7B, PDE8A, PDE8B, SLC29A1"
CP,probenecid,7.69,"MRP inhibitor, TRPV agonist, uricosuric blocker","1.38, 0.33",,BRD-K95237249,"0.00, 0.00","SLC22A6, ABCC1, PANX1, SLC22A11, SLC22A8, SLCO1C1, TRPV2"
CP,carvedilol,7.56,"adrenergic receptor antagonist, reducing agent, ryanodine receptor channel modulator","0.88, 0.16",,BRD-A10977446,"0.00, 0.00","ADRB1, ADRB2, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB3, CYP2C19, CYP2E1, GJA1, HIF1A, KCNH2, NDUFC2, NPPB, RYR2, SELE, VCAM1, VEGFA"
CP,BRD-K14048378,7.53,lysophospholipid receptor agonist,"0.89, 0.23",,BRD-K14048378,"11.11, 0.00",S1PR3
CP,ascorbyl-palmitate,7.33,antioxidant,"1.15, 0.44",,BRD-A14985772,"10.00, 0.00",
CP,thiethylperazine,7.22,dopamine receptor antagonist,"0.92, 0.26",Dopamine receptor antagonist,BRD-K69600043,"0.00, 0.00","DRD1, DRD2, DRD4"
CP,chlormadinone,-2.18,progesterone receptor agonist,"0.64, 0.23",,BRD-A01593789,"0.00, 0.00",PGR
CP,cyclopamine,-2.29,"smoothened receptor antagonist, hedgehog pathway inhibitor","0.88, 0.26",,BRD-K58938839,"10.00, 10.00","SMO, DHH, IHH, PTCH1"
CP,RO-10-5824,-2.36,dopamine receptor partial agonist,"1.47, 0.36",,BRD-K79684402,"10.00, 10.00",DRD4
CP,ritanserin,-2.45,serotonin receptor antagonist,"0.77, 0.20",,BRD-K40887525,"20.00, 20.00","HTR2A, HTR2C, HTR2B, ADRA1A, ADRA1B, ADRA1D, HTR1A, HTR1B, HTR1D, HTR5A, HTR6, HTR7"
CP,fulvestrant,-2.47,"estrogen receptor antagonist, DNA directed DNA polymerase inhibitor, soluble epoxide hydrolase inhibitor","0.42, 0.17",,BRD-A90490067,"0.00, 0.00","ESR1, EPHX2, ESR2, GPER1"
CP,NVP-TAE684,-2.65,"ALK tyrosine kinase receptor inhibitor, ALK tyrosine kinase receptor mutant inhibitor, leucine rich repeat kinase inhibitor","1.82, 0.51",,BRD-K50140147,"0.00, 0.00","ALK, INSR"
CP,milrinone,-2.77,phosphodiesterase inhibitor,"0.42, 0.07",,BRD-K67080878,"0.00, 0.00","PDE3A, PDE2A, PDE3B, PDE5A"
CP,pinacidil,-2.81,"ATP channel activator, potassium channel agonist","1.03, 0.25",,BRD-A58207013,"10.00, 10.00","ABCC9, KCNJ8"
CP,solanine,-2.98,acetylcholinesterase inhibitor,"0.63, 0.15",,BRD-K70881766,"0.00, 0.00",
CP,AM-92016,-3.05,"glutamate receptor antagonist, ionotropic glutamate receptor antagonist, time-dependent delayed rectifier potassium current blocker","0.78, 0.19",,BRD-A11813248,"0.00, 0.00","GRIN1, GRIN2B"
CP,BAY-59-3074,7.09,cannabinoid receptor partial agonist,"0.63, 0.17",Cannabinoid receptor agonist,BRD-K18799075,"0.00, 0.00","CNR1, CNR2"
CP,BRD-K00256256,7.02,protein phosphatase inhibitor,"1.00, 0.28",,BRD-K00256256,"0.00, 0.00",
CP,isoxicam,6.81,cyclooxygenase inhibitor,"1.00, 0.19",,BRD-A75552914,"0.00, 0.00","PTGS1, PTGS2"
CP,finasteride,6.73,"5 alpha reductase inhibitor, androgen receptor antagonist, steroid 5alpha-reductase inhibitor","0.77, 0.14",,BRD-K01095011,"10.00, 0.00","SRD5A2, SRD5A1, AKR1D1, AR"
CP,SU-4312,6.73,"platelet-derived growth factor receptor (PDGFR) inhibitor, tyrosine kinase inhibitor, vascular endothelial growth factor receptor (VEGFR) inhibitor, vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor","0.88, 0.31",VEGFR inhibitor,BRD-K20287671,"10.00, 10.00","KDR, PDGFRB"
CP,fenofibrate,6.64,"PPAR receptor agonist, apolipoprotein expression enhancer, lipase clearing factor inhibitor","1.01, 0.25",,BRD-K50388907,"0.00, 0.00","PPARA, APOA1, CYP2C19, CYP2C8, MMP25"
CP,gitoxigenin,6.63,ATPase inhibitor,"0.82, 0.30",ATPase inhibitor,BRD-A29082194,"10.00, 10.00",ATP1A1
CP,gedunin,6.49,HSP inhibitor,"1.02, 0.28",,BRD-A17819071,"0.00, 0.00",HSP90AA1
CP,chlorphenamine,6.33,histamine receptor antagonist,"0.41, 0.08",,BRD-A04553218,"0.00, 0.00","HRH1, SLC6A2, SLC6A3, SLC6A4"
CP,ketorolac,6.27,cyclooxygenase inhibitor,"0.77, 0.16",,BRD-A40639672,"0.00, 0.00","PTGS1, PTGS2"
CP,O-1918,-1.34,cannabinoid receptor antagonist,"0.81, 0.30",,BRD-K18316707,"0.00, 0.00",
CP,JNJ-26854165,-1.45,"HDAC inhibitor, MDM inhibitor","1.40, 0.39",,BRD-K83837640,"10.00, 0.00","HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9, MDM2"
CP,cortisone,-1.47,glucocorticoid receptor agonist,"0.72, 0.15",,BRD-A54487287,"0.00, 0.00",NR3C1
CP,malonoben,-1.5,"protein tyrosine kinase inhibitor, tyrosine kinase inhibitor","1.84, 0.60",,BRD-K38477985,"0.00, 0.00",EGFR
CP,tofacitinib,-1.6,"JAK inhibitor, disease modifying antirheumatic drug, immunosuppressant, MAP kinase inhibitor, tyrosine kinase inhibitor","0.80, 0.15",,BRD-K31283835,"0.00, 0.00","JAK3, JAK1, JAK2, CYP2C19, TYK2"
CP,desloratadine,-1.7,histamine receptor antagonist,"0.78, 0.17",,BRD-K82357231,"0.00, 0.00",HRH1
CP,strychnine,-1.95,acetylcholine receptor antagonist,"0.85, 0.19",,BRD-A09094913,"0.00, 0.00","GLRA1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA9, GLRA2, GLRA3, GLRB"
CP,FK-888,-1.97,tachykinin antagonist,"1.00, 0.35",Tachykinin antagonist,BRD-K83508485,"10.00, 10.00","TACR1, TACR2"
CP,domperidone,-2.05,"dopamine receptor antagonist, breast cancer resistance protein inhibitor","0.81, 0.09",,BRD-K38305202,"0.00, 0.00","DRD2, DRD3, ABCG2, CYP3A5"
CP,bisbenzimide,-2.08,"BCL inhibitor, DNA binding, topoisomerase inhibitor","0.94, 0.38",,BRD-K08554278,"0.00, 0.00","BCL2L1, TOP1"
CP,MMPX,6.05,phosphodiesterase inhibitor,"0.97, 0.36",,BRD-K53878242,"0.00, 0.00",
CP,butoconazole,5.75,"cell wall synthesis inhibitor, sterol demethylase inhibitor","0.58, 0.18",,BRD-A16665823,"0.00, 0.00",
CP,primidone,5.75,"GABA receptor antagonist, unidentified pharmacological activity","0.44, 0.11",,BRD-K32247306,"0.00, 0.00","GABRA1, CHRNA4, CHRNA7, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2"
CP,ezetimibe,5.63,"cholesterol absorption inhibitor, Niemann-Pick C1-like 1 protein antagonist, liver bile acid transporter inhibitor, Niemann-Pick C1-like 1 protein inhibitior","0.97, 0.18",,BRD-A41519720,"0.00, 0.00","NPC1L1, ANPEP, SOAT1"
CP,tolbutamide,5.55,ATP channel blocker,"1.03, 0.28",,BRD-K85119730,"0.00, 0.00","ABCC8, CYP2B6, CYP2C19, CYP2C8, KCNJ1, KCNJ11, KCNJ8"
CP,lomerizine,5.49,"calcium channel antagonist, calcium channel blocker, P glycoprotein inhibitor","1.78, 0.67",Calcium channel blocker,BRD-K62858456,"0.00, 0.00","ABCB1, CACNA1B, SCN5A"
CP,prednisone,5.43,glucocorticoid receptor agonist,"0.74, 0.22",,BRD-A62525898,"0.00, 0.00","NR3C1, HSD11B1"
CP,desoximetasone,5.38,glucocorticoid receptor agonist,"1.52, 0.51",Glucocorticoid receptor agonist,BRD-K30697463,"10.00, 10.00","NR3C1, PLA2G1B"
CP,nafadotride,5.15,dopamine receptor antagonist,"0.90, 0.17",,BRD-A71262238,"0.00, 0.00","DRD3, DRD2, HTR1A"
CP,amthamine,5.09,histamine receptor agonist,"0.82, 0.24",,BRD-K39670393,"0.00, 0.00",HRH2
CP,argatroban,-0.5,"thrombin inhibitor, peptidase inhibitor, protease inhibitor","0.98, 0.25",,BRD-A48261811,"12.50, 0.00","F2, CYP3A5"
CP,betamethasone,-0.52,"corticosteroid agonist, glucocorticoid receptor agonist","1.30, 0.82",Glucocorticoid receptor agonist,BRD-A92177080,"0.00, 0.00",NR3C1
CP,tetrahydropalmatine,-0.53,serotonin release inhibitor,"0.50, 0.14",,BRD-A43940795,"0.00, 0.00",
CP,alprenolol,-0.65,adrenergic receptor antagonist,"0.57, 0.13",,BRD-A00993607,"0.00, 0.00","ADRB1, ADRB2, HTR1A"
CP,17-beta-estradiol,-0.78,estrogen receptor agonist,"1.56, 0.55",Estrogen receptor agonist,BRD-K66766661,"12.50, 12.50",ESR1
CP,isradipine,-0.9,"calcium channel blocker, L-type calcium channel blocker","1.82, 0.56",,BRD-A69927616,"0.00, 0.00","CACNA1C, CACNA1D, CACNA2D1, CACNA1F, CACNA1H, CACNA1S, CACNA2D2, CACNB2"
CP,pinacidil,-0.97,"ATP channel activator, potassium channel agonist","1.16, 0.40",,BRD-A22897758,"10.00, 0.00","ABCC9, KCNJ8"
CP,carbenoxolone,-0.99,11-beta hydroxysteroid dehydrogenase inhibitor,"1.07, 0.26",,BRD-K12765235,"10.00, 10.00","HSD11B1, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3"
CP,lobendazole,-1.14,anthelmintic agent,"1.11, 0.27",,BRD-K15834839,"0.00, 0.00",
CP,bulleyaconitine-a,-1.32,non-opiod analgesic,"1.14, 0.45",,BRD-A26097136,"0.00, 0.00",
CP,SR-57227A,5.06,"serotonin receptor agonist, serotonin release enhancer","0.53, 0.13",,BRD-K09397065,"0.00, 0.00",HTR3A
CP,adipiodone,4.81,serum albumin binder,"0.93, 0.32",,BRD-K67261995,"0.00, 0.00",ALB
CP,SDZ-WAG-994,4.75,adenosine receptor agonist,"1.30, 0.43",,BRD-A31007383,"10.00, 0.00",ADORA1
CP,diphenhydramine,4.7,histamine receptor antagonist,"1.67, 0.52",,BRD-K47278471,"0.00, 0.00",HRH1
CP,benzamil,4.55,epithelial sodium channel blocker,"0.70, 0.20",,BRD-K87158025,"0.00, 0.00","PKD2L1, SCNN1A, SCNN1B, SCNN1G, ASIC1, SCNN1D, SLC8A1"
CP,dantron,4.52,stimulant laxative,"0.89, 0.15",,BRD-K10065684,"0.00, 0.00",
CP,simvastatin,4.51,HMGCR inhibitor,"2.36, 0.61",HMGCR inhibitor,BRD-A81772229,"0.00, 0.00","HMGCR, CYP2C8, CYP3A4, CYP3A5, ITGB2"
CP,NS-1619,4.43,"calcium channel activator, large conductance potassium channel activator","0.84, 0.17",,BRD-K54210043,"0.00, 0.00","KCNMA1, KCNT1, KCNT2, KCNU1"
CP,PD-160170,4.43,neuropeptide receptor antagonist,"1.17, 0.32",,BRD-K12079898,"10.00, 10.00",NPY1R
CP,vanoxerine,4.36,"dopamine reuptake inhibitor, dopamine transporter inhibitor, monoamine oxidase inhibitor","1.47, 0.31",,BRD-K32501161,"0.00, 0.00","SLC6A3, MAOA, MAOB"
CP,isocarboxazid,0.4,monoamine oxidase inhibitor,"1.28, 0.35",,BRD-K93332168,"10.00, 10.00","MAOA, MAOB"
CP,LY-225910,0.38,CCK receptor antagonist,"0.90, 0.19",CCK receptor antagonist,BRD-K33864865,"0.00, 0.00",CCKBR
CP,pidorubicine,0.26,"topoisomerase inhibitor, DNA intercalating drug","2.40, 0.72",Topoisomerase inhibitor,BRD-K04548931,"0.00, 0.00",TOP2A
CP,securinine,0.23,"GABA receptor antagonist, TP53 activator","1.26, 0.41",,BRD-A25775766,"0.00, 0.00",GABRA1
CP,zatebradine,0.06,"HCN (hyperpolarization activated cyclic nucleotide gated) channel blocker, HCN channel antagonist, potassium channel antagonist, sodium channel blocker","0.68, 0.17",,BRD-K92446736,"10.00, 10.00","HCN1, HCN2, HCN3, HCN4"
CP,pivmecillinam,0.01,cell wall synthesis inhibitor,"1.03, 0.27",,BRD-K67100011,"10.00, 0.00",
CP,meclozine,-0.15,constitutive androstane receptor (CAR) agonist,"0.80, 0.23",,BRD-A50311610,"0.00, 0.00","NR1I3, HRH1"
CP,clobetasol,-0.22,glucocorticoid receptor agonist,"1.39, 0.81",,BRD-A63894585,"0.00, 0.00","NR3C1, PLA2G1B"
CP,RG-13022,-0.46,"EGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor","0.88, 0.32",,BRD-K82688027,"0.00, 0.00","EGFR, PDGFRA, PDGFRB"
CP,darinaparsin,-0.47,"apoptosis stimulant, NADPH oxidase stimulant","1.13, 0.31",,BRD-K35723520,"10.00, 10.00",
CP,PD-166793,4.32,"collagenase inhibitor, metalloproteinase inhibitor, stromelysin inhibitor","1.16, 0.31",,BRD-A75478957,"0.00, 0.00","MMP13, MMP2, MMP3"
CP,cytosporone-b,4.19,HMR receptor agonist,"0.92, 0.31",,BRD-K86191271,"10.00, 0.00",NR4A1
CP,rabeprazole,3.97,"ATPase inhibitor, gastrin inhibitor","0.77, 0.14",,BRD-A39390670,"0.00, 0.00","ATP4A, CYP2C19"
CP,auranofin,3.91,"disease modifying antirheumatic drug, immunosuppressant, NFkB pathway inhibitor, prostanoid receptor inhibitor, thioredoxin reductase inhibitor","2.74, 0.50",NFkB pathway inhibitor,BRD-A79465854,"0.00, 0.00","IKBKB, PRDX5, TRPA1, TXNRD1, TXNRD2"
CP,fipronil,3.88,"GABA gated chloride channel blocker, glutamate gated chloride channel blocker","0.72, 0.19",,BRD-A50675702,"0.00, 0.00",
CP,L-750667,3.86,dopamine receptor antagonist,"0.98, 0.35",,BRD-K28806945,"0.00, 0.00",DRD4
CP,naloxone,3.7,opioid receptor antagonist,"1.11, 0.22",,BRD-A41833852,"0.00, 0.00","OPRM1, OPRK1, OPRD1, CREB1, ESR1, TLR4"
CP,TGX-221,3.63,PI3K inhibitor,"0.98, 0.31",PI3K inhibitor,BRD-A41692738,"0.00, 0.00","PIK3CB, PIK3CD"
CP,molsidomine,3.59,"activator of soluble guanylyl cyclase, nitric oxide donor, nitric oxide stimulant","0.84, 0.31",,BRD-K35531059,"0.00, 0.00",GUCY1A3
CP,lithocholic-acid,3.56,"FXR antagonist, MDM inhibitor, PXR ligand, tyrosine phosphatase inhibitor, vitamin D receptor ligand","1.42, 0.32","Bile acid, FXR antagonist, Vitamin D receptor agonist",BRD-K20986251,"0.00, 0.00","NR1I2, VDR, GPBAR1, MDM2, MDM4, NR1H4, PTPN1"
CP,ouabain,0.99,"ATPase inhibitor, alpha subunit binder","2.09, 0.56",ATPase inhibitor,BRD-A68930007,"0.00, 0.00","ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, ATP1B4, FXYD2"
CP,BRD-A28422330,0.96,CDC inhibitor,"0.83, 0.13",,BRD-A28422330,"0.00, 0.00",
CP,axitinib,0.77,"VEGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, angiogenesis inhibitor, KIT inhibitor, VEGFR antagonist","0.99, 0.20",VEGFR inhibitor,BRD-K29905972,"0.00, 0.00","KDR, FLT1, FLT4, CSF1, CYP2C19, CYP3A5, KIT, PDGFRB, PLK4"
CP,estriol,0.75,"estrogen receptor agonist, estrogen receptor antagonist","0.95, 0.30",,BRD-A84205515,"10.00, 0.00","ESR1, ESR2"
CP,CGP-13501,0.62,GABA receptor modulator,"1.01, 0.28",,BRD-K95851186,"10.00, 10.00",GABBR1
CP,flunisolide,0.6,"cytochrome P450 inhibitor, corticosteroid agonist, corticosteroid hormone receptor agonist, glucocorticoid receptor agonist, immunosuppressant","1.23, 0.76",Glucocorticoid receptor agonist,BRD-A65449987,"0.00, 0.00",NR3C1
CP,methylergometrine,0.57,"dopamine receptor antagonist, partial serotonin receptor agonist","0.78, 0.28",,BRD-A63667919,"10.00, 0.00","DRD1, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C"
CP,dexamethasone,0.56,"glucocorticoid receptor agonist, corticosteroid agonist, immunosuppressant","1.25, 0.52",Glucocorticoid receptor agonist,BRD-A93424738,"10.00, 10.00","ANXA1, CYP3A4, CYP3A5, NOS2, NR0B1, NR3C1, NR3C2"
CP,pancuronium,0.55,acetylcholine receptor antagonist,"1.82, 0.60",,BRD-A84134924,"0.00, 0.00","CHRM2, CHRM3, CHRNA1, CHRNA2"
CP,rottlerin,0.52,"large conductance potassium channel activator, MAP kinase inhibitor, PKC inhibitor, protein kinase inhibitor, tissue transglutaminase inhibitor","2.56, 0.93",,BRD-K03816923,"0.00, 0.00","KCNH2, PRKCD, TGM2"
CP,VX-745,3.49,p38 MAPK inhibitor,"0.86, 0.30",P38 MAPK inhibitor,BRD-K91900765,"0.00, 0.00","MAPK14, MAPK11, MAPK12"
CP,iodophenpropit,3.49,"histamine receptor antagonist, histamine receptor inhibitor, ionotropic glutamate receptor antagonist","1.10, 0.33",,BRD-K51918615,"10.00, 0.00","HRH3, HRH4, GRIN2B"
CP,anandamide,3.45,"cannabinoid receptor agonist, potassium channel blocker, TRPV agonist","0.77, 0.25",Cannabinoid receptor agonist,BRD-K78280988,"10.00, 0.00","CNR1, CNR2, TRPV1, CACNA1G, CACNA1H, CACNA1I, GLRA1, GPR119, GPR18, GPR55, KCNA2, KCND3, KCNK3, KCNK9, TRPM8"
CP,SDZ-205-557,3.45,serotonin receptor antagonist,"0.76, 0.10",,BRD-K15868788,"0.00, 0.00","HTR3A, HTR3B, HTR4"
CP,CP-55940,3.39,"cannabinoid receptor agonist, CC chemokine receptor antagonist","1.01, 0.33",,BRD-A03816571,"0.00, 0.00","CNR1, CNR2, CXCR4, GPR55"
CP,BRL-54443,3.24,serotonin receptor agonist,"0.97, 0.26",,BRD-K17868609,"0.00, 0.00","HTR1E, HTR1F"
CP,rosuvastatin,3.23,HMGCR inhibitor,"0.58, 0.19",HMGCR inhibitor,BRD-K82941592,"0.00, 0.00",HMGCR
CP,amantadine,3.17,"glutamate receptor antagonist, acetylcholine channel inhibitor, dopamine receptor agonist","0.81, 0.13",,BRD-K70330367,"20.00, 10.00","DRD2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A"
CP,bisindolylmaleimide-ix,3.03,"PKC inhibitor, glycogen synthase kinase inhibitor, leucine rich repeat kinase inhibitor, SIRT inhibitor","2.49, 0.91",,BRD-K06543683,"0.00, 0.00","SIRT1, AKT1, GSK3B, LCK, LRRK2, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SIRT2"
CP,reboxetine,2.97,"adrenergic receptor antagonist, adrenergic transmitter uptake inhibitor, norepinephrine reputake inhibitor, norepinephrine transporter inhibitor","1.36, 0.47",,BRD-A43974499,"0.00, 0.00",SLC6A2
CP,fluvastatin,1.61,HMGCR inhibitor,"0.69, 0.13",HMGCR inhibitor,BRD-K66296774,"0.00, 0.00","HMGCR, CYP2C8"
CP,clarithromycin,1.57,50S ribosomal subunit inhibitor,"1.41, 0.39",,BRD-K49668410,"0.00, 0.00","CYP2C19, CYP3A4, CYP3A5, CYP3A7"
CP,mifepristone,1.56,"glucocorticoid receptor antagonist, progesterone receptor antagonist, androgen receptor ligand, internal ribosomal entry site inhibitor","0.69, 0.16",,BRD-K37270826,"10.00, 0.00","PGR, NR3C1, AR, CYP2B6, CYP2C8, CYP3A5, CYP3A7, NR1I2"
CP,idarubicin,1.54,"topoisomerase inhibitor, radical formation stimulant, RNA synthesis inhibitor","1.25, 0.26",,BRD-A71390734,"0.00, 0.00",TOP2A
CP,indirubin,1.33,"CDK inhibitor, glycogen synthase kinase inhibitor, cyclin-dependent kinase inhibitor, PKC inhibitor","1.20, 0.28","CDK inhibitor, Glycogen synthase kinase inhibitor",BRD-K19136521,"0.00, 0.00","CDK1, CDK5, CCNE1, CDK2, CDK4, CDK5R1, CDK9, GSK3A, GSK3B, LCK, LRRK1, LRRK2"
CP,nisoldipine,1.28,"calcium channel blocker, L-type calcium channel blocker","1.45, 0.64",Calcium channel blocker,BRD-A96107863,"0.00, 0.00","CACNA1C, CACNA1D, CACNA1S, CACNA2D1, CACNB2, CYP3A5"
CP,doxepin,1.25,"histamine receptor antagonist, adrenergic transmitter uptake inhibitor, histamine receptor inhibitor, norepinephrine reputake inhibitor, serotonin reuptake inhibitor, tricyclic antidepressant","0.38, 0.06",,BRD-K37694030,"0.00, 0.00","HRH1, HRH2, SLC6A2, SLC6A4, ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CYP2C19, DRD2, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, KCNH2, SLC6A3"
CP,rifabutin,1.23,"DNA directed DNA polymerase inhibitor, DNA directed RNA polymerase inhibitor, protein synthesis inhibitor","0.94, 0.24",,BRD-K31484631,"0.00, 0.00","CYP3A4, HSP90AA1, HSP90B1"
CP,pirinixic-acid,1.18,PPAR receptor agonist,"1.06, 0.30",PPAR receptor agonist,BRD-K01902415,"0.00, 0.00",PPARA
CP,pirenzepine,1.03,acetylcholine receptor antagonist,"1.38, 0.34",,BRD-K89375097,"0.00, 0.00","CHRM1, CHRM2, CHRM3, CHRM4, CHRM5"
CP,pergolide,2.93,"dopamine receptor agonist, calcium-activated potassium channel blocker, potassium channel blocker, prolactin inhibitor","0.58, 0.14",,BRD-K60770992,"10.00, 10.00","DRD1, DRD2, ADRA2A, ADRA2B, ADRA2C, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, ADRA1A, ADRA1B, ADRA1D, KCNA5"
CP,carmoxirole,2.81,dopamine receptor agonist,"0.95, 0.26",,BRD-K82484965,"10.00, 10.00",DRD2
CP,morphothebaine,2.81,adrenergic receptor inhibitor,"0.58, 0.15",,BRD-K32412559,"0.00, 0.00",
CP,homoveratrylamine,2.72,dopamine analog,"1.41, 0.34",,BRD-K59570838,"0.00, 0.00",
CP,PHA-665752,2.58,"c-Met inhibitor, hepatocyte growth factor receptor inhibitor","1.49, 0.38",,BRD-K95435023,"0.00, 0.00",MET
CP,BRD-A07614565,2.57,botulin neurotoxin inhibitor,"1.35, 0.34",,BRD-A07614565,"0.00, 0.00",
CP,fludroxycortide,2.56,"corticosteroid, glucocorticoid receptor agonist","1.44, 0.72",,BRD-K00824317,"0.00, 0.00","NR3C1, SERPINA6"
CP,salicin,2.43,antiinflammatory agent,"1.13, 0.30",,BRD-K64614248,"10.00, 10.00",
CP,GANT-61,2.3,GLI antagonist,"0.76, 0.11",,BRD-K09485525,"10.00, 10.00","DHH, IHH"
CP,BRD-K19985802,2.16,protein phosphatase inhibitor,"1.06, 0.27",,BRD-K19985802,"0.00, 0.00",
CP,nitazoxanide,2.13,"pyruvate ferredoxin oxidoreductase inhibitor, pyruvate synthase inhibitor","1.03, 0.27",,BRD-K96471533,"12.50, 12.50",
CP,ML-3163,2,p38 MAPK inhibitor,"0.93, 0.22",P38 MAPK inhibitor,BRD-K95202259,"0.00, 0.00","CYP2D6, CYP3A4, MAPK11, MAPK12, MAPK14"
CP,flupentixol,1.96,dopamine receptor antagonist,"1.06, 0.28",,BRD-K70487031,"0.00, 0.00","DRD2, DRD1, ADRA1A, CHRM1, DRD3, DRD5, HTR2A"
CP,gemcitabine,1.93,"cell cycle inhibitor, DNA repair enzyme inhibitor, DNA synthesis inhibitor, pyrimidine antagonist, ribonucleoside reductase inhibitor, ribonucleotide reductase inhibitor","1.97, 0.58",Ribonucleotide reductase inhibitor,BRD-K15108141,"0.00, 0.00","RRM1, CMPK1, RRM2, TYMS"
CP,EMD-386088,1.9,serotonin receptor agonist,"0.47, 0.09",Serotonin receptor agonist,BRD-K47659338,"0.00, 0.00",HTR6
CP,gavestinel,1.74,"glutamate receptor antagonist, glycine receptor antagonist","1.19, 0.34",,BRD-K49890030,"0.00, 0.00",GLRB
CP,PSB-06126,1.7,NTPDase inhibitor,"0.70, 0.15",,BRD-K71266197,"0.00, 0.00",ENTPD3
